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Abstract
Superfamilies are a classification system to combine proteins that are related through a
common evolutionary origin, share similar sequences, structures, and core reaction mech-
anisms, but exert different functions. Today, for most superfamilies tens of thousands of
sequences and hundreds of structures are known and most of the different functions of
their members have been elucidated. Superfamilies thus provide a formal and biologically
sensible framework to study evolutionary relationships between proteins. In the present
work, the frameworks of three enzyme superfamilies were utilized to get insights into
several important aspects of enzyme evolution.
The first part of this work addresses the question how enzymatic mono- and bi-functio-
nality have evolved in the superfamily of ribose-binding (βα)8-barrel sugar isomerases.
This superfamily contains the homologous enzymes HisA and TrpF, which catalyze similar
reactions in histidine and tryptophan biosynthesis, as well as the bi-functional enzyme
PriA, which catalyzes both the HisA and TrpF isomerization reactions. HisA and TrpF are
ubiquitous in Archaea and Bacteria, whereas PriA is only found in certain Actinobacteria.
These species have lost the dedicated TrpF enzyme and PriA is consequently part of both
tryptophan and histidine biosynthesis. Much has been speculated on the evolutionary
relationship of these enzymes and whether the bi-functionality of PriA is a remnant from
ancient evolutionary times or a more recent development in Actinobacteria. Using ances-
tral sequence reconstruction it was demonstrated in this work that evolutionary ancestors
of modern HisA enzymes display bi-functionality, reminiscent of PriA. A detailed enzy-
matic characterization of three reconstructed HisA ancestors showed that they catalyze
not only the HisA but also the TrpF reaction with comparable catalytic efficiencies in vitro.
Metabolic complementation experiments with hisA and trpF deficient Escherichia coli
strains furthermore demonstrated that the bi-functional HisA ancestors could support
both histidine and tryptophan biosynthesis in vivo. By a combination of sequence- and
network-based in silico methods, several modern HisA enzymes were subsequently iden-
tified that possess sequence motifs typical for bi-functional PriA enzymes. The enzymatic
characterization of three such modern HisA representatives revealed that they are also
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bi-functional, albeit to a lesser extent, although the respective organisms possess dedi-
cated TrpF enzymes. Thus, the ancestral bi-functionality has pertained for billions of years
in HisA enzymes, without any obvious selective pressure. Consequently, a new model
for the evolution of HisA, TrpF, and PriA was proposed: The bi-functionality of ancient
HisA variants may have played an important role in maintaining early metabolism by
supporting both histidine and tryptophan biosynthesis. After the emergence of dedicated
TrpF enzymes the bi-functionality of the ancestors became expendable and diminished
to the level observed in modern HisA enzymes. However, the inherent bi-functionality
of HisA contributed to the robustness of microbial metabolism and made possible to
compensate the loss of a dedicated trpF gene in some Actinobacteria. In these organisms,
the available bi-functionality of HisA was exploited, selected for, and enhanced, which
eventually led to the modern PriA enzymes.
The second part of this work deals with the evolution of substrate specificity and
secondary metabolic enzymes in a superfamily of chorismate-utilizing enzymes, named
MST-superfamily. Chorismate is a central metabolic node molecule and the starting point
for the biosynthesis of various important metabolites, including aromatic amino acids,
folate, or iron-chelating siderophores. The MST-enzymes catalyze the committed steps of
these biosynthetic pathways and are highly similar in sequence, structure, and reaction
mechanism. However, the MST-enzymes that are part of primary metabolic pathways
employ exclusively ammonia as a nucleophile to aminate chorismate, whereas those
that are part of secondary metabolic pathways exclusively employ water as a nucleophile
to hydroxylate chorismate. Based on the notion that secondary metabolic enzymes are
descendants of primary metabolic ones, it was investigated in this part of this work by
which mechanism the transition from primary metabolic to secondary metabolic MST-
enzymes went along with a change in nucleophile-specificity from ammonia to water.
Initially, network-based, phylogenetic, and structure-based in silico methods were applied
to identify two key amino acids in the nucleophile access channel of the active site that dis-
tinguish primary-metabolic/ammonia-utilizing and secondary-metabolic/water-utilizing
MST-enzymes. The importance of these key positions was subsequently examined by
rationally designing sixteen variants of the MST-enzyme anthranilate synthase, which
normally employs ammonia as a nucleophile. The enzymatic characterization of these
variants by HPLC-MS showed that the right combination of amino acids at the two key
positions indeed resulted in a broadening of nucleophile specificity to also include water.
These anthranilate synthase variants hydroxylated chorismate and formed isochorismate
with efficiencies comparable to native secondary-metabolic/water-utilizing isochorismate
synthases. Moreover, these variants were still able to employ ammonia as a nucleophile
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and formed their native product anthranilate; hence they were bi-functional. These ex-
periments demonstrated that nucleophile specificity in the MST-superfamily can readily
switch from ammonia to water. Moreover, the observed bi-functionality of the anthrani-
late synthase variants argues that the evolution of secondary metabolic MST-enzymes may
have proceeded through bi-functional intermediates. Such metabolic generalists may
have allowed for the formation of novel metabolites (isochorismate) while maintaining the
formation of important primary metabolic metabolites (anthranilate). This scenario con-
sequently does not a priori require gene duplication events and thus precludes negative
metabolic effects linked to retaining redundant gene copies.
The third part of this work pursues the question how protein-protein interaction
specificity is assured in superfamilies of structurally related protein complexes and how
the determinants of interaction specificity have evolved. Specific interactions between
proteins are vital for almost all cellular functions. This specificity is usually achieved by
shape and electrostatic complementarity of protein interfaces. However, the number
of different protein folds and interface geometries found in Nature is limited, due to
the constraints imposed by efficiently packing hydrogen-bonded secondary structure
elements. It is thus a challenging question how interaction specificity is achieved despite
structural limitations and how the formation of non-physiological complexes is avoided
when several possible interaction partners with similar interface geometries are avail-
able. In order to address this problem, initially a comprehensive computational survey
of the interface geometries of over 300 bacterial, heteromeric protein complexes and all
their homologs of respective superfamilies was performed. This survey revealed that in
about 10% of the superfamilies interface geometries vary significantly between related
complexes that share homologous subunits. In these cases interfaces were extended by so-
called interface add-ons, which typically comprise 10-20 amino acids, form well-defined
secondary structure elements, and significantly contribute to complex stability. These
characteristics suggested that interface add-ons differentiate between structurally related
protein complexes and contribute to interaction specificity through negative design. In
order to back this assumption, the case of the interface add-on found in a superfamily of
glutamine amidotransferase complexes involved in tryptophan and folate biosynthesis
was subsequently analyzed in detail. These complexes comprise synthase and glutami-
nase subunits that interact to transfer ammonia from glutamine to an acceptor substrate.
A subset of synthase subunits exclusively involved in tryptophan biosynthesis contains the
interface add-on, whereas it is absent in all other homologous synthase subunits, includ-
ing those exclusively involved in folate biosynthesis. The comprehensive experimental
characterization of 54 combinations of different synthase and glutaminase subunits by
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chromatographic methods, light scattering, mass spectrometry, and enzyme kinetics
demonstrated that the presence or absence of the interface add-on determines interaction
specificity. An in silico genetic profiling of over 15000 archaeal and bacterial genomes
together with in vivo growth assays showed that the interface add-on found in complexes
of tryptophan biosynthesis is biologically relevant for preventing cross-interactions with
the homologous complexes of folate biosynthesis, which would lead to harmful metabolic
cross-talk that negatively affects cellular fitness. It was finally shown by protein design
that the evolution of the interface add-on in these complexes most likely proceeded via
intermediary complexes with relaxed interaction specificity. In conclusion, this part of this
work demonstrates that interface add-ons are evolutionary tools to facilitate interaction
specificity in superfamilies of homologous proteins or in cases where a protein has to
discriminate between several potential interaction partners that share similar interface
geometries.
In summary, the presented work leads to an improved understanding of the mech-
anisms behind the evolution of enzymatic mono- and bi-functionality, emphasizes the
importance of generalist, bi- or multi-functional enzymes for the evolution of secondary
metabolic pathways, and finally describes a so far overlooked structural tool for the evolu-
tionary specification of protein-protein interactions.
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Kurzfassung der Arbeit
Superfamilien stellen ein Klassifikationsschema zur Gruppierung von Proteinen dar, die
auf einen gemeinsamen evolutionären Ursprung zurück gehen und Ähnlichkeiten in
Sequenz, Struktur und Reaktionsmechanismus besitzen, jedoch unterschiedliche Funk-
tionen ausüben. Die meisten Superfamilien sind heute umfassend charakterisiert und
häufig sind für eine Superfamilie mehr als zehntausend Sequenzen, mehrere hundert
Strukturen sowie die zentralen Funktionen bekannt. Superfamilien erlauben daher als
formales und gleichzeitig biologisch sinnvolles Rahmenwerk die Untersuchung der evolu-
tionären Zusammenhänge zwischen Proteinen. Für die vorliegende Arbeit wurden drei
Enzym-Superfamilien herangezogen, um Einblicke in mehrere wichtige Fragestellungen
der Evolution von Enzymen zu gewinnen.
Der erste Teil dieser Arbeit befasst sich mit der Evolution enzymatischer Mono- und
Bifunktionalität in der Superfamilie der Ribose-bindenden Zuckerisomerasen mit (βα8)-
Fass Struktur. Diese Superfamilie enthält unter anderem die verwandten Enzyme HisA
und TrpF, die ähnliche Reaktionen in der Biosynthese der Aminosäuren Histidin und Tryp-
tophan katalysieren. Zusätzlich enthält die Familie auch das bifunktionale Enzym PriA,
welches sowohl die HisA, als auch die TrpF Isomerisierungsreaktion katalysiert. Während
HisA und TrpF in den meisten Archaeen und Bakterien vorkommen, ist PriA ausschließlich
in bestimmten Actinobakterien zu finden. Diesen Spezies fehlt ein dediziertes TrpF En-
zym und PriA ist daher essentiell für die Biosynthese sowohl von Histidin als auch von
Tryptophan. Es wurden bisher mehrere Hypothesen über die genauen evolutionären
Zusammenhänge dieser drei Enzyme aufgestellt; so auch beispielsweise ob die in PriA
beobachtete Bifunktionalität ein Überrest von evolutionsgeschichtlich alten Enzymen ist
oder ob sie sich erst in neuerer Zeit speziell in Actinobakterien entwickelt hat. Anhand
der Rekonstruktion anzestraler Proteinsequenzen wurde in dieser Arbeit gezeigt, dass die
evolutionären Vorfahren moderner HisA Enzyme eine zu PriA ähnliche Bifunktionalität
aufweisen. Die genaue enzymatische Charakterisierung dreier HisA-Vorläufer ergab, dass
diese nicht nur die HisA-Reaktion, sondern auch die TrpF-Reaktion in vitro mit vergleich-
barer Effizienz katalyiseren. Mittels metabolischer Komplementationsexperimente wurde
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weiterhin gezeigt, dass die bifunktionalen HisA-Vorläufer in vivo die Aufrechterhaltung
von Histidin- und Tryptophanbiosynthese ermöglichen. Darauf aufbauend wurden mittels
einer Kombination aus sequenz- und netzwerkbasierten in silico Methoden mehrere mod-
erne HisA Enzyme identifiziert, die Sequenzmotive enthalten, die für bifunktionale PriA
Enzyme typisch sind. Die enzymatische Charakterisierung dreier solcher HisA Vertreter
zeigte, dass diese ebenfalls einen gewissen Grad an Bifunktionalität aufweisen. Interessan-
terweise besitzen die zugehörigen bakteriellen Spezies jedoch eigenständige TrpF Enzyme.
Die ursprüngliche Bifunktionalität von HisA hat sich folglich über mehrere Milliarden
Jahre erhalten; offenbar ohne direkten Selektionsdruck oder evolutionären Vorteil. Auf-
bauend auf diesen Ergebnissen wurde abschließend ein neues Modell zur Erklärung der
Evolution von HisA, TrpF und PriA vorgeschlagen: In der evolutionären Frühzeit waren
bifunktionale HisA Varianten vermutlich wichtig für die Aufrechterhaltung einer primi-
tiven Art von Metabolismus, da sie sowohl die entscheidende Isomerisierungsreaktion
in der Histidinbiosynthese, als auch die analoge Reaktion in der Tryptophanbiosynthese
katalysieren konnten. Nachdem im Laufe der Evolution allerdings für letztere Reaktion
dedizierte TrpF Enzyme entstanden waren, führte ein geringerer Selektionsdruck auf HisA
zu einer Abnahme der Bifunktionalität auf das Niveau moderner HisA Vertreter. Dennoch
spielte die den HisA Enzymen eigene Bifunktionalität eine wichtige evolutionäre Rolle, da
sie die Anpassungsfähigkeit des bakteriellen Metabolismus vergrößerte. So ermöglichten
bifunktionale HisA Varianten beispielsweise den Verlust eines dedizierten TrpF Enzyms in
Actinobakterien auszugleichen. In diesen Organismen wurde die HisA Bifunktionalität in
Folge durch Selektion verstärkt, woraus letztendlich die modernen, bifunktionalen PriA
Enzyme hervorgingen.
Im zweiten Teil dieser Arbeit wurde die Evolution von Substratspezifität und sekundär-
metabolischen Enzymen am Beispiel einer Superfamilie von Chorismat-bindenden En-
zymen, der MST-Superfamilie, untersucht. Chorismat ist ein zentraler metabolischer
Knotenpunkt und der Ausgangspunkt für die Biosynthese zahlreicher wichtiger Metabo-
lite wie der aromatischen Aminosäuren, Folsäure, oder eisenchelatierender Siderophore.
Die initialen Reaktionen dieser Biosynthesewege werden ausgehend von Chorismat von
Enzymen der MST-Superfamilie katalysiert, die hohe Ähnlichkeiten in Sequenz, Struktur
und Reaktionsmechanismus aufweisen. Dennoch nutzen diejenigen MST-Enzyme, die
Teil von primärmetabolischen Stoffwechselwegen sind, ausschließlich Ammoniak als
Nukleophil für die Bildung von aminosubstituierten Chorismatderivativen, wogegen die
MST-Enzyme, die Teil von sekundärmetabolischen Wegen sind, ausschließlich Wasser
als Nukleophil für die Bildung von hydroxysubstituierten Chorismatderivativen nutzen.
Gemäß der Vorstellung, dass sich sekundärmetabolische Enzyme aus den evolutionär
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älteren primärmetabolischen Enzymen entwickelt haben, wurde in diesem Teil der Arbeit
zunächst untersucht, inwiefern der Übergang von primär- zu sekundärmetabolischen
MST-Enzymen mit dem Übergang von Ammoniak auf Wasser als Nukleophil zusammen-
hängt. Dazu wurden zunächst mit netzwerkbasierten, phylogenetischen und struktur-
basierten in silico Methoden zwei entscheidende Aminosäuren in einem Zugangskanal
des aktiven Zentrums identifiziert, die sich signifikant zwischen den primärmetabolis-
chen, Ammoniak-umsetztenden und den sekundärmetabolischen, Wasser-umsetztenden
MST-Enzymen unterscheiden. Der Beitrag dieser beiden Aminosäuren zur Substrat-
bzw. Nukleophilspezifität wurde mittels rationalem Design von sechzehn Varianten des
primärmetabolischen MST-Enzyms Anthranilatsynthase überprüft. HPLC-MS Experi-
mente zeigten, dass verschiedene Kombinationen von zueinander passenden Aminosäuren
an den beiden identifizierten Positionen zu einer Verbreiterung der Nukleophilspezifität
von Ammoniak auf Wasser führen. Die aktiven Varianten waren in der Lage, Chorismat
unter Verwendung von Wasser als Nukleophil zu Isochorismat umzuwandeln; deren
Effizienz war dabei mit der von nativen Isochorismatsynthasen vergleichbar. Diese Vari-
anten konnten ebenso Ammoniak als Nukleophil für die Bildung von Anthranilat zu
nutzen, waren also bifunktional. Zusammenfassend wurde durch diese Experimente
gezeigt, dass die Nukleophilspezifität von MST-Enzymen ohne große Hürden von Am-
moniak auf Wasser ausgedehnt werden kann. Die beobachtete Bifunktionalität der An-
thranilatsynthasevarianten lässt vermuten, dass die Evolution der sekundärmetabolischen
MST-Enzyme über vergleichbare, bifunktionale Enzymintermediate verlaufen ist. Solche,
oft als metabolische Generalisten bezeichnete, Enzyme könnten die Bildung von neuar-
tigen Sekundärmetaboliten (Isochorismat) unter gleichzeitiger Aufrechterhaltung der
Biosynthese wichtiger primärer Metaboliten (Anthranilat) erlaubt haben. Ein solches evo-
lutionäres Szenario setzt nicht zwingenderweise eine initiale Genduplikation voraus und
vermeidet folglich negative metabolische Effekte, die beispielsweise aus der Beibehaltung
von duplizierten, redundanten Genkopien resultieren.
Der dritte Teil dieser Arbeit befasst sich mit der Problematik, wie spezifische Protein-
Protein Interaktionen in Superfamilien von strukturell ähnlichen Proteinkomplexen sicher-
gestellt werden und wie die für Interaktionsspezifität entscheidenden Faktoren evolviert
sind. Praktisch alle zellulären Prozesse sind essentiell abhängig von spezifischen Interak-
tionen zwischen Proteinen. Die nötige Spezifität wird generell durch das Zusammenspiel
von räumlich und elektrostatisch komplementären Proteinoberflächen, den so genannten
interfaces, erreicht. Allerdings ist die Zahl der in der Natur vorkommenden Proteinstruk-
turen und folglich auch die Zahl der Protein interfaces begrenzt; dieser Umstand ist bedingt
durch den Zwang bei der Proteinfaltung die 2D-Strukturelemente räumlich möglichst
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effizient zu packen. Zentrale Fragen sind daher, wie trotz der strukturellen Limitationen
ausreichende Interaktionsspezifität sichergestellt und wie die Bildug unphysiologischer
Komplexe vermieden wird, wenn mehrere Interaktionspartner mit strukturell ähnlichen
interfaces vorhanden sind. Um sich diesen Problemen zu nähern, wurden in diesem Teil
der Arbeit zunächst die interface Geometrien von über 300 bakteriellen, heteromeren
Proteinkomplexen im Vergleich zu ihren homologen Verwandten aus den entsprechen-
den Superfamilien bioinformatisch ausgewertet. Diese Untersuchung zeigte, dass in
10% aller Komplexe, die strukturell ähnliche Untereinheiten besitzen, deutliche Varia-
tionen in den interface Geometrien auftreten. In diesen Fällen sind die interfaces durch
zusätzliche, definierte Sekundärstrukturelemente, die so genannten interface add-ons,
erweitert, die aus ca. 10-20 Aminosäuren bestehen und signifikante Beiträge zur Stabil-
ität der Proteinkomplexe leisten. Aufgrund dieser Eigenschaften lässt sich folgern, dass
interface add-ons als eine Art negatives Designelement wirken, dadurch strukturell ähn-
liche Proteinkomplexe voneinander differenzieren und somit zur Interaktionsspezifität
von Proteinkomplexen beitragen. Um diese Vermutung experimentell zu untersuchen,
wurde anschließend eine Superfamilie von Glutaminamidotransferasekomplexen, die an
der Biosynthese von Tryptophan und Folsäure beteiligt sind, genauer untersucht: Diese
heteromeren Komplexe bestehen aus Synthase- und Glutaminaseuntereinheiten, welche
miteinander interagieren, um Ammoniak von Glutamin auf ein Akzeptorsubstrat zu über-
tragen. Ein Teil der Glutaminamidotransferasen dieser Superfamilie – ausschließlich
solche, die an der Biosynthese von Tryptophan beteiligt sind – trägt in der Synthaseun-
tereinheit ein interface add-on. Alle anderen homologen Synthaseuntereinheiten der
Superfamilie – auch diejenigen, die an der Biosynthese von Folsäure beteiligt sind –
besitzen dieses interface add-on nicht. Die umfassende Charakterisierung von insge-
samt 54 Kombinationen verschiedener Synthase- und Glutaminaseuntereinheiten mittels
chromatografischer, biophysikalischer, massenspektrometrischer und enzymkinetischer
Methoden zeigte eindeutig, dass die An- bzw. Abwesenheit des interface add-ons in der
Synthaseuntereinheit die Spezifität für die Interaktionen mit den Glutaminaseunterein-
heiten bestimmt. In silico erstellte Profile von über 15000 archaeellen und bakteriellen
Spezies sowie in vivo Wachstumsexperimente machten weiterhin deutlich, dass das inter-
face add-on der Komplexe aus der Tryptophanbiosynthese biologische Relevanz besitzt:
Das interface add-on verhindert Kreuzinteraktionen mit den Untereinheiten des homolo-
gen Komplexes aus der Folsäurebiosynthese, welche sich ansonsten negativ auf die zel-
luläre Fitness auswirken und das Zellwachstum behindern. Abschließend wurde anhand
von rational designten Glutaminaseuntereinheiten aufgezeigt, dass in der Evolution des
interface add-ons dieser Superfamilie vermutlich intermediäre Komplexe mit breiterer
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Interaktionsspezifität aufgetreten sind. Bei interface add-ons handelt es sich folglich um
evolutionäre Instrumente, die es ermöglichen, spezifische Protein-Protein Interaktionen
zu etablieren, wenn aufgrund von ähnlichen interface Geometrien zwischen mehreren
potentiellen Interaktionspartnern unterschieden werden muss.
Zusammenfassend vertieft die vorliegende Arbeit das Verständnis der Mechanismen,
die der Evolution von enzymatischer Mono- und Bifunktionalität zu Grunde liegen, unter-
streicht die Bedeutung von multifunktionellen, generalistischen Enzymen für die Evolu-
tion des Sekundärmetabolismus und beschreibt ein bisher nicht erkanntes strukturelles
Element zur evolutionären Spezifizierung von Protein-Protein Interaktionen.
– xiii –

List of Publications
This cumulative dissertation is composed of the following published or submitted
manuscripts:
A Plach, M.G., Reisinger, B., Sterner, R., and Merkl, R. (2016). Long-term persistence
of bi-functionality contributes to the robustness of microbial life through exapta-
tion. PLoS Genetics 12:e1005836
B Plach, M.G., Löffler, P., Merkl, R., and Sterner, R. (2015). Conversion of anthranilate
synthase into isochorismate synthase: Implications for the evolution of chorismate-
utilizing enzymes. Angewandte Chemie International Edition 54:11270-11274
C Plach, M.G., Semmelmann, F., Busch, F., Busch, M., Heizinger, L., Wysocki, V.H.,
Merkl, R., and Sterner, R. (2017). Evolutionary diversification of protein-protein
interactions by interface add-ons. Submitted for Publication
In the course of this work, I contributed to further publications, which are not part
of the dissertation:
D Veprinskiy, V., Heizinger, L., Plach, M.G., and Merkl, R. (2017). Assessing in silico
the recruitment and functional spectrum of bacterial enzymes from secondary
metabolism. BMC Evolutionary Biology. Accepted.
E Kandlinger, F., Plach, M.G., and Merkl, R. (2017). AGeNNT: annotation of enzyme
families by means of refined neighborhood networks. Submitted for publication
– xv –

Personal Contributions
Publication A
The research was designed by myself, Bernd Reisinger, Reinhard Sterner, and Rainer Merkl.
The experiments were performed by myself and Bernd Reisinger in equal parts. Ancestral
sequence reconstruction was done by Rainer Merkl. The work was supervised by Reinhard
Sterner and Rainer Merkl, and the publication was written by myself, Reinhard Sterner,
and Rainer Merkl.
Publication B
The research was designed and the experimental was work performed by myself. Patrick
Löffler performed molecular dynamics simulations. The work was supervised by Rainer
Merkl and Reinhard Sterner, and the publication was written by myself, Patrick Löffler,
Rainer Merkl, and Reinhard Sterner.
Publication C
The research was designed by myself, Florian Semmelmann, Rainer Merkl, and Rein-
hard Sterner. Cloning, expression, purification, and experimental characterization of
glutaminases and synthases were done by myself and Florian Semmelmann. Florian
Busch performed mass spectrometry experiments and was supervised by Vicky Wysocki.
All other experiments were performed by myself. Computational tools and scripts were
provided by myself, Markus Busch, and Leonhard Heizinger. Rainer Merkl and Reinhard
Sterner supervised the work. The publication was written by myself, Florian Semmelmann,
Rainer Merkl, and Reinhard Sterner.
– xvii –

Table of contents
Abstract ix
Kurzfassung der Arbeit xiv
List of Publications xvi
Personal Contributions xviii
1 General Introduction 1
1.1 A short history of evolution . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.2 The driving forces of evolution . . . . . . . . . . . . . . . . . . . . . . . . . . 3
1.3 The concept of homology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
1.4 Protein superfamilies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
1.5 Aim and scope of this work . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
1.6 Guide to the following chapters . . . . . . . . . . . . . . . . . . . . . . . . . . 11
2 Long-term persistence of bi-functionality contributes to the robustness
of microbial life through exaptation (Synopsis of publication A) 13
2.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
2.1.1 The superfamily of ribulose-phosphate binding (βα)8-barrels . . . 13
2.1.2 Promiscuity and bi-functionality . . . . . . . . . . . . . . . . . . . . . 15
2.1.3 Ancestral sequence reconstruction . . . . . . . . . . . . . . . . . . . 16
2.2 Summary and Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
2.2.1 Ancient HisA precursors are bi-functional, PriA-like enzymes . . . . 19
2.2.2 Ancient bi-functionality persists in modern HisA enzymes . . . . . 23
3 Conversion of anthranilate synthase into isochorismate synthase:
Implications for the evolution of chorismate-utilizing enzymes
(Synopsis of Publication B) 27
3.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
Table of contents
3.1.1 Chorismate-utilizing enzymes and the MST superfamily . . . . . . . 27
3.1.2 Primary and secondary metabolism . . . . . . . . . . . . . . . . . . . 34
3.2 Summary and Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
3.2.1 Establishing isochorismate-synthase activity on an anthranilate-
synthase scaffold . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
3.2.2 Secondary-metabolic MST-enzymes might have evolved via bi-
functional intermediates . . . . . . . . . . . . . . . . . . . . . . . . . 42
4 Evolutionary diversification of protein-protein interactions by
interface add-ons (Synopsis of Publication C) 47
4.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
4.1.1 Protein-protein interactions . . . . . . . . . . . . . . . . . . . . . . . 47
4.1.2 Protein interfaces . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
4.1.3 Glutamine amidotransferases . . . . . . . . . . . . . . . . . . . . . . 54
4.2 Summary and Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
4.2.1 The role of interface add-ons for protein-protein interaction specificity 56
4.2.2 Biological relevance of interface add-ons . . . . . . . . . . . . . . . . 64
4.2.3 Evolution of protein-protein interactions in AS and ADCS com-
plexes: The role of the interface add-on . . . . . . . . . . . . . . . . . 66
5 Abbreviations 71
6 References 75
7 Publications 107
7.1 Publication A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 107
7.2 Publication B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 133
7.3 Publication C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 163
List of figures 233
List of tables 235
Acknowledgements 237
– xx –
1 General Introduction
1.1 A short history of evolution
Life in its entire spectrum formally bursts with complexity. One, for instance, might
think of the remarkable biosynthetic capabilities of microorganisms, the specialization
and connectivity of individual cells in multi-cellular plants and animals, or the highly
sophisticated cognitive abilities of the human brain. These developments did, of course,
not come overnight but rather from a painstakingly slow but gradual adaptation process.
This process, referred to as evolution, was first formulated as a scientific theory in the early
19th century (Hoyle and Wickramasinghe, 2000). At that time scholars recognized that the
driving forces behind the differentiation of life into the countless species were constant
adaptation to ecological niches and competition for resources (Darwin, 1859).
But what did evolution begin with? One longstanding theory suggests that life itself
started in the primordial oceans. During a time-period with a reducing atmosphere (Laz-
cano and Miller, 1996; Oparin and Morgulis, 2003) complex organic compounds formed
from carbon dioxide or methane under the influence of ultraviolet light or electricity
(Bada, 2013; Miller, 1953). Despite some disagreements (Bernhardt, 2012), it is widely
acknowledged that RNA was among these first compounds (de Farias et al., 2016; Gilbert,
1986). This "RNA world" concept suggests that RNA molecules could catalyze simple
biochemical reactions and also store the information needed for their replication. The
concept is supported by the observation that some modern biosynthetic machineries like
ribosomes contain catalytic RNA molecules and by the simple enzymatic reduction of
ribose nucleotides that yields deoxyribose nucleotides as they appear in the later emerged
DNA (Higgs and Lehman, 2015).
Evolution really kicked off when the information stored in RNA and DNA became
meaningful in early forms of genes. These served as blueprints for small primordial
peptides that were able to interact with RNA and to support RNA-based catalysis (Alva
et al., 2015). These small peptides are thought to have gradually fused, multiplied, and
recombined to eventually give rise to the relatively small set of not more than a thousand
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different modern protein geometries or folds (Chothia, 1992). Recent experimental dis-
coveries identified sets of primordial peptides (Farías-Rico et al., 2014), showed that they
can self-assemble and form larger, biochemically active proteins (Smock et al., 2016), and
highlighted that duplication and fusion can lead to symmetric proteins structurally similar
to modern ones (Longo and Blaber, 2014; Park et al., 2015; Richter et al., 2010).
The inclusion of such primitive proteins together with RNA, DNA, and other organic
molecules in cell-like bubbles made of amphipathic fatty molecules was the basis for first
simple self-replicating units. These units eventually formed the last universal common
ancestor (LUCA) of all living things, which existed approximately between 3.8 and 4.5 bil-
lion years ago (Nisbet and Sleep, 2001). It is assumed that this enigmatic single entity was
rather simple (Di Giulio, 2011; Koonin, 2003; Woese, 1998), yet its true nature and physiol-
ogy is still widely debated (Kim and Caetano-Anollés, 2011; Weiss et al., 2016). For instance,
analyses of gene content, co-evolution, and proteomes favor a more sophisticated LUCA
physiology (Doolittle, 2000; Ouzounis et al., 2006; Tuller et al., 2010). Originating from the
LUCA, formation and diversification of species ("macro-evolution") took on, first yielding
uni-cellular microorganisms like archaea and bacteria and eventually the evolutionary
young multi-cellular plants and animals. Given some remarkable similarities between
different animal species or between animals and plants, this common origin has already
been noticed in the 17th century (Hoyle and Wickramasinghe, 2000). Indeed, modern
methods of genetic analyses allow one to reconstruct the evolutionary relationship of all
known species back to their common root in a so-called tree-of-life (Figure 1).
Finally, there is one more point to stress out: Evolution is no completed process that
has begun sometime in the past and that has led to all the species and organisms we know
today. On the contrary, evolution is highly dynamic and new species, new organisms,
and new functions constantly emerge. This is best seen from the rapid development of
microbial drug resistance against common antibiotics that have only been in use for nearly
a decade (Barlow and Hall, 2002; Boyanova et al., 2015; Hall, 2004) or the appearance of
microbial enzymes that are capable of degrading chemicals that have not been in the
ecosystem for longer than 50 years (Copley, 2009; Hartley et al., 2006; Janssen et al., 2005;
Seffernick and Wackett, 2016). The herbicide atrazine, for example, was invented in 1958
and has been applied in millions of tons since then. Already 40 years later, bacterial strains
were identified that are able to degrade atrazine completely and metabolize its degradation
products (Boundy-Mills et al., 1997; de Souza et al., 1998b). The atrazine-hydrolyzing
enzymes produced by these bacteria are assumed to have emerged very recently from
amidohydrolases like melamine deaminase in soil-living Pseudomonas species (de Souza
et al., 1998a; Seffernick et al., 2001; Shapir et al., 2007).
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Figure 1. Tree-of-life.
Phylogenetic tree, as constructed from the comparison of 31 concatenated genes that oc-
cur in 191 species with fully sequenced genomes (Ciccarelli et al., 2006). In this illustration
the root of the tree is in the middle and the branches radiate outwards, with each new
species descending from a common ancestor resulting in a new branch. Note that branch
lengths are not to scale. Bacterial and archaeal species are spanned by blue and magenta
arcs, respectively. Eukaryotic species are marked by a green arc.
1.2 The driving forces of evolution
The common ancestry of all species and the relationship between them makes clear how
new species emerge: By segregation from already existing ones. Such speciation events
take place when two populations of the same species get separated by some kind of
barrier, for instance an entrapment in an ecological niche, and adapt to their respective
conditions. Over time the populations will genetically drift apart, up to a point where
genetic exchange between the daughter and the parental population is no longer possible
(Safran and Nosil, 2012). Evolution is thus driven by constant adaptation processes
to changing environments through the emergence of novel functionalities, which are
eventually just novel genes that lead to novel proteins with novel capacities.
But how do novel genes arise? In fact, this is simply a matter of chance. DNA is
not just an information carrier that is filed somewhere inside a cell but is constantly
transcribed into RNA blueprints for proteins and replicated for genetic reproduction.
Although a highly complex and sophisticated catalytic machinery has developed for these
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essential tasks, errors occasionally occur. For instance, sometimes the wrong nucleotide
is incorporated into replicated DNA thus changing the genetic information (Kunkel and
Bebenek, 2000). Additionally, response systems can fail to repair DNA damage coming
from the exposure to UV light or oxidizing compounds and different parts of a genome
can be recombined due to viruses or erroneous DNA ligation (Friedberg, 2003; Hakem,
2008).
These changes in the genetic information are known as mutations, which can be
classified into insertions, deletions, and substitutions, depending on whether additional
nucleotides were inserted into the sequence, a stretch of nucleotides was lost, or a single
nucleotide was changed to another one. Although the effects of mutations in protein
coding genes are buffered by a redundancy in coding nucleotide triplets, many mutations
are deleterious. For instance, a mutation may lead to a loss of function by substituting a
hydrophobic residue in the protein core with a polar one, which could cause the protein
to misfold. Likewise, substituting a catalytic residue in an enzyme might render it inactive.
For uni-cellular organisms like bacteria such mutations can have lethal consequences,
clearing the corresponding mutants from the population and the gene pool. However, by
chance, some mutations will occur at just the right spot; they may lead to a more stable
protein by filling a hole in its structure with a bulky amino acid, may allow the defense
against antibiotic agents by modifying the catalytic capacity of a hydrolase enzyme, or
increase the catalytic efficiency of an enzyme by introducing an amino acid that aids in
binding its substrate. Such mutations lead to novel functionalities that can give the mutant
a lead in competition and adaptation, eventually allowing it to prevail in the population
and conserve the new functionality.
1.3 The concept of homology
A great caveat of mutational adaptation is, as mentioned above, that most mutations are
deleterious and severely impair the viability of organisms. Today, evolution is thus no
longer viewed as a strictly linear, gradual adaptation process but more as a drift through a
landscape of neutral mutations, which are neither beneficial nor harmful, with random
fixation of mutations (Kimura, 1983). Moreover, it has been realized that other processes
of greater genetic variation must exist that enable the accumulation of mutations while
buffering their negative effects. Ohno postulated in his seminal work Evolution by Gene
Duplication (Ohno, 1970) that the duplication of a gene or even larger genomic segments
creates redundant copies that are free from selective pressure, which allows for the accu-
mulation of otherwise detrimental or lethal mutations.
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Genes that are related through such duplication events and that have diverged in function
are formally referred to as paralogs (Figure 2). The frequency of paralogs in bacterial
genomes is quite high; already in a genome comprising 2000 genes about one fourth of
the genes are paralogs (Hooper and Berg, 2003). Although the term paralog, in its original
definition referred to genes (Fitch, 1970), it is commonly used to describe the relationship
of proteins. In this sense, paralogous proteins share many properties like their overall
three-dimensional structure but often differ in crucial features like enzymatic function or
stability. For example, the enzyme 1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino)-
methylideneamino]-imidazole-4-carboxamide isomerase (HisA) and the cyclase subunit
of the imidazole glycerol phosphate synthase (HisF) share the same fold and are similar
with respect to their amino acid sequences, but have evolved quite different catalytic
activities for the biosynthesis of the amino acid histidine.
In contrast to paralogs, orthologs are genes that are related through speciation events
and that have retained their original function in the descendant species (Fitch, 1970),
because they are still subject to the same selective pressure as in the paternal species
(Figure 2). Following the example from above, the HisA enzymes from Thermotoga mar-
itima and Salmonella enterica are orthologs, because they both have descended from
their common HisA ancestor and they both still catalyze the fourth step of histidine
biosynthesis.
In a generalization of these two concepts, genes and their products are called homologs,
if they are related to each other by descent from a common ancestor through a series of
duplication and speciation events (Figure 2). However, it is complicated to infer homol-
ogy for genes or proteins that have diverged from a common ancestor billions of years
ago, because their sequences often show hardly any similarities. Thus, a more practical
definition of homology is applied today: Two genes (or two proteins) are homologs, if they
are simply similar enough that it is unlikely that this similarity arose just by coincidence.
The most common lower threshold for inferring homology of proteins is a minimum of
20-30% identical amino acids across the length of their aligned sequences, as this value
correlates with an almost certain structure similarity (Orengo and Thornton, 2005).
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Figure 2. Illustration of the concepts of paralogs, orthologs, and homologs.
The enzymes HisA (magenta) and HisF (blue) have emerged from a common ancestor by
gene duplication but have evolved different functions in the biosynthesis of the amino acid
histidine. Their relation is apparent from structural similarity and the similar amino acid
sequences of modern HisA and HisF enzymes (41% and 42% for the pairs from S. enterica
and T. maritima, respectively, determined with EMBOSS Needle (Rice et al., 2000)). HisA
and HisF are paralogs, because they are related through a duplication event and have
diverged in their respective functions. In contrast, orthologs are genes or proteins that
are related through a speciation event and that have retained the same function. In
general, homologs are genes or proteins that are related through descent from a common
ancestor by a series of duplication and speciation events. The homology between HisA
from T. maritima and HisF from S. enterica is evident from their structural similarity and
the high degree of sequence similarity (43%, determined with EMBOSS Needle).
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1.4 Protein superfamilies
Homology is no completely precise concept: For instance, closely related homologs may
share almost identical structures and perform very similar functions, like the catalysis
of the same reaction with just a slightly different substrate. On the other hand, distantly
related proteins that may have little in common – their structures may be rather strong
variations of the same core fold and they may catalyze completely different chemistries
– are counted as homologs as long as their sequences are similar enough. Thus a more
fine-grained classification of homology in the context of proteins is necessary. Such is
provided by combining homologs that have highly similar sequences (e.g. >40% identity)
and that also share common functional properties into families. In turn, several families
can be further grouped together to larger entities whose members have less similar se-
quences (generally <30% identity) and have fewer traits in common, for instance only the
overall three-dimensional structure or a core reaction chemistry. Margaret Dayhoff first
coined the term superfamily for these groups to reflect their super-ordinate character and
broader evolutionary relationship compared to families (Dayhoff, 1965). Superfamilies are
frequently functionally diverse (Almonacid and Babbitt, 2011); only about 60% of the pro-
teins from the same superfamily also have the same function (Hegyi and Gerstein, 2001)
and this variability can even span all six Enzyme Commission classes in some enzyme
superfamilies (Baier et al., 2016). To summarize, the term superfamily shall be defined
within the scope of this thesis as follows: A superfamily is a group of homologous proteins
that (i) are derived from a common evolutionary ancestor, (ii) hence share similarities in
sequence, structure, and – for enzymes – core reaction mechanism, but (iii) differ in their
specific functions.
The first comprehensive implementation of the family-superfamily concept was
achieved in the Structural Classification of Proteins database (SCOP) (Murzin et al., 1995).
This database provides a hierarchical classification of proteins into families and superfam-
ilies, based on evolutionary relationship, and into folds and classes, based on structural
features and similarities (Figure 3). For example, different glucosidases and glycosyltrans-
ferases that all act on α-linked oligosaccharides are summarized in the α-amylase family.
This family is, in turn, grouped together with other families like the β-galactosidases,
-glucanases, and -amylases to the superfamily of glycosyltransferases. While families are
collections of related but very similar enzymes, superfamilies provide an overview of the
different functions that have been established on a common protein scaffold and the
evolutionary relationship between these different functions.
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based
Species
Figure 3. Hierarchical illustration of the SCOP database.
The hierarchical classification of proteins in the SCOP database comprises six levels. At
the bottom species represent distinct protein sequences, which are grouped together with
similar proteins of essentially the same function on the protein level. The family level
summarizes proteins with highly similar sequences and similar functions. The superfamily
level combines individual families with similar structural features, a common evolutionary
origin, but different functions. Above this level fold and class group superfamilies based
on structural features and do not imply homology. The figure is adapted from the SCOP
version 1.75 documentation (Andreeva et al., 2008).
A look at frequently used databases that classify proteins into families and superfamilies
points out, however, that the definition of a superfamily is not general and that it is of-
ten not clear where to draw the line between a family and a superfamily. For example,
the latest release of the SCOP database (version 1.75, June 2009) lists 1962 superfamilies
and 3902 families. More recent and more sophisticated databases like InterPro (ver-
sion 60.0, November 2016) and Pfam (version 30.0, June 2016) yet list 1749/19851 and
595/16306 corresponding entries, respectively. These databases have been created us-
ing high-performance and high-sensitive algorithms that accurately assign new protein
sequences to the correct families and superfamilies (Finn et al., 2016; Mitchell et al., 2014).
An equally challenging task is to put the inherent information of protein superfamilies
on evolutionary relationship and functional diversity to use. Traditional phylogenetic
approaches to dissect and sub-divide a superfamily are often problematic, because the
data-sets frequently contain tens of thousands of sequences and the amino acid simi-
larities between iso-functional sub-families can be very low (Punta et al., 2012). A more
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Figure 4. Visualization of pairwise sequence similarity relationships between mem-
bers of a protein superfamily in a sequence similarity network.
The SSN shows the relationship between selected members of the glycosyl transferase
superfamily (InterPro entry IPR000312), which comprises structurally similar but func-
tionally distinct AMP-phosphorylases (green), thymidine phosphorylases (magenta), and
anthranilate phosphoribosyltransferases (blue). The network was generated at a similarity
cut-off of 10−97 (BLAST E-value9 and is shown in a force-directed layout generated with
Cytoscape 3.4 (Shannon et al., 2003). Selected edges are marked in red and annotated
with their respective E-value and the corresponding sequence identity (seq-id) of the
connected sequences.
robust and computationally less demanding alternative nowadays widely used for pro-
cessing superfamilies are sequence similarity networks (SSNs), developed by Babbitt and
co-workers (Atkinson et al., 2009) and made available by the Enzyme Function Initiative
(Gerlt et al., 2015). SSNs rely on the pre-defined protein family and superfamily data-sets
from InterPro or Pfam and are constructed from an all-by-all sequence comparison be-
tween all members of a superfamily using the well-established BLAST algorithm (Altschul
et al., 1990). The key of SSNs is that these inter-relationships can be visualized as a net-
work graph (Figure 4). In such networks, nodes represent individual members of the
superfamily (protein sequences) and connecting edges represent the pairwise sequence
relation (sequence similarity score or BLAST E-value), if the corresponding proteins are
more similar than a pre-defined threshold.
For most thresholds closely related members of a superfamily will be inter-connected
more densely than distantly related members. With the threshold chosen appropriately for
a specific superfamily, the network can reveal iso-functional groups within a superfamily.
For example, an exemplary SSN of the glycosyltransferase superfamily (Figure 4) shows
that AMP phosphorylases and thymidine phosphorylases are more closely related to each
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other than to the anthranilate phosphoribosyltransferases. This simple visual analysis tells
much about the evolution of this superfamily and the functional relationship between its
members. It is thus hardly surprising that superfamily data-sets together with SSNs have
been used frequently with great success to get insight about enzyme evolution (Brown and
Babbitt, 2014), to discover and predict enzymatic activities of uncharacterized proteins
(Baier et al., 2016; Chow et al., 2015; Gerlt et al., 2015; Zhao et al., 2014), and to analyze the
sequence-structure-function relationship, the fundamental axiom of modern molecular
biology (Mashiyama et al., 2014).
1.5 Aim and scope of this work
Although the number of protein and whole genome sequences as well as the number
of elucidated protein structures and functions have soared in the last decade, the evolu-
tionary relationship between proteins and the paths that evolution took from the ancient
ancestral entities to the modern ones is still enigmatic in all but few cases. And yet the
lessons learned from unraveling, for example, how a specific enzymatic function is dis-
tributed across the members of the respective superfamily and how this function might
have been established during evolution are the most important; first and foremost for a
better understanding of the principles of biology and evolution. But these lessons will
also tell us which enzyme scaffolds might be used to alter their catalytic capabilities to
a desired function and how the transition to the new function might be achieved in the
laboratory or via computer-aided design. Eventually, these lessons will help us to better
understand the sequence-structure-function relationship, which in turn could tell what
functional aspects or structural features of a protein superfamily might be targeted by
drugs that could aid human health.
To study the evolution of protein traits and characteristics, one heavily relies on ex-
ploiting homology relationships between proteins. Superfamilies are of great value in
this context, because they provide a formal but also biologically sensible framework to
sub-divide and dissect groups of related proteins and – with the right tools in hand – to
draw far-reaching conclusions and gain valuable insights. In this thesis, these concepts are
used together with computational, biochemical, and biophysical techniques to investigate
the evolution of enzymatic mono- and bi-functionality, the determinants of substrate
specificity in enzyme superfamilies, the evolution of secondary metabolic enzymes, as
well as the structural determinants of protein-protein interactions, their evolutionary
history, and their physiological significance.
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1.6 Guide to the following chapters
The following three chapters each deal with one of the three first-author publications (A-C)
that constitute this thesis. These chapters are not intended to repeat the publications
one-to-one. They are rather formulated as synopses that give the reader a profound
introduction into the individual concepts and ideas important for the respective topics,
highlight the key findings of each publication, and discuss these with attention to the
corresponding literature.
In the chapter Long-term persistence of bi-functionality contributes to the robustness of
microbial life through exaptation SSNs and ancestral sequence reconstruction (ASR) are
used to demonstrate that the evolution of modern sugar isomerases with different catalytic
functions originated from a bi-functional common ancestor. The chapter further describes
that this bi-functionality has persisted to a certain degree in modern members of the
corresponding sugar isomerase superfamily.
In the following chapter Conversion of anthranilate synthase into isochorismate synthase:
Implications for the evolution of chorismate-utilizing enzymes the functional divergence
within a superfamily of enzymes is examined and key catalytic residues that determine
substrate specificity of these enzymes are identified. It is further demonstrated that this
information can be used to modify the function of enzymes from this superfamily and
finally the implications of this functional change for the evolution of secondary metabolic
enzymes from primary metabolic enzymes are highlighted.
In the final chapter Evolutionary diversification of protein-protein interactions by interface
add-ons structural determinants of protein-protein interaction specificity are identified
from an extensive analysis of heteromeric protein complex structures. A superfamily of
glutamine amidotransferases is then used to demonstrate that these structural features
prevent the formation of non-physiological complexes and an evolutionary scenario for
the emergence of these structural elements is provided.
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2 Long-term persistence of bi-functio-
nality contributes to the robustness
of microbial life through exaptation
(Synopsis of Publication A)
2.1 Introduction
2.1.1 The superfamily of ribulose-phosphate binding (βα)8-barrels
The ribulose-phosphate binding barrel superfamily (SCOP 51366) comprises, among oth-
ers, several iso-functional families of (βα)8-barrel enzymes from histidine and tryptophan
biosynthesis. One of its members is the enzyme HisA, which catalyzes the isomerization of
the aminoaldose N’-[(5’-phosphoribosyl)-formimino]-5-aminoimidazole-4-carboxamide-
ribonucleotide (ProFAR) to the aminoketose N’-[(5’-phosphoribulosyl)-formimino]-5-
aminoimidazole-4-carboxamide-ribonucleotide (PRFAR) (Henn-Sax et al., 2002) for the
fourth step of the biosynthesis of the essential amino acid histidine (Figure 5A). Another
prominent member of this superfamily is the enzyme TrpF, which catalyzes a similar iso-
merization reaction involving the aminoaldose N-(5’-phosphoribosyl)anthranilate (PRA)
and the aminoketose 1-(o-carboxyphenylamino)-1-deoxyribulose-5-phosphate (CdRP) in
the biosynthesis of tryptophan (Hommel et al., 1995). The common evolutionary history
of HisA and TrpF is not only evident from their highly similar structures and their high
degree of sequence similarity (List et al., 2011) but is also supported by establishment
of PRA isomerase activity on HisA scaffolds through both random mutagenesis (Jürgens
et al., 2000) and spontaneous mutations under selective pressure (Näsvall et al., 2012).
The InterPro database associates HisA with the phosphoribosylformimino-5-amino-
imidazole-carboxamide-ribotide isomerase superfamily (InterPro entry IPR023016). In
the current InterPro release (version 60.0, November 2016) this entry comprises 9565
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Figure 5. Reactions catalyzed by the homologous enzymes HisA, PriA, and TrpF and a
SSN representation of the HisA InterPro family.
(A) HisA and TrpF catalyze analogous Amadori rearrangements of the aminoaldoses
ProFAR and PRA to the corresponding aminoketoses PRFAR and CdRP in histidine and
tryptophan biosynthesis, respectively. The bi-functional enzyme PriA catalyzes both reac-
tions. (B) SSN of the phosphoribosylformimino-5-aminoimidazole-carboxamide-ribotide
isomerase superfamily. Nodes are colored by the five main bacterial phyla contributing to
the superfamily. The figure is adapted from publication A.
members, which mainly correspond to HisA enzymes from bacterial and archaeal species.
An SSN shows that the superfamily is basically iso-functional, with a certain sub-cluster
structure as a result of phylum specific sequence variations (Figure 5B). The most uniform
and most separated sub-cluster is that of Actinobacteria. Most Actinobacteria do not
possess HisA enzymes, but rely for the biosynthesis of histidine and tryptophan on a
homolog of HisA called phosphoribosyl isomerase A (PriA). PriA is a bi-substrate spe-
cific enzyme processing ProFAR as well as PRA with equal efficiency (Barona-Gómez and
Hodgson, 2003). Actinobacteria that possess a priA gene lack a dedicated trpF gene, and
consequently PriA is part of both histidine and tryptophan biosynthesis. The genomic
neighborhoods of hisA and priA, i.e. the genes upstream and downstream, are highly simi-
lar, further indicating that PriA is a homolog of HisA (Publication E). Structural comparison
with HisA makes clear that PriA utilizes the same two phosphate binding sites formed by
βα-loops three and four as well as βα-loops seven and eight to bind ProFAR (Due et al.,
2011; Wright et al., 2008). The C-terminal site used for binding PRA is also identical to the
single phosphate binding site of its superfamily relative TrpF (Due et al., 2011; Henn-Sax
et al., 2002). Its quite unusual characteristics have made PriA a well-examined member
of this superfamily with respect to structure and catalytic mechanism (Due et al., 2011;
Küper et al., 2005; Wright et al., 2004) as well as its evolutionary relationship with HisA
and TrpF (Noda-García et al., 2013, 2015; Verduzco-Castro et al., 2016).
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2.1.2 Promiscuity and bi-functionality
Enzymes are traditionally viewed as remarkably specific catalysts that process only one
out of the countless possible substrates present in cells with extremely high catalytic
efficiency. Casually speaking, the textbook description of enzyme catalysis is one enzyme
– one substrate – one reaction. However, it has long been acknowledged that at least
some enzymes are actually capable of catalyzing more than one reaction. Early reported
examples are carbonic anhydrase (Pocker and Stone, 1965), pepsin (Reid and Fahrney,
1967), chymotrypsin (Nakagawa and Bender, 1969), and L-asparaginase (Jackson and
Handschumacher, 1970). In the recent years, more and more enzymes were identified
and described in detail that possess in addition to their native function some kind of
alternative activity; see the reviews by Hult and Berglund (2007), Nobeli et al. (2009), and
Khersonsky and Tawfik (2010).
The term promiscuity was first introduced by O’Brien and Herschlag (1999) to describe
such alternative activities but without any generally applicable definition to it. However,
there has formed an understanding that promiscuity refers to enzymatic activities that
(i) are different from the native activity for which an enzyme has evolved and that (ii) are
not part of the physiology and metabolic network of a corresponding organism (Copley,
2003; Khersonsky and Tawfik, 2010). In other words, promiscuous enzymes coincidentally
catalyze more than one reaction that differ in the third, second, or even first digit of their
Enzyme Commission numbers, indicating different classes of substrates or even different
reaction categories and mechanisms (Bornscheuer and Kazlauskas, 2004). Also, the
catalytic efficiencies for the promiscuous reactions are usually several orders of magnitude
lower than those for the native reaction (Khersonsky and Tawfik, 2010). Promiscuous
enzymes have been identified in many protein families and superfamilies: The enolase
superfamily for instance contains the o-succinylbenzoate synthase that has a promiscuous
N-acylaminoacid racemase activity, albeit with a 1000-fold lower catalytic efficiency
(Palmer et al., 1999). To name one more, a member of the amidohydrolase superfamily,
the dihydroorotase, has a promiscuous phosphotriesterase activity with a 106-fold lower
catalytic efficiency (Roodveldt and Tawfik, 2005). Today it is assumed that on average
at least half of the members of large and diverse enzyme superfamilies display either
substrate or functional promiscuity (Baier et al., 2016).
For some enzymes, on the contrary, there is almost no difference in activities for the
different reactions they catalyze, so that the terms promiscuous, native, and alternative
are not really justified in these cases. For instance, cytochrome P450s or detoxifying
glutathione S-transferases can efficiently perform several more or less similar functions
(Khersonsky et al., 2006; Zhang et al., 2012b). Such enzymes that catalyze different re-
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actions with two or more substrates are termed bi- or multi-functional. In analogy to
the definition of promiscuity above, bi-functional enzymes have a priori evolved to cat-
alyze two reactions with comparable efficiency, which are also part of the physiology
of the corresponding organism. Thus PriA is a classical bi-functional enzyme, because
it converts ProFAR to PRFAR in histidine biosynthesis and PRA to CdRP in tryptophan
biosynthesis with catalytic efficiencies of 104−105 M−1 s−1 in both cases (Due et al., 2011;
Küper et al., 2005). Also, both reactions are essential for the viability of Actinobacteria
like Streptomyces coelicolor or Mycobacterium tuberculosis and thus neither of the two
activities is promiscuous.
Before moving on, two more points should be stressed: First, real bi- or even multi-
functional enzymes are rare; although frequently designated as bi-functional (Zhang et al.,
2009), enzymes that possess two distinct active sites on the same polypeptide chain –
for example as a result of gene fusion – do not meet the definition made above. Second,
the terms promiscuity and bi-functionality only apply to naturally occurring enzymes
and substrates. Even strictly mono-specific and non-promiscuous enzymes may still
transform artificial substrates (Villiers and Hollfelder, 2009); this is because they have
never been exposed to these substrates and thus the "artificial" activities have never been
selected against.
2.1.3 Ancestral sequence reconstruction
The connection between promiscuity or multi-functionality and protein evolution was
first made by Jensen in 1976 when he put forward his patchwork hypothesis (Jensen, 1976).
He made the claim that, unlike modern enzymes that tend to be specialists, ancient
enzymes featured very broad substrate specificities and thus only few multi-functional
enzymes acted on multiple substrates, covering a wide range of early metabolic functions.
Only later, divergence through gene duplication, mutation, and selection yielded the
highly specialized extant enzymes.
Direct experimental evidence supporting or rebutting Jensen’s hypothesis has re-
mained elusive for quite some time, not least due to the lack of macromolecular fossils
(Nisbet and Sleep, 2001). However, in recent years the technique of ancestral sequence
reconstruction (ASR) has matured and now allows one to reconstruct and experimentally
characterize extinct proteins. ASR goes back to the idea put forward by Zuckerkandl and
Pauling over half a century ago that it should be possible to infer the sequence of an
ancient protein from the amino acid composition of its modern descendants (Pauling
and Zuckerkandl, 1963). And indeed the basic process of reconstructing the evolutionary
ancestors of extant proteins follows their notion (Figure 6): Initially a set of sequences of
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Figure 6. The strategy of ancestral sequence reconstruction.
ASR generally comprises three steps: First, a set of sequences of extant proteins is compiled
and aligned. Second, this MSA is used to calculate a phylogenetic tree whose topology
and branch lengths represent the evolutionary relationship between the extant proteins
(colored circles). Third and last, precursor sequences (grey circles) can be reconstructed.
extant proteins is compiled and used to generate a multiple sequence alignment (MSA).
This in turn serves to calculate a phylogenetic tree, which reflects the evolutionary rela-
tionship between the extant proteins. In such a tree every node that links two branches
corresponds to an individual ancestral sequence and the branch lengths are a measure
of the time lying between connected nodes. Computing this tree requires the use of an
appropriate evolutionary model, which takes into account the probability of mutations,
insertions, and deletions that led from a specific node to its child. Finally, the amino acid
sequences at all internal nodes of the tree, back to its root, can be reconstructed. This
process is, however, not as simple as that. The initial sequence set has to be carefully
compiled and the correct topology of the phylogenetic tree has to be ensured. Also, the
evolutionary model used to reconstruct ancestral sequences has to be chosen with cau-
tion, as it for instance has to take temporal changes of mutation rates into account. For
these technical aspects of ASR the interested reader is referred to reviews on this topic
(Liberles, 2007; Merkl and Sterner, 2016).
So far, ASR has been applied to reconstruct numerous protein ancestors that presum-
ably existed millions of years (Wilson et al., 2015; Yokoyama et al., 2014) or billions of years
ago in the Paleoarchaean era around the time of the enigmatic LUCA (Perez-Jimenez et al.,
2011; Reisinger et al., 2013) or even in the pre-LUCA era (Fournier and Alm, 2015). Among
the reconstructed and resurrected ancient proteins are visual (Chang et al., 2002; Shi and
Yokoyama, 2003; Yokoyama et al., 2008) and fluorescent pigments (Field and Matz, 2010;
Ugalde et al., 2004), elongation factors (Gaucher et al., 2008), steroid receptors (Bridgham
et al., 2006; Carroll et al., 2011; Eick et al., 2012; Ortlund et al., 2007), and a number of
enzymes; terpene synthases (Guzzetti et al., 2016), alcohol dehydrogenases (Thomson
et al., 2005), kinases (Akanuma et al., 2013), glutamine amidotransferases (Reisinger et al.,
2013), and tryptophan synthases (Busch et al., 2016) just to name a few.
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Even more interesting than the reconstructed proteins themselves are the lessons to be
learned from such experiments. For instance, the reconstruction of translation elongation
factors (Gaucher et al., 2008) and thioredoxins (Perez-Jimenez et al., 2011) from 0.5-4
billion years ago demonstrated that the thermal stability of these proteins decreased by
about 30 ◦C in that time span, which is in accordance with the temperature trend observed
from the deposition of silicone isotopes (Robert and Chaussidon, 2006). Reconstructed
ancestors have also been used to address crucial questions of molecular evolution, includ-
ing the evolution of protein-ligand interactions (Eick et al., 2012; Kuang et al., 2006) and
protein-protein interactions (PPIs) (Finnigan et al., 2012), the effect of gene duplication
on evolutionary innovation (Voordeckers et al., 2012), the changes of conformational
flexibility during evolution (Hart et al., 2014; Wilson et al., 2015), and the sophistication of
enzyme complexes (Busch et al., 2016; Perica et al., 2014; Reisinger et al., 2013).
Coming back to Jensen’s patchwork hypothesis, ASR has also been applied frequently
to shed light on whether primordial enzymes were indeed multi-functional. However,
the characterization of reconstructed ancestral enzymes has not yet brought forward a
conclusive result. For example, ancestral variants of serine proteases or HisF were specific
enzymes that could only process one substrate and did not display activity for other,
similar substrates (Chandrasekharan et al., 1996; Reisinger et al., 2013). On the other
hand, the reconstructed ancestors of terpene synthases processed two isomers of a cyclic
sesquiterpene (Guzzetti et al., 2016). Furthermore, reconstructed Precambrian ancestors
of β-lactamases displayed catalytic versatility and hydrolyzed several β-lactam antibiotics
with catalytic efficiencies comparable to those of modern enzymes (Risso et al., 2013;
Zou et al., 2014). However, also many modern β-lactamases process several antibiotic
substrates (Delmas et al., 2008; Tomatis et al., 2008). The far more interesting question
whether ancient enzymes were really bi- or multi-functional and could processes different
substrates with equal catalytic efficiencies – as it would have been required to sustain
any form of simple primordial metabolism – has not been answered to date; none of the
reconstructed proteins so far displayed true bi- or multi-functionality.
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2.2 Summary and Discussion
2.2.1 Ancient HisA precursors are bi-functional, PriA-like enzymes
Since its first description in 2003, PriA has often been described as a "molecular fossil",
or in other words a remnant of ancient, bi- or multi-functional enzymes (Barona-Gómez
and Hodgson, 2003). If this holds true, modern HisA and TrpF enzymes would have
evolved from an ancient PriA-like ancestor. However, as this assumption could never be
demonstrated experimentally, it has also been postulated that PriA is rather a modern
development of Actinobacteria and that it has emerged via several intermediates from
mono-functional, specialist HisA enzymes (Noda-García et al., 2015). The details of these
evolutionary scenarios will be discussed later on.
In order to directly investigate the enzymatic properties of ancient HisA and PriA
enzymes, we applied ASR to computationally reconstruct three precursor enzymes. To
this end we used a set of 103 sequences of extant HisA and PriA enzymes from Firmi-
cutes, Spirochaetes, Bacteroidetes, Proteobacteria, and Actinobacteria. We constructed
a reliable phylogenetic tree and inferred the sequences of the last common ancestors
of Actinobacteria (CA-Act-HisA), of Proteobacteria (CA-Prot-HisA), and of all bacteria
(CA-Bact-HisA). A representation of the tree is shown in Figure 7. It should be stressed that
for the reconstruction of the more ancient precursors (CA-Prot-HisA and CA-Bact-HisA)
the actinobacterial sequences were removed from the tree to exclude any effect of these
sequences – especially their active site motifs – on the reconstruction process.
Notably, all three precursors catalyzed the isomerization of ProFAR (HisA reaction), as
well as of PRA (TrpF reaction) with catalytic efficiencies in the order of 102−105 M−1 s−1
and 102−103 M−1 s−1, respectively (Figure 7). For comparison, the modern PriA enzyme
from S. coelicolor (scPriA) displays catalytic efficiencies for the HisA and TrpF reaction of
3.2×104 M−1 s−1 and 3.0×106 M−1 s−1, respectively. Thus, these three precursors are, to
our knowledge, the first examples of ancestral metabolic enzymes that were shown to be
bi-functional. It is appropriate to use the term bi-functional in this context, because we
were able to show that all three ancestors could support both histidine and tryptophan
biosynthesis in the context of a hisA and trpF deficient Escherichia coli strain. Their TrpF
activity is thus clearly distinct from mere promiscuity, which would not play a role for the
physiology of the E. coli host cells (Table 1).
A comparison of the sequences of the three precursors with those of extant HisA and
PriA enzymes now allows one to determine which residues of PriA are likely to be crucial for
its bi-functionality (Figure 8A). Several sequence motifs and structural elements have been
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Figure 7. Evolutionary relationship between HisA and PriA enzymes.
The shown phylogenetic tree was constructed from HisA sequences from Firmicutes,
Spirochaetes (Sp.), Bacteroidetes (Bact.), and Proteobacteria, as well as PriA sequences
from Actinobacteria. The vertical bar corresponds to 0.5 mutations per site. CA-Bact-HisA,
CA-Prot-HisA, and CA-Act-HisA refer to the common ancestors of HisA and PriA enzymes
from all bacteria, all Proteobacteria, and all Actinobacteria, respectively. For the recon-
struction of CA-Bact-HisA and CA-Prot-HisA a pruned tree with removed Actinobacteria
sequences was used. Modern HisA enzymes that were characterized are marked by dia-
monds. For each enzyme its catalytic efficiency for the HisA (red) and TrpF reaction (blue)
are given. The figure is taken from publication A.
suggested in the past to play important roles in this context; the N-terminal phosphate
binding site, which interacts with the second ribose phosphate moiety of ProFAR, the
residues that participate in substrate binding, as well as the residues of βα-loop five that
play a role in catalysis of both the HisA and TrpF reactions (List et al., 2011).
The N-terminal phosphate binding site comprises the motif SGG in PriA and GGG
in HisA enzymes (Noda-García et al., 2015). Its importance for PriA function has been
inferred from the role of the serine in PriA enzymes for the binding of PRA (Due et al.,
2011) and the complete loss of TrpF activity by substitution of the serine with the highly
similar amino acid threonine (Noda-García et al., 2010). However, CA-Prot-HisA and
CA-Bact-HisA contain the GGG motif but are still able to catalyze the isomerization of
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CA-Act-HisA    --MLTLLPAV VRDGQAV LVQGEAGSETSYG-DPLEAARTWQEDGAEWIHLVDLDAAF-D R
CA-Prot-HisA   ---MLIIPAI LKDGRCV LEQGDMEKATVYNDDPAAMARQWVEQGAEWLHLVDLDGAFAD R
CA-Bact-HisA   ---MRIIPAI LKDGRCV LVQGDMEKATVYNDDPLEMAKQWVEQGAEWLHVVDLDGAFAD R
ecHisA         ----MIIPAL LIDGTVV LHQGDYGKQRDYGNDPLPRLQDYAAQGAEVLHLVDLTGAKDD R
scPriA         MSKLELLPAV VRDGQAV LVHGESGTETSYG-SPLEAALAWQRSGAEWLHLVDLDAAF-D R
CAM1           --MFALLPAV VAEGRAV LVQGAAGTETDYG-DPVAAARSWVEQGAPWIHLVDLDAAF-D R
                      ::**:*: :*  *** :*   .   *. .*      :  .**  :*:*** .*
CA-Act-HisA GG   GRGSNRELIAEVVRAV--DVNVEL IRDDDSLDAALATGAARVNIGTAAL NPEWVRKS E
CA-Prot-HisA GGG   GKPVNEDAIKAIAEAV--SIPVQL IRDLETIEAYLEAGIDRVIIGTVAV NPELVREK
CA-Bact-HisA GGG   GKPVNEDVIKEIAQKV--SVKVQL IRDLEDIEAYLDAGVDRVIIGTVAV NPELVREK
ecHisA GGG         PAKRQIPLIKTLVAGV--NVPVQV VRSEEDVAALLEAGVARVVVGSTAV SQDMVKGK
scPriA GG        GTGDNRALIAEVAQAM--DIKVEL IRDDDTLAAALATGCTRVNLGTAAL TPEWVAKS E
CAM1 AGG          GRGDNRAVVHRVVQAVGGDVHVEV IRDDASLDAALASGASRAVIGTAAM NPDWVRSE
                     :   :  :.  :  .: *::.**:*.   : * * :*  *. :*:.*::. : *
CA-Act-HisA GW    VIDRYG-DRIAVGL VR-----GTTLAA TRD...D R
CA-Prot-HisA GW   ACRAFP-GRIVVGI AR-----DGMVAV AEV...D K
CA-Bact-HisA GW   MVEKYG-ERIVVGI AR-----DGMVAV KET...D K
ecHisA GW         WFERFGADALVLAL VRIDEQGNKQVAV QEN...D S
scPriA GW         VIAEHG-DKIAVGL VR-----GTTLRG TRD...D R
CAM1 GW           AIDRYG-DRLAVSL VR-----GHTLAA TTE...D R
                   .    :.:.:*.*     .  :   **      
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Figure 8. MSA of HisA and PriA enzymes and the two states of the PriA active site.
(A) The MSA contains the sequences of the reconstructed HisA ancestors CA-Act-HisA,
CA-Prot-HisA, and CA-Bact-HisA, as well as those of HisA from E. coli (ecHisA), PriA from
S. coelicolor (scPriA), and CAM1, which is a supposed intermediate between HisA and PriA
and was identified from a metagenome sequence set in Noda-García et al. (2015). Residues
that are part of the N-terminal phosphate binding site, that are involved in substrate
binding, and that are part of the catalytically important βα-loop 5 are highlighted in
gray, red, and green, respectively. The residues are colored according to their chemical
properties (red, acidic; blue, basic; green, polar; black, small or hydrophobic). Important
residues are numbered as in panel B. (B) Schematic view of the active site of PriA from
M. tuberculosis in its TrpF- and HisA-state. Residue coloring is as in panel A. rCdRP and
PRFAR are a product analogue and the product of the TrpF and HisA reactions, respectively.
The figure is modified from publication A.
– 21 –
Long-term persistence of bi-functionality
PRA both in vitro (Figure 7) and in vivo (Table 1). The loss of TrpF activity upon Ser→Thr
mutation in HisA must thus result from other, more intricate effects on the active site.
Instead, we propose the βα-loop five as the element that determines HisA-like mono-
functionality or PriA-like bi-functionality, respectively. In ecHisA this loop comprises the
amino acid motif SGW. In fact, only the sub-motif GW is conserved in HisA enzymes, as
there is no observable preference for any amino acid on the first position of the motif
(Publication A). Now on the other hand, in Actinobacteria this motif is strictly conserved
as RGW and all three HisA precursors feature RGW or KGW. The presence of either arginine
or lysine in βα-loop five is essential for bi-functionality, as this loop exhibits significant
ligand-induced conformational dynamics, triggered by the presence of either the HisA
substrate ProFAR or the TrpF substrate PRA (List et al., 2011; Wright et al., 2008): In the TrpF
state, the arginine (Arg143 in Figure 8B) is positioned by an aspartate (Asp130) to recruit
the catalytic aspartate (Asp175). In the HisA state on the other hand the arginine is drawn
away from the substrate by interacting with a glutamate (Glu109) and consequently the
catalytic aspartate (Asp175) can be recruited by another arginine (Arg19) in a conformation
required for the HisA reaction. A similar differential recruiting of the catalytic aspartate is
not possible without a large basic residue in βα-loop five.
It is known that only few amino acid substitutions are necessary to establish PRA
isomerization activity on the HisA scaffold. For instance, the substitution of two aspartate
residues in the vicinity of the active site by hydrophobic valines – in combination with two
other mutations – relieved electrostatic repulsion of the PRA substrate and thus allowed
for PRA isomerization (Claren et al., 2009). Along these lines it would be interesting to see
if the single Ser143→Arg substitution would suffice to establish TrpF activity on the ecHisA
scaffold. Moreover, the crystal structures of the HisA precursors would be informative
whether βα-loop five can adopt different conformations as in extant PriA enzymes and if
the reaction mechanism of the precursors is therefore similar.
Another intriguing issue to be addressed in future work would be the shifts in the
degree of bi-functionality from the most ancient CA-Bact-HisA precursor to the modern
PriA enzymes. Our data show that the catalytic efficiency for isomerization of ProFAR
decreased by about one order of magnitude, whereas that for the isomerization of PRA
increased by about three orders of magnitude. Following the strategy successfully applied
for identifying binding hot-spots in the imidazole glycerole phosphate synthase complex
(Holinski et al., 2017) the characterization of evolutionary intermediates (representing
internal nodes in the tree leading from its root to the modern PriA enzymes) might be
informative on which residues contribute to the observed changes in catalytic efficiencies
and thus modulate bi-functionality in modern PriA enzymes.
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Table 1. In vivo complementation of auxotrophic E. coli strains by HisA-ancestors as well
as modern HisA and PriA enzymes. The complementation time tells when colonies of
E. coli strains lacking either hisA, trpF, or both, after transformation with plasmids carrying
the genes coding for the indicated enzymes, appeared on selective agar plates.
complementation time in hours
∆hisA strain ∆trpF strain ∆hisA∆trpF strain
CA-Act-HisA 48 23 47
CA-Prot-HisA 16 33 28
CA-Bact-HisA 16 45 39
scPriA 22 22 23
ddHisA 16 153 181
pcHisA 15 70 63
tmHisA 16 114 144
2.2.2 Ancient bi-functionality persists in modern HisA enzymes
Enzymes, especially those that are part of highly coordinated and regulated metabolic
pathways, tend to be specialized for their single task in this pathway and are not known to
perform side reactions with other substrates, as this might impair differential regulation
of the pathways. It was therefore quite exceptional that we found the RGW motif, which
we have linked to PriA-typical bi-functionality, also in about 5% of modern HisA enzymes
from organisms that have dedicated histidine and tryptophan biosynthetic pathways and
contain a trpF gene. We selected and characterized three RGW-HisA enzymes from the
Proteobacteria Desulfovibrio desulfuricans (ddHisA) and Pelobacter carbinolicus (pcHisA),
as well as from T. maritima (tmHisA). All three did not only catalyze their native reaction
but could also isomerize PRA, albeit with about 105-fold lower catalytic efficiency than
modern TrpF enzymes (Figure 7). Nevertheless, these HisA enzymes are the first ones that
have been shown to possess also TrpF activity.
Although we could show that all three tested HisA enzymes were able to rescue the
growth of hisA and trpF deficient E. coli strains (Table 1), it is unlikely that their TrpF
activity is physiologically relevant, because the K PR AM values are 10-170-fold higher than
the K Pr oF ARM values and the catalytic efficiencies kcat /K
PR A
M are no higher than 14 M
−1 s−1
(Figure 7). Presumably, these very low efficiencies make the TrpF side-activities tolerable
and prevent competition with the HisA reaction.
Our results are not conclusive on whether all modern HisA enzymes possess a TrpF
side-activity. We also tested several HisA enzymes that do not contain the PriA-typical
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RGW motif. And indeed, these enzymes were not able to complement hisA and trpF
deficient E. coli strains, although in some experiments after long incubation times very
small colonies could be observed (Publication A). It is likely that the residual TrpF activity
of inherent E. coli enzymes like PurF is responsible cell growth (Patrick and Matsumura,
2008). Nonetheless, these observations further support our view of the RGW motif as the
decisive element that determines PriA-typical bi-functionality. Along these lines the bi-
functional PriA enzymes from a sub-clade of the genus Corynebacterium became mono-
functional HisA enzymes after the horizontal acquisition of a whole-pathway tryptophan
operon (including a dedicated trpF gene) from a member of the γ-Proteobacteria and
a change of the RGW motif to NGW (Noda-García et al., 2013). It is therefore plausible
to assume that the mutational barrier between bi-functional and mono-functional HisA
variants did not pose a real hurdle during evolution and that mono- or bi-functionality
are easily accessible under corresponding selective pressure.
To put this rather complicated matter in a nutshell: Where did bi-functional PriA
enzymes come from and why do Actinobacteria rely on them? The latter issue can be
answered relatively straightforward. Actinobacteria like Streptomycetes have lost their trpF
gene and thus simply have to rely on PriA for histidine and tryptophan biosynthesis. Also,
they do not face any drawbacks from this strategy, because their amino acid biosynthesis
is not regulated by feedback inhibition and the expression of biosynthetic enzymes is
not coordinated in a pathway-specific manner (Hodgson, 2000). Thus, enzymes with
multiple functions in multiple pathways are more likely to occur in Actinobacteria than in
organisms with strict regulation of biosynthetic pathways.
Much, however, has been speculated about the evolutionary origins of PriA. It has been
suggested that modern PriA enzymes are a remnant of ancient, bi-functional enzymes
that supported histidine and tryptophan metabolism and that diverged into modern HisA
and TrpF enzymes (Barona-Gómez and Hodgson, 2003). Only recently, another origin
story was proposed from the analysis of marine meta-genome samples (Noda-García et al.,
2015). In these samples, sequences were identified that bridged the gap between PriA-like
and HisA-like sequences with respect to the sequence motif of the N-terminal phosphate
binding site. It was proposed that the transition from the HisA motif SGG to the PriA
motif GGG proceeded via intermediary enzymes possessing an AGG motif that display
PriA-like bi-functionality (compare the transition enzyme CAM1 in Figure 8A). Thus,
PriA might have developed from mono-functional HisA enzymes after the formation of
Actinobacteria. However, with our data at hand, this scenario is rather unlikely considering
the following two arguments: First, the study by Noda-García et al. (2015) only considered
marine metagenome samples and Actinobacteria are not known to be prevalent in marine
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environments, which argues against a relation of these transition enzymes and modern
Actinobacteria. Second, our characterization of the HisA ancestors shows that the N-
terminal phosphate binding site motif is not relevant for PriA-like bi-functionality. On
the contrary, CAM1 already possesses the PriA-typical RGW motif in βα-loop 5, arguing
against a role for transition from HisA to PriA.
We propose a different scenario for the evolution of HisA, TrpF, and PriA: Our results
show that HisA is an enzyme whose ancestral bi-functionality has pertained for over two
billion years of evolution, most likely without immediate and obvious benefit and without
any evolutionary pressure. Its bi-functionality may have played an important role in
the Precambrian era to maintain early metabolism but became expendable upon the
integration of dedicated trpF genes into genomes. In the following the TrpF side-activity
of the HisA enzymes evolved in a way that it was not lost completely but just went down
to a physiologically not harmful level. Although the remaining bi-functionality of HisA
was neither actively selected for, nor against, it was still a factor of metabolic flexibility
not to be neglected. Consequently, the loss of the trpF gene in Actinobacteria could be
compensated by the presence of a bi-functional HisA enzyme.
Such innovations that originate non-adaptively are called exaptations (Gould and
Vrba, 1982). In other words, these are traits whose function has shifted during evolution
and that did not originally form for their eventual purpose. A vivid example for exap-
tation are feathers, which were adopted to assist flight only after they had evolved for
temperature regulation of primordial reptiles (Gould and Vrba, 1982). In the same way,
the bi-functionality of ancient HisA enzymes did no longer serve its original purpose
after the emergence of TrpF (in analogy, keeping the reptiles warm) but was exploited
when there was the necessity due to the loss of trpF in Actinobacteria (in analogy, using
feathers for flying). Although exaptation has not frequently been observed, there are some
other examples: The light-refracting crystallins in the lens of the human eye stem from
glutathione S-transferase (Tomarev and Piatigorsky, 1996) and a single point mutation in
human β-globin causes sickle-cell anaemia but has in recent evolutionary timescales also
been selected for in African populations as it confers resistance against malaria (Friedman
and Trager, 1981; Ingram, 1959).
– 25 –

3 Conversion of anthranilate synthase
into isochorismate synthase:
Implications for the evolution of
chorismate-utilizing enzymes
(Synopsis of Publication B)
3.1 Introduction
3.1.1 Chorismate-utilizing enzymes and the MST superfamily
The shikimate pathway is a major metabolic route in bacteria, fungi, and plants. It is
estimated that up to 20-50% of the photosynthetically fixated carbon is channeled into it
in plants (Corea et al., 2012; Weiss, 1986). As the shikimate pathway is absent in animals
it has sparked considerable interest as a target for potential herbicides and antibiotics.
For instance, one enzyme of the pathway is the target of glyphosate, the most widely
used herbicide in the 20th century (Duke and Powles, 2008). The pathway comprises
seven enzymatic steps that convert D-erythrose-4-phosphate and phosphoenolpyruvate
to chorismate (CH), the common precursor of the three proteinogenic aromatic amino
acids tryptophan, tyrosine, and phenylalanine, folate coenzymes, benzoid and napthoid
quinones, iron chelators, antibiotics, and innumerable other, mostly aromatic secondary
metabolites like alkaloids, flavonoids, or lignins (Haslam, 2014; Tohge et al., 2013). CH
has thus often been referred to as a central metabolic node molecule (Dosselaere and
Vanderleyden, 2001).
The enzymes that catalyze the initial steps in the biosynthesis of the numerous CH-
derived metabolites, i.e. chorismate-utilizing enzymes (CUEs), can be grouped into four
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Figure 9. Reactions catalyzed by chorismate-utilizing enzymes.
The central metabolic node molecule chorismate is converted to several products that
are the starting points for the biosynthesis of a wide range of primary and secondary
metabolites in plants, fungi, and bacteria. The MST-superfamily comprises AS, ADCS,
ADICS, ICS, and SS, which catalyze the formation of the metabolites highlighted in green.
CMs belong to two different superfamilies and catalyze the formation of prephenate,
highlighted in red. CLs convert chorismate to para-hydroxybenzoate, highlighted in blue.
different superfamilies (Figure 9). Anthranilate synthases (ASs), aminodeoxychorismate
synthases (ADCSs), aminodeoxyisochorismate synthases (ADICSs), isochorismate syn-
thases (ICSs), and salicylate synthases (SSs) belong to the SCOP superfamily 56322 (ADC
synthase), which was dubbed MST-superfamily, referring to the CH derivatives menaqui-
none, siderophores, and tryptophan (Kolappan et al., 2007). Chorismate mutases (CMs)
are known to have two different folds and are thus grouped into the SCOP superfamilies
48600 (chorismate mutase II) and 55298 (YjgF-like). Finally, chorismate lyases (CLs) be-
long to SCOP superfamily 64288 (chorismate lyase-like). In the following paragraphs the
various CUEs are described with respect to structure and function.
The most heterogeneous group of CUEs are CMs. Based on their folds, they are grouped
in the AroH class (trimeric, pseudo-(αβ)-barrel fold), which is prevalent in Gram-positive
bacteria (Chook et al., 1994; Gray et al., 1990) and the AroQ class (dimeric, all-helix bundle
fold), which is prevalent in Gram-negative bacteria (Goerisch and Lingens, 1974). CMs
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catalyze the committed step in the biosynthesis of the aromatic amino acids tyrosine
and phenlyalanine by converting CH in a 3,3-sigmatropic Claissen-rearrangement of
its enolpyruvyl sidechain to prephenate (PA) (Dosselaere and Vanderleyden, 2001). CLs
comprise a 6-stranded anti-parallel β-sheet core with few surrounding, short α-helices
(Gallagher et al., 2001). They catalyze a 1,2-elimination of the enolpyruvyl moiety of CH to
yield para-hydroxybenzoate (PHB), which is a key precursor of quinones like coenzyme Q
(Walsh et al., 1990).
The remaining CUEs are paralogs and belong to the MST-superfamily. The close
evolutionary relationship between them is evident from several facts. Pairwise alignments
of consensus AS, ADCS, ADICS, ICS, and SS sequences reveal similarities between 25
and 50%. The C-terminal, catalytic halves of individual MST-enzymes share between
24 and 32% identical residues, with this value going up to 70% for the active site and
surrounding residues. The structures of MST-enzymes superimpose with root-mean-
square deviation (RMSD) values of 0.9−1.6 Å over all Cα-atoms (Figure 10). Moreover,
all MST-enzymes depend on Mg2+ as a cofactor and work according to the same general
catalytic mechanism (He et al., 2004). In typical SN 2′′ manner, their reactions involve
a nucleophilic attack on C2 of CH and concomitant loss of water at C4. Nevertheless,
the different MST-enzymes catalyze considerably different transformations of CH: Based
on the nucleophile employed, ammonia-utilizing MST-enzymes (AMEs) – AS, ADICS,
and ADCS – can be differentiated from water-utilizing MST-enzymes (WMEs) – ICS and
SS. Alternatively, based on the nature of the product, the superfamily can be grouped
into the enzymes that form aromatic products (AS and SS) and such that form non-
aromatic products, which still contain the enolpyruvyl sidechain of CH (ADICS, ADCS,
and ICS). The combination of the same fold, similar sequences, the same substrate,
and the overall same catalytic mechanism, but subtle differences in reaction chemistries
and formed products makes the MST-superfamily an ideal model to study the sequence-
structure-function relationship and the evolutionary links between members of protein
superfamilies.
The best characterized family of MST-enzymes are ASs, which belong to the group of
glutamine amidotransferases (GATases). These enzyme complexes utilize glutamine to
introduce amino-substituents in numerous anabolic pathways leading to nucleotides,
amino acids, coenzymes, or antibiotics (Zalkin and Smith, 2009). AS catalyzes the commit-
ted step of the tryptophan biosynthetic pathway; the only metabolic pathway in nature
that generates an aromatic indole ring from non-aromatic precursor molecules (Figure 9).
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Figure 10. Structure and sequence relationship in the MST-superfamily.
The proteins and complex subunits that are members of the MST-superfamily are colored
in light gray. Structurally not related glutaminase subunits are colored in dark gray. The
active sites of the MST-enzymes are indicated by sphere-representations of CH (cyan) and
a Mg2+ ion (green); those of glutaminase subunits by glutamine (magenta). Each MST-
enzyme is arranged such that it is next to its two closest homologs from the superfamily.
Sequence identities/similarities between the MST-enzymes are given as percentages,
RMSD values over all Cα-atoms are given in Å. The values were determined for the
following proteins: ICS from E. coli (PDB ID 3hwo), SS from M. tuberculosis (PDB ID 2fn1),
ADICS from Burkholderia lata (PDB ID 3r76), AS from Serratia marcescens (PDB ID 1i7q),
and ADCS from E. coli (PDB ID 1k0e; note that the glutaminase subunit and an α-helix
are not resolved in the structure and are thus sketched).
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So far, the crystal structures of three ASs have been solved and reveal heterotetrameric
complexes with a2b2 stoichiometry (Knöchel et al., 1999; Morollo and Eck, 2001; Spraggon
et al., 2001) (Figure 10). Only the larger subunit – commonly referred to as the synthase
or TrpE – is a member of the MST-superfamily and shows the typical MST-fold. This fold
comprises a complex α/β-sandwich with two anti-parallel β-sheets forming a core grove,
surrounded by α-helices. The active site is located near a prominent, kinked α-helix,
which coordinates the Mg2+ ion essential for CH binding and catalysis (Parsons et al.,
2008; Sridharan et al., 2010). The smaller subunit – referred to as the glutaminase or TrpG –
has a class I GATase fold, which is characterized by a catalytic triad comprising a cysteine,
a histidine, and a glutamate residue (Zalkin and Smith, 2009). In the AS from Salmonella
typhimurium and S. marcescens the two dimers associate via their TrpE subunits, whereas
in the AS from Sulfolobus solfataricus they associate via their TrpG subunits.
The reaction catalyzed by AS comprises the amination of CH at C2 and the subse-
quent aromatization to yield anthranilate (AA). This step is highly regulated through
various genetic repression and attenuation mechanisms (Dosselaere and Vanderleyden,
2001; Merino et al., 2008; Yanofsky et al., 1984) and feedback inhibition of AS by trypto-
phan (Caligiuri and Bauerle, 1991; Spraggon et al., 2001). The reaction itself proceeds
in three steps: Initially, glutamine is hydrolyzed in the active site of TrpG and nascent
ammonia is channeled to the active site of TrpE, where it reacts with CH in a reversible
syn-1,5-substitution of the C4 hydroxyl group to an aminodeoxyisochorismate (ADIC) in-
termediate (Kozlowski et al., 1995; Walsh et al., 1990). The final cis-elimination of pyruvate
from ADIC renders the total reaction irreversible and yields AA (Walsh et al., 1990).
ADCSs convert CH to aminodeoxychorismate (ADC) in the committed step of folate
biosynthesis (Dosselaere and Vanderleyden, 2001). Folate is a precursor of tetrahydro-
folate, an important one-carbon donor molecule that takes part in various biosynthetic
pathways leading for example to purines, methionine, glycine, and pantothenic acid
(Dosselaere and Vanderleyden, 2001). The biosynthesis of tetrahydrofolate is targeted
by two of the most common drugs used against infectious diseases, trimethoprim and
sulfamethoxazole (Masters et al., 2003). In Streptomycetes, ADC additionally serves as the
precursor for several antibiotics, including cancidin, chloramphenicol, and pristinamycin
(Blanc et al., 1997; Brown et al., 1996; Criado et al., 1993).
Similar to ASs, ADCSs are GATases and comprise a large synthase subunit, commonly
named PabB, which shows the typical MST-fold (Figure 10), and a small glutaminase
subunit, named PabA, which is structurally similar to the glutaminase subunit of AS.
Although only the structure of PabB has been solved so far (Bera et al., 2012; Parsons
et al., 2008), it is assumed that the quaternary structure of ADCSs resembles that of one AS
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dimer (Parsons et al., 2008). Interestingly, the PabB subunit contains the same tryptophan
binding site as TrpE, despite no inhibition of ADCS by tryptophan has been observed.
This, however, is another hint at the common evolutionary history of the MST-enzymes.
In contrast to AS, ADCS catalyzes the amination of CH under retention of the original
regio- and stereochemistry in ADC (Walsh et al., 1987) (Figure 9). For this, ADCS employ
a lysine side chain nucleophile to covalently link the ADIC-like reaction intermediate to
the enzyme. This covalent complex is subsequently resolved in a second SN 2′′ reaction
with nascent ammonia as the nucleophile, which has been generated from the hydrolysis
of glutamine at the PabA subunit (He et al., 2004). Interestingly, some ADCSs, mainly
those from Firmicutes, do not rely on the enzyme-provided lysine nucleophile but utilize
two molecules of free ammonia for the two SN 2′′ reactions with release and re-uptake of
the ADIC reaction intermediate (Schadt et al., 2009). The obvious difference between AS
and ADCS catalyzed reactions – the fate of the enolpyruvyl moiety – has recently been
traced back to two factors: In lyase-active MST-enzymes like AS the reaction intermediate
is bound with three-fold higher affinity than in lyase-inactive ones like ADCS (Meneely
et al., 2016). Furthermore, the lyase-active enzymes bind the reaction intermediate in
an equatorial conformation, which favors elimination of pyruvate by presenting the C2-
hydrogen to a lysine catalytic base (Culbertson et al., 2015).
ADICSs are homologs of AS and ADCS and are unique to Pseudomonas species. These
enzymes, also called PhzE, occur as fusion proteins of TrpE and TrpG domains. The
structure of PhzE from Burkholderia lata shows that two fused TrpE-TrpG dimers associate
via their TrpE domains (Li et al., 2011) (Figure 10). Their quaternary structure thus differs
from canonical AS quaternary structures. ADICSs aminate CH at C2 like ASs but do not
eliminate pyruvate and thus form a non-aromatic product like ADCSs (Figure 9). This
characteristic is exploited in the biosynthesis of ADIC-based, blue-green, redox-active
pigments called phenazines (Blankenfeldt, 2013), which have recently been discovered as
a source for novel antibiotics against multi-drug resistant Staphylococcus aureus strains
(Borrero et al., 2014).
ICSs also show the typical MST-fold but are, unlike the previously discussed AMEs, mono-
mers or homo-dimers and do not contain other, non-MST-type subunits (Figure 10). ICSs
provide a fork from CH towards the metabolic pathways leading to dihydroxybenzoate-
based siderophores and menaquinone, by converting CH with regio- and stereo-specificity
to isochorismate (IC) (Liu et al., 1990; Walsh et al., 1990) (Figure 9). Siderophores are
iron-chelator molecules that are produced by bacteria to assist in iron-uptake (Crosa,
1997; Zwahlen et al., 2007), because iron is mainly present as the highly insoluble ferric
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hydroxide form in the environment and is thus severely limited in its biological availability.
Siderophores bind ferric iron with extremely high affinities of up to 1052 M−1 (Harris et al.,
1979) and thus allow for the uptake of external iron (Neilands, 1995) or enable infec-
tious pathogens to scavenge iron from iron-containing host-proteins (Domagalski et al.,
2013). The efficiency of iron-uptake through siderophores is directly related to virulence
in many pathogenic bacteria (Ratledge, 2004; Ratledge and Dover, 2000). Consequently,
siderophore biosynthetic enzymes and siderophore carrier proteins have been suggested
as targets for novel antimicrobials (Lamb, 2015). IC is also the precursor for menaquinone
and the derived compounds menaquinol, phylloquinone, and phylloquinol. Under anaer-
obic conditions these quinones are required for electron transport and ATP synthesis
(Dosselaere and Vanderleyden, 2001) and some bacteria like the pathogen M. tuberculosis
solely rely on menaquinone for oxidative phosphorylation (Dhiman et al., 2009). As vita-
mins of the K group, menaquinone and its derivatives play a important roles for blood
clotting in humans and must be obtained from the intestinal flora or from dietary sources
(DiNicolantonio et al., 2015; Olson, 1984). Due to these considerably different utilizations
of IC most bacteria possess two distinct ICS isozymes (EntC-type and MenF-type), which
are specific for siderophore and quinone biosynthesis, respectively (Dahm et al., 1998).
SSs are structurally and functionally closely related to ICSs. They are also monomers or
homo-dimers and show the typical MST-fold (Figure 10). SSs provide a fork from CH
towards the biosynthesis of salicylate-based siderophores like yersiniabactin and myco-
batin (Dosselaere and Vanderleyden, 2001) (Figure 9). These compounds are essential for
pathogenic bacteria like M. tuberculosis, Yersinia pestis, or several Pseudomonas species
for survival under iron-deficient conditions and for establishment and maintenance of
infection (Cornelis and Matthijs, 2007; De Voss et al., 2000).
The most intriguing difference between ICS and SS is the fate of the enolpyruvyl moiety
of CH. SS eliminates pyruvate from the IC reaction intermediate to give the aromatic
product salicylate (SA), with the consequence that the derived siderophores carry mono-
hydroxyl substituted phenyl rings. ICS, on the other hand, does not eliminate pyruvate and
releases the non-aromatic IC, which leads to di-hydroxyl substituted siderophores. This
subtle difference is attributed to different conformations of IC in the respective active sites.
In SS, it is bound such that the pi-orbitals of the enolpyruvyl methenyl-group overlap with
the orbital of the hydrogen at C2, allowing for a pericyclic, sigmatropic elimination without
the involvement of solvent protons (Lamb, 2011; Zwahlen et al., 2007). In ICS, however, IC
is bound in a pseudo-axial conformation that precludes a sigmatropic elimination due to
unfavorable dihedral angles of the enolpyruvyl moiety (Sridharan et al., 2010).
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3.1.2 Primary and secondary metabolism
It has been mentioned in the preceding section that the MST-superfamily can be grouped
into AMEs (AS, ADCS, ADICS) and WMEs (ICS, SS), depending on whether ammonia
or water is utilized as a nucleophile in the first step of the SN 2′′ reaction. Interestingly,
this subdivision of the MST-superfamily is also reflected in the assignment of AMEs to
primary metabolism and of WMEs to secondary metabolism. The two terms primary
and secondary have entered general usage in the scientific community to differentiate
between the branches of metabolism that produce essential metabolites and such that
produce metabolites that are less relevant for an organism, e.g. that are needed only under
certain conditions. The terms date back to the first coarse-grained classification of plant
metabolism by physiological chemist Albrecht Kössel in the 19th century (Kössel, 1891).
Since then primary metabolism is understood as the collection of enzymatic reactions
that produce metabolites, i.e. chemical compounds, that are directly involved in growth,
development and reproduction of an organism; recall the essential amino acid trypto-
phan, which is produced in the metabolic pathway starting from the AME AS. Typically,
carbohydrate, lipid, amino acid, and nucleotide metabolism are core parts of primary
metabolism. Usually, primary metabolic pathways are target-oriented and only make a
single product and no side products (Fischbach and Clardy, 2007). In other words, they
are stream-lined in order to maximize the yield of the essential metabolites they produce
and to minimize the waste of metabolic resources. Also, the enzymes that build up such
pathways are highly optimized and coordinated; for instance, only seven enzymatic ac-
tivities are necessary to generate the complex aromatic amino acid tryptophan from its
precursor CH (Yanofsky and Crawford, 1987).
Using the principle of exclusion, secondary metabolism is defined to comprise all
enzymatic reactions that yield products that are not directly involved in growth, develop-
ment, and reproduction, but rather play different roles in the ecology and physiology of
organisms. Such secondary metabolites could be competitive agents (antibiotics, iron
chelators), agents of symbiosis, sexual hormones, signaling molecules among microorgan-
isms (Demain and Fang, 2000; Straight et al., 2007), or mediators of interaction between
microbial and multi-cellular organisms (Engel et al., 2002; Strobel and Daisy, 2003). Gen-
erally speaking, secondary metabolites confer some sort of competitive advantage to their
producers under certain environmental conditions (Stone and Williams, 1992). Secondary
metabolites are also a rich source of antibiotics (Sosio et al., 2004), chemotherapeutics
(Tang et al., 2000), immunosuppressants (Schwecke et al., 1995), or cholesterol-lowering
agents (Hendrickson et al., 1999) and thus play an enormous role in medicine and econ-
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omy. Modern genetic and microbiological methods even allow for the tailoring of custom,
artificial secondary metabolic pathways (Leitão and Enguita, 2016).
In contrast to the few hundreds of primary metabolites, hundreds of thousands of
secondary metabolites have been identified so far (Hartmann, 2007) that also have a much
wider range of chemical structures and functions than primary metabolites (Vining, 1992).
For instance, flavonoids can act as UV screens in plants and as signaling molecules or
defense compounds in bacteria (Firn and Jones, 2009). Gibberilins, a class of over hundred
structurally related terpenes, are plant hormones that regulate growth and developmental
processes (Hedden et al., 2001) but are also synthesized by fungi to render plants more
susceptible to fungal infection (Tudzynski, 2005) and are even produced by some bacte-
ria, albeit with unknown function (Fischbach and Clardy, 2007). Secondary metabolic
pathways are thus not target- but diversity-oriented and are usually organized as complex
networks of enzymatic reactions. Some pathways contain more than 40 enzymes (Trefzer
et al., 2002) that are encoded in large clusters on continuous DNA stretches of up to
100.000 base pairs (McAlpine et al., 2005), which are often referred to as biosynthetic gene
clusters (BGCs) (Fischbach and Walsh, 2006; Medema et al., 2015).
Why did such a complexity evolve and what selective pressures shaped secondary metabo-
lic pathways? Two theoretical models have been put forward that aim to answer this issue.
The target-based model assumes that evolutionary pressure led to the formation of path-
ways that yield metabolites, which specifically act against competitors and thus confer
selective advantages. One assumed mechanism, for example, is high-affinity binding
to cellular targets of other organisms in the same environment (Williams et al., 1989).
For instance rapamycin, produced by Streptomycetes, forms high-affinity complexes
with cis/trans peptidylprolyl isomerases and thus inhibits their function as protein fold-
ing chaperones (Heitman et al., 1991; Koltin et al., 1991). It is one of the most potent
anti-fungal agents known and confers Streptomycetes with growth advantages against
competing organisms like Candida fungi (Sehgal, 2003).
The diversity-based model was put forward by Firn and Jones and assumes two key
points: First, potent biological activity as displayed by rapamycin is rare. Second, selective
pressure would favor organisms that could generate and retain chemical diversity at low
genetic and metabolic costs (Firn and Jones, 2000, 2009). It suggests that the higher the
number of secondary metabolites produced by an organism, the higher the chances are
that some possess potent biological activity. This model is supported by the fact that
although most secondary metabolic pathways form hundreds of different products, like
the gibberilins mentioned above, only few of these metabolites are highly biologically
active and bind to their targets with low nanomolar affinity. Moreover, the organization of
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Figure 11. Links between primary and secondary metabolism.
The path in the center of the figure symbolizes the primary metabolic route leading from
deoxyarabino-heptulonate-phosphate (DAHP) over shikimate and CH to phenylalanine
and tryptophan. The secondary metabolic pathway leading to the antibiotic rifamycin
(top left corner) involves the enzyme RifG, which acts on amino-DAHP. RifG is a homolog
of AroB, which is part of the central primary pathway (blue circles). The secondary
metabolic pathway leading to enterobactin (top right corner) starts with ICS, which acts
on chorismate, similar to its homolog AS in the primary pathway leading to tryptophan
(red circles). The primary metabolite phenylalanine is the precursor of a wide variety
of phenylpropanoid secondary metabolites that are synthesized in a complex network
of interdependent reactions (bottom part). It is assumed that some of the genes coding
for the respective secondary metabolic enzymes have evolved from genes of the primary
metabolic shikimate pathway; for details see Tohge et al. (2013).
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secondary metabolic pathways in network- or matrix-style manner reduces genetic and
metabolic costs while feeding metabolites to as many enzymes as possible (Fischbach
and Clardy, 2007). A typical example of such a network is the phenylpropanoid pathway
that starts from phenylalanine (Figure 11). A highly-interconnected network of enzymatic
reactions converts phenylalanine into a range of structurally and functionally diverse
metabolites including coumarins, isoflavones and flavones, tannin derivatives, antho-
cyanins, flavonols, lignin derivatives, and phenylpropanoids (Tohge et al., 2013).
Although these theories might explain the evolutionary forces that shaped secondary
metabolic pathways, they do not provide an answer where the genes that code for sec-
ondary metabolic enzymes originally stem from. However, the fact that all secondary
metabolites are ultimately derived from a primary metabolic precursor (Wink, 2011)
already points in the direction of the answer. For example, in addition to the phenyl-
propanoids mentioned above, terpene building blocks originate from intermediates of
glycolysis (Kirby and Keasling, 2009) and nitrogen-containing alkaloids are formed from
purine nucleoside and amino acid precursors (Facchini, 2001). It has thus been acknowl-
edged that also the enzymes of secondary metabolism must ultimately have their origin
in primary metabolic pathways (Firn and Jones, 2000; Vining, 1992; Weng, 2014). And
indeed, secondary metabolic pathways often comprise enzymes highly similar to enzymes
from primary metabolism. For instance, the enzyme RifG catalyzes the cyclization of
amino-deoxyarabino-heptulonate-phosphate (amino-DAHP) in the secondary metabolic
pathway that leads to the antibiotic rifamycin (August et al., 1998; Rascher et al., 2003; Yu
et al., 2001) (Figure 11). A homolog of RifG, AroB, catalyzes a nearly identical cyclization
of DAHP in the primary metabolic shikimate pathway (Carpenter et al., 1998). It has
consequently been speculated that RifG evolved from AroB through gene duplication
and functional divergence (Fischbach et al., 2008). Duplicated genes coding for primary
metabolic enzymes can be recruited for secondary metabolism via multiple paths, in-
cluding mutational divergence, changes in transcriptional, translational, or allosteric
regulation as well as changes in protein structure and protein-protein interactions (Moghe
and Last, 2015). Another example for such recruitment events is the phenylpropanoid
pathway. Many of its enzymes are assumed to have originated from the enzymes of the
closely related shikimate and phenylalanine biosynthetic pathways (Tohge et al., 2013).
To conclude, and to come back to the MST-superfamily, also AMEs and WMEs provide
a link between primary and secondary metabolism. AS catalyzes the conversion of CH
to IC in the primary metabolic pathway leading to tryptophan, while the homologous
ICS catalyzes a very similar reaction in the secondary metabolic pathway leading to the
siderophore enterobactin (Figure 11).
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3.2 Summary and Discussion
3.2.1 Establishing isochorismate-synthase activity on an anthranilate-
synthase scaffold
Based on the assumptions about the evolution of secondary metabolic enzymes outlined
in the prior section, we hypothesized that a transition in nucleophile specificity from
ammonia to water was the basis for the evolution of secondary metabolic WMEs from
ancestral, primary metabolic AMEs. To retrace this putative evolutionary path we first
identified the residues in AMEs and WMEs that are crucial for preference of ammonia or
water as a nucleophile and subsequently established ICS activity on an AS scaffold.
An SSN of the MST-superfamily shows that AMEs and WMEs can be distinguished with
high certainty at the sequence level (Figure 12). The ammonia-utilizing ASs and ADCSs are
mostly grouped together in a large cluster, but are well separated from the water-utilizing
SSs and ICSs. From the SSN we extracted the sequences of ASs, ADCSs, SSs, and ICSs
and generated MSAs for each group, which in turn were used to compute a phylogenetic
tree of AMEs and WMEs and finally sequence logos of the individual families (Figure 13).
Also in the phylogenetic tree, primary metabolic AMEs and secondary metabolic WMEs
are well separated with the posterior probabilities of important branches above 80%. To
focus the search for the residues that determine nucleophile specificity, we made use of
the fact that the AMEs AS and ADCS are heteromeric GATase complexes, in which the
ammonia nucleophile is channeled from the active site of the glutaminase subunit to the
active site of the synthase subunit (Raushel et al., 2003). We identified a 30 Å long channel
that connects the active sites in the AS from S. typhimurium (stAS), similar to the channel
observed in the crystal structure of a homologous ADICS (Li et al., 2011). Three residues
principally shape the channel near the active site of the synthase where CH is bound:
Gln263 in β-strand 11 as well as Met364 and Leu365 in α-helix 12 of stAS (Figure 13, inset).
This trio of residues is conserved as QML in AS and QMI in ADCS. Although the WMEs ICS
and SS are monomers and neither channel a nucleophile nor a reaction intermediate, it
stands to reason, due to homology and similar active sites, that the hydroxide nucleophile
reaches the CH electrophile via the same route as the ammonia does in AMEs. The three-
residue motif is predominant as KLV in ICS and KIS in SS. The lysine residue in these
motifs was shown to act as the catalytic base necessary for generation of the reactive
hydroxide ion from water in the reactions of ICS and SS (Kolappan et al., 2007; Zwahlen
et al., 2007). However, a simple substitution of Gln263 by lysine in AMEs is not sufficient
to establish ICS or SS activity (Kerbarh et al., 2006).
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Figure 12. Sequence similarity network of the MST-superfamily.
The SSN of the MST-superfamily was generated from the InterPro data-set IPR019999
(anthranilate synthase component I-like) at an E-value threshold of 10−80. Nodes corre-
sponding to AMEs and WMEs, according to the InterPro annotation, are colored in shades
of blue and red, respectively. Gray nodes refer either to ambiguously annotated sequences
or to proteins with unknown function.
However, by combining the Gln263→Lys substitution with other substitutions at positions
364 and 365 in α-helix 12 of stAS, we were able to generate twelve enzyme variants that
formed IC in amounts comparable to the native ICS EntC from E. coli (Figure 14A). On
average, these stAS variants converted 20% of the supplied CH to IC within three hours,
with the most active KIA variant, reaching about 37% IC, which falls in the range of EntC.
The incomplete conversion is the result of an equilibrium between CH and IC, as has been
described for EntC (Liu et al., 1990). Importantly, upon mutation of the supposed catalytic
lysine of the triple-motif in the KLS variant, the resulting ALS variant lost all of its ICS
activity, demonstrating that the introduced lysine acts as a catalytic base.
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Figure 13. Sequence-structure-function relationship between ammonia- and water-
utilizing MST-enzymes.
The primary metabolic AMEs AS and ADCS (blue) catalyze the formation of the aminated
CH-derivatives AA and ADC. The small inset on the left shows the putative ammonia
channel that connects the active sites of the AS glutaminase subunit (indicated by a Gln
ligand and Cys87) and the AS synthase subunit (indicated by a CH ligand). The sequence
logos show the residues of β-strand 11 and α-helix 12, which mostly shape the channel as
it approaches the synthase active site. The secondary metabolic WMEs ICS and SS (red)
catalyze the formation of the hydroxylated CH-derivatives IC and SA. The sequence logos
show the same residues as for the AMEs. The figure is modified from publication B.
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Figure 14. HPLC analysis of product distribution after reaction of chorismate with wa-
ter or ammonia catalyzed by AS wild-type and variants.
For the four products AA, ADIC, SA, and IC their fraction out of all products formed is
shown (% conversion). All analyzed variants share Lys263 and are grouped by residue 364
(e.g. KM* describes the four stAS variants with Lys263, Met364, and either Leu, Val, Ser, or
Ala at position 365). All variants were assayed in the presence of the glutaminase stTrpG.
“wt” refers to the product distribution of the native AS from S. typhimurium, “EntC” to
that of the ICS from E. coli, and “(-)” to that of a control reaction in the absence of any
enzyme. Each data point represents the mean of at least three independent experiments.
Error bars are omitted for clarity, because the average and maximum absolute errors were
only 0.3% and 3.7%, respectively. Step lines connecting data points were added to aid
visual tracking of product-specific values. (A) Product distributions in the absence of any
ammonia source. (B) Product distributions in the presence of glutamine as an ammonia
source. The figure is modified from publication B.
Interestingly, apart from the catalytic lysine in β-strand 11, ICS activity only depends on
the occupation of position 365. The nature of the residue at position 364 is irrelevant for
IC formation; all tested amino acids (Met, Leu, Ile, and Ala) lead to active KM*, KL*, KI*,
and KA* variants (Figure 14A). These results argue against a role of the residue at position
364 in positioning the catalytic lysine via hydrophobic interactions, as has been suggested
previously (Ziebart and Toney, 2010).
Molecular dynamics simulations predicted that the occupation of position 365 with a
relatively small amino acid is crucial for ICS activity: The presence of a residue with a larger
sidechain than that of valine blocks the access of hydroxide ions to CH bound in the active
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site. In accordance with this prediction, all tested variants with a leucine at this position
were inactive (Figure 14A). Moreover, virtually none of the ICS and SS sequences in our
MST data-set contained a residue larger than valine at this crucial position. The chemical
properties of the residue at position 365 seem to be less important; variants with Val, Ser,
or Ala all displayed ICS activity (Figure 14A). Therefore, ICS activity is not dependent on a
hydrogen-bond acceptor close to the catalytic lysine, as it has been suggested (Ziebart and
Toney, 2010). Moreover, a hydrogen bond acceptor residue like serine is not conserved in
SS and is not present in ICS.
3.2.2 Secondary-metabolic MST-enzymes might have evolved via
bi-functional intermediates
Notably, all stAS variants that displayed ICS activity were still able to utilize ammonia and
form AA, implying a broadened nucleophile specificity (Figure 14B). In other words, these
variants are bi-functional and formed substantial amounts of AA and IC at the same time
(see for example the stAS variant with the KIA motif, which forms about 40% AA and 20%
IC). This demonstrates that a lysine catalytic base is required for the activation of water as
a nucleophile but still allows for the access of ammonia to the active site.
Does this bi-functionality hint at a possible evolutionary path leading from AMEs
to WMEs? It is generally acknowledged that secondary metabolic pathways have been
assembled through the acquisition of genes coding for primary metabolic enzymes (Fis-
chbach et al., 2008; Vining, 1992). The thought process behind this assumption involves
the duplication of a gene coding for a primary metabolic enzyme and the shaping of
its biological activity through mutations (neo-functionalization) (Firn and Jones, 2000;
Fischbach et al., 2008; Ohno, 1970). Although the novel metabolite that is formed by
the mutated enzyme may not immediately be beneficial for its producer organism, it
might add to the overall chemical and metabolic potential by generating additional new
metabolites through spontaneous transformations or through conversion by enzymes
with broad substrate spectra (Vining, 1992). In the end, mutations that confer some
kind of evolutionary advantage, are fixated in the genome. This could for example be a
novel biomolecular activity, like high-affinity binding to cellular receptors of competing
organisms, or a novel physiochemical property, like the diversification of cell wall and
membrane components, making them less susceptible to enzymatic degradation (Firn
and Jones, 2009). Later in evolution the duplicated genes are step by step integrated into
BGCs that diverge through loss or gain of genes and through differentiating mutations in
their enzymes (Fischbach et al., 2008; Traitcheva et al., 2007).
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Most of such recruitment events have been described for enzymes from plant secondary
metabolism (Moghe and Last, 2015); most likely because these events happened much
more recently in evolutionary time-scales than comparable events in prokaryotic or-
ganisms and are thus easier to track. Just to give two examples, an isopropylmalate
synthase from acylsugar biosynthesis has recently been traced back to its homolog from
leucine biosynthesis (Ning et al., 2015) and a fatty acid-binding protein from primary
metabolism was identified as the origin of a chalcone isomerase that is part of flavonoid
biosynthesis (Ngaki et al., 2012). For bacteria, polyketid synthases and non-ribosomal
peptide-synthethases have been directly and experimentally traced back to their primary
metabolic homologs (Jenke-Kodama and Dittmann, 2009; Jenke-Kodama et al., 2008;
Ziemert et al., 2014).
The notion of duplication-divergence-integration might, however, be a gross simplifi-
cation, because it is not completely reasonable to assume that during evolution thousands
and thousands of duplicate genes just emerged, mutated, and eventually led to hitherto
unknown metabolites that also conferred a selective advantage to their producing or-
ganisms. Three key points argue against this assumption: First, as mentioned in the
introduction to this chapter, decent biological activity with physiological relevance of any
chemical compound is very rare (Firn and Jones, 2009). Second, gene duplication comes at
a significant cost. Aside from the immediate physiological costs including the expenditure
of energy for replicating, transcribing, and translating the extra genes, duplication may
also lead to deleterious changes in gene dosages (Papp et al., 2003; Veitia, 2004). For
example, an increased flux of important primary metabolites into a specific amino acid
biosynthetic pathway, due to a duplication of the gene that codes for the enzyme of the
committed step, would lead to a depletion of other amino acids, with the consequences
at hand (Freeling and Thomas, 2006). Third, the rare mutations necessary for altering
the phenotype of the gene towards novel metabolic diversity can only accumulate if the
duplicated gene remains in the genome or population for a sufficient time (Bergthorsson
et al., 2007). To ensure this, some kind of selective pressure would have to act on the
redundant gene to be maintained, despite conferring no immediate benefit to its owner.
This selective pressure would in turn restrict the ability of the gene copy to accumulate
mutations; the cat evidently catches its tail here. Consequently, the overwhelming ma-
jority of duplicated genes are lost (Hughes, 1994; Lynch and Conery, 2000), especially
duplicates of genes that code for primary metabolic enzymes (Chae et al., 2014).
Evolution should thus favor such organisms that can produce chemical diversity at
low genetic and metabolic costs, which means, not necessarily through an obligatory
gene duplication. This is possible by exploiting promiscuity and multi-functionality of
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enzymes. Richard Firn described this idea in the following example (Firn and Jones, 2009):
Consider an organism, which contains an enzyme that produces an orange pigment.
Now a mutation occurs in the gene coding for that enzyme, leading to either a relaxed
substrate specificity so that the enzyme accepts a structurally related but chemically
different substrate or to a slightly altered reaction chemistry. The result is a new pigment
with similar physicochemical properties that still absorbs in the orange but now also in
the yellow part of the visible spectrum. This mutant might thus exert no drawbacks on the
organism (i.e. loss of absorption of orange light) and there will be no selective pressure to
return the mutant enzyme to its original state. Moreover, there would also be no selective
pressure due to increased genetic or metabolic costs as described above, because this
scenario does not require a preceding gene duplication; the phenotype of the original
gene is adequately retained in the new, mutated version.
Such multi-functional enzymes are often called metabolic generalists and are sup-
posed to be an important part of metabolic evolution (Weng et al., 2012). An example
of such sub-functionalization of a metabolic generatlist enzyme is the biosynthesis of
pyrrolizidine alkaloids in plants (Moghe and Last, 2015): The enzyme deoxyhypusine
synthase is essential in primary metabolism for covalently modifying a lysine residue
of an eukaryotic translation initiation factor. It has also gained the ability to catalyze
a similar reaction with putrescine as a substrate, which mimics the four-carbon lysine
sidechain with its ϵ-amino group (Ober et al., 2003). This reactivity is important in the
biosynthesis of the pyrrolizidine alkaloids. Modern plants however, contain two homologs
of the deoxyhypusine synthase, whereby the secondary metabolic homolog has lost the
ability to modify the translation initiation factor and only accepts putrescine as a substrate
(Kaltenegger et al., 2013). Of course, such side-functions must not negatively impact
the original function (Copley, 2015). Consequently, generalist enzymes are often inef-
ficient compared to highly specialized primary metabolic enzymes, possibly to avoid a
competition for metabolic resources (Bar-Even and Tawfik, 2013).
We have identified an example for the transition from a primary metabolic enzyme
to a secondary metabolic one that fits Firn’s generalist allegory remarkably well. Two
mutations are sufficient to convert the primary metabolic AS into a generalist enzyme that
accepts both ammonia and water as nucleophiles and thus forms AA and IC. An evolu-
tionary intermediate similar to our bi-functional stAS variants could have generated novel
metabolic diversity by opening the route to hydroxyl-substituted CH derivatives while at
the same time maintaining the formation of AA for tryptophan biosynthesis. At this stage,
duplication may have increased the efficiency of such a generalist through gene dosage ef-
fects (Näsvall et al., 2012) and sub-functionalization through gradual adaptation led to an
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increase in catalytic efficiency and specificity for the formation of IC. It can be speculated
that some inherent property of a generalist AS/ICS intermediate may have influenced
the retention of the duplicates in the genome, which would be an important factor for
sub-functionalization. It has been suggested that promiscuity or multi-functionality and
the possibility to explore a diverse chemical reaction space are such properties that favor
retention of duplicate genes (Moghe and Last, 2015; Weng and Noel, 2012).
The question remains of course, how such metabolic novelty as in the case of IC
was conserved and integrated into modern secondary metabolites. From IC only two
additional enzymatic activities, exerted by EntB and EntA, are required to yield 2,3-
dihydroxybenzoic acid (2,3-DHB), a molecule that itself can act as a siderophore, albeit
with lower affinity than enterobactin (Lopez-Goñi et al., 1992). EntB and EntA are fre-
quently found together in small genomic cluster with the ICS EntC (Crosa, 1989; May et al.,
2001). We recently traced back the evolutionary history of EntB and EntA to their primary
homologs from fatty acid and nucleotide metabolism (Publication D), which further adds
to the notion that the enterobactin biosynthetic pathway was recruited from primary
metabolic enzymes. It can thus be assumed that the enterobactin pathway evolved piece
by piece: Initially a rudimentary pathway for the biosynthesis of 2,3-DHB was estab-
lished from EntC, EntB, and EntA and later three iron-chelating 2,3-DHB molecules were
linked together via a serine peptide scaffold through the recruitment of non-ribosomal
peptide-synthetase-like enzymes into the pathway (Fischbach et al., 2008).
Although the acquisition of primary metabolic enzymes for secondary metabolism
has long been known and numerous examples have been characterized, the true extent of
these recruitment processes was not clear. We have recently identified primary metabolic
homologs for 55% of the secondary metabolic enzymes listed in the MIBiG database
(Publication D). It may thus be safe to say that about half of all known secondary metabolic
enzymes can be traced back to their primary metabolic ancestors. It will be interesting
to see whether experiments similar to those described in this chapter will enable one to
transform primary metabolic homologs into their secondary metabolic relatives and thus
to uncover more and more of the intricate evolutionary relationships between primary and
secondary metabolism. One obvious challenge would be to reconstruct the enterobactin
pathway from the identified primary homologs. The results presented in this chapter
might also guide other metabolic engineering approaches involving siderophores, like the
alteration of the biosynthetic capabilities of human pathogenic Burkholderia strains to
produce different types of hydroxamate siderophores (Franke et al., 2014).
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4 Evolutionary diversification of
protein-protein interactions by
interface add-ons
(Synopsis of Publication C)
4.1 Introduction
4.1.1 Protein-protein interactions
Life in its full complexity would not be possible without protein-protein interactions (PPIs)
or in other words the specific and mutual recognition of individual proteins and the non-
covalent formation of larger complexes. In fact, interacting proteins are at the very basis
of virtually every cellular function, including but not limited to replication, transcription,
translation, membrane transport, signal transfer, and cell-cell communication (Keskin
et al., 2016). With such critical roles to play in key cellular processes, it is not surprising
that a number of severe diseases including cancer (Zinzalla and Thurston, 2009) and
neurodegenerative diseases (Menche et al., 2015) are linked to dis-regulated PPIs (Meyer
et al., 2014; Schuster-Böckler and Bateman, 2008).
In contrast to the old doctrine that phenotypic complexity directly relates to genetic
complexity it is now clear that instead the extent and connectivity of interacting and
inter-playing proteins determine the developmental stage of organisms. In this context,
the sequencing of the first complete genomes has shown that not only the number of base
pairs (around 3×109) but also the number of genes (around 6000 to 30000) is comparable
between lower and higher species (Blattner et al., 1997; Goffeau et al., 1996; Venter et al.,
2001). However, for uni-cellular organisms like Saccharomyces cerevisiae the number
of binary PPIs is projected to be around 18000 to 75000 (Yu et al., 2008; Zhang et al.,
2012a), whereas for higher species like humans, this number is at least 10-fold higher, with
– 47 –
Evolutionary diversification of protein-protein interactions by interface add-ons
PPI
obligate
non-
obligate
permanent
transient
homo-
meric
hetero-
meric
glutathione
S-transferase
P-cresol methyl-
hydroxylase
SOD1 dimer
trypsin-
BPTI complex
NFκB
dimer
ubiquitin-UEV
complex
A B
homo-
meric
hetero-
meric
homo-
meric
hetero-
meric
Figure 15. The human interactome and a classification of PPIs.
(A) Network representation of a part of the human interactome showing 14000 binary
PPIs derived from small-scale and systematic high-throughput experiments (Rolland
et al., 2014). Each node represents a protein and connecting edges represent PPIs. (B)
Classification of PPIs as proposed by Nooren and Thornton (2003a) and Keskin et al. (2016).
PPIs can be organized based on the stability of the resulting complexes (obligate vs. non-
obligate), based on the affinity between the subunits (transient vs. permanent), and based
on the subunit composition of the complexes (homomeric vs. heteromeric). Identical
subunits of the example complexes are colored in different shades of blue, structurally
different subunits are colored green. The structures were taken from the PDB.
about 200000 to 600000 projected PPIs (Stumpf et al., 2008; Venkatesan et al., 2009). The
resulting highly inter-connected networks of PPIs are often referred to as interactomes
(Figure 15A). The complexity of interactomes is also evident from the observation that in
S. cerevisiae, for example, over 70% of all proteins undergo at least one PPI (Gavin et al.,
2006; Krogan et al., 2006). In other words, the interaction of proteins is much rather the
norm that the exception and only few proteins act isolated. Our understanding of PPIs
and interactomes is, however, still in its early stages. Only about 10% of all human PPIs
have been experimentally validated and characterized so far (Hart et al., 2006). Moreover,
structural information of protein complexes is often inaccessible. For example, of the
75000 projected binary PPIs in S. cerevisiae, only 300, or about 0.5%, are structurally char-
acterized (Zhang et al., 2012a).
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The different types of PPIs are as diverse as the tasks they are involved in. Nooren and
Thornton (2003a) proposed a classification scheme based on three important aspects of
PPIs: stability, affinity, and composition of the resulting complexes (Figure 15B). Con-
cerning stability, PPIs are divided into obligate and non-obligate interactions. Obligate
complexes are exclusively present in oligomeric form and the corresponding monomers
are not found in free or isolated form in vivo. Their association is often compulsory
due to simultaneous gene expression and translation (Nooren and Thornton, 2003a) and
their function usually critically depends on complex formation. Examples for obligate
complexes are ribosomes (Yusupov et al., 2001), chaperones (Xu et al., 1997), glutathione
S-transferase (Strange et al., 2001), or P-cresol methylhydroxylase (Kim et al., 1995).
In contrast, non-obligate complexes exist in an equilibrium between the oligomeric
form and the free, monomeric subunits (Jones and Thornton, 1996; Levy and Teichmann,
2013). Non-obligate interactions can further be classified based on the affinity between
the subunits into permanent and transient PPIs (Figure 15B). Permanent interactions are
characterized by high affinities between complex subunits and corresponding dissociation
constants are usually in the low nanomolar range or below (Jones and Thornton, 1996).
A typical example are antibody-antigen complexes, which form with high affinity and
usually dissociate slowly. Other examples are the human superoxide dismutase (SOD1)
that forms highly stable dimers but is also active in its monomeric form (Banci et al., 1998)
or complexes between proteases like trypsin and corresponding high-affinity inhibitors
like the bovine pancreatic trypsin inhibitor, which binds to trypsin with a dissociation
constant of 10−14 M (Vincent and Lazdunski, 1972). In contrast, transient complexes are
characterized by a much weaker interaction between their subunits with dissociation
constants generally in the micromolar range or higher (Nooren and Thornton, 2003b).
Usually, key components of cellular signaling pathways like NFκB-target complexes or
complexes between ubiquitin and corresponding ubiquitin-binding proteins are transient.
Their dynamic, continuous association and dissociation allows the formation of many
diverse effector complexes, depending on temporal and spatial conditions (Plowman and
Hancock, 2005; Verma et al., 1995).
Finally, PPIs can be classified based on the composition of the resulting complexes.
Binary or dimeric complexes comprise only two subunits, whereas higher-order or multi-
meric complexes like ribosomes, chaperons, or virus particles can comprise up to 1200
individual subunits (Klose and Rossmann, 2014). Homomeric complexes are formed
through the association of identical subunits, whereas heteromeric complexes are formed
through the association of non-identical subunits. It should be noted at this point that,
no matter how well such classification schemes perform, they are just simplifications
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that make it easier to comprehend the continuum of PPIs that results in the most diverse
protein complexes, reflecting specific physiological conditions, the presence of effector
molecules and inhibitors, or cellular co-localization.
The variety of PPIs and protein complexes is the result of evolutionary processes that have
shaped each interaction in a way to optimize their associated function (Janin et al., 2008;
Marsh and Teichmann, 2015). For instance, obligate complexes have possibly evolved
for reasons of stability or because of the need for a tight and permanent interaction that
allows the formation of a shared active site (Dobson et al., 2004; Wente and Schachman,
1987). Just as well, transient PPIs were shaped that way for reasons of multi-specificity or
for the ability to interact with numerous different partners in signal transduction pathways
(Nooren and Thornton, 2003a).
The evolution of protein complexes most likely proceeded via step-by-step assembly
of individual subunits to higher-order complexes. These processes have been retraced
in the laboratory for a number of protein complexes (Levy et al., 2008; Marsh et al.,
2013; Marsh and Teichmann, 2014). Moreover, it has recently been demonstrated that
complex evolution most likely only involved three basic steps: subunit dimerization,
cyclization, and addition (Ahnert et al., 2015). However, due to the complexity of PPIs
and interaction networks, their evolutionary history still lies mostly in the dark. This
is furthermore aggravated by the fact that only a minor fraction of protein complexes
are accessible by traditional structural biology methods like crystallography, nuclear
magnetic resonance spectroscopy, or electron microscopy. Also, small-scale but high-
quality in vitro analyses of PPIs are often limited to indirect and labor-intensive methods
like gel filtration chromatography or mass spectrometry that do not yield immediate
three-dimensional structure information on protein complexes. Thus, mapping of whole
interactome networks heavily relies on high-throughput but low-quality methods like
two-hybrid screenings (Brückner et al., 2009; Fields and Sternglanz, 1994; Warbrick, 1997)
and tandem affinity purifications coupled to mass spectrometry (Kaiser et al., 2008; Völkel
et al., 2010). Two hybrid and related split systems are based on the genetic fusion of
suspected interaction partners to DNA-binding and transcription-activation domains of
transcription factors or to two domains of an enzyme in a way that the intact reporter
construct (full transcription factor or full active enzyme) is only formed when the two
fused proteins interact. Aside from unraveling whole organism interactomes (Parrish
et al., 2006) such systems have been successfully applied to detect over 300 novel phospho-
tyrosine based PPIs related to cancer signaling pathways (Grossmann et al., 2015) or for
the analysis of extra-cellular, cross-synaptic PPIs (Martell et al., 2016). One of the newest
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methods for high-throughput analysis of PPIs are protein-based micro-arrays (Hall et al.,
2007), which helped, for instance, to identify inhibitors of protein complexes associated
with the development of breast cancer (Na et al., 2014). However, the big caveats of these
high-throughput approaches are the high rate of falsely identified (Huang et al., 2007;
Williamson and Sutcliffe, 2010) or unspecific PPIs (Hayes et al., 2016) and the frequent
loss of transient interactions (Yu et al., 2008).
Consequently, computational approaches have long played a key role in investigating
PPIs. One task is to predict possible interaction partners as exactly as possible based
only on non-structural information like sequence homology, gene co-expression, and
phylogenetic profiling (Shoemaker and Panchenko, 2007). Importantly, the combination
of such methods with experimentally derived structural information, homology modeling,
or docking procedures has proven to yield more accurate results and more coverage of
interactomes compared to experimental high-throughput methods (Zhang et al., 2012a).
In the last decade, a lot of effort has been put into integrating the results of experimental
and computational approaches into PPI-databases like STRING (Szklarczyk et al., 2011),
BioGRID (Chatr-Aryamontri et al., 2015), or DIP (Salwinski et al., 2004). Computational
tools can also further assist in the characterization of PPIs. For instance, the technique
of in silico alanine scanning (Kortemme et al., 2004) allows for the replacement of every
amino acid of a protein complex by alanine and the computation of the resulting change
in binding free energy. Modern applications like mCSM (Pires et al., 2014) or FoldX
(Schymkowitz et al., 2005) even predict the actual experimental change in binding free
energy with high confidence. For details of the computational approaches targeted at PPIs
and protein complexes see the reviews of Keskin et al. (2016), Shoemaker and Panchenko
(2007), and Wetie et al. (2014).
4.1.2 Protein interfaces
So far, one important aspect of PPIs has been left out: What is their molecular basis?
Eventually, every PPI comes down to three steps. First, the subunits have to mutually
approach each other by diffusion, possibly supported by cellular co-localization. Second,
geometrically and electrostatically complementary surfaces allow the subunits to arrange
each other in a precise orientation, which, third, enables the formation of hydrophobic,
ionic, or hydrogen-bond contacts between amino acid backbone and side-chain groups
across the interface between the individual subunits. These interfaces are as diverse as
PPIs themselves and often reflect the type of interaction that is conveyed (Conte et al.,
1999; Jones and Thornton, 1997). For example, the interfaces of proteins that form non-
obligate, transient complexes are often much smaller and more planar in geometry than
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the interfaces of proteins that form highly stable, permanent homo-dimers (Nooren and
Thornton, 2003a). Figure 16 illustrates the concept of geometric complementarity of
interfaces at the example of an AS dimer from S. typhimurium.
Nevertheless, there is a consensus that interface regions significantly differ from the
remaining protein surface (Glaser et al., 2001; Jones and Thornton, 1996; Ofran and Rost,
2003). Interfaces generally comprise more hydrophobic and aliphatic residues, whereas
the remaining surface contains more polar and charged ones (Hamer et al., 2010). The
interfaces of the two subunits of the AS dimer reflect this preference as both are relatively
hydrophobic (Figure 16, dark red). Additionally, serine, alanine, and glycine residues are
under-represented and arginine, cysteine, and histidine are over-represented in interfaces
(Hamer et al., 2010). Also, the propensity of interface residues to form salt-bridges is
generally higher (Sheinerman et al., 2000). However, as mentioned above, the precise char-
acteristics of interfaces vary considerably between different types of protein complexes;
for instance, the interfaces of obligate, homomeric complexes have a much higher propor-
tion of hydrophobic residues than that of non-obligate, heteromeric complexes, which
possibly reflects a hydrophobic effect-like principle during the simultaneous folding and
association of the homomers (Ofran and Rost, 2003).
Interfaces differ from the remaining protein surface also with respect to amino acid
conservation. In general, interface residues tend to be more conserved than other surface
residues (Caffrey et al., 2004; Valdar and Thornton, 2001). On closer inspection, it is
evident that most interfaces can also be sub-divided into a highly conserved central core
and a less conserved, peripheral rim (Bouvier et al., 2009; Chakrabarti and Janin, 2002;
Guharoy and Chakrabarti, 2005). The interfaces of the AS dimer also reflect this tendency;
notice the almost completely conserved central core in both the synthase and glutaminase
interface (Figure 16, dark magenta). The interface of the synthase subunit also shows that
the highly conserved core regions are often more hydrophobic than the peripheral regions
(Chakrabarti and Janin, 2002).
The common properties of protein interfaces have been exploited for the development
of over 70 different computational procedures (Esmaielbeiki et al., 2016) that aim to
predict interfaces from the primary sequence alone (Chen and Li, 2010; Yu et al., 2010a)
or from a combination of sequence and structure information (Dong et al., 2014; Liu
et al., 2014; Zellner et al., 2012). However, such methods strongly depend on the quality of
available training data and their prediction quality is still limited (Yu et al., 2010b). Thus,
most protein interface databases like PISA (Krissinel and Henrick, 2007) and PDBsum
(de Beer et al., 2014) still rely on experimentally determined protein structures for the
identification of interfaces .
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Figure 16. Illustration of common interface properties.
The interface between a synthase (light gray) and a glutaminase subunit (dark gray) of the
AS complex from S. typhimurium demonstrates the shape-complementarity typical for
protein interfaces. Interface residues are shown in sphere representation. In the lower
half of the figure the synthase and glutaminase subunits are rotated by 90° clock-wise
and counter clock-wise, respectively, to allow a plan view of the interfaces. The subunits
are also shown in surface representation, either colored by hydrophobicity or amino
acid conservation. Especially the synthase interface makes clear that protein interfaces
comprise a highly conserved, mostly hydrophobic core region and a less conserved, more
polar peripheral rim region. Hydrophobicity was calculated according to the scale from
Eisenberg et al. (1984). Amino acid conservation in the interface was adapted from
publication C.
Despite the overall conservation and the common properties of interfaces, it has become
more and more evident that only very few amino acids in interfaces are actually impor-
tant for forming and sustaining interactions between proteins. These so-called binding
hot-spots are often responsible for the majority of binding free energy (Ma et al., 2001;
Ofran and Rost, 2007; Reichmann et al., 2007) and are defined such that a substitution
by alanine decreases this energy by at least 2 kcalmol−1, thus significantly destabilizing
the corresponding complex (Bogan and Thorn, 1998; Thorn and Bogan, 2001). These
hot-spots are usually identified by site-directed mutagenesis (Fowler and Fields, 2014;
Hinkley et al., 2011; Van Petegem et al., 2008) or in silico alanine-scanning (Kortemme
et al., 2004; Robin et al., 2014).
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4.1.3 Glutamine amidotransferases
A vivid example for the importance of PPIs are GATases. As mentioned in section 3.1.1
these non-obligate complexes are essential for the incorporation of nitrogen into a variety
of metabolites. Interactions between their glutaminase and synthase subunits are impor-
tant to shield the generated ammonia from the solvent and to couple its formation to a
biosynthetic reaction (Figure 17). Hence, an unnecessary hydrolysis of glutamine and the
formation of nascent, possibly toxic ammonia is prevented.
GATases can adopt various quaternary structures, ranging from heterodimers like
the imidazole glycerolphosphate synthase (Douangamath et al., 2002) or ADCS (Parsons
et al., 2002), to tetrameric complexes like AS (Knöchel et al., 1999; Morollo and Eck, 2001;
Spraggon et al., 2001) and dodecamers like the pyridoxalphosphate synthase (Strohmeier
et al., 2006; Zein et al., 2006). The synthase subunits are as diverse as the respective
reactions they catalyze (Massiere and Badet-Denisot, 1998). The glutaminases on the
other hand can be grouped into two classes based on the chemistry applied to hydrolyze
glutamine. Class I glutaminases display an α/β-hydrolase like fold (Ollis et al., 1992) and
possess a catalytic triad comprising cysteine, histidine, and glutamate for the hydrolysis of
glutamine via a glutamyl thioester intermediate (Thoden et al., 1998). This class includes
AS (Figure 17), ADCS, imidazole glycerolphosphate synthase (Douangamath et al., 2002),
carbamoylphosphate synthase (Thoden et al., 1997), formylglycinamide synthase (Anand
et al., 2004), guanosine-5’-monophosphate synthase (Tesmer et al., 1996), cytidine-5’-
triphosphate synthase (Goto et al., 2004), and pyridoxalphosphate synthase (Strohmeier
et al., 2006). Class II glutaminases also posses an α/β-hydrolase like fold (Ollis et al., 1992)
but contain an N-terminal nucleophilic cysteine instead of a catalytic triad and are thus
often referred to as N-terminal nucleophile (NTN) glutaminases (Zalkin and Smith, 2009).
This class includes asparagin (Nakatsu et al., 1998) and glutamate synthase (Binda et al.,
2000), glutamine phosphoribosylpyrophosphate amidotransferase (Smith, 1998), and
glucosamine-6-phosphate synthase (Milewski, 2002).
Despite the different classes of glutaminases and the considerable structural and func-
tional variability of synthases, most GATases act in a similar, highly coordinated manner
(Bera et al., 1999; Goto et al., 1976; Miles et al., 1998). Usually, glutamine hydrolysis is
allosterically triggered by binding of the synthase and the acceptor substrate. Several
cases can be discerned in this context: The glutaminase activity of the pyridoxalphosphate
synthase from Bacillus subtilis critically depends on complex formation but is not further
increased by the presence of an acceptor substrate in the synthase active site (Raschle
et al., 2005). In a certain way similar, interaction with the synthase subunit is mandatory
for glutaminase activity in AS (List et al., 2012) and imidazole glycerol phosphate synthase
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Figure 17. Anthranilate synthase as an example of glutamine amidotransferases.
AS catalyzes the formation of anthranilate from chorismate and glutamine. Here, one
of the two TrpE:TrpG dimers of the AS from S. marcescens is shown (PDB ID 1i7q). The
glutaminase subunit TrpG is a class I glutaminase, which utilizes a catalytic triad compris-
ing cysteine, histidine, and glutamate (see cut-out) for the hydrolysis of glutamine into
glutamate and nascent ammonia. The ammonia is subsequently channeled through a
roughly 40 Å long channel (pink mesh object) to the active site of the synthase subunit
TrpE (represented by cyan benzoate and pyruvate stick models). After elimination of
pyruvate, the amino-substituted product anthranilate is released. The activity of the glu-
taminase TrpG is dependent on the binding to TrpE (thin green arrow) and the additional
presence of chorismate in the active site of TrpE leads to a further allosteric activation of
TrpG (thick green arrow).
(Beismann-Driemeyer and Sterner, 2001). In these complexes, however, the additional
binding of the acceptor substrates PRFAR or CH (Figure 17) drastically increases the
reaction rate of glutamine hydrolysis 30-fold and up to 4900-fold, respectively (Klem
et al., 2001; Klem and Davisson, 1993; Zalkin and Smith, 2009). Although similar activa-
tion mechanisms are observed for ADCS, their glutaminases also display basal, albeit
weak, glutamine hydrolysis activity. This indicates that the functional coupling between
glutamine hydrolysis and ammonia consumption is not always fully guaranteed.
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4.2 Summary and Discussion
4.2.1 The role of interface add-ons for protein-protein
interaction specificity
PPI-networks are often highly inter-connected and of complex topology. The E. coli and
human interactomes deposited in the STRING database comprise hundreds of thou-
sands of interactions, inferred from high-throughput experiments, gene-neighborhoods,
co-expression, other databases, and text mining (Szklarczyk et al., 2011). This high con-
nectivity suggests that many proteins not only interact with one specific but with multiple,
different partners. One example is the well-characterized p53 protein, the key player in
response to DNA damage and oncogene activation. p53 assuredly interacts with at least
30 different proteins (Dartnell et al., 2005). Just the same, the NFκB transcription factor
forms complexes with a multitude of different partners in various signaling pathways
(Nooren and Thornton, 2003a).
However, PPI-networks tend to overstate the number of multi-specific proteins, as they
often contain a high number of falsely identified and non-specific interactions (Hayes et al.,
2016; Williamson and Sutcliffe, 2010). The E. coli interactome is drastically simplified to
about 2200 interactions when only high-confidence, experimental evidence is considered
(Figure 18A). Moreover, this reduction makes clear that over two thirds of all proteins
that undergo any kind of interaction only bind to one or two other proteins. Thus, most
interactions are highly specific, which means that many proteins are engaged in only
a single or a very limited number of complexes (Schreiber and Keating, 2011). Such
specific PPIs are crucial for many essential physiological functions like the assembly of
catalytic enzyme complexes or the formation of toxin-antitoxin (Fiebig et al., 2010) or
antibody-antigen complexes (Van Regenmortel, 2014).
But how is interaction specificity achieved and which conditions may influence it?
First of all, proteins do not exist in isolation but rather in the crowded environment of a cell.
For example, E. coli expresses over 4000 different proteins (Karp et al., 2002). The resulting
macromolecular crowding is extensive – up to 30% of cellular dry mass is composed of pro-
teins (Elcock, 2010) – and it can even limit protein diffusion (Wang et al., 2010). Proteins
thus logically come into contact with a wide variety of others inside a cell (Levy et al., 2012;
Sarkar et al., 2013). Interaction specificity consequently depends on that proteins not
only bind their native partners but also disfavor non-native interactions and thus avoid
the formation of non-physiological complexes (Sikosek and Chan, 2014). The affinity
between and the local concentration of the protomers as well as possible sub-cellular
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Figure 18. Protein-protein interaction specificity.
(A) Network representation of a part of the E. coli interactome derived from high-
confidence, experimental data deposited in the STRING database. The network shows the
878 proteins (nodes) that interact with at least one other protein and the resulting 2285
interactions (edges). Proteins with only one or two interaction partners are represented
by blue nodes (B-D) Illustration of PPI specificity. (B) In principle, several homologous
subunits with similar interface geometries (circle segments and hexagons, respectively)
create the possibility of erroneous interactions (dashed arrows) in addition to native inter-
actions (solid arrows). (C) Specificity determining mutations (black) are a possible means
to enforce native interactions. (D) An interface add-on (green extension) as an alternative
means to prevent erroneous interactions without modifying the conserved interface core.
co-localization have been described to play important roles in this context (Schreiber
and Keating, 2011). The most important point for interaction specificity, however, is the
geometric and electrostatic complementarity between matching protein interfaces and
the lack of it between non-related interfaces (Nooren and Thornton, 2003a). But the
necessary variability in interface structures or geometries has its limitations: First, the
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protein structure space is finite (Levitt, 2009; Skolnick et al., 2009; Zhang and Skolnick,
2005) and comprises not more than 1000-1500 different folds (Chothia, 1992; Gao and
Skolnick, 2010), most likely due to the physical constraints resulting from the need for
efficient and compact packing of hydrogen-bonded secondary-structure elements during
protein folding (Finkelstein and Ptitsyn, 1987; Zhang et al., 2006). Consequently, the
same biophysical constraints limit the number of possible interface geometries to around
one thousand (Gao and Skolnick, 2010). Second, the overall relatively flat architecture
of protein interfaces as well as functional constraints additionally limit larger structural
variations. For example, several serine protease-inhibitor complexes utilize highly similar
interfaces in spite of structurally different inhibitors (Gao and Skolnick, 2010). A direct con-
sequence of these limitations is the relatively low number of possible protein quaternary
structures of supposedly only 4000 (Garma et al., 2012). Taken together, it is not surprising
that the detailed molecular basis of interaction specificity is not well understood.
The problem of assuring interaction specificity becomes even more challenging, if
several homologous interaction partners exist (Figure 18B). In this case, similarities in
sequence, structure, and consequently interface geometry and electrostatics create the risk
of erroneous interactions and formation of non-physiological complexes. This has been
recognized as a particular problem in large, paralogous enzyme families (Schreiber and
Keating, 2011). One obvious solution is the diversification of interfaces by adaptational
mutations (Figure 18C) (Capra et al., 2012). In this scenario, complementary mutations in
the native interaction partners prevent non-native cross-interactions. Although interfaces
possess such variability (DePristo et al., 2005; Harms and Thornton, 2013), there are several
restraints limiting mutational diversification. First, the alphabet of proteinogenic amino
acids is limited and hence also the set of different physicochemical properties of interfaces
(Sikosek and Chan, 2014). Second, interfaces often convey a function beyond binding; e.g.
the formation of a shared active site (Giroux et al., 1994; Wente and Schachman, 1987), the
propagation of allosteric signals (Beismann-Driemeyer and Sterner, 2001; Rivalta et al.,
2012), or the transfer of reaction intermediates (Huang et al., 2001). These constraints
are reflected in the lower mutational rate of interface residues relative to non-interface
ones and the higher number of functionally equivalent and neutral mutations (Ames et al.,
2016; Mintseris and Weng, 2005).
We hypothesized that another concept exists, which avoids the limitations described
above. PPIs require the geometric complementarity of protein interfaces; local varia-
tions in interface geometries themselves might thus contribute to the specification of
interactions. We speculated that such geometric variability might preferentially exist
on the peripheral rim regions of interfaces that are not as conserved as the central core
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(Bouvier et al., 2009; Guharoy and Chakrabarti, 2005). In a comprehensive computational
survey of heteromeric, bacterial protein complexes, we identified large structural inser-
tions at protein interfaces that significantly change interface geometry and named them
accordingly interface add-ons (Figure 18D). Interface add-ons typically comprise 10-20
amino acids and form well-defined secondary structure elements. They are also crucial
for PPIs in the respective complexes, because they contain at least one and mostly three or
more binding hot-spot residues, which means that a substitution of these amino acids by
alanine significantly destabilizes the corresponding protein complexes (Bogan and Thorn,
1998; Thorn and Bogan, 2001).
A detailed description of this survey is available in publication C. In brief, we compiled
a reference set of bacterial, heteromeric protein complex structures and compared them
with their homologs of the corresponding superfamilies. By that we were able to identify
in the reference complexes large insertions that are not present in other superfamily
homologs. Vice versa, we identified in some superfamily homologs large insertions that
are missing in the reference complexes. Protein superfamilies are well suited for this
approach, because they provide a high level of classification and group proteins with
a broader structural and functional relationship than the more narrowly defined, often
iso-functional protein families. Several filter routines made sure that only such insertions
were accepted as interface add-ons that conform with the points made above. In total,
we found interface add-ons in about 10% of the analyzed complexes. Moreover, they are
not limited to certain phyla and we detected them in complexes from Actinobacteria, the
Deinococcus-Thermus group, Firmicutes, Thermotogae, and γ-Proteobacteria.
In the following, four examples are be described that illustrate why interface add-
ons may contribute to PPI-specificity. Cysteine desulfurases (Figure 19A) are enzyme
complexes that catalyze the transfer of sulfur from cysteine or selenocysteine to various
acceptor substrates in different biosynthetic pathways (Loiseau et al., 2005; Mihara and
Esaki, 2002). In E. coli, the CsdA2:CsdE2 complex contains interface add-ons in the CsdA
subunits, which form parts of the interface with CsdE. Importantly, E. coli also contains
the very similar IscS2:TusA2 complex, in which IscS is homologous to CsdA but TusA is
structurally and functionally different from CsdE. The IscS2:TusA2 complex does not con-
tain the interface add-ons, which suggests that they might contribute to the differentiation
of the CsdA and IscS homologs and their respective biosynthetic pathways.
A second example are the isocitrate- and isopropylmalate dehydrogenase complexes
from E. coli (Figure 19B). The former contains α-helical interface add-ons in its cat-
alytic IcdA subunits that are part of the interface with the isocitrate-dehydrogenase-
kinase/phosphatase AceK. Binding of the IcdA catalytic to the AceK regulatory subunits is
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CsdE
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TusA
TusA
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IscS
IcdA
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AceK
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LeuB
A Bcysteine desulfurases isocitrate/isopropylmalate dehydrogenases
GCAα
GCAβ
GCAα
GCAβ
C class III/class I aminocephalosporanic acid acylases
TrpE
TrpE
TrpE
TrpG
TrpG
TrpG
D anthranilate synthases
LeuB
Figure 19. Examples of heteromeric protein complexes with interface add-ons.
Subunits with interface add-ons are shown in cartoon representation; other subunits in
surface representation. Interface add-ons are colored green and their location is marked
by red spheres in complexes that lack the interface add-ons. The examples are two cysteine
desulfurases from E. coli (A), the isocitrate and isopropylmalate dehydrogenases from
E. coli (B), two aminocephalosporanic acid acylases from Pseudomonas species (C), and
two anthranilate synthases from S. typhimurium and S. solfataricus (D).
important for tuning isocitrate flux between the citric acid and the glyoxylate cycle (La-
porte and Koshland, 1982; Laporte, 1993). The isopropylmalate synthase LeuB, which is
part of leucine biosynthesis in E. coli, does not contain the interface add-on. The interface
add-on in IcdA might allow for a specific recognition by the regulatory AceK subunits and
thus differentiate the isocitrate dehydrogenase from the isopropylmalate dehydrogenase
for which no comparable phosphorylation/dephosphorylation mechanism is known.
Another example of homologous protein complexes that are differentiated by an
interface add-on are the glutaryl-7-aminocephalosporanic acid acyclases from Pseu-
domonas species (Figure 19C). These enzyme complexes are involved in penicillin and
cephalosporin biosynthesis (Kim et al., 1999). Class III representatives contain in their β-
subunit two interface add-ons, which form large parts of the interface with the α-subunit
(Golden et al., 2013). In contrast, class I representatives lack both interface add-ons and
the interface between the two subunits is less extended.
The final example shall be ASs. These GATase complexes catalyze the committed step
in tryptophan biosynthesis (Zalkin and Smith, 2009). Tetrameric ASs like the one from
S. typhimurium contain a large interface add-on in the TrpE synthase subunit, which
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Figure 20. Genetic profiling of prokaryotic species for TrpEx, TrpE, PabB, TrpG, and
PabA homologs and the functional consequences.
The phylogenetic tree is representative for the over 15000 profiled archaeal and bacterial
genomes. It shows that all TrpEx-species (magenta) are γ-Proteoacteria that arose from
the split between Pseudomonas and Shewanella species (indicated by an asterisk). TrpEx-
species possess two paralogous AS and ADCS complexes. The interface add-on in TrpEx is
colored in a rainbow gradient. All Archaea and the remaining Bacteria are TrpE-species
(green), which possess only a single PabA glutaminase for both AS and ADCS complexes.
forms parts of the interface to the TrpG glutaminase subunit (Figure 19D). Dimeric ASs
like the one from S. solfataricus, in contrast, do not contain the interface add-on. In order
to avoid any possibility of confusion, TrpE homologs that contain the interface add-on are
hereafter denoted by "TrpEx" (extended).
A genetic profiling of over 15000 archaeal and bacterial species revealed that TrpEx
proteins are limited to a group of γ-Proteobacteria. Figure 20 shows a representative
phylogenetic tree with the branches leading to these TrpEx-species colored in magenta.
TrpEx-species also possess the homologous ADCS complex, which catalyzes a reaction
similar to that of AS as the committed step of folate biosynthesis (Figure 20, top right).
Both synthase subunits of the complexes (TrpEx, PabB) as well as both glutaminase
subunits (TrpG, PabA), are homologs and share high sequence and structure similarity.
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The majority of prokaryotic species, in contrast, possess ASs with TrpE-subunits that lack
the interface add-on; the branches to these TrpE-species are colored in green in Figure 20.
Not surprisingly, also TrpE-species possess the folate biosynthetic pathway. However, our
profiling showed that they only contain a PabA glutaminase and no TrpG glutaminase.
This suggests that both AS and ADCS complexes share the same glutaminase subunit for
their respective reactions in tryptophan and folate biosynthesis. These results confirmed
early reports that Firmicutes like B. subtilis rely on a single, amphibolic glutaminase for the
two biosynthetic pathways (Kane, 1977). Given the high sequence and structure similarity
between the two synthase subunits TrpE and PabB it is not surprising that the single PabA
glutaminase is re-used for both AS and ADCS complexes; a tendency that has also been
observed for other protein complex subunits (Kühner et al., 2009). The presence of just
one glutaminase in TrpE-species but two different glutaminases in TrpEx-species suggests
that the interface add-on in TrpEx acts as a negative design element to differentiate the
otherwise highly similar AS and ADCS complexes and to ensure specific TrpEx-TrpG and
PabB-PabA interactions.
We experimentally tested this assumption by heterologously expressing and purifying
several TrpEx, TrpE, and PabB synthases, as well as several TrpG and PabA glutaminases
and characterizing their ability to form AS and ADCS complexes by chromatographic meth-
ods, light scattering, mass spectrometry, and enzyme kinetic measurements (Figure 21).
Such a combination of several orthologous methods is important to minimize the proba-
bility of detecting false-positive interactions or missing interactions due to false-negative
results (Hayes et al., 2016). As expected, we only observed interactions between TrpEx
synthases and TrpG glutaminases on the one hand and between TrpE or PabB synthases
and PabA glutaminases on the other hand (Figure 21A). Interestingly, the conservation of
the interfaces is so extensive that even glutaminases and synthases from different species
bind to each other. Moreover, practically all observed AS and ADCS complexes were en-
zymatically active and formed AA or ADC in a glutamine-dependent manner, indicating
functional, GATase-typical ammonia channeling (Figure 21B). Moreover, these complexes
also displayed allosteric communication between the subunits, because the activity of the
glutaminases was stimulated by binding of the different synthases (Figure 21C). In sum-
mary, these results indicate that the interface add-on determines interaction specificity in
AS and ADCS complexes. We could further experimentally affirm this by partially deleting
the interface add-on in TrpEx and by showing that the resulting TrpEx-variant was able to
form a complex with PabA and to stimulate its glutaminase activity (Publication C).
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Figure 21. Structural and functional characterization of interactions between TrpEx,
TrpE, and PabB synthases and TrpG and PabA glutaminases.
(A) Oligomeric states of glutaminases, synthases, and complexes determined by size-
exclusion chromatography, static light scattering, and native mass spectrometry. (B)
Catalytic efficiencies of the glutamine-dependent conversion of CH to AA (for complexes
with TrpEx or TrpE) and ADC (for complexes with PabB). Complexes with PabB from
B. subtilis (bsPabB) were inactive under the applied experimental conditions. (C) Apparent
turnover rates of glutamine hydrolysis by TrpG (kapp ) and stimulation of PabA glutamine
hydrolysis by the presence of the different synthases ( fst i m). The figure is modified from
publication C.
Other studies investigating the role of insertions and deletions for PPI-specificity to the
same computational and experimental extent are rare. Panchenko and co-workers inves-
tigated the tendency of proteins to form homo-oligomers (Hashimoto and Panchenko,
2010). Based on in silico analyses, the authors showed that insertions mediating homo-
oligomerization have a significant tendency to be located at protein interfaces. However,
although over 100 protein complexes with such insertions were identified, most of them
comprised only one to four amino acids and were merely extensions of already existing
secondary structure elements of protein interfaces. Moreover, the interfaces of homo-
oligomers additionally differ from other types of protein interfaces in terms of amino
acid composition and residue-residue contact preferences (Ofran and Rost, 2003) and are
thus a relatively special case. Although the authors speculated that the insertions might
differentiate homo-dimeric and monomeric paralogs and thus prevent the formation of
undesired interactions and assure the separation of functional pathways, no experimental
evidence for such characteristics of insertions in protein interfaces are available to date.
The following section describes our experimental approach to show that interface add-ons
display such characteristics.
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4.2.2 Biological relevance of interface add-ons
The observation that TrpEx and TrpG have been retained in all descendants of the split
between Pseudomonas and Shewanella species approximately 950 million years ago
(Battistuzzi and Hedges, 2009), suggests that the specific formation of AS and ADCS
complexes confers a selective advantage, or at least does not impair the fitness of the
respective organisms. Given the central roles of the two complexes in the biosynthetic
pathways leading to the essential metabolites tryptophan and folate, we assumed that
such a selective advantage could be the prevention of cross-interactions between AS and
ADCS synthases and glutaminases and thus of potentially harmful biosynthetic cross-talk.
Such cross-talk is in principle possible in TrpE-species, which contain only PabA
that interacts with both TrpE and PabB. Firmicutes have evolved sophisticated regula-
tory mechanisms acting on the transcriptional and translational level to assure that the
intracellular concentration of PabA is always properly adjusted to the demands of tryp-
tophan and/or folate biosynthesis (Babitzke, 1997; Yakhnin et al., 2007; Yanofsky, 2007).
However, the participation of PabA in both AS and ADCS complexes fundamentally links
tryptophan and folate biosynthesis together and creates the risk of potentially harmful
metabolic cross-talk. We simulated such a situation by over-expressing either pabB or trpE
in B. subtilis cells and monitoring their growth on minimal medium plates (Figure 22).
We hypothesized that high intracellular amounts of PabB would take up all available PabA
glutaminase and thus deduct it from folate biosynthesis. Similarly, the over-expression of
trpE could impair folate biosynthesis. Although no effect was observed for over-expression
of pabB, the over-expression of trpE significantly impaired cell growth (Figure 22A). We
could also demonstrate that this effect is based on compromised folate biosynthesis,
because the supplementation of folate or an intermediate of its biosynthesis completely
compensated the effect of trpE over-expression (Figure 22B). A similar metabolic conflict
is impossible in TrpEx-species, because their glutaminases are highly specific for the
respective synthases and consequently two independent, paralogous AS and ADCS com-
plexes exist. It remains to be shown if similar effects can be observed for other paralogous
complexes. Interesting targets would be the cysteine desulfurases or the isocitrate/iso-
propylmalate dehydrogenase complexes (Figure 19A, B). In both cases E. coli contains
one complex with and one complex without an interface add-on that are part of different
metabolic pathways.
One other aspect of the TrpEx interface add-on that has possible practical applications
should be mentioned at this point. Many TrpEx-species are highly pathogenic, causing
cholera, severe gastroenteritis, respiratory tract infections, the bubonic plague, haemolytic
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Figure 22. B. subtilis growth experiments.
(A) Minimal medium plates with B. subtilis colonies grown from cells transformed with
plasmids carrying the genes for PabB or TrpE from B. subtilis. The plates, either lacking or
containing IPTG for induction of protein expression, were incubated at 37° for 48 hours.
(B) The supplementation of the minimal medium with either folate or an intermediate
of its biosynthesis (p-aminobenzoic acid, PABA) offsets the detrimental effect of bstrpE
over-expression. The figure is modified from publication C.
syndromes, or typhoid (Berman, 2012). In the light of more and more prevalent multi-drug
resistant bacterial strains, the development of alternatives to traditional antibiotics is
among the most important future tasks for research and medicine (Czaplewski et al., 2016).
Inhibitors of PPIs are one possible alternative and act by preventing the formation of pro-
tein complexes that are either essential for pathogenicity or viability of the pathogens.
Some small molecule- and antibody-based PPI-inhibitors have already shown great ther-
apeutic and clinical potential (Petta et al., 2015). However, such inhibitors often have a
limited cell-delivery, structural flexibility, or chemical variability, which is why peptide-
based PPI-inhibitors have come into focus more and more (Araghi and Keating, 2016).
For example, the peptide enfuvirtide, which is derived from a C-terminal fragment of the
HIV envelope glycoprotein gp41, blocks membrane fusion of the virus particles and thus
inhibits viral cell entry (Matthews et al., 2004). Moreover, peptides have been developed
that target Bcl-2 family complexes, which are involved in the formation and progression of
several cancer types (Oltersdorf et al., 2005), and p53-binders, which impede the guarding
role of p53 in the cell cycle (Liu et al., 2010).
Pathogenic TrpEx-species might be similarly targeted with a selective PPI-inhibitor.
One possibility would be to design a peptide that mimics the 3D-structure of the interface
add-on in the TrpEx subunit of AS and thus compete with TrpEx for binding to the TrpG
subunit. Vice versa, the interface part of TrpG that contacts the TrpEx interface add-on
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might serve as a starting scaffold for the grafting of a peptide that tightly binds to the
interface add-on and thus prevents TrpG from binding to TrpEx. Targeting the TrpEx-type
AS to engage pathogenic Proteobacteria is a feasible approach for several reasons: First,
AS is essential for tryptophan biosynthesis and its blockage is lethal for many pathogenic
bacteria (Leonhardt et al., 2007; Wang et al., 2014; Zhang et al., 2012c). Second, AS is
absent from eukaryotic cells, which reduces the possibility of adverse side effects of
peptide-based inhibitors on human cells. Third, all bacteria other than Proteobacteria
contain TrpE instead of TrpEx. Thus a TrpEx-specific inhibitor would not impair many of
the beneficial bacterial species in the human gut microbiome, of which only about 2% are
Proteobacteria (D’Argenio and Salvatore, 2015).
4.2.3 Evolution of protein-protein interactions in AS and ADCS com-
plexes: The role of the interface add-on
As we have shown, a possible cross-talk between AS and ADCS complexes and hence
tryptophan and folate biosynthesis can impair cellular fitness. Such a cross-talk is highly
unlikely in TrpEx-species, which have evolved specific interactions between TrpEx and
TrpG in the AS complex and between PabB and PabA in the ADCS complex. It can be as-
sumed that the resulting effective separation of these two essential biosynthetic pathways
and the concomitant possibility for differential and independent regulation conferred
selective advantages to TrpEx-species, because TrpEx and TrpG have been retained since
their first emergence in Shewanella species.
The phylogenetic distribution of TrpEx, TrpE, and PabB suggests that TrpEx-species
have evolved from TrpE-species (Figure 20). This transition requires at least two events:
The incorporation of the interface add-on into TrpE and the emergence of the TrpG glu-
taminase. The origin of the interface add-on cannot reliably be traced back; we assume
that the corresponding DNA sequence has been integrated into the trpE gene via homolo-
gous recombination or events related to horizontal gene transfer. TrpG has most likely
evolved via duplication of an ancestral PabA glutaminase and a subsequent change in
interaction specificity from TrpE/PabB to TrpEx.
But how do protein complexes evolve such changes in interaction specificity? Com-
putational studies have demonstrated that interacting proteins typically co-evolve with
similar mutational rates (Fraser et al., 2002; Ovchinnikov et al., 2014). The implicit assump-
tion underlying this idea is that a mutation in one complex subunit that would disrupt the
interaction on its own is balanced by a compensating mutation in the other subunit. The
interplay of these two (or more) mutations assures that the resulting complex is specific
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Figure 23. Possible scenarios for the evolution of TrpEx and TrpG.
The scenarios describe the evolution leading from TrpE-species (single PabA glutaminase
and the two synthases PabB and TrpE) to TrpEx-species (two specific glutaminases PabA
and TrpG for the two synthases PabB and TrpEx). (A) Compensatory model. The emer-
gence of TrpEx in an organism with just a PabA glutaminase creates a non-functional
intermediate (X). Granted that this dead-end has been overcome somehow, after dupli-
cation of the gene for PabA, compensatory mutations lead to the development of TrpG.
(B) Promiscuous model. The two illustrated paths both involve a promiscuous PabA*
glutaminase that interacts with TrpE/PabB synthases as well as with TrpEx synthases. On
the right hand side experimentally characterized interactions are shown that represent
the respective evolutionary phases. The figure is modified from publication C.
and that its subunits no longer bind to their predecessor partners. Applied to the evolution
of TrpEx-species, this compensatory model (Aakre et al., 2015) required a duplication of the
pabA gene after the emergence of TrpEx and the subsequent accumulation of mutations in
the duplicate to shape its interaction specificity towards TrpEx (Figure 23A). However, the
implicit flaw of the compensatory model in this case is clear: After the emergence of TrpEx
an organism would be non-viable due to missing interactions between TrpEx and PabA
and thus non-functional tryptophan biosynthesis. In general terms, the compensatory
model requires that the evolution of a protein complex passes through a non-functional
– 67 –
Evolutionary diversification of protein-protein interactions by interface add-ons
state, when the first mutation (incorporation of the interface add-on) has not yet been
compensated by the second one (adaptation to the interface add-on).
Given the critical role of AS complexes in metabolism, non-functional states in their
evolution are highly unlikely. We thus propose another scenario (Figure 23B), inspired
by recent findings of Laub an co-workers (Aakre et al., 2015). This promiscuity model
assumes that the "adaptation" of PabA to TrpEx has preceded the emergence of the latter.
This pre-adaptation requires mutations in the interface region of PabA that maintain
productive interactions with PabB and TrpE but at the same time tolerate the binding
of a TrpEx synthase with an interface add-on. How easily is such a promiscuous state
reached from a PabA scaffold? We could show by rational protein design that only five
mutations in PabA from the TrpE-species Pseudomonas putida are sufficient to achieve
such interaction promiscuity. The resulting ppPabA* variant was able to form functional
AS complexes with both TrpE and TrpEx synthases, as well as functional ADCS complexes
with a PabB synthase (Figure 23B, traffic-light visualizations). Importantly, the catalytic
efficiencies of the resulting complexes were only one order of magnitude lower than those
of native AS and ADCS complexes. This suggests that such a promiscuous glutaminase
could have supported both tryptophan and folate biosynthesis in vivo.
In principle, two different evolutionary trajectories are in line with the promiscuity
model. The neo-functionalization trajectory (Figure 23B, left) involves an initial duplica-
tion of the gene for PabA, allowing one copy to accumulate mutations that lead to a relaxed
interaction specificity. After the emergence of TrpEx this promiscuous PabA* copy became
essential for maintaining tryptophan biosynthesis and mutational drift and co-evolution
eventually yielded the specific AS and ADCS complexes of TrpEx-species. Alternatively, in
the sub-functionalization trajectory (Figure 23B, right) mutational drift led to a relaxed
interaction specificity in the single PabA glutaminase, which tolerated the emergence of
TrpEx. Duplication of the promiscuous PabA* glutaminase was probably favored by gene
dosage effects and sub-functionalization of the copies eventually led to the specific AS
and ADCS complexes of TrpEx-species.
How likely is the promiscuity model for explaining the evolution of the TrpEx-TrpG
interaction? One important aspect is that it avoids any non-functional evolutionary
intermediate. However, it heavily relies on gene duplication and mutational drift to
explain the development of the promiscuous PabA* glutaminase and the sub- or neo-
functionalization to contemporary TrpG. It has recently been shown that the rate of
sequence divergence after gene duplication of protein complex subunits is relatively high
with about 6×10−3 per PPI and per million years (Ames et al., 2016). Moreover, work with
yeast has demonstrated that gene duplicates evolve up to three times faster than single
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copy genes and that duplication is usually followed by a burst in sequence divergence
(Conant and Wagner, 2003; Scannell and Wolfe, 2008). Taken into account that only five
mutations separate the specific PabA and the promiscuous PabA* states, it can be assumed
that relaxed interaction specificity could be easily reached during evolution.
Similar low hurdles between interaction specificity and promiscuity have been ob-
served for other protein complexes. Bacterial toxins are stable and globular proteins
that inhibit cell growth or impair cell viability unless bound and sequestered by their
cognate antitoxin (Hallez et al., 2010). New toxin-antitoxin pairs often arise from gene
duplication and subsequent divergence of interaction specificities (Yamaguchi et al., 2011).
During this process it is critical that toxins can evolve new specificities while never losing
interaction with their cognate antitoxin to prevent self-inflicted toxicity. It has recently
been shown that only four mutations are sufficient to achieve interaction promiscuity in
these toxins, allowing the antitoxins to follow them during sequence divergence (Aakre
et al., 2015). Similarly, the transition from one selective pair of the SOS-induced colicin
DNA-nuclease and its cognate inhibitor to another functionally insulated pair proceeded
in the laboratory through inhibitors with interaction promiscuity (Levin et al., 2009).
Our design of the PabA* variant demonstrates that relaxed interaction specificity
can easily be reached not only in toxin-antitoxin or DNA-nuclease-inhibitor complexes
but also in essential metabolic enzyme complexes. These findings are important for
an understanding how prevalent such promiscuous evolutionary intermediates are and
whether they can be easily reached from specific starting complexes (Aakre et al., 2015).
Moreover, the PabA* glutaminase is, to our knowledge, the first example of a protein with
interaction promiscuity that has been generated by rational protein design. Last but
not least, this promiscuous glutaminase demonstrates that the concept of PPI evolution
through promiscuous intermediates is not only applicable to protein complexes whose
interaction specificity is determined by individual amino acids in the interface but also to
complexes whose specificity is defined by large changes in interface geometry caused by
interface add-ons.
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5 Abbreviations
2,3-DHB 2,3-dihydroxybenzoic acid
AA anthranilate
ADC aminodeoxychorismate
ADCS aminodeoxychorismate synthase
ADIC aminodeoxyisochorismate
ADICS aminodeoxyisochorismate synthase
AME ammonia-utilizing MST-enzyme
AS anthranilate synthase
ASR ancestral sequence reconstruction
B. lata Burkholderia lata
B. subtilis Bacillus subtilis
BGC biosynthetic gene cluster
CdRP 1-(o-carboxyphenylamino)-1-deoxyribulose-5-phosphate
CH chorismate
CL chorismate lyase
CM chorismate mutase
CUE chorismate-utilizing enzyme
D. desulfuricans Desulfovibrio desulfuricans
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DNA deoxyribonucleic acid
E. coli Escherichia coli
GATase glutamine amidotransferase
HisA 1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino)-
methylideneamino]-imidazole-4-carboxamide
isomerase
HisF cyclase subunit of imidazole glycerol phosphate synthase
IC isochorismate
ICS isochorismate synthase
LUCA last universal common ancestor
M. tuberculosis Mycobacterium tuberculosis
MSA multiple sequence alignment
P. carbinolicus Pelobacter carbinolicus
P. putida Pseudomonas putida
PA prephenate
PHB para-hydroxybenzoate
PPI protein-protein interaction
PRA N-(5’-phosphoribosyl)anthranilate
PRFAR N’-[(5’-phosphoribulosyl)-formimino]-5-aminoimidazole-4-
carboxamide-ribonucleotide
PriA phosphoribosyl isomerase A
ProFAR N’-[(5’-phosphoribosyl)-formimino]-5-aminoimidazole-4-
carboxamide-ribonucleotide
RMSD root-mean-square deviation
RNA ribonucleic acid
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S. aureus Staphylococcus aureus
S. cerevisiae Saccharomyces cerevisiae
S. coelicolor Streptomyces coelicolor
S. enterica Salmonella enterica
S. marcescens Serratia marcescens
S. solfataricus Sulfolobus solfataricus
S. typhimurium Salmonella typhimurium
SA salicylate
SS salicylate synthase
SSN sequence similarity network
T. maritima Thermotoga maritima
TrpF phosphoribosylanthranilate isomerase
WME water-utilizing MST-enzyme
Y. pestis Yersinia pestis
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Abstract
Modern enzymes are highly optimized biocatalysts that process their substrates with
extreme efficiency. Many enzymes catalyze more than one reaction; however, the persis-
tence of such ambiguities, their consequences and evolutionary causes are largely
unknown. As a paradigmatic case, we study the history of bi-functionality for a time span of
approximately two billion years for the sugar isomerase HisA from histidine biosynthesis. To
look back in time, we computationally reconstructed and experimentally characterized three
HisA predecessors. We show that these ancient enzymes catalyze not only the HisA reac-
tion but also the isomerization of a similar substrate, which is commonly processed by the
isomerase TrpF in tryptophan biosynthesis. Moreover, we found that three modern-day
HisA enzymes from Proteobacteria and Thermotogae also possess low TrpF activity. We
conclude that this bi-functionality was conserved for at least two billion years, most likely
without any evolutionary pressure. Although not actively selected for, this trait can become
advantageous in the case of a gene loss. Such exaptation is exemplified by the Actinobac-
teria that have lost the trpF gene but possess the bi-functional HisA homolog PriA, which
adopts the roles of both HisA and TrpF. Our findings demonstrate that bi-functionality can
perpetuate in the absence of selection for very long time-spans.
Author Summary
The term exaptation describes the process by which a trait that is initially just a by-product
of another function may become important in a later evolutionary phase. For example,
feathers served to insulate dinosaurs before helping birds fly. On the level of enzymes, bi-
functionality can contribute to microbial evolution through exaptation. However, bi-func-
tional enzymes may cause metabolic conflicts, if they are involved in different metabolic
pathways. By characterizing properties of modern and computationally reconstructed
ancestral variants of the sugar isomerase HisA, we demonstrate that it has been a bi-func-
tional enzyme for the last two billion years. Most likely, bi-functionality persisted because
the remaining TrpF activity is not harmful or its elimination would concurrently
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compromise HisA activity. Moreover, this substrate ambiguity is advantageous, as it allows
compensating a gene loss as exemplified by the Actinobacteria. These microbes have lost
the isomerase TrpF but possess the bi-functional HisA homolog PriA, which takes over
the roles of both HisA and TrpF. Our results argue to view bi-functionality not as an evo-
lutionary disadvantage but rather as a contribution to the evolvability of novel functions
via exaptation.
Introduction
Enzymes are remarkably specific catalysts and this characteristic led to the traditional view of
“one enzyme, one substrate, one reaction”, which assumes an evolutionary preference for
mono-functionality. However, it is clear now that enzymes can catalyze reactions other than
those for which they evolved; see [1] and references therein. Prominent examples of multi-
functional enzymes are glutathione S-transferases and cytochrome P450s, which can process
several different substrates [1]. However, multi-functional enzymes may cause metabolic con-
flicts if they are involved in different, possibly independent, metabolic pathways [2]. Along
these lines, multi-functionality seems to be of no immediate advantage for an organism, which
argues against a positive selection of this trait. Presumably, neutral drift causes the broadening
or narrowing of reaction specificity, see [1] and references therein; however it is unclear,
whether multi-functionality is a short-term or a long-term trait.
Some evolutionary innovations originate non-adaptively as exaptations [3], i. e. as by-prod-
ucts of other, positively selected traits. These features were not built by natural selection for
their current role. For example, feathers evolved for temperature regulation prior to their func-
tion in flight [3] and the light-refracting lens crystallins stem from enzymes [4]. In silico analy-
ses suggest that exaptation is an important means of evolutionary innovation for metabolic
systems [5]. The contribution of exaptation to evolutionary processes would be of even greater
importance, if such traits existed over a long evolutionary time-span. In order to address this
issue, we traced bi-functionality of a key metabolic enzyme over two billion years.
Most microbial genomes harbor a hisA and a trpF gene, which are located within the histi-
dine and tryptophan operons, respectively. The gene products HisA and TrpF catalyze analo-
gous isomerizations of the aminoaldoses ProFAR (Nʹ-[(5ʹ-phosphoribosyl)-formimino]-
5-aminoimidazole-4-carboxamide-ribonucleotide) and PRA (N-(5ʹ-phosphoribosyl)anthrani-
late) into the aminoketoses PRFAR (Nʹ-[(5ʹ-phosphoribulosyl)-formimino]-5-aminoimida-
zole-4-carboxamide-ribonucleotide) and CdRP, respectively [6] (Fig 1). Most likely, genes for
HisA and TrpF were present in the genome of the last universal common ancestor (LUCA) [7];
thus it can be expected that their modern successors process their specific substrates with high
efficiency. The situation is different, however, in the Actinobacteria. Within this phylum, the
trpF gene is missing in many genomes. As a substitute, the bi-functional isomerase PriA cata-
lyzes both the HisA and the TrpF reactions [8] (Fig 1). PriA is a HisA homolog; the two
enzymes are highly similar to each other with respect to sequence and structure [9, 10].
A detailed tracing of HisA bi-functionality required an analysis in two dimensions: A survey
of PriA-like characteristics in modern HisA homologs and a retrospect of ancestors related to
bacterial speciation. To begin with, we used in silico analyses and in vitro characterization of
extant HisA enzymes and found that PriA-like bi-functionality is not strictly limited to Actino-
bacteria. Furthermore, we reconstructed in silico the sequences of the HisA/PriA ancestors of
all Actinobacteria, all Proteobacteria, and all Bacteria, and tested the resulting precursor pro-
teins for their ProFAR and PRA isomerase activities. Our results show that all three
Long-Term Persistence of Bi-functionality
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reconstructed ancestral enzymes are bi-functional in vitro and in vivo. Thus, our findings pro-
vide an example for an enzyme, whose bi-functionality pertained for two billion years of evolu-
tion, most likely without obvious, immediate benefit, except for exaptation.
Results
Occurrence and functional characterization of extant HisA and PriA
enzymes
The existence of the bi-functional PriA enzyme has originally been described for two actino-
bacterial species, namely Streptomyces coelicolor andMycobacterium tuberculosis [8]. In order
to determine the distribution of PriA-like enzymes within all bacterial phyla, we computed a
sequence similarity network (SSN) of the HisA/PriA superfamily (Fig 2). In an SSN, nodes rep-
resent individual sequences and edges correspond to statistically significant similarities
deduced from pairwise alignments, calculated by BLAST [11]. Our analysis showed that hisA
genes are present in all major phylogenetic groups (Fig 2A) and that the occurrence of anno-
tated priA genes is indeed restricted to the Actinobacteria (Fig 2B, top right cluster). The mean
sequence identity in the Actinobacteria cluster is 52±9%; it can thus be assumed that all these
sequences correspond to PriA enzymes.
The ability of PriA to catalyze both the HisA and the TrpF reaction requires that its active
site can bind the two respective substrates in a productive conformation. As it is evident from
the crystal structure of PriA fromM. tuberculosis (mtPriA) [9], both substrates are bound in
the same active site pocket (Fig 3). The most notable difference between the HisA state (Fig
3A) and the TrpF state (Fig 3B) is a twist of loop 5 and a concomitant swap of the localization
of R143 and W145. This goes along with rearranged hydrogen bond networks at positions 19
and 109. Despite that, however, the same eight residues are involved in forming the active site
in both states. We thus analyzed and compared their conservation in HisA and PriA sequences
from the major SSN clusters. The actinobacterial PriA active site is characterized by a strong
residue conservation resulting in the motif D-R-E-D-R-G-W-D (Fig 3C, Actinobacteria
Fig 1. Isomerization of the aminoaldoses ProFAR and PRA to the aminoketoses PRFAR and CdRP. In most prokaryotes the two reactions are
catalyzed by the enzymes HisA and TrpF, respectively. In Actinobacteria, however, the bi-functional PriA catalyzes both isomerizations.
doi:10.1371/journal.pgen.1005836.g001
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sequence logo). In contrast, the majority of HisA sequences deviate from the PriA-typical
motif in 2-3 residues, mainly at positions 109 and 143 (Fig 3C, remaining sequence logos). Sur-
prisingly, however, the PriA-typical motif is present in some HisA enzymes from Bacteroidetes
(1 representative corresponding to 0.4% of all Bacteroidetes sequences), Euryarchaeota (6 /
5.1%), Firmicutes (25 / 8.9%), and Proteobacteria (43 / 4.9%). Moreover, the PriA-typical motif
is also found in HisA from Thermotoga maritima (tmHisA), except that Lys is present at posi-
tion 143 instead of the PriA-typical Arg.
In order to test if the presence of the PriA-typical active site sequence motif in HisA
enzymes leads to TrpF activity, tmHisA and two HisA enzymes from Proteobacteria (Pelobac-
ter carbinolicus, pcHisA; Desulfovibrio desulfuricans, ddHisA) were produced by heterologous
gene expression in Escherichia coli. The recombinant proteins were purified and characterized
by steady-state kinetics with respect to their ProFAR and PRA isomerization activities. Com-
pared to PriA from S. coelicolor (scPriA) andM. tuberculosis (mtPriA), the catalytic efficiencies
kcat=K
ProFAR
M of tmHisA, ddHisA, and pcHisA are about tenfold higher (Table 1, HisA reaction).
They are comparable to the catalytic efﬁciency kcat=K
ProFAR
M of HisA from Salmonella enterica
(seHisA), which is considered to be an archetypical representative of the HisA family [12].
Strikingly, tmHisA, ddHisA, and pcHisA also displayed TrpF-activity, something that has not
been shown before. However, their catalytic efﬁciencies kcat=K
PRA
M are lower by about 10
5–106-
fold compared to scPriA and mtPriA (Table 1, TrpF reaction).
In vivo complementation experiments showed that tmHisA, ddHisA, and pcHisA were able
to rescue the growth deficiency of an E. coli ΔhisA strain. Moreover, despite their weak in vitro
TrpF activity, they were also able to complement a ΔtrpF strain (Table 2). The enzymes were
further able to complement a ΔhisAΔtrpF double deletion strain (Table 2), whereby the time
required for complementation is clearly limited by their TrpF activity.
Fig 2. Sequence similarity network of the HisA/PriA superfamily. Nodes are colored by either the main five phyla contributing to this superfamily (A) or by
annotation as HisA or PriA (B). The network was generated from all-by-all BLAST comparisons of 7428 HisA and PriA sequences. Each node represents a
single sequence or a group of sequences with more than 95% identical residues; experimentally characterized HisA or PriA proteins are marked by
diamonds. Each edge in the network represents a bi-directional BLAST hit with an E-value 1E−54 (corresponding to a median sequence identity of 44%).
At this cutoff, the PriA cluster is clearly separated from, but still connected to the central HisA cluster. Lengths of edges are not meaningful except that
sequences in tightly clustered groups are relatively more similar to each other than sequences with few connections.
doi:10.1371/journal.pgen.1005836.g002
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Reconstruction of ancient sequences
We next asked whether the bi-functionality of HisA is an ancient feature that has been con-
served in certain extant enzymes. To this end, we computationally reconstructed three HisA
precursors as described in the following. It has been shown that concatenating related
sequences increases the strength of the phylogenetic signal available for tree construction [14].
Thus, we concatenated species-wise HisA with HisH and HisF sequences. The respective genes
were most likely part of the LUCA genome [7] and have remained elements of the histidine
Fig 3. Two states of the PriA active site fromM. tuberculosis. (a) Schematic view of the site in the HisA-state (bound product PRFAR, PDB ID 3zs4). (b)
The same active site in the TrpF-state (bound product analogue reduced-CdRP, PDB ID 2y85). Residues of the active site are shown as stick models.
Residue numbering is based on PDB ID 3zs4. (c) Sequence logos showing the conservation of the motif as deduced from SSN clusters of the HisA/PriA
superfamily. Basic and acidic residues are colored blue and red, respectively.
doi:10.1371/journal.pgen.1005836.g003
Table 1. Steady-state kinetic parameters of extant PriA and HisA enzymes, and reconstructed HisA ancestors.
HisA reaction TrpF reaction
Enzyme kcat [s-1] KProFarM [μM] kcat=K
ProFAR
M [M
-1s-1] kcat [s-1] KPRAM [μM] kcat=K
PRA
M [M
-1s-1]
scPriA 1 0.9 28 3.2  104 12 4 3.0  106
mtPriA 2 0.23 19 1.2  104 3.6 21 1.7  105
tmHisA 3 1.0 5.6 1.8  105 6.7  10−3 60 1.1  101
ddHisA 3 1.3 2.8 4.6  105 2.3  10−3 161 1.4  101
pcHisA 3 0.4 1.8 2.2  105 1.0  10−3 303 0.3  101
seHisA 4 7.8 17.0 4.5  105 n. d. n. d. n. d.
CA-Act-HisA 5 n. d. n. d. 3.0  102 1.0  10−2 3 3.3  103
CA-Prot-HisA 6 0.05 0.3 1.8  105 5.3  10−4 2.7 2.0  102
CA-Bact-HisA 6 0.05 0.5 1.0  105 2.3  10−4 3.2 0.7  102
1 Data taken from [10].
2 Data taken from [9].
3 Unlike in previous work [13], tmHisA (as well as ddHisA and pcHisA) showed measurable albeit very low TrpF activity. Although the exact reasons for
this discrepancy are unknown, it may be due to differences in enzyme puriﬁcation and handling.
4 Data taken from [12]; n. d.: values were not determined.
5 n. d.: kcat and KProFARM could not be determined individually; kcat=K
ProFAR
M was deduced from the linear part of the saturation curve.
6 The kcat and KProFARM values were determined by analyzing entire transition curves with the integrated Michaelis-Menten equation.
3,5,6 The standard errors for kcat and KM were between 5% and 40%.
doi:10.1371/journal.pgen.1005836.t001
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operon since then. Bacterial and archaeal genomes were scanned for the occurrence of hisA
genes, and species were selected for which hisA, hisF, and hisHwere gene neighbors. We picked
sequences from Euryarchaeota (5 species), Crenarchaeota (20), Bacteroidetes (8), Firmicutes
(11), Spirochaetes (5), and the α-, β-, γ-, and δ-Proteobacteria (21, 5, 1, 5). Moreover, we added
22 actinobacterial sequence sets, by selecting genes whose products contain the above men-
tioned PriA active site sequence motif.
The resultingMSAHisFAH comprised 103 concatenations (species names listed in S1 Table).
After preprocessing this input, a phylogenetic tree was determined and assessed by means of
PhyloBayes v3.3 [15]. Four independent MCMC samplings of length 50,000 were computed
using pb and compared to ensure convergence. Several parameters confirmed the validity of
our approach: Convergence and mixing were checked by means of the discrepancy index max-
diff; for the pairwise comparison of all chains, the maxdiff value was at most 0.06. The effective
size was at least 100, as determined by means of tracecomp. A consensus tree was deduced
from the concatenation of these four chains (S1 Fig). The posterior probability of edges inter-
linking ancestors of phyla or classes was at least 0.87, which testifies to the high quality of the
tree.
This tree and the correspondingMSAHisFAH were used to deduce a predecessor of the acti-
nobacterial enzymes (CA-Act-HisA) by means of FASTML [16]. In order to exclude any effect
of the 22 actinobacterial sequences (and especially their active site motif) on the reconstruction
of more ancient predecessors of HisA, these sequences were removed fromMSAHisFAH. The
resultingMSAHisFAH-Act, which contained the remaining 81 non-actinobacterial sequences, was
used to calculate a second tree (S2 Fig). Applying FASTML, the sequences of the common
ancestors of Proteobacteria (CA-Prot-HisA) and of Bacteria (CA-Bact-HisA) were determined.
A schematic representation of the two trees is given in Fig 4. The archaeal sequences served as
an outgroup in both reconstructions.
Table 2. In vivo complementation of auxotrophic E. coli strains by PriA, HisA, HisA ancestors, and
TrpF.
complementation time in hours
ΔhisA strain ΔtrpF strain ΔhisAΔtrpF strain
scPriA 22 22 23
tmHisA 16 114 144
ddHisA 16 153 181
pcHisA 15 70 63
CA-Act-HisA 48 23 47
CA-Prot-HisA 16 33 28
CA-Bact-HisA 16 45 39
tmTrpF no growth 24 no growth
For all experiments, the mean time is given after which visible colonies appeared on minimal medium agar
plates. All experiments were repeated independently at least three times. A growth time of 16 hours
indicates that colonies appeared over night. Growth times below 120 hours could be reproduced with a
maximum error of 25%, growth times above 120 hours with a maximum error of 40%. “No growth” indicates
that no colonies were observed after 14 days. A negative control with empty pTNA plasmid did not lead to
growth within 14 days, either.
doi:10.1371/journal.pgen.1005836.t002
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Experimental assessment of HisA precursors
The genes coding for the three precursors were synthesized and heterologously expressed in E.
coli. The recombinant proteins were soluble and stable, and could be purified. Steady-state
kinetic analysis yielded kcat=K
ProFAR
M values in the order of 10
2–105 M-1s-1 for the HisA reaction,
and kcat=K
PRA
M values in the order of 10
2–103 M-1s-1 for the TrpF reaction (Table 1). Compared
to scPriA and mtPriA, the catalytic efﬁciency of the ancestral proteins for the TrpF reaction is
therefore only two to three orders of magnitude lower. For all three proteins this is the result of
a lower kcat value; the KPRAM is practically identical to that of scPriA. Furthermore, all three pre-
cursors were able to complement the growth deﬁciencies of ΔhisA and ΔtrpF strains (Table 2).
The time required for in vivo complementation agrees well with kcat/KM values determined
from in vitromeasurements. For example, CA-Bact-HisA and CA-Prot-HisA have the highest
kcat=K
ProFAR
M values and required the least time to complement the ΔhisA strain. CA-Act-HisA
has the highest kcat=K
PRA
M value and required the least time to complement the ΔtrpF strain. All
three HisA-ancestors were further able to complement the growth deﬁciency of a ΔhisAΔtrpF
double deletion strain (Table 2). The observed complementation times agree well with those
Fig 4. Phylogenetic tree depicting the position of extant HisA and PriA enzymes (diamonds) and their relationship to the reconstructed ancestral
HisA enzymes (circles). The topology of the tree was inferred from the phylogenetic trees used for sequence reconstruction (S1 and S2 Figs). CA-Act-HisA,
CA-Prot-HisA, and CA-Bact-HisA are the predecessor of HisA enzymes from Actinobacteria, Proteobacteria and Bacteria, respectively. Note that
actinobacterial sequences were omitted for reconstruction of CA-Prot-HisA and CA-Bact-HisA (indicated by grey shading of the Actinobacteria branch).
ddHisA and tmHisA were not used for sequence reconstruction and are only listed because they were characterized experimentally. The vertical bar
indicates the branch length that corresponds to 0.5 mutations per site. The catalytic efficiencies kcat/KM of the enzymes for processing ProFAR and PRA are
given in red and blue, respectively. Abbreviations: sc, S. coelicolor; dd, D. desulfuricans; pp, P. carbinolicus; tm, T.maritima; Sp., Spirochaetes; Bact.,
Bacteroidetes.
doi:10.1371/journal.pgen.1005836.g004
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determined from the single deletion strains. The complementation by CA-Act-HisA is limited
by its ability to compensate for the missing HisA reaction, whereas complementation by
CA-Prot-HisA and CA-Bact-HisA is limited by their ability to catalyze the missing TrpF
reaction.
The active site sequence motif of CA-Act-HisA is identical to that of modern PriA enzymes.
The motifs of CA-Prot-HisA and CA-Bact-HisA match in six of the eight residues. Non-
matching is position 109, which contains a Lys instead of a Glu. At the second non-matching
position 143, both precursors contain a Lys instead of an Arg. It is therefore plausible to assume
that a basic residue at position 143 is crucial for bi-functionality. In contrast, the recently pub-
lished SGG sequence motif of PriA [17] seems not to be required for bi-functionality. Only the
immediate actinobacterial precursor CA-Act-HisA contains the SGG-motif whereas both
other precursors displayed significant bi-functionality albeit containing a GGG-motif.
Discussion
In contrast to previous results [18], the reconstructed CA-Prot-HisA and CA-Bact-HisA are to
our knowledge the first examples of ancestral metabolic enzymes from approximately 2.5 to 2.0
billion years ago [19] that were shown to be bi-functional. This trait is even more interesting
when one considers that only extant HisA sequences but no extant PriA sequences were
selected to reconstruct the CA-Prot-HisA and CA-Bact-HisA predecessors.
Strikingly, we also detected bi-functionality in the modern tmHisA, pcHisA, and ddHisA
and thus provide the first examples of HisA/TrpF bi-functionality in extant HisA enzymes. It is
worth noting that these three species all contain a trpF gene, which suggests that no selective
pressure exists for these species to maintain the bi-functionality in HisA. Moreover, the in vivo
complementation experiments show that tmTrpF is functional and is able to rescue an E. coli
ΔtrpF strain (Table 2). Also, the bi-functionality of these modern HisA enzymes does not force
their hosts to face functional trade-offs because KPRAM values are 10- to 170-fold higher than
KProFARM values. Thus the obligate HisA activity of these enzymes is most likely not impaired by
the binding of PRA or CdRP. Moreover, the catalytic efﬁciencies kcat=K
PRA
M are in a physiologi-
cally irrelevant range below 14 M-1s-1 thus making TrpF side-activity tolerable. Along these
lines, the CA-Bact-HisA predecessor evolved most likely in a similar way such that the remain-
ing TrpF side-activity was physiologically not harmful.
Our results do not allow us to decide whether all modern HisA enzymes are bi-functional:
We have performed in vivo complementation experiments with four additional HisA enzymes
from Bacteroidetes, Firmicutes, Proteobacteria, and Euryarchaeota lacking the PriA-typical
sequence motif. These enzymes were unable to rescue ΔtrpF or ΔhisAΔtrpF deletion strains
within eight days. Nevertheless, extremely slow growing colonies were observed occasionally.
This growth may be due to residual TrpF activity of inherent E. coli enzymes like PurF [20] and
may therefore indicate the existence of additional routes of exaptation. The active site motifs
(Fig 3) suggest that bi-functionality is determined by Glu 109 and Arg 143. HisA homologs
that retained bi-functionality have conserved the PriA typical residues at these two positions,
despite a relatively low overall sequence identity. As this bi-functionality seems to be neither
beneficial nor harmful for an organism, we assume that its presence is simply a matter of his-
torical contingency. This conclusion is in agreement with the finding that a few mutations
acquired in not more than several thousand generations were sufficient to transform a bi-func-
tional HisA variant from S. enterica into a specialized HisA enzyme lacking TrpF activity or
vice versa [21]. Along these lines, the bi-functional PriA became a mono-functional HisA
enzyme in the Corynebacteria, a distinct genus within the Actinobacteria. This re-narrowing of
substrate specificity in the so-called subHisA occurred after the horizontal acquisition of a
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whole pathway tryptophan operon (including a trpF gene) from a member of the γ-Proteobac-
teria [22]. Again, this transition from a bi-functional PriA to a mono-functional HisA enzyme
required only subtle sequence alterations [17]. Noteworthy is a change from Arg 143 to an
Asn, which supports the important role of Arg 143 for bi-functionality. Again, mono-function-
ality of HisA is easily accessible, if under evolutionary constraints. For Corynebacteria, this
evolutionary pressure is most likely due to a metabolic conflict between histidine and trypto-
phan biosynthesis.
This bi-functionality provided a means for compensating the loss of the trpF gene within
the Actinobacteria. Importantly, such exaptations are not rare: A screening of 104 single-gene
knockout strains made clear that approximately 20% of these auxotrophs were rescued by the
overexpression of at least one noncognate E. coli gene [23]. Thus, the functional diversity of
gene products contributes to metabolic robustness and evolvability. These evolutionary advan-
tages are further increased, if a bi-functionality that confers no cost or benefit to organismal fit-
ness, can be conserved throughout long evolutionary time-spans. The characteristics of ancient
and extant HisA and PriA enzymes confirm that this is feasible, even for enzymes of the pri-
mary metabolism.
Materials and Methods
Generation of sequence similarity networks
The SSN of the HisA/PriA-superfamily (7824 sequences, IPR023016 from InterPro release 47.0
[24]) was created using standard methods [25] provided by the Enzyme Function Initiative
[26]. In order to eliminate sequence fragments, the length of the sequences that were included
in the all-by-all BLAST comparison was restricted to 230–260 amino acids. From the remain-
ing 7428 sequences, a representative network with an E-value cut-off of 1E-54 was generated in
which sequences that share>95% identity were grouped into single nodes by CD-HIT [27].
Detailed phylogenetic information (superkingdom, phylum, class, order, family, genus) was
added for each node using a modified version of Key2Ann [28]. Networks were visualized with
the organic y-files layout in Cytoscape 3.2.0 [29, 30]. Phylum-specific sequence sets were com-
piled from the SSN and used to compute sequence logos of the active site residues, essentially
as described [31].
Reconstruction of ancestral sequences
BLAST [11] and the nr database of the NCBI were used to search for the sequences of HisA
homologs in completely sequenced genomes. Species where chosen, where hisA and the hisF
and hisH genes were neighbors in the genome; the respective sequences were concatenated. We
selected species from the archeal phyla Euryarchaeota and Crenarchaeota, and from the bacte-
rial phyla Bacteroidetes, Firmicutes, Spirochaetes, Actinobacteria, and Proteobacteria. A multi-
ple sequence alignment (MSA) was deduced by means of MAFFT [32]. Positions containing
more than 50% gaps were removed by using GBlocks [33]. The resulting MSA contained 430
meaningful positions. The program pb (version 3.3 of PhyloBayes, [15]) with options–cat–
gtr was used to compute in four independent Monte Carlo Markov Chains (MCMC) 50 000
samples each. The options–cat–gtr induce an infinite mixture model, whose components
differ by their equilibrium frequencies. The quality of mixing was assessed by computing the
discrepancy index (maxdiff) by means of bpcomp and the minimum effective size with
tracecomp. A consensus tree was determined by means of readpb, the burnin was 5000.
An MSA and a rooted tree determined as described were the input for FASTML [16]. The
JTT substitution model and the maximum likelihoodmethod were used for indel recon-
struction. As a representative predecessor, we chose the most likely sequence related to the
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respective node of the phylogenetic tree. Nucleotide and amino acid sequences of synthesized
genes for ancestral proteins are given in S2 Table.
Site directed mutagenesis and cloning
A list of all oligonucleotides used for cloning and site-directed mutagenesis is provided in S3
Table. The scpriA gene from S. coelicolor, which served as a positive control in the in vivo com-
plementation assays, was amplified from scPriA-pTYB4 (a gift of Dr. Matthias Wilmanns) by
standard PCR, using the oligonucleotides 5ʹscpriA_SphI/3ʹscpriA_ Stop_HindIII, and cloned
into the pTNA vector [6] via the introduced restriction sites for SphI and HindIII. The tmtrpF
gene from T.maritima, which served as a negative control in the in vivo complementation
assays, was available in a pTNA vector from previous work [34].
The hisA gene from T.maritima (tmhisA) was amplified using the template pDS56/RBSII_hisA
[35] with the oligonucleotides 5ʹtmhisA_NdeI/3ʹtmhisA_NotI (pET21a) and 5ʹtmhisA_SphI/
3ʹtmhisA_Stopp_HindIII (pTNA) and subsequently cloned into pET21a (Stratagene) and pTNA
vectors using the respective terminal restriction sites. The genomic DNA of D. desulfuricans ssp.
Desulfuricans and P. carbinolicuswere ordered fromDSMZ (DSM2380 and DSM6949, respec-
tively). The respective hisA genes (ddhisA and pchisA) were amplified in a standard PCR using the
oligonucleotides 5ʹddhisA_NdeI/3ʹddhisA_XhoI and 5ʹpchisA_NdeI/3ʹpchisA_XhoI, respectively,
and subsequently cloned into the pET24a vector (Stratagene) via the introduced restriction sites
forNdeI and XhoI. For in vivo complementation assays both hisA genes were cloned into the
pTNA vector via the restriction sites for SphI andHindIII. To this end, pchisAwas amplified with
the oligonucleotides 5ʹpchisA_SphI and 3ʹpchisA_Stopp_HindIII, whereas in the case of ddhisA an
overlap extension PCR [36] was necessary to remove an intrinsic SphI restriction site. This reaction
was performed with the oligonucleotides 5ʹddhisA_SphI, 3ʹddhisA_C516T, 5ʹddhisA_C516T, and
3ʹddhisA_Stopp_HindIII.
The genes coding for the reconstructed ancestors were optimized for their expression in E. coli,
synthesized (LifeTechnologies), and cloned into the pTNA and pET24a vectors using the terminal
restriction sites for SphI andHindIII. In order to render pET24a compatible for cloning with
SphI, two QuikChange mutagenesis steps were performed: theNdeI restriction site of pET24a
was replaced by a SphI restriction site using the oligonucleotides 5ʹpET24a_NdeI_to_SphI and
3ʹpET24a_NdeI_to_SphI, whereas a SphI restriction site remote from the multiple cloning site was
removed using the oligonucleotides 5ʹpET24a_A536T and 3ʹpET24a_A536T. All gene constructs
were entirely sequenced to exclude inadvertent mutations.
Heterologous expression and purification of recombinant proteins
Gene expression, harvesting of cells, and cell lysis were performed essentially as described [18].
The genes pchisA and ddhisA were expressed in E. coli T7 Express cells (New England Biolabs)
containing the pRARE helper plasmid [34]. The gene tmhisA was expressed in E. coli BL21-Co-
donPlus-(DE3)-RIPL cells (Agilent Technologies). The genes for the reconstructed proteins
were expressed in E. coli BL21-Gold (DE3) cells (Agilent Technologies). For purification of
tmHisA, heat denaturation (70°C, 15 min) was performed to remove most of the host proteins.
Soluble cell extracts were loaded onto a HisTrapFF crude column (5 mL; GE Healthcare),
which had been equilibrated with 50 mM potassium phosphate, pH 7.5, 300 mM sodium chlo-
ride, and 10 mM imidazole. After washing with equilibration buffer, the bound protein was
eluted by applying a linear gradient of 10–375 mM imidazole. Subsequently, fractions with
pure protein were pooled and dialyzed twice against 50 mM TrisHCl, pH 7.5. Before dialyzing
the reconstructed proteins CA-Bact-HisA, CA-Prot-HisA, and CA-Act-HisA in the same man-
ner, fractions containing the respective protein were loaded onto a Superdex75 column
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(HiLoad 26/60, 320 mL, GE Healthcare) operated with 50 mM TrisHCl, pH 7.5, and 50 mM
sodium chloride at 4°C. In all cases, at least 1 mg protein was obtained per liter of culture. All
proteins were more than 95% pure, as judged by SDS-PAGE.
Steady-state enzyme kinetics
The HisA reaction was measured spectrophotometrically at 300 nm and 25°C as described [6].
The TrpF reaction was followed at 25°C by a fluorimetric assay (excitation at 350 nm, emission
at 400 nm) [37]. The substrate PRA was generated in situ from anthranilate and phosphoribo-
sylpyrophosphate (PRPP) using 1 μM yeast anthranilate phosphoribosyl transferase. To assure
a constant concentration of the unstable PRA during the individual TrpF activity measure-
ments, a 30-fold molar excess of PRPP over anthranilate was used. The kcat and KM values for
both reactions were determined by fitting the hyperbolic saturation curves with the Michaelis-
Menten equation. For unknown reasons, the CA-Prot-HisA and CA-Bact-HisA proteins
exhibited a strong hysteresis, both in the HisA and TrpF reaction. Therefore, entire progress
curves were recorded starting with as many as five different initial substrate concentrations.
The curves were analyzed with COSY [38] using the integrated Michaelis-Menten equation for
progress curves of the HisA reaction and a Michaelis-Menten equation that includes product
inhibition for progress curves of the TrpF reaction.
E. coli knockout strains
The E. coli ΔhisA strain was generated according to a classical protocol [39]. In brief, an ampi-
cillin resistance gene was integrated into an E. coliDY329 helper strain to replace the genomic
hisA gene with the aid of this strain’s genetically encoded bacteriophage λ Red recombination
system [40]. The resistance gene was then transferred to E. coli BW25113 via P1 phage trans-
duction and replaced the genomic hisA gene. The complete deletion of the hisA gene was veri-
fied by sequencing. The E. coli ΔhisAΔtrpF double deletion strain was generated from the
ΔhisA strain in the same manner, with the genomic trpF gene being replaced by a chloram-
phenicol resistance gene. The E. coli ΔtrpF single deletion strain (E. coli JMB9r-m+ΔtrpF) was
available from previous work [41].
In vivo complementation assays
Complementation assays with pTNA_scpriA, pTNA_tmhisA, pTNA_tmtrpF, pTNA_ddhisA,
and pTNA_pchisA, as well as with the pTNA constructs of the reconstructed ancestors
CA-Act-HisA, CA-Prot-HisA, and CA-Bact-HisA were performed on M9 minimal medium
agar plates. An identical experimental procedure was followed in all cases: First, the respective
plasmid was used to transform either chemical competent ΔhisA, ΔtrpF, or ΔhisAΔtrpF E. coli
cells. Next, single colonies were picked in order to inoculate 5 mL of LB medium supplemented
with 150 μg/mL ampicillin only (ΔhisA cells) or with 150 μg/mL ampicillin and 30 μg/mL
chloramphenicol (ΔtrpF and ΔhisAΔtrpF cells). After incubation at 37°C overnight, 5 mL of LB
medium containing the respective resistance markers were inoculated (optical density of 0.1 at
600 nm) and incubated at 37°C until an optical density of about 1 at 600 nm was reached (cor-
responding to approximately 108 cells). Subsequently, the cells in 1 mL suspension were col-
lected by centrifugation (4°C, 4000 g, 10 min) and washed three times with 1% NaCl. Finally,
1:105 and 1:104 dilutions were streaked out on M9 minimal medium agar plates containing
150 μg/mL ampicillin and incubated at 37°C.
Long-Term Persistence of Bi-functionality
PLOS Genetics | DOI:10.1371/journal.pgen.1005836 January 29, 2016 11 / 14
Supporting Information
S1 Fig. Phylogenetic tree based on 103 HisA sequences. Each sequence consists of the
concatenated sequences of a HisA, a HisF, and a HisH protein. The tree was determined using
pb, which is part of the PhyloBayes package. Posteriori probabilities are given for the splits; the
length of the bar at the top corresponds to 0.5 mutations per site. Names encode the phyloge-
netic lineage of the species, see S1 Table. The node that corresponds to the reconstructed com-
mon ancestor of Actinobacteria (CA-Act-HisA) is marked with a filled circle.
(PDF)
S2 Fig. Phylogenetic tree based on 81 HisA sequences. Each sequence set consists of the
concatenated sequences of a HisA, a HisF, and a HisH protein. The tree was determined using
pb, which is part of the PhyloBayes package. Posteriori probabilities are given for the splits; the
length of the bar at the top corresponds to 0.5 mutations per site. Names encode the phyloge-
netic lineage of the species, see S1 Table. The nodes that correspond to the reconstructed com-
mon ancestor of Proteobacteria (CA-Prot-HisA) and Bacteria (CA-Bact-HisA) are marked
with a filled circle.
(PDF)
S1 Table. Species names and their abbreviations. The data set for the determination of a phy-
logenetic tree consisted of concatenated sequences of one HisA, one HisF, and one HisH, origi-
nating from the species listed below. For each phylum, the number of sequences is given in
brackets. In the list, each species name is followed by the abbreviation (in brackets) used to
label leaves of phylogenetic trees. The first symbol of the abbreviation indicates the superking-
dom, the next four groups of two characters each give phylum, class, order, family, and the last
three characters indicate the species name. Additional numbers were added by the algorithm
used to create the abbreviations [28] but have no meaning in this context.
(PDF)
S2 Table. Nucleotide and amino acid sequences of synthesized genes for ancestral proteins.
(PDF)
S3 Table. List of oligonucleotides used for cloning and site-directed mutagenesis.
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S1 Table: Species names and their abbreviations  
The data set for the determination of a phylogenetic tree consisted of concatenated sequences of one 
HisA, one HisF, and one HisH, originating from the species listed below. For each phylum, the 
number of sequences is given in brackets. In the list, each species name is followed by the 
abbreviation (in brackets) used to label leaves of phylogenetic trees. The first symbol of the 
abbreviation indicates the superkingdom, the next four groups of two characters each give phylum, 
class, order, family, and the last three characters indicate the species name. Additional numbers were 
added by the algorithm used to create the abbreviations 1 but have no meaning in this context. 
Crenarchaeota (20): Vulcanisaeta distributa (ACrThTh_Vdi), Pyrolobus fumarii (ACrThDe_Pfu), 
Acidianus hospitalis (ACrThSuSu_Aho), Metallosphaera cuprina (ACrThSuSu_Mcu), 
Metallosphaera sedula (ACrThSuSu_Mse), Metallosphaera yellowstonensis (ACrThSuSu_Mye), 
Sulfolobus acidocaldarius (ACrThSuSu_Sac), Sulfolobus islandicus (ACrThSuSu_Sis), Sulfolobus 
solfataricus (ACrThSuSu_Sso), Sulfolobus tokodaii (ACrThSuSu_Sto), Sulfolobales archaeon Acd1 
(ACrThSu_Sar), Caldivirga maquilingensis (ACrThTh_Cma), Pyrobaculum arsenaticum 
(ACrThTh_Par), Pyrobaculum calidifontis (ACrThTh_Pca), Pyrobaculum islandicum 
(ACrThTh_Pis), Pyrobaculum oguniense (ACrThTh_Pog), Pyrobaculum sp. 1860 (ACrThTh_Psp), 
Thermoproteus neutrophilum (ACrThTh_Tne), Thermoproteus tenax (ACrThTh_Tte), Thermoproteus 
uzoniensis (ACrThTh_Tuz) 
Euryarchaeota (5): Archaeoglobus veneficus (AEuArAr_Ave), Methanoculleus marisnigri 
(AEuMeMe_Mma_8), Methanoculleus marisnigri (AEuMeMe_Mma_9), Methanoplanus petrolearius 
(AEuMeMe_Mpe), Archaeoglobus fulgidus (AEuArAr_Afu) 
Bacterioidetes (8): Prevotella buccae (BBaBaBa_Pbu), Parabacteroides distasonis (BBaBaBa_Pdi), 
Tannerella sp. 6_1_58FAA_CT1 (BBaBaBa_Tsp), Algoriphagus machipongonensis (BBaCyCy_Asp), 
Leadbetterella byssophila (BBaCyCy_Lby), Marivirga tractuosa (BBaCyCy_Mtr), Spirosoma 
linguale (BBaCyCy_Sli), Prevotella bergensis (BBaBaBa_Pbe) 
Firmicutes (11): Bacillus amyloliquefaciens (BFiBaBa_Bam), Bacillus amyloliquefaciens 
(BFiBaBa_Bam_4), Bacillus pumilus (BFiBaBa_Bpu), Bacillus pumilus (BFiBaBa_Bpu_1), Bacillus 
sp. NRRL B-14911 (BFiBaBa_Bsp), Bacillus sp. 1NLA3E (BFiBaBa_Bsp_3), Bacillus subtilis 
(BFiBaBa_Bsu), Bacillus subtilis (BFiBaBa_Bsu_2), Bacillus subtilis (BFiBaBa_Bsu_3), Bacillus 
subtilis (BFiBaBa_Bsu_5), Bacillus megaterium (BFiBaBaBa_Bme) 
Spirochaetes (5): Leptospira biflexa (BSpSpSp_Lbi), Leptospira borgpetersenii (BSpSpSp_Lbo), 
Leptonema illini (BSpSpSp_Lil), Leptospira (BSpSpSp_Lin__1), Leptospira noguchii 
(BSpSpSp_Lno) 
Proteobacteria (32): Afipia birgiae (BPrAlRhBr_Abi), Afipia bromae (BPrAlRhBr_Abr), Afipia felis 
(BPrAlRhBr_Afe), Bradyrhizobium elkanii (BPrAlRhBr_Bel), Bradyrhizobium japonicum 
(BPrAlRhBr_Bja), Bradyrhizobium sp. BTAi1 (BPrAlRhBr_Bsp), Oligotropha carboxidovorans 
(BPrAlRhBr_Oca), Rhodopseudomonas palustris (BPrAlRhBr_Rpa__2), Rhodopseudomonas 
palustris (BPrAlRhBr_Rpa__3), Rhodopseudomonas palustris (BPrAlRhBr_Rpa__5), 
Rhodopseudomonas sp. B29 (BPrAlRhBr_Rsp), Bradyrhizobium sp. WSM4349 (BPrAlRhPh_Msp), 
Rhodovulum sp. PH10 (BPrAlRhRh_Rsp), Starkeya novella (BPrAlRhXa_Sno), Xanthobacter 
autotrophicus (BPrAlRhXa_Xau), Roseovarius nubinhibens (BPrAlRh_Rnu), Roseovarius sp. 
TM1035 (BPrAlRh_Rsp_14), Roseobacter sp. AzwK-3b (BPrAlRh_Rsp_16), Rhodobacter 
sphaeroides (BPrAlRh_Rsp_4), Roseovarius sp. 217 (BPrAlRh_Rsp_5), Rhodobacter sphaeroides 
(BPrAlRh_Rsp_8), Methylovorus (BPrBeMe_Mgl), Neisseria elongata (BPrBeNe_Nel), Neisseria 
lactamica (BPrBeNe_Nla), Nitrosomonas sp. AL212 (BPrBeNi_Nsp), Methylobacillus flagellatus 
(BPrBeMe_Mfl), Pelobacter carbinolicus (BPrDeDe_Pca), Psychrobacter sp. PRwf-1 
(BPrGaPs_Psp_2), Halomonas (BPrGaOc_Hsp), Acinetobacter (BPrGaPs_Ara_1), Acinetobacter 
(BPrGaPs_Asp), Psychrobacter sp. 1501 (BPrGaPs_Psp_1) 
Actinobacteria (22): Propionibacterium avidum (BAcAcAc_Pav), Propionibacterium acnes 
(BAcAcAc_Pac__2), Propionibacterium acnes (BAcAcAc_Pac), Propionibacterium freudenreichii 
(BAcAcAc_Pfr), Microlunatus phosphovorus (BAcAcAc_Mph), Bifidobacterium longum 
(BAcAcBi_Blo__2), Bifidobacterium longum (BAcAcBi_Blo__1), Bifidobacterium longum 
(BAcAcBi_Blo), Bifidobacterium breve (BAcAcBi_Bbr), Bifidobacterium bifidum 
(BAcAcBi_Bbi__1), Bifidobacterium dentium (BAcAcBi_Bde__1), Bifidobacterium adolescentis 
(BAcAcBi_Bad), Streptomyces sp. C (BAcAcAc_Ssp_8), Streptomyces sp. Mg1 (BAcAcAc_Ssp_6), 
Streptomyces sp. e14 (BAcAcAc_Ssp_4), Streptomyces coelicolor (BAcAcAc_Sco_1), Streptomyces 
violaceusniger (BAcAcAc_Svi_2), Streptomyces himastatinicus (BAcAcAc_Shi), Streptomyces 
bingchenggensis (BAcAcAc_Sbi), Frankia sp. EUN1f (BAcAcAc_Fsp__3), Frankia sp. EAN1pec 
(BAcAcAc_Fsp), Frankia alni (BAcAcAc_Fal) 
 
S2 Table. Nucleotide and amino acid sequences of synthesized genes for ancestral 
proteins  
Nucleotide sequence for CA-Act-HisA (restriction sites for SphI and HindIII are underlined): 
GCATGCTCACCCTGCTGCCTGCAGTTGATGTTCGTGATGGTCAGGCAGTTCGTCTGGTTCAGGGTGAA
GCAGGTAGCGAAACCAGCTATGGTGATCCGCTGGAAGCAGCACGTACCTGGCAAGAGGATGGTGCAGA
ATGGATTCATCTGGTTGATCTGGATGCAGCATTTGGTCGTGGTAGCAATCGTGAACTGATTGCCGAAG
TTGTTCGTGCCGTTGATGTTAATGTTGAACTGAGCGGTGGTATTCGTGATGATGATAGCCTGGATGCC
GCACTGGCAACCGGTGCAGCACGTGTTAATATTGGCACCGCAGCACTGGAAAATCCGGAATGGGTTCG
TAAAGTTATTGATCGTTATGGCGATCGTATTGCAGTTGGTCTGGATGTGCGTGGCACCACCCTGGCAG
CCCGTGGTTGGACCCGTGATGGTGGTGAACTGTTTGAAGTTCTGGCACGTCTGGATGCGGCAGGTTGT
GCACGTTATGTTGTTACCGATGTTGCACGTGATGGTATGCTGACCGGTCCGAATGTGGAACTGCTGCG
TGAAGTTACCGCAGCAACCGATCGTCCGGTTGTTGCAAGCGGTGGTGTTAGCAGTCTGGATGATCTGC
GTGCACTGGCAGCGCTGGTTCCGGAAGGTGTTGAAGGTGCAATTGTTGGTAAAGCACTGTATGCCGGT
GCATTTACCCTGCCGGAAGCACTGGCCGTTGCACGTAAGCTT 
 
Nucleotide sequence for CA-Prot-HisA (restriction sites for SphI and HindIII are underlined): 
GCATGCTGATTATTCCGGCAATCGATCTGAAAGATGGTCGTTGTGTTCGTCTGGAACAGGGTGATATG
GAAAAAGCAACCGTGTATAATGATGATCCGGCAGCAATGGCACGTCAGTGGGTTGAGCAGGGTGCAGA
ATGGCTGCATCTGGTTGATCTGGATGGTGCATTTGCAGGTAAACCGGTTAATGAAGATGCCATTAAAG
CAATTGCAGAAGCAGTTAGCATTCCGGTTCAGCTGGGTGGTGGTATTCGTGATCTGGAAACCATTGAA
GCATATCTGGAAGCAGGTATTGATCGTGTTATTATTGGCACCGTTGCAGTGAAAAATCCGGAACTGGT
TCGTGAAGCATGTCGTGCATTTCCGGGTCGTATTGTTGTTGGTATTGATGCACGTGATGGTATGGTTG
CAGTTAAAGGTTGGGCAGAAGTTACCGAAGTTAAAGCCACCGATCTGGCCAAACGTTTTGAAGATGCG
GGTGTTGAAGCAATCATTTATACCGATATTGCCCGTGATGGCATGATGCAGGGTCCGAATATTGAAGC
AACCCGTGCACTGGCAAAAGCAGTTTCAATTCCGGTTATTGCAAGCGGTGGTGTTAGCAGCCTGGAAG
ATATCGAAGCACTGCTGGCAATTGAAGATAGCGGTGTGACCGGTGTTATTACCGGCAAAGCACTGTAT
GAAGGTAGCCTGGATCTGCGTGAAGCACTGGCACTGGCCAAAAAGCTT 
 
Nucleotide sequence for CA-Bact-HisA (restriction sites for SphI and HindIII are underlined): 
GCATGCGCATTATTCCGGCAATCGATCTGAAAGATGGTCGTTGTGTTCGTCTGGTTCAGGGTGATATG
GAAAAAGCAACCGTGTATAATGATGATCCGCTGGAAATGGCAAAACAGTGGGTTGAACAGGGTGCAGA
ATGGCTGCATGTTGTTGATCTGGATGGTGCATTTGCAGGTAAACCGGTTAATGAAGATGTGATCAAAG
AAATCGCACAGAAAGTTAGCGTTAAAGTTCAGCTGGGTGGTGGTATTCGTGATCTGGAAGATATTGAA
GCATATCTGGATGCCGGTGTTGATCGTGTTATTATTGGCACCGTTGCAGTTAAAAATCCGGAACTGGT
TCGTGAAATGGTGGAAAAATATGGTGAACGTATTGTGGTTGGTATTGATGCACGTGATGGTATGGTTG
CCGTTAAAGGTTGGAAAGAAACCACCGAAGTTAAAGCCACCGATCTGGCCAAACGTTTTGAAGATGCA
GGCGTTGAAGCAATCATTTATACCGATATTGCCCGTGATGGCATGATGCAGGGTCCGAACATTGAAGC
CATTCGTGAACTGGCAAAAGCAGTTAGCCTGCCGGTTATTGCAAGCGGTGGTGTTAGCAGCCTGGAAG
ATATCGAGGCACTGCTGGCAATTGAAGAAAGCGGTGTTGCGGGTGTTATTGTTGGTAAAGCACTGTAT
GAAGGTCGTCTGGATCTGCGTGAAGCACTGGCACTGGCCAAAAAGCTT 
 
Amino acid sequence of CA-Act-HisA: 
MLTLLPAVDVRDGQAVRLVQGEAGSETSYGDPLEAARTWQEDGAEWIHLVDLDAAFGRGSNRELIAEV
VRAVDVNVELSGGIRDDDSLDAALATGAARVNIGTAALENPEWVRKVIDRYGDRIAVGLDVRGTTLAA
RGWTRDGGELFEVLARLDAAGCARYVVTDVARDGMLTGPNVELLREVTAATDRPVVASGGVSSLDDLR
ALAALVPEGVEGAIVGKALYAGAFTLPEALAVAR 
 
Amino acid sequence of CA-Prot-HisA: 
MLIIPAIDLKDGRCVRLEQGDMEKATVYNDDPAAMARQWVEQGAEWLHLVDLDGAFAGKPVNEDAIKA
IAEAVSIPVQLGGGIRDLETIEAYLEAGIDRVIIGTVAVKNPELVREACRAFPGRIVVGIDARDGMVA
VKGWAEVTEVKATDLAKRFEDAGVEAIIYTDIARDGMMQGPNIEATRALAKAVSIPVIASGGVSSLED
IEALLAIEDSGVTGVITGKALYEGSLDLREALALAK 
 
Amino acid sequence of CA-Bact-HisA: 
MRIIPAIDLKDGRCVRLVQGDMEKATVYNDDPLEMAKQWVEQGAEWLHVVDLDGAFAGKPVNEDVIKE
IAQKVSVKVQLGGGIRDLEDIEAYLDAGVDRVIIGTVAVKNPELVREMVEKYGERIVVGIDARDGMVA
VKGWKETTEVKATDLAKRFEDAGVEAIIYTDIARDGMMQGPNIEAIRELAKAVSLPVIASGGVSSLED
IEALLAIEESGVAGVIVGKALYEGRLDLREALALAK 
 
S3 Table. List of oligonucleotides used for cloning and site-directed mutagenesis 
Name Sequence 
5`ddhisA_NdeI ccgtatcatatgattatttttcccgctgttg 
3`ddhisA_XhoI 
5`ddhisA_SphI 
agccccctcgaggcgctttcgggcgtgtttttc 
ggagatggcatgctgatttttcccgctg 
3`ddhisA_Stopp_HindIII tgccaagcttcaggcgctttcgggcgtg 
5`ddhisA_C516T attgaacgcgacggtatgcagtgcggc 
3`ddhisA_C516T gccgcactgcataccgtcgcgttcaat 
5`pchisA_NdeI ccgtatcatatgatagttattcccgccatcg 
3`pchisA_XhoI agccccctcgaggctttgcccttggtcagagcc 
5`pchisA_SphI ggagatggcatgctggttattcccgcca 
3`pchisA_Stopp_HindIII tgccaagcttcaggctttgcccttggt 
5`tmhisA_NdeI ccgtatcatatgctcgttgtcccggcgat 
3`tmhisA_NotI atagcggccgcgcgagcatatctcttcatcac 
5`tmhisA_SphI atagcatgctcgttgtcccggcg 
3`tmhisA_Stopp_HindIII tgccaagctttagcgagcatatct 
5`scpriA_SphI ggagatggcatgcgcaagctcgaactc 
3`scpriA_ Stopp_HindIII tgccaagcttcacgacgtagcctccaa 
5`pET24a_NdeI_to_SphI ccaccagtcatgctagccgcatgcatatctccttcttaaag 
3`pET24a_NdeI_to_SphI ctttaagaaggagatatgcatgcggctagcatgactggtgg 
5`pET24a_A536T cgccatctccttgcttgcaccattccttg 
3`pET24a_A536T caaggaatggtgcaagcaaggagatggcg 
Restriction sites are underlined; modified bases are in bold. 
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Abstract: Chorismate-utilizing enzymes play a vital role in the
biosynthesis of metabolites in plants as well as free-living and
infectious microorganisms. Among these enzymes are the
homologous primary metabolic anthranilate synthase (AS)
and secondary metabolic isochorismate synthase (ICS). Both
catalyze mechanistically related reactions by using ammonia
and water as nucleophiles, respectively. We report that the
nucleophile specificity of AS can be extended from ammonia to
water by just two amino acid exchanges in a channel leading to
the active site. The observed ICS/AS bifunctionality demon-
strates that a secondary metabolic enzyme can readily evolve
from a primary metabolic enzyme without requiring an initial
gene duplication event. In a general sense, these findings add to
our understanding how nature has used the structurally
predetermined features of enzyme superfamilies to evolve
new reactions.
Chorismate (CH) is a central metabolic branch-point
molecule and the common precursor of essential primary
(folate, tryptophan) and important secondary (menaqui-
nones, siderophores, antibiotics) metabolites that are vital
for plants as well as free living and infectious microorgan-
isms[1] (Figure 1). The CH-related pathways are therefore
notable targets for antimicrobials and herbicides. The
enzymes catalyzing the committed steps of these pathways
share a common fold and use similar reaction mechanisms.
Presumably, they originated from a common ancestor and
have therefore been grouped together as the MST (menaqui-
none, siderophores, tryptophan) superfamily.[2] Within this
superfamily, the primary metabolic anthranilate and amino-
deoxychorismate synthases (AS, ADCS) employ ammonia as
a nucleophile to form aminated chorismate derivatives,
whereas the secondary metabolic isochorismate and salicylate
synthases (ICS, SS) use water as a nucleophile to hydroxylate
chorismate (Figure 1). These two subfamilies are hereafter
termed ammonia-utilizing and water-utilizing MST enzymes,
respectively (AMEs, WMEs). Based on the assumption that
each enzyme of secondary metabolism stems from an enzyme
of primary metabolism,[3] the subdivision of the MST super-
family suggests that a transition of nucleophile specificity
from ammonia to water underlay the evolution of WMEs
(ICS, SS) from AME (AS, ADCS) ancestors. We retraced this
putative evolutionary path by identifying the residues that
contribute to nucleophile specificity in MST enzymes and by
subsequently establishing ICS activity on an AS scaffold.
The AS from Salmonella typhimurium (stAS) is a hetero-
tetramer comprising two synthase and two glutaminase
subunits (stTrpE and stTrpG, respectively).[4] Glutamine is
hydrolyzed in the active site of stTrpG to yield nascent
ammonia, which is subsequently channeled to the active site
of stTrpE.[4, 5] To identify the residues of stTrpE that are
involved in this channeling and that may therefore come into
contact with the ammonia nucleophile, we applied
MOLE 2.0, a program for analyzing macromolecular chan-
nels.[6] We identified a 30 è-long channel connecting the
active sites in stAS (Figure 2a). This channel is similar to the
channel observed in the crystal structure of the homologous
aminodeoxyisochorismate (ADIC) synthase PhzE.[7] As the
channel approaches the CH ligand, it is predominantly shaped
by three residues: Gln263 in b-strand 11 as well as Met364 and
Leu365 in a-helix 12. To estimate whether the nature of these
residues correlates with nucleophile specificity in AMEs and
WMEs, we computed individual multiple sequence align-
ments (MSAs) of ADCS, AS, ICS, and SS. Notably, these
sequences formed four distinct subtrees in a phylogenetic
analysis (Figure S1 in the Supporting Information), which
makes them representative for their MST groups. Further-
more, all of the MSAs contained sequences of at least four
major phyla. The resulting sequence logos of b-strand 11 and
a-helix 12 (Figure 2b) confirmed the strict conservation of
Gln263 in AS and of Lys at the corresponding position in ICS
and SS, which has been noted previously.[2] It was further
shown that this Lys acts as a catalytic base for water activation
in ICS and SS.[2, 8] In a number of ADCS sequences, Gln263 is
substituted by Glu. Residues 364 and 365 are conserved to
a large extent within AMEs and WMEs, but clearly differ
between the two groups. In AMEs, Met364 is strictly
conserved, as are Leu365 in AS and Ile365 in ADCS. In
WMEs however, several hydrophobic residues (Leu, Ile, Phe,
Val) are abundant at position 364, as are Val in ICS and Ser in
SS at position 365. Other positions were not considered since
they are either conserved throughout all fourMST groups, not
conserved within AMEs orWMEs, or not involved in forming
the nucleophile channel in stAS.
Based on this analysis, we attempted to shift the nucle-
ophile specificity of stAS from ammonia to water by mutating
residues 263, 364, and 365 of the stTrpE subunit. For this
purpose, 16 variants were generated and assayed byHPLC for
the formation of reaction products starting from CH. The
WME-typical catalytic Lys replaced the wild-type Gln263 in
all of the variants and was combined with the different
residues 364/365 found in WMEs (Table S1). The variants are
hereafter denoted by their residues 263–364–365 combination
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Institut fír Biophysik und physikalische Biochemie
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(e.g. KML for the variant with Lys263, Met364, and Leu365).
All variants expressed as soluble proteins and no adverse
effects on protein stability were observed compared to wild-
type stTrpE.
Twelve of these variants formed IC in the absence of an
ammonia source (Figure 3a and Figure S2a). The product was
unambiguously identified by ESI mass spectrometry and
enzymatic conversion to SA (Figure S3). All twelve variants
feature the Gln263Lys substitution. In three of these variants,
the Gln263Lys substitution is combined with a mutation at
position 365 (KMV, KMS, KMA). Therefore, just two
mutations are sufficient for the establishment of IC specificity
on the stTrpE scaffold. In nine of the variants, an additional
mutation is present at position 364. Averaged over the 12
variants, 20% of supplied CH was converted to IC; the best
variant, KIA, converted 37.1%. In comparison, the ICS EntC
from Escherichia coli formed 31.5% IC, with the observed
incomplete conversion being caused by equilibrium between
CH and IC.[9]Upon replacing Lys263 byAla in the IC-forming
KLS variant, the resulting ALS variant became inactive,
pointing to a catalytic role for Lys263 in our stAS variants
similar to that in native ICS and SS.[2, 8] Furthermore, no IC
was formed in control reactions with wild-type stTrpE or in
the absence of any enzyme.
For the KML variant, which carries only the single
Gln263Lys replacement, neither IC nor SA was detected,
thus indicating that Lys263 alone is not sufficient for the use
of water as a nucleophile. Accordingly, the Abell group could
also not detect IC or SA when characterizing the equivalent
single Gln263Lys replacement in the AS from Serratia
marcescens.[10] Ziebart and Toney
reported in a comprehensive study on
nucleophile specificity in MSTenzymes
that the Gln263Lys variant of stAS
(equivalent to our KML variant)
formed traces of IC and SA.[11] How-
ever, only 0.008% and 0.03% of CH
were converted to IC and SA, respec-
tively, under conditions comparable to
our experimental setup. In any case, the
central finding of our work, namely
inversion of the nucleophile specificity
of stAS through a few amino acid
replacements, as exemplified by the
KAS and KAAvariants, is independent
of whether the single Gln263Lys
replacement leads to no or extremely
low amounts of IC or SA.
It is worth noting that only four of
the ICS-active stAS variants also
formed SA, which involves the elimi-
nation of pyruvate from IC. This find-
ing seems counterintuitive at first
because the generic product of stAS is
AA, which has, like SA, undergone
elimination of pyruvate. However, it
was recently shown that the elimination
of pyruvate from chorismate-derived
reaction intermediates in MSTenzymes
is controlled by the conformation of the chorismate ring
structure.[12] Therefore, the most plausible explanation for the
lack of pyruvate-elimination activity in most ICS-active stAS
variants is perturbations in the IC ring conformation caused
by the introduced mutations.
To examine the effects of the mutations on the use of the
generic nucleophile ammonia, we investigated product for-
mation by the stAS variants in the presence of glutamine
(Figure 3b and Figure S2b). Under these conditions, all
twelve ICS-active variants formed not only IC but also AA
and its precursor ADIC, thus implying a broadened nucleo-
phile specificity. Interestingly, while forming substantial
amounts of AA, some variants showed only a modest
reduction in IC formation compared to the absence of
glutamine (KMV: 2.5-fold, KIV: 1.4-fold). Other variants,
while also forming considerable amounts of AA, even showed
an increase in IC formation upon the addition of glutamine
(e.g., KAV: 2.2-fold).
Independent of the presence or absence of an ammonia
source, a striking increase in IC formation was observed for
the residue sequence Leu!Val!Ser/Ala365. Variants with
Leu365 are catalytically inactive, both for IC and AA
formation. The presence of Val, Ser, and Ala instead leads
to average CH to IC conversions of 8.2%, 28.1%, and 24.6%,
respectively.
As pointed out before, residues 263, 364, and 365 line the
nucleophile channel in stTrpE. We therefore assumed that
differently sized residues at these positions might reshape the
channel and thus lead to the different reactivities observed.
To allow a statistically sound prediction of the general
Figure 1. Chorismate is a central branch point between primary and secondary metabolism. It is
converted into aminodeoxychorismate (ADC) and anthranilate (AA) by the primary metabolic
ammonia-utilizing MST enzymes (AMEs) ADCS and AS. Both enzymes are heteromeric
complexes comprising glutaminase (PabA, TrpG) and synthase (PabB, TrpE) subunits. ADC and
AA are part of folate and tryptophan biosynthesis, respectively. The water-utilizing MST-enzymes
(WMEs) ICS and SS convert chorismate into isochorismate (IC) and salicylate (SA), respectively.
Both products are precursors of important secondary metabolites like iron-chelating siderophores
and respiratory-chain components (menaquinone). A special characteristic of AS and SS is that
pyruvate is eliminated from the reaction intermediates aminodeoxyisochorismate (ADIC) and IC
to yield aromatic products.
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nucleophile path in the stTrpE variants, we performed
molecular dynamics (MD) simulations and applied MOLE
to generate 600 putative nucleophile trajectories (PNTs) for
each variant. A PNT is defined by the centerline of the
corresponding MOLE channel.
We found that a reduction in the size of residue 365 leads
to a shift in PNT localization in a 10 è shell around CH
(Figure 4a). In wild-type stTrpE, PNTs pass Met364 and
Gln263, bend around Leu365, and end at C2 of CH, which is
where the nucleophilic attack by ammonia takes place. The
single Gln263Lys mutation in the KML variant does not alter
this course. Since both KML and wild-type stTrpE feature
Leu365, this course of PNTs was termed the L-path (Fig-
ure 4b). In the KML variant, however, the PNT-associated
channels are clearly constricted between Lys263, Leu365, and
Val265 owing to a change in the van der Waals volume of
residue 263 from 114 è3 (Gln) to 135 è3 (Lys).[13] Ammonia
or water therefore cannot access CH via these PNTs, thus
resulting in the observed loss of activity in the Leu365
variants. Replacing Leu365 by Val (volume reduction from
124 è3 to 105 è3) has two consequences for the PNTs: The
associated channels of L-path PNTs are enlarged and 31% of
the PNTs shift away from the L-path and approach CH from
Val365 and Thr425. This effect becomes even more pro-
nounced for the KMS variant with Ser365, the low volume
(73 è3) of which allows 79% of the PNTs to approach CH via
this alternative path. Finally, Ala365 (67 è3) leads to a com-
plete shift of PNTs to this path, which was therefore termed
the A-path (Figure 4b).
For the other twelve stAS variants, MD simulations and
computations of PNTs were performed in a similar manner
(Figure S4, Table S2). The PNT distributions in these variants
are consistent with those described above for the KML, KMV,
KMS, and KMA variants. Taken together, it is evident that
high CH to IC conversion rates correlate with high fractions
of PNTs proceeding along the A-path (Figure 4c).
These findings provide a conclusive view on water
utilization by WMEs. Ziebart and Toney suggested that two
properties of WMEs promote the water-activating capacity of
Lys263.[11] First, two hydrogen-bond acceptors were thought
to assist in deprotonating the e-amino group. However, one of
these acceptors, a glutamic acid residue, is conserved not only
in WMEs but in all but one of the 1222 MST enzymes in our
dataset. The other, a serine residue corresponding to Ser365,
is not conserved in SS (7% Ala) and is not present at all in
ICS. Furthermore, we could show that Ser365 is not required
for IC formation (Figure 4c). The second element proposed
was the residue corresponding to Met364 in stTrpE. It is
conserved as a hydrophobic residue (Leu, Ile, Val, Phe) in
WMEs and was thought to assist in the proper orientation of
Lys263 by making van der Waals contact with the Lys
methylene groups. However, variants with wild-type Met364
or Ala364 display IC specificity as well (Figure 4c), which
argues against a role for residue 364 in positioning the
catalytic Lys.
In summary, we have demonstrated that nucleophile
specificity in MSTenzymes is controlled by two factors: 1) the
presence or absence of Lys263 as a catalytic base and
2) sufficient space for the nucleophile to reach CH. These
findings agree well with the amino acid distribution in
naturally occurring ICS and SS. Only five ICS and no SS in
our MST dataset contain a residue larger than Val at position
365. Moreover, the assignment of Leu365 in those five ICS
sequences is most likely due to a misalignment, since in all
cases, Val directly precedes this Leu.
The straightforward establishment of ICS activity on the
evolutionarily related AS scaffold indicates that the MST-
superfamily represents a flexible and adaptive link between
primary and secondary metabolism. It is generally accepted
that each secondary metabolic pathway has its origin in
mutations that accumulated in a primary metabolic gene.
Consequently, these mutations should 1) enhance overall
metabolic chemical diversity by yielding molecules with novel
biological activities, 2) allow the retention of existing chem-
ical variety, and 3) do so with minimum fitness costs.[3a] Our
Figure 2. Location and conservation of residues characteristic for
AMEs and WMEs. a) Nucleophile channel connecting the active sites
of stTrpG (blue; represented by Cys87 and a glutamine ligand) and
stTrpE (pale blue; represented by CH and a Mg2+ ion) in stAS (model
based on PDB ID 1i7q). The channel-lining residues of stTrpE mutated
in this work are shown as stick models. b) Sequence logos of b-strand
11 and a-helix 12. The b-strand contains a conserved Gln/Glu in AMEs
and a strictly conserved Lys in WMEs. The a-helix contains the
conserved Met–Leu and Met–Ile pairs in AS and ADCS, respectively. In
ICS, this pair is mainly conserved as [Leu,Phe,Val]–[Val,Ala] and in SS
as [Ile,Leu]–[Ser,Ala]. Residue numbering is based on stTrpE. Residues
263, 364, and 365 are colored by their chemical properties (purple:
amido functionality, red: acidic, blue: basic, black: hydrophobic, green:
hydroxyl functionality, orange: small).
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data strongly support this
hypothesis. Only two mutations
are necessary to establish ICS
activity and all these stTrpE var-
iants were still able to employ
ammonia as a nucleophile to
form AA for tryptophan biosyn-
thesis. Following this reasoning,
the evolution of IC formation
does not necessarily require gene
duplication but could have pro-
ceeded via a bifunctional inter-
mediate similar to the stTrpE
variants of this work.
Substrate or nucleophile
channeling, which is crucial for
enzymatic function in MST
enzymes, is no rare phenomenon.
More than 64% of all known
enzyme structures contain at
least two channels reaching to
their active sites.[14] Our
approach may thus prove valua-
ble for modifying the reactivities
of such enzymes, which could
ultimately yield novel enzymatic
functions.
Figure 3. Product distributions of reactions of stTrpE variants with chorismate in the absence (a) and
presence (b) of glutamine as an ammonia source. The variants share Lys263 and are grouped by residue
364 (e.g., KM* describes the four variants with Lys263, Met364, and either Leu, Val, Ser, or Ala at
position 365). All stTrpE variants were assayed in the presence of stTrpG. The product distributions of
control reactions are shown on the right: wild-type stTrpE (wt), ecEntC (EntC), Lys263Ala knockout of
the KLS variant (ALS), and enzyme-free control (¢). For each product, its fraction out of all of the
products formed is shown (% conversion). Each data point represents the mean of at least three
independent experiments. Error bars are omitted for clarity because the average and maximum absolute
errors were only 0.3% and 3.7%, respectively. Step lines connecting data points were added to aid
visual tracking of product-specific values.
Figure 4. Visualization and quantitative analysis of PNTs in wild-type and mutant stTrpE variants. a) Comparison of PNTs in wild-type stTrpE and
the KML, KMV, KMS, and KMA variants. The diameters of the PNT-associated channels are color-coded and important channel-lining residues are
shown as stick models. The key observation is the correlation between decreasing size of residue 365 (Leu>Val>Ser>Ala) and a shift in PNT
localization from the L-path to the A-path [see (b)]. b) The L-path (cyan) and A-path (magenta) reflect the majority of PNTs in variants with
Leu365 and Ala365, respectively, and thus show the boundaries of the PNT shift. The directions from which the two paths approach CH can be
separated by a plane specified by CH-C2 and the Ca-atoms of Met364 and Thr425 (for details see the methods section in the Supporting
Information). c) Comparison of the average CH-to-IC conversion by all stTrpE variants with Lys263 and the fraction of PNTs proceeding along the
A-path in these variants.
Angewandte
Chemie
11273Angew. Chem. Int. Ed. 2015, 54, 11270 –11274 Ó 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.angewandte.org
Acknowledgements
M.G.P. was supported by a PhD fellowship from the Fonds der
Chemischen Industrie. We thank Kristina Heyn for help with
phylogenetic analyses and Christiane Endres, Sonja Fuchs,
and Jeannette Ueckert for expert technical assistance.
Keywords: chorismate · enzyme catalysis · enzyme evolution ·
nucleophile specificity · protein design
How to cite: Angew. Chem. Int. Ed. 2015, 54, 11270–11274
Angew. Chem. 2015, 127, 11423–11427
[1] F. Dosselaere, J. Vanderleyden, Crit. Rev. Microbiol. 2001, 27,
75 – 131.
[2] S. Kolappan, J. Zwahlen, R. Zhou, J. J. Truglio, P. J. Tonge, C.
Kisker, Biochemistry 2007, 46, 946 – 953.
[3] a) R. D. Firn, C. G. Jones, Mol. Microbiol. 2000, 37, 989 – 994;
b) L. C. Vining, Gene 1992, 115, 135 – 140.
[4] A. A. Morollo, M. J. Eck, Nat. Struct. Biol. 2001, 8, 243 – 247.
[5] A. A. Morollo, R. Bauerle, Proc. Natl. Acad. Sci. USA 1993, 90,
9983 – 9987.
[6] D. Sehnal, R. Svobodova Varekova, K. Berka, L. Pravda, V.
Navratilova, P. Banas, C. M. Ionescu, M. Otyepka, J. Koca, J.
Cheminf. 2013, 5, 39.
[7] Q. A. Li, D. V. Mavrodi, L. S. Thomashow, M. Roessle, W.
Blankenfeldt, J. Biol. Chem. 2011, 286, 18213 – 18221.
[8] J. Zwahlen, S. Kolappan, R. Zhou, C. Kisker, P. J. Tonge,
Biochemistry 2007, 46, 954 – 964.
[9] J. Liu, N. Quinn, G. A. Berchtold, C. T. Walsh, Biochemistry
1990, 29, 1417 – 1425.
[10] O. Kerbarh, D. Y. Chirgadze, T. L. Blundell, C. Abell, J. Mol.
Biol. 2006, 357, 524 – 534.
[11] K. T. Ziebart, M. D. Toney, Biochemistry 2010, 49, 2851 – 2859.
[12] J. E. Culbertson, D. H. Chung, K. T. Ziebart, E. Espiritu, M. D.
Toney, Biochemistry 2015, 54, 2372 – 2384.
[13] N. J. Darby, T. E. Creighton,Protein structure, OxfordUniversity
Press, Oxford, UK, 1993.
[14] L. Pravda, K. Berka, R. Svobodova Varekova, D. Sehnal, P.
Banas, R. A. Laskowski, J. Koca, M. Otyepka, BMC Bioinf.
2014, 15, 379.
Received: June 3, 2015
Revised: June 23, 2015
Published online: August 6, 2015
.Angewandte
Communications
11274 www.angewandte.org Ó 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Angew. Chem. Int. Ed. 2015, 54, 11270 –11274

Publication B
Supporting Information for Publication B
Conversion of anthranilate synthase into isochorismate synthase:
Implications for the evolution of chorismate-utilizing enzymes
Maximilian G. Plach, Patrick Löffler, Rainer Merkl, and Reinhard Sterner (2015).
Angewandte Chemie International Edition 54:11270-11274
– 141 –

Supporting Information
Conversion of Anthranilate Synthase into Isochorismate Synthase:
Implications for the Evolution of Chorismate-Utilizing Enzymes
Maximilian G. Plach, Patrick Lçffler, Rainer Merkl, and Reinhard Sterner*
anie_201505063_sm_miscellaneous_information.pdf
1 
 
Supporting Information 
Table of Contents 
Page Contents 
S2 Experimental Materials and Methods 
  Materials 
  Computation of AS, ADCS, ICS, and SS sequence logos 
  Cloning and site-directed mutagenesis 
  Heterologous expression and purification of recombinant proteins 
  HPLC analysis of reaction products 
  Mass spectrometry 
  Enzymatic conversion of isochorismate to salicylate 
  Molecular dynamics simulations 
  Computation of putative nucleophile paths in wild-type stTrpE and stTrpE variants 
S9 Supplementary Figures 
  Figure S1:  Unrooted phylogenetic tree comprising the four groups of MST  
    enzymes 
  Figure S2: HPLC chromatograms of product mixtures from reactions of stTrpE  
    variants and control reactions 
  Figure S3: Identification of isochorismate by HPLC-ESI-MS and by  
    enzymatic conversion to salicylate 
  Figure S4: Comparison of PNTs in 16 stTrpE variants containing Lys263 
  Figure S5: Principles used to quantify the spatial distribution of PNTs  
S16 Supplementary Tables 
  Table S1: List of plasmids and oligonucleotides used for generating sttrpE  
    variants 
  Table S2: Fractions of PNTs approaching the CH ligand along the A-path  
  Table S3: List of oligonucleotides used for amplification of sttrpE, sttrpG,  
    ecentC and papchB genes 
S18 Supplementary References 
  
2 
 
Experimental Materials and Methods 
Materials. 
Chorismate was purchased as the barium salt from Sigma Aldrich. Barium was removed by the 
addition of a slight excess of sodium sulfate. All other chemical reagents were purchased from 
Sigma Aldrich in analytical grade and used without further purification. 
 
Computation of AS, ADCS, ICS, and SS sequence logos. 
Sequences of ADCS (6189), AS (7330), ICS (7933), and SS (986) were taken from the InterPro 
entry IPR015890 (InterPro release 47.0 [1]) to create multiple sequence alignments (MSAs) by 
means of MAFFT in FFT-NS1 mode [2]. The resulting MSAs were filtered to represent pairwise 
sequence identity values ranging from 25 to 90%. Finally, the remaining sequences (410 ADCS, 
428 AS, 313 ICS, and 71 SS) were combined in a single dataset and aligned using MAFFT in 
L-INS-I mode; the final MSA was named MSA_MST.  
To verify that MSA_MST contains only correctly annotated ADCS, AS, ICS, and SS sequences a 
phylogenetic tree of MSA_MST was constructed as follows: In order to eliminate poorly aligned 
regions, Gblocks was utilized to remove columns that contain more than 50% gaps [3]. 
PhyloBayes [4] was used to generate a total of 100,000 tree topologies, based on a Markov Chain 
Monte Carlo approach with five independent Markov chains. The first 10,000 burn-in topologies 
of each chain were discarded and an unrooted consensus tree was derived from the remaining 
topologies using readpdb in PhyloBayes.  
This tree (Figure S1) confirmed the correct annotation and grouping of the four different types of 
MST sequences in MSA_MST. Therefore, these AS, ADCS, ICS, and SS sequences were used to 
calculate sequence logos of β-strand 11 (Gly259 - Pro266 in the TrpE subunit of stAS) and α-
helix 12 (Ser359 - Leu372). The logos were created with WebLogo, version 3.3 [5]. 
 
Cloning and site-directed mutagenesis. 
The Salmonella typhimurium trpE and trpG genes were amplified from S. enterica subsp. 
enterica serovar Typhimurium str. LT2 genomic DNA using the oligonucleotides 
5’sttrpE_NdeI / 3’sttrpE_XhoI and 5’sttrpG_NdeI / 3’sttrpG_XhoI, respectively. The E. coli entC 
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gene was cloned from E. coli MG1655 whole cell lysate using the oligonucleotides 
5’ecentC_NdeI / 3’ecentC_XhoI. Pseudomonas aeruginosa pchB was amplified from 
P. aeruginosa PAO1 genomic DNA using the oligonucleotides 5’papchB_NdeI / 3’papchB_XhoI. 
The sequences of the oligonucleotides used for gene amplification are listed in Table S3. All 
amplified genes were subsequently cloned into the pET21a vector (Stratagene, providing a C-
terminal hexahistidine-tag) via the introduced restriction sites for NdeI and XhoI. Variants of 
sttrpE were generated by a modified QuickChange mutagenesis protocol [6] using the 
combinations of plasmids and oligonucleotides specified in Table S1. All gene constructs were 
entirely sequenced to exclude inadvertent mutations. 
 
Heterologous expression and purification of recombinant proteins. 
The stTrpE, stTrpG, ecEntC and paPchB wild-type proteins as well as all stTrpE variants were 
produced by expressing the respective genes in E. coli BL21-Gold (DE3) cells (Agilent 
Technologies). To this end, 4 L of Luria broth (LB) medium supplemented with 150 µg/mL 
ampicillin were inoculated with pre-cultures of individual clones and incubated at 37 °C. After an 
OD600 of 0.6 was reached, the temperature was lowered to 20 °C. Expression was induced by 
adding 0.5 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) and growth was continued 
overnight. Cells were harvested by centrifugation (2700 g, 4 °C), suspended in 50 mM Tris-HCl, 
pH 7.5, 300 mM potassium chloride, 10 mM imidazole, and lysed by sonification. The soluble 
fraction of the cell extract was separated from the insoluble fraction by centrifugation (23000 g, 
4 °C). Supernatants were loaded onto a HisTrapFF crude column (5 mL, GE Healthcare), which 
had been equilibrated with 50 mM Tris-HCl, pH 7.5, 300 mM potassium chloride, 10 mM 
imidazole. After washing with equilibration buffer, the bound protein was eluted by applying a 
linear gradient of 10-750 mM imidazole. Subsequently, fractions containing the protein of 
interest, as judged by SDS-PAGE, were pooled. For further purification, the pool was loaded 
onto a Superdex 75 column (HiLoad 26/60, 320 mL, GE Healthcare), equilibrated with 50 mM 
Tris-HCl, pH 7.5, 50 mM KCl, 5 mM MgCl2, 2 mM DTT at 4 °C. In all cases but one, at least 
15 mg pure protein was obtained per liter of culture. Only for the KAA variant a maximum of 
1 mg protein per liter of culture could be obtained. EcEntC and paPchB were additionally 
purified by anion-exchange chromatography. To this end, both proteins were dialyzed twice 
against 50 mM Tris-HCl, pH 7.5, 2 mM MgCl2, 2 mM DTT and subsequently loaded onto a 
MonoQ column (HR 16/10, 20 mL, GE Healthcare), which had been equilibrated with the same 
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buffer. The column was washed and bound protein was eluted by applying a linear gradient of 0-
3 M potassium chloride. Fractions containing ecEntC and paPchB, respectively, as judged by 
SDS-PAGE, were pooled and dialyzed against 50 mM Tris-HCl, pH 7.5, 50 mM KCl, 5 mM 
MgCl2, 2 mM DTT. 
 
HPLC analysis of reaction products. 
The standard reaction for the enzymatic generation of various products from chorismate was 
carried out in 50 mM potassium phosphate buffer, pH 7.0, and contained 5 mM MgCl2, 1 mM 
DTT, 10 µM stTrpE variant or ecEntC, 10 µM stTrpG, and 500 µM chorismate. If needed, 
20 mM glutamine were added as an ammonia source. Conditions for control reactions (no 
enzymes) were identical. After 3 h at 25 °C the samples were ultrafiltrated to remove proteins 
(Amicon Ultra 0.5 mL centrifugal unit, 10 kDa molecular weight cut-off, 4 °C). Protein-free 
filtrates were analyzed on an Agilent 1200 HPLC system with a 5 µm Agilent Zorbax Eclipse 
XDB C18 column (150 mm × 4.6 mm, Figure S2). Mobile phase A consisted of 0.1% formic acid 
in H2O, mobile phase B of 0.1% formic acid in acetonitrile. Reaction mixtures were separated at 
10 °C with a flow rate of 1 mL/min in the following manner: isocratic elution at 5% B from 0-5 
minutes, linear gradient from 5-100% B from 6-20 minutes. Elution was monitored by using 
absorbance at 280 nm and 320 nm and fluorescence emission at 400 nm following excitation at 
310 nm. To report each product formed by the different stTrpE variants as a fraction of all 
products formed, peak areas were converted into molar amounts either by comparison with 
standards of known concentration (for AA and SA) or by using the molar extinction coefficients 
of 11500 M-1cm-1 at 280 nm for ADIC and 8300 M-1cm-1 at 278 nm for IC [7]. AA and SA peaks 
were assigned based on a comparison of retention times with those of authentic standards. ADIC 
was identified based on previously reported HPLC analyses of chorismate derivatives [8]. IC was 
unambiguously identified by HPLC-ESI mass spectrometry (Figures S3a and S3b) and enzymatic 
conversion to SA by the isochorismate-pyruvate-lyase PchB from P. aeruginosa (Figure S3c). 
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Mass spectrometry. 
The bona fide IC peak detected in the HPLC experiments, was confirmed by HPLC-ESI mass 
spectrometry. To this end, the stTrpE_KLS variant was incubated with 500 µM chorismate under 
the following conditions: 10 mM bicine buffer, pH 8.5, 5 mM MgCl2 and 1 mM DTT. After 3 h 
at 25 °C the sample was ultrafiltrated to remove the protein (Amicon Ultra 0.5 mL centrifugal 
unit, 10 kDa molecular weight cut-off, 4 °C). The protein-free filtrate was analyzed on an Agilent 
1290 HPLC system with a 5 µm Agilent Zorbax Eclipse XDB C18 column (150 mm × 4.6 mm) 
coupled to an Agilent 6540 Ultra High Definition Accurate Mass Q-TOF LC/MS System. Mobile 
phases and elution profile were identical to the standard HPLC setup described above. Elution 
was monitored by using absorbance at 280 nm and 320 nm. ESI mass spectrometry was 
performed in negative ion mode. 
 
Enzymatic conversion of isochorismate to salicylate. 
IC was additionally identified in the product mixtures of the stTrpE variants by enzymatic 
conversion to SA. The isochorismate-pyruvate-lyase PchB from Pseudomonas aeruginosa 
converts IC to SA and pyruvate. It is also reported to directly convert CH to prephenic acid by its 
promiscuous chorismate mutase activity [9]. A direct conversion of CH to SA, however, has not 
been described for PchB. StTrpE variants KMA, KLA, and KLS, as well as ecEntC, were 
incubated with chorismate under reaction conditions similar to those described in the mass 
spectrometry section. After 3 h at 25 °C the samples were ultrafiltrated to remove proteins 
(Amicon Ultra 0.5 mL centrifugal unit, 10 kDa molecular weight cut-off, 4 °C). One third of the 
protein-free filtrate was directly subjected to standard HPLC analysis. The second third of the 
filtrate was incubated at 25 °C for 30 minutes without any further modification before standard 
HPLC analysis and the last third was supplemented with PchB (5 µM), incubated at 25 °C for 
30 minutes, ultrafiltrated, and subjected to standard HPLC analysis. 
 
Computation of the structures of wild-type stTrpE and stTrpE variants. 
The available crystal structure of stTrpE in complex with stTrpG (PDB ID 1i1q) represents an 
unliganded, open, inactive T-state form [10]. Therefore a stTrpE:stTrpG homology model was 
generated based on the crystal structure of the TrpE:TrpG complex from Serratia marcescens 
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(PDB ID 1i7q), which resembles a ligand-bound form with a closed active site [11]. Modeling was 
performed with YASARA Structure Version 14.7.17 employing the YASARA2 force field [12]. 
The high similarity of target and template sequences argues in favor of a good 3D-model. 
Sequence identity values determined by EMBOSS Needle were 71.3% (TrpE) and 79.8% (TrpG). 
Moreover, YASARA’s Z-scores were -0.462 (TrpE) and -0.352 (TrpG), indicating good model 
quality. CH was placed in the active site of the stTrpE model, substituting the benzoate and 
pyruvate ligands present in 1i7q; the RMSD for all matching atoms was 0.713 Å. Structures of 
mutant stTrpE variants were generated by in silico mutating residues 263, 364, and 365 of the 
stTrpE homology model. Mutated residues were rotamer-optimized employing the SCWALL 
method of YASARA [13]. To remove conformational stress, all homology models were 
equilibrated by means of a short molecular dynamics (MD) simulation, resulting in equilibrated 
homology models (EHMs). For details of the protocol see below. 
 
Molecular dynamics simulations. 
MD simulations were performed at 298 K under periodic boundary conditions with explicit 
water, using a multiple time step of 1 fs for intramolecular and 2 fs for intermolecular forces. 
Lennard-Jones and long-range electrostatic interactions were treated with a 7.86 Å cut-off, the 
latter were calculated using the Particle Mesh Ewald method [14]. Temperature was adjusted using 
a Berendsen thermostat based on the time-averaged temperature; the atmospheric pressure was 
kept constant. Each simulation cell was 5 Å larger than the protein along each axis; cells were 
filled with water to a density of 0.997 g/ml and counter ions were added to a final concentration 
of 0.9% NaCl. Protonation states of protein side chains were assigned as described [12] and 
parameterization of glutamine and chorismate was performed using the AM1BCC method. Each 
snapshot was energy-minimized as follows: After an initial steepest descent phase, energy of the 
system was further minimized by means of simulated annealing (time step 2 fs, atom velocities 
scaled down by 0.9 every 10th step) until energy did not improve by more than 0.05 kJ/mol per 
atom during 200 consecutive steps. 
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Computing putative nucleophile paths in wild-type stTrpE and stTrpE variants. 
An intrinsic feature of the stAS complex is the intermolecular transport of ammonia from the 
active site of stTrpG to the active site of stTrpE. To identify the most likely paths of ammonia in 
wild-type stAS and of the nucleophile in stAS complexes with mutated stTrpE variants, the 
respective EHMs were subjected to MD simulations and nucleophile channels were computed as 
follows. EHMs of wild-type stTrpE and of each stTrpE variant were simulated in three 
production MD runs. To reassign initial atom velocities and seed independent calculations, the 
temperature was slightly changed (±0.1 K) for the second and third run. Trajectories were 
sampled at intervals of 10 ps for a total of 2 ns, resulting in 600 snapshots for each stTrpE 
variant. These structures were further energy minimized prior to the computation of channels. 
Moreover, for visual inspection, average 3D models were generated for each MD trajectory as 
follows: An EHM served as a reference structure and average positions for all atoms were 
deduced after superimposing the protein structures from all snapshots.  
Nucleophile channels were computed utilizing MOLE 2.0, version 2.13.9.6 [15]. Default values 
were used except a probe radius of 2.14 Å, which is the size of ammonia in the given force-field. 
The starting point was the all-atom centroid of the ligand glutamine and Cys87 in stTrpG that 
approximates the location where nascent ammonia is generated. The endpoint was the all-atom 
centroid of the ligand CH and Ala327 in stTrpE that approximates the location of the CH-C2 
atom where the initial nucleophilic attack in the AS reaction occurs. For each of the 600 resulting 
channels per variant, the channels centerlines served to specify a putative nucleophile trajectory 
(PNT). As the MD simulations induced small translational and rotational movements of the stAS 
complexes, a direct comparison of related PNTs was not possible. To compensate for this effect, 
all PNTs were superimposed on the respective EHM [16] and the resulting PNT-bundles were 
analyzed further.  
Visual inspection of PNT-bundles by means of PyMol [17] in the region near the CH ligand 
indicated a preference for two major paths (Figure S4); one proceeding alongside Val265 and the 
other one alongside residues 365 and 425 (Figure S5a). Due to their prevalence in Leu365 and 
Ala365 variants, these paths were termed L-path and A-path, respectively. The spatial 
distribution of PNTs observed in a variant (Table S2) was determined by counting the number of 
PNTs that proceed along the L-path or the A-path, as follows: First, for each PNT j, the segment 
with a distance of 3 to 7 Å from CH-C2 was identified (Figure S5b). Due to the complexity of the 
local curvature of individual PNTs, these segments were represented by a different number of 3D 
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coordinates. Thus, we binned the coordinates ,i jkcoord  in 16 shells i (thickness ¼ Å, centered on 
CH-C2) and computed the vector ,i jkpv  that starts at ,i jkcoord  and ends in CH-C2. Then a plane Pj 
(with normal vector nvj) was defined by CH-C2 and the Cα atoms of the PNT-lining residues 
Met364 and Thr425. Each ,i jkpv  was multiplied with the normal vector nvj; the sign of the scalar 
product (+, -) ,i jks  indicates the position of ,i jkcoord  relative to Pj. For each shell i and PNT j, the 
mean , ,
1
1 li j i j
kk
s s
l =
= ∑ , where l is the number of coordinates ,i jkcoord , was computed and 
normalized to [0, 1]. A value of 0 indicates that all PNT coordinates are located on the L-path 
side of Pj and a mean of 1 shows that all coordinates are on the A-path side of Pj. The shell-wise 
computed mean ,
1
1 mi i j
js sm =
= ∑ , where m is the number of PNTs in this shell, was then used to 
determine 
1
1 n i
i
s s
n =
= ∑ , where n is the number of shells, which is the percentage of all PNTs 
along the A-path in the 3 - 7 Å shell around CH-C2. This fraction was considered indicative for 
the prevalent localization of PNTs and proposes the overall putative nucleophile path of each 
variant. 
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Figure S1. Unrooted phylogenetic tree comprising the four groups of MST enzymes. The edges leading to 
the AS, ADCS, ICS, and SS leaves, respectively, are colored accordingly. Posterior probabilities are 
shown for important splits. For each MST group, the contribution of six predominant bacterial phyla as 
well as archaea is given by color bars that represent the corresponding fractions. Importantly, the four 
MST groups form distinct subtrees and each group is represented by sequences from at least four different 
major phyla. 
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Figure S2. HPLC chromatograms of product mixtures from reactions of stTrpE variants in the presence of 
stTrpG. The retention times of aminodeoxyisochorismate (ADIC), isochorismate (IC), chorismate (CH), 
anthranilate (AA), and salicylate (SA) are indicated by arrows. In cases where only minimal SA amounts 
were detected, an inset, placed at the correct retention time, shows the fluorescence signal at 400 nm after 
excitation at 310 nm. StTrpE variants are denoted by their three-letter-abbreviations (cf. Table S1). “wt”, 
“EntC”, “ALS” and “(-)” refer to control reactions with wild-type stTrpE, with the native ICS EntC from 
E. coli, with a Lys263Ala knockout variant and without any enzyme, respectively. a) Product mixtures in 
the absence of an ammonia source. 
  
11 
 
 
Figure S2 continued. b) Product mixtures in the presence of 20 mM glutamine as an ammonia source. 
Note the different y-axis scales. Small variations in ADIC retention times are due to minor differences in 
chromatographic conditions. 
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Figure S3. Identification of isochorismate (IC) by HPLC-ESI-MS and by enzymatic conversion to 
salicylate (SA). a) Total ion count (TIC) chromatograms for all m/z values (left) and for m/z value 
225.0424 (right). In an enzyme-free control reaction (top), only chorismate (CH) and two impurities 
denoted by # and PHB (p-hydroxybenzoate), but no isochorismate (IC) were detected. In contrast, IC was 
detected at an m/z value of 226.0497 (the m/z-value of 225.0424 corresponds to the [M-H]--ions of IC and 
CH) in the reaction mixture of the stTrpE KLS variant. The m/z value is in good agreement with the 
theoretical value of 226.0477. b) ESI scans of IC and CH peaks from the TIC chromatograms shown in 
panel a). As IC and CH are constitutional isomers, both share the same m/z value of 226.0497 and appear 
in the corresponding TIC chromatogram of the reaction mixture of the stTrpE KLS variant. However, the 
ESI scans of the IC and CH peaks, selected based on retention times of 8.419-8.497 min and 8.619-
8.696 min, respectively, reveal differences in their ion compositions. Although both patterns are 
dominated by ions that underwent the loss of H2O (-18), CH2O (-46), H2O + CO2 (-62), and pyruvate (-
88), the relative peak heights differ. The fraction of “intact” molecular ions ([M-H]-) is greater for IC, 
whereas the fraction of [M-H2O-H]- ions is greater for CH. c) HPLC chromatograms depicting the 
enzymatic conversion of IC to SA by the isochorismate-pyruvate-lyase PchB. The retention times of IC, 
CH, and SA are indicated by arrows. “Reaction mix” denotes the product mixture after incubation of the 
enzymes (stTrpE variants KLA, KMA, and KLS, as well as the native ICS EntC from E. coli) with 
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500 µM CH at pH 8.5 and 25 °C for three hours. “Filtrate” denotes the product mixture after removal of 
enzymes by ultrafiltration and subsequent incubation at 25 °C for 30 minutes. “Filtrate + PchB” denotes 
the product mixture after removal of enzymes and subsequent incubation at 25 °C for 30 minutes with 
supplementation of PchB. Upon addition of PchB to the filtrate, IC is entirely converted to SA. The 
supplementation of PchB also leads to a slight decrease in the amount of residual CH in the filtrate. This is 
most likely due to the promiscuous chorismate mutase activity of PchB [9]. 
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Figure S4. Comparison of PNTs in 16 stTrpE variants containing Lys263. PNT localization is almost 
exclusively determined by residue 365. To a great extent, PNTs of Leu365-variants proceed along Val265, 
i.e. along the L-path (cf. Figure S5). In variants with Val365, approximately half of the PNTs proceed 
along the L-path; in the KAV variant this distribution is less pronounced. In variants with Ser365, PNTs 
further shift towards the A-path (cf. Figure S5). This effect is most pronounced in the KIS variant. In the 
Ala365-variants, nearly all PNTs follow the A-path. Diameters of the PNT associated channels can be 
deduced from the red-grey-green color scale. 
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Figure S5. Principles used to quantify the spatial distribution of PNTs. a) Distribution of PNTs near 
Lys263 and residues 364 and 365 in the KML, KMV, KMS, and KMA variants. The localization of PNTs 
shifts with decreasing size of residue 365 (Leu > Val > Ser ≈ Ala) from one predominant path to a second 
one. As the majority of PNTs in Leu365-variants proceed along the path visible in the KML panel, the 
respective path was termed L-path. Accordingly, the predominant path deduced from the KMA variant 
was termed A-path. b) Graphical representation of L- and A-path (cyan and magenta, respectively) as well 
as of the plane Pj and its normal vector nvj used for quantifying the spatial distribution of PNTs. Pj was 
specified by CH-C2 and the Cα atoms of residues 364 and 425 (yellow circles). For binning of PNT 
coordinates, sixteen ¼ Å shells (black circles) spanning a segment of 3 to 7 Å from CH-C2 were defined. 
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Table S1. List of plasmids and oligonucleotides used for generating sttrpE variants. 
Variant Template Oligonucleotide Sequence (5’3’) 
sttrpE_ 
Q263K  
(=KML) 
pET21a_sttrpE 5’sttrpE_Q263K 
3’sttrpE_Q263K 
GCGGGCGAGATATTTAAAGTGGTGCCGTCGC 
GCGACGGCACCACTTTAAATATCTCGCCCGC 
sttrpE _ 
Q263K_L365V  
(=KMV) 
pET21a_sttrpE_ 
Q263K 
5’sttrpE_L365V 
3’sttrpE_L365V 
GCTTTCCGAACATCTGATGGTGGTCGATCTGGCGCG 
CGCGCCAGATCGACCACCATCAGATGTTCGGAAAGC 
sttrpE _ 
Q263K_L365S  
(=KMS) 
pET21a_sttrpE_ 
Q263K 
5’sttrpE_L365S 
3’sttrpE_L365S 
GCTTTCCGAACATCTGATGTCTGTCGATCTGGCGCG 
CGCGCCAGATCGACAGACATCAGATGTTCGGAAAGC 
sttrpE _ 
Q263K_L365A  
(=KMA) 
pET21a_sttrpE_ 
Q263K 
5’sttrpE_L365A 
3’sttrpE_L365A 
GCTTTCCGAACATCTGATGGCGGTCGATCTGGCGCG 
CGCGCCAGATCGACCGCCATCAGATGTTCGGAAAGC 
sttrpE _ 
Q263K_M364L  
(=KLL) 
pET21a_sttrpE_ 
Q263K 
5’sttrpE_M364L 
3’sttrpE_M364L 
GCTTTCCGAACATCTGCTGCTGGTCGATCTGGC 
GCCAGATCGACCAGCAGCAGATGTTCGGAAAGC 
sttrpE _ 
Q263K_M364L_L365V 
(=KLV) 
pET21a_sttrpE_ 
Q263K_M364L_L365S 
5’sttrpE_S365V 
3’sttrpE_S365V 
CTTTCCGAACATCTGCTGGTGGTCGATCTGGCGCG 
CGCGCCAGATCGACCACCAGCAGATGTTCGGAAAG 
sttrpE _ 
Q263_M364L_L365S 
(=KLS) 
pET21a_sttrpE_ 
Q263K_L365S 
5’sttrpE_M364L_v2 
3’sttrpE_M364L_v2 
GAGCTTTCCGAACATCTGCTGTCTGTCGATCTGGCGCG 
CGCGCCAGATCGACAGACAGCAGATGTTCGGAAAGCTC 
sttrpE _ 
Q263K_M364L_L365A 
(=KLA) 
pET21a_sttrpE_ 
Q263K_M364L_L365S 
5’sttrpE_S365A 
3’sttrpE_S365A 
CTTTCCGAACATCTGCTGGCTGTCGATCTGGCGCG 
CGCGCCAGATCGACAGCCAGCAGATGTTCGGAAAG 
sttrpE _ 
Q263K_M364I  
(=KIL) 
pET21a_sttrpE_ 
Q263K 
5’sttrpE_M364I 
3’sttrpE_M364I 
GCTTTCCGAACATCTGATCCTGGTCGATCTGGC 
GCCAGATCGACCAGGATCAGATGTTCGGAAAGC 
sttrpE _ 
Q263K_M364I_L365V  
(=KIV) 
pET21a_sttrpE_ 
Q263K 
5’sttrpE_M364I_L365V 
3’sttrpE_M364I_L365V 
GAGCTTTCCGAACATCTGATCGTGGTCGATCTGGCGCG 
CGCGCCAGATCGACCACGATCAGATGTTCGGAAAGCTC 
sttrpE _ 
Q263K_M364I_L365S 
(=KIS) 
pET21a_sttrpE_ 
Q263K_M364I_L365V 
5’sttrpE_V365S 
3’sttrpE_V365S 
GCTTTCCGAACATCTGATCTCGGTCGATCTGGCGCG 
CGCGCCAGATCGACCGAGATCAGATGTTCGGAAAGC 
sttrpE _ 
Q263K_M364I_L365A 
(=KIA) 
pET21a_sttrpE_ 
Q263K_M364I_L365V 
5’sttrpE_V365A 
3’sttrpE_V365A 
GCTTTCCGAACATCTGATCGCGGTCGATCTGGCGCG 
CGCGCCAGATCGACCGCGATCAGATGTTCGGAAAGC 
sttrpE _ 
Q263K_M364A 
(=KAL) 
pET21a_sttrpE_ 
Q263K 
5’sttrpE_M364A 
3’sttrpE_M364A 
GCTTTCCGAACATCTGGCGCTGGTCGATCTGGC 
GCCAGATCGACCAGCGCCAGATGTTCGGAAAGC 
sttrpE _ 
Q263K_M364A_L365V 
(=KAV) 
pET21a_sttrpE_ 
Q263K_M364L_L365V 
5’sttrpE_L364A_v2 
3’sttrpE_L364A_v2 
GCTTTCCGAACATCTGGCGGTGGTCGATCTGGC 
GCCAGATCGACCACCGCCAGATGTTCGGAAAGC 
sttrpE _ 
Q263K_M364A_L365S 
(=KAS) 
pET21a_sttrpE_ 
Q263K_M364L_L365S 
5’sttrpE_L364A 
3’sttrpE_L364A 
GCTTTCCGAACATCTGGCGTCTGTCGATCTGGCG 
CGCCAGATCGACAGACGCCAGATGTTCGGAAAGC 
sttrpE _ 
Q263K_M364A_L365A 
(=KAA) 
pET21a_sttrpE_ 
Q263K_M364A_L365S 
5’sttrpE_S365A_v2 
3’sttrpE_S365A_v2 
GCTTTCCGAACATCTGGCGGCTGTCGATCTGGCGCGC 
GCGCGCCAGATCGACAGCCGCCAGATGTTCGGAAAGC 
sttrpE _ 
Q263A_M364L_L365S 
(=ALS) 
pET21a_sttrpE_ 
Q263K_M364L_L365S 
5’sttrpE_K263A 
3’sttrpE_K263A 
GCGGGCGAGATATTTGCAGTGGTGCCGTCGC 
GCGACGGCACCACTGCAAATATCTCGCCCGC 
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Table S2. Fractions of PNTs (̅) approaching the CH ligand along the A-path. 
Residue 365 
L V S A 
R
es
id
u
e 
36
4 M 5% 32% 79% 100% 
L 2% 61% 86% 98% 
I 5% 58% 99% 98% 
A 4% 23% 66% 97% 
Table S3. List of oligonucleotides used for amplification of sttrpE, sttrpG, ecentC and papchB genes. 
Oligonucleotide Sequence (5’→3’) 
5’sttrpE_NdeI  GGAATTCCATATGCAAACACCAAAACCC 
3’sttrpE_XhoI AAACTCGAGGAAGGTCTCCTGT 
5’sttrpG_NdeI  GGAATTCCATATGGCTGATATTCTGCT 
3’sttrpG_XhoI AATCTCGAGCTTTTGCTGCGCCCAG 
5’ecentC_NdeI  CAGGGCATATGGATACGTCACTGGCTGAG 
3’ecentC_XhoI CCCTGCTCGAGATGCAATCCAAAAACGTTC 
5’papchB_NdeI CAGGGCATATGAAAACTCCCGAAGAC 
3’papchB_XhoI CCCTGCTCGAGTGCGGCACCCCGTGTCTG 
Restriction sites are underlined. 
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SUMMARY 
Cells contain a multitude of protein complexes whose 
subunits interact with high specificity. However, the 
number of different protein folds and interface 
geometries found in Nature is limited. This raises the 
question how protein-protein interaction specificity is 
achieved on the structural level and how the formation of 
non-physiological complexes is avoided. Here we 
describe structural elements called interface add-ons 
that fulfill this function and elucidate their role for the 
diversification of protein-protein interactions during 
evolution. By performing a systematic computational 
survey, we identified interface add-ons in 10% of 
bacterial, heteromeric protein complexes. The 
paradigmatic experimental characterization of over 30 
cognate and hybrid glutamine amidotransferase 
complexes in combination with comprehensive genetic 
profiling and protein design demonstrated that interface 
add-ons are determinants of protein-protein interaction 
specificity. Moreover, in vivo experiments showed that 
the lack of interface add-ons can lead to physiologically 
harmful cross-talk between essential biosynthetic 
pathways. We conclude that interface add-ons are an 
effective evolutionary tool to facilitate interaction 
specificity when a protein has to discriminate between 
several potential partners that share similar interface 
geometries. 
 
INTRODUCTION 
Protein-protein interactions are essential for key cellular 
processes, ranging from the formation of molecular 
machineries to the assembly of signal transduction networks. A 
huge number of interactions have evolved to accomplish the 
various biological functions. For example, experimental and in 
silico methods projected the interactome of yeast to comprise 
approximately 18 000 binary protein-protein interactions (Yu et 
al., 2008). In the light of such dense protein networks, it is not 
trivial for a cell to guarantee interaction specificity in crucial 
cases such as toxin-antitoxin, antibody-antigen, protease-
inhibitor or multi-enzyme complexes. This problem is 
aggravated by the limited number of different interface 
geometries that mediate protein-protein interactions. It is 
estimated that not more than 1000-4000 such geometries exist 
(Gao and Skolnick, 2010; Garma et al., 2012) and that their 
number is restricted by the same biophysical constraints that 
limit the number of protein folds (Chothia, 1992; Zhang et al., 
2006). 
Understanding the principles of protein-protein interactions in 
general and the assurance of interaction specificity in spite of 
the limited number of interface geometries in particular is an 
important biological challenge. A recent in silico analysis 
indicated that relatively small insertions and deletions in protein 
interfaces can differentiate between monomers and homo-
dimers and that these elements may preclude undesired 
interactions (Hashimoto and Panchenko, 2010). However, the 
interfaces in homo-oligomers are unique with respect to amino 
acid composition and residue-residue contact preferences and 
differ significantly from those found in other types of protein 
complexes such as hetero-oligomers (Ofran and Rost, 2003a). 
For the latter, the assurance of interaction specificity is most 
demanding in cases where two or more proteins with similar 
interface geometries exist that in principle compete for the 
same interaction partner (Schreiber and Keating, 2011). An 
example would be a complex A:B, in which A can interact with 
several homologous potential interaction partners B, Bʹ, and Bʹʹ. 
The putative interfaces of Bʹ and Bʹʹ, whose binding has to be 
avoided, are often similar to that of the genuine partner B, 
creating the risk of erroneous and potentially harmful A-Bʹ and 
A-Bʹʹ interactions.  
In order to contribute to the understanding of interaction 
specificity in hetero-oligomers, we started with a systematic in 
silico survey of the interfaces from 305 representative 
heteromeric protein complexes. Not considering small 
differences in secondary structure elements or slightly different 
quaternary structures, in about 10% of this sample interface 
geometries vary significantly between related complexes that 
share homologous subunits. In these cases, interfaces are 
extended by additional loops and entire secondary structure 
elements that contain residues crucial for complex stability. We 
designated these elements “interface add-ons” and presumed 
that they differentiate interfaces between related complexes 
that share homologous subunits and thus contribute to 
interaction specificity by negative design (Schreiber and 
Keating, 2011), much like additional bits turn a master key into 
a special key. 
In order to experimentally back this assumption, we 
comprehensively analyzed protein interaction specificities in a 
family of glutamine amidotransferase complexes (GATases) 
that are part of the tryptophan and folate biosynthesis 
pathways. These heteromeric enzyme complexes comprise 
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glutaminase and synthase subunits which interact to transfer 
ammonia from glutamine to an acceptor substrate (Raushel et 
al., 1999). The synthase subunits of these GATases, as well as 
the glutaminase subunits, respectively, are homologs, share 
high sequence similarity, and belong to the same folds. A 
subset of synthase subunits exclusively involved in tryptophan 
biosynthesis contains an interface add-on, which is absent in all 
other homologous synthase subunits, including those 
exclusively involved in folate biosynthesis. We experimentally 
characterized 54 combinations of nine synthases (three 
containing the interface add-on) with six different glutaminases, 
as well as a rationally designed synthase with a deletion in its 
interface add-on. Our results show that glutaminase-synthase 
interaction specificity is determined by the presence or absence 
of the interface add-on, independent of the phylogenetic origin 
of the proteins and their participation in tryptophan or folate 
biosynthesis. 
The profiling of more than 15 000 bacterial and archaeal 
genomes highlights the greater biological relevance of this 
finding: Most species possess two homologous synthases that 
do not contain an interface add-on for tryptophan and folate 
biosynthesis and thus rely on a single type of glutaminase to 
interact with the two similar synthases. In contrast, in species 
that possess a synthase with an interface add-on and a second 
synthase without an interface add-on, an additional, specifically 
adapted type of glutaminase is present. We assume that 
positive selection favored this diversification of the synthases 
as it allowed for an effective separation of tryptophan and folate 
biosynthesis. In vivo experiments show that this separation is 
physiologically relevant as its override is detrimental for cellular 
growth. From a broader perspective, our complementary in 
silico and experimental analysis argues that interface add-ons 
are an evolutionary strategy to prevent the formation of non-
physiological complexes by specializing protein-protein 
interactions. 
 
RESULTS 
Identification of interface add-ons  
Interfaces of protein complexes can be partitioned into highly 
conserved core and more variable rim regions (Bouvier et al., 
2009; Guharoy and Chakrabarti, 2005). We speculated that this 
variability can lead to diverse peripheral geometries which 
might contribute to protein-protein interaction specificities 
within heteromeric complexes. For a systematic computational 
assessment of interface geometries, we combined structural 
information from PDB entries (Berman et al., 2000) with the 
sequences provided by the corresponding InterPro families 
(Hunter et al., 2012), which contained on average 12 000 
homologs. Our protocol (Figure 1A) comprises seven filter 
routines that systematically refine the specification of an 
interface add-on and simultaneously narrow down the number 
of candidates (Table S1).  
The survey was based on those 1739 heteromeric bacterial 
protein complex structures deposited in PDB that were devoid 
of non-protein macromolecules and had subunit 
stoichiometries of AB, A2B2, A3B3, A4B4, A6B6, ABC, and A2B2C2. 
Removing identical proteins and focusing on structures that are 
associated with family entries in InterPro reduced the number 
to 305 complexes. In the following, we name them “reference 
complexes” and use SU to address one of the subunits A, B, or 
C. For each subunit SU and all its InterPro homologs H we 
computed pairwise sequence alignments PW(SU, H) 
(Figure 1B) and eliminated all PW(SU, H) of poor quality as well 
as heavily fragmented ones. Subsequently, those PW(SU, H) 
were identified that showed in SU or H an additional fragment 
containing at least eight residues. Thus, our approach excludes 
minor alterations of interface topologies that are related to 
shorter indels and identifies fragments that can fold into 
defined secondary structure elements.  
For the computational analysis of the remaining PW(SU, H), 
two cases had to be distinguished: First, SU can contain one or 
more additional fragments (insertions) that are not present in 
the aligned homolog H. Second, H can contain one or more 
additional fragments that are not present in SU (deletions). To 
assess the first case, the insertions resulting from all PW(SU, H) 
were mapped onto the sequence of SU and a histogram was 
computed that specifies the number of insertions overlapping 
each residue position (Figure 1B); for details see Experimental 
Procedures. Subsequently only those insertions were 
considered further that exceeded a pre-defined significance 
threshold; compare grey area in the histogram shown in 
Figure 1B and the examples in Figure S1A. Thus, 209 insertions 
were found in 117 of the reference complexes with most of 
insertions comprising between 10 and 20 amino acids 
(Figure 1C). To assess the second case, a histogram specifying 
the number of deletions beginning at each residue position of 
SU was analyzed analogously. In total, we identified 392 
deletions associated with 212 reference complexes; examples 
are shown in Figure S1B. A detailed characterization of the 
corresponding insertions in H is difficult, because their 
structures are not known and in homology models the local 
topology of such large insertions is often unreliable (Webb and 
Sali, 2014). Moreover the subsequent docking of the model into 
the given reference complex introduces further errors; thus we 
did not further examine these cases.  
In contrast, the 209 fragments that correspond to an 
insertion in SU could be analyzed in detail. To begin with, we 
identified 162 insertions in 95 reference complexes that 
contained at least one interface residue (IFR); see Experimental 
Procedures. Next, we assessed in silico the contribution of 
these insertions to complex stability. The algorithm mCSM 
estimates the effect of mutations on protein stability and 
protein-protein affinity and the resulting ∆∆? values correlate 
well with experimental findings  (Pires et al., 2014).  
We used mCSM for an alanine scanning of all 162 insertions by 
mutating each non-alanine IFR individually to alanine. According 
to mCSM classification, a large number of the IFR→Ala 
mutations are highly destabilizing for the complex (∆∆????→???
??????? 
< 2 kcal/mol) (Figure 1D). Consistently, alanine mutations of 
interface residues that are crucial for complex stability (hot-
spots) typically result in similar ∆∆? values (Bogan and Thorn, 
1998; Thorn and Bogan, 2001). It is important to note that these 
effects are not caused by destabilized subunits, because 90% 
of the corresponding ∆∆????→??????????  values deduced from subunit 
structures are above -1.0 kcal/mol (Figure 1D).  
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Figure 1: Survey of interface add-ons in heteromeric protein complexes. 
A) Step diagram providing an overview of the survey for interface add-ons in 1739 bacterial, heteromeric protein complexes from the Protein Data 
Bank (PDB). For each of the six steps the proportion of reference structures passed to the next step is given. The total number of structures (nS) 
and identified insertions (nI) is given for steps 3-6. A detailed listing is provided in Table S1 and the final set of interface add-ons is listed in 
Table S2. B) Analysis of pairwise alignments PW(SU, Hn) for the identification of insertions in a subunit of a reference complex (SU), relative to its 
homologs (H1-H5) from the corresponding InterPro family entry. Insertion with a length of at least eight residues (white boxes) were mapped onto 
each residue position k of SU, resulting in the counts hist(k). After correcting for potential noise, insertions (grey areas) were identified as described 
in Experimental Procedures. C) Histogram of insertion lengths. The majority of insertions contain between ten and twenty residues. One outlier 
with a length of 165 residues is not shown. D) Histogram of predicted protein-protein affinity change values ∆∆????→???
??????? (red) and ∆∆????→??????????
(blue). The dashed vertical line indicates the threshold of -2 kcal/mol used for classifying interface add-ons. E) Examples of heteromeric protein 
complexes that contain interface add-ons. Subunits with interface add-ons are shown in cartoon representation; other subunits of the complexes 
are shown in surface representation. The add-ons are colored green. A detailed description of the examples is provided in Table S3. 
Assuming that interface add-ons contribute little to the 
stability of the subunits but considerably to the stability of the 
complex, we classified an insertion as an interface add-on, if 
at least one ∆∆????→???
??????? value was below -2 kcal/mol. In the 
end, a total of 30 interface add-ons in 26 reference complexes 
passed a final manual control. Thus, a conservative 
estimation suggests that about 10% of bacterial, heteromeric 
protein complexes contain interface add-ons (Table S2). 
 
Interface add-ons in heteromeric, bacterial protein 
complexes 
Interface add-ons generally form well defined secondary-
structure elements (Figure 1E) and, on average, comprise 23 
amino acids of which 63% are involved in protein-protein 
interactions. The corresponding complexes are involved in a 
variety of key biological functions like amino acid and 
pyrimidine biosynthesis, β-oxidation of fatty acids, 
biosynthesis of aminoacyl-tRNAs, sulfur metabolism, 
respiratory chains, biosynthesis of antibiotics, and the citric 
acid cycle. A detailed description of selected examples in the 
context of the respective protein families is provided in 
Table S3. On average, these interface add-ons are present in 
about 8% of the InterPro homologs and show high sequence 
conservation. 
Three examples shall be highlighted in the following: The 
reference structure 4lw4 (Figure 1E, Table S3) is a hetero-
tetrameric CsdA2:CsdE2 cysteine desulfurase. CsdA catalyzes 
the transfer of sulphur from cysteine or selenocysteine to the 
acceptor subunit CsdE in the cysteine-sulfinite-desulfinase 
system (Loiseau et al., 2005). CsdA contains an interface add- 
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on of 14 residues that form two anti-parallel β-strands of the 
interface with CsdE. Importantly, E. coli not only contains the 
CsdA2:CsdE2 complex but also the IscS2:TusA2 cysteine 
desulfurase complex in which IscS is homologous to CsdA.  
The IscS2:TusA2 complex is part of a different biosynthetic 
branch, namely biogenesis of iron-sulfur clusters (Mihara and 
Esaki, 2002). IscS does not contain the CsdA interface add-on 
and binds to the acceptor subunit TusA instead of the 
structurally different CsdE. A second example is the reference 
structure 4p69 (Figure 1E, Table S3), which is the hetero-
tetrameric complex of the E. coli isocitrate dehydrogenase 
IcdA and the isocitrate-dehydrogenase-kinase/phosphatase 
AceK. The latter is important for phosphorylating and 
dephosphorylating IcdA as a means to regulate isocitrate flux 
between the citric acid cycle and the glyoxylate cycle (LaPorte, 
1993; LaPorte and Koshland, 1982). IcdA contains an 
interface add-on consisting of 24 residues that fold into an α-
helix located in the interface between the two IcdA and the 
two AceK chains. The isopropylmalate dehydrogenase LeuB 
from E. coli, which is part of leucine biosynthesis, is 
homologous and functionally related to IcdA. However, LeuB 
lacks the interface add-on of IcdA and no interactions with 
kinases/phosphatases like AceK have been described. 
The third example is the reference structure 1i1q 
(Figure 1E, Table S3), which is the anthranilate synthase from 
Salmonella typhimurium. Anthranilate synthases (AS) are 
hetero-tetrameric GATase complexes that catalyze the initial 
step in the biosynthesis of the essential amino acid 
tryptophan (Zalkin, 1973). Their glutaminase subunits TrpG 
hydrolyze glutamine to glutamate. The concomitantly formed 
ammonia is subsequently channeled to the synthase subunits 
TrpE (Raushel et al., 2003), where it reacts with chorismate to 
anthranilate (Figure 2). The interface add-on is located in TrpE 
and, with a length of 51 residues, is one of the largest add-ons 
indentified in our survey. It folds into two α-helices connected 
by two β-strands and prominently protrudes into the 
TrpE:TrpG dimer interface with loop L2 and α-helix H2 
(Figure 3A). Although the interface add-on as a whole 
contains only few conserved residues, the two α-helices 
contain several conserved hydrophobic (H1) and 
charged/polar (H2) amino acids, respectively (Figure 3B). In 
contrast to the AS from S. typhimurium, those from 
Mycobacterium tuberculosis and Sulfolobus solfataricus, for 
example, contain TrpE subunits without this interface add-on. 
In the following, we thus use the term “TrpE” to refer to AS 
synthase subunits that do not contain the interface add-on 
and use the term “TrpEx” (“extended”) to refer to AS synthase 
subunits that contain the interface add-on. 
Some organisms not only possess AS (TrpEx2:TrpG2) but 
also the related complex aminodeoxychorismate synthase 
(ADCS, PabB:PabA), which catalyzes the first step of folate 
biosynthesis (Figure 2) (Dosselaere and Vanderleyden, 2001). 
Its synthase subunit PabB is homologous to TrpEx, but lacks 
the interface add-on, and its glutaminase subunit PabA is 
homologous to TrpG. A sequence-similarity-network (Gerlt et 
al., 2015) of the common InterPro family of TrpEx, TrpE, and 
PabB sequences shows that TrpE and PabB proteins, which 
both do not contain the interface add-on, are highly similar in 
sequence as they tightly cluster together (Figure 3C). In 
contrast, TrpEx sequences are grouped into a distinct 
subcluster. A comparison of representative TrpEx, TrpE, and 
PabB structures shows that the interface add-on is the only 
major structural difference between these three homologs 
(Figure 3D). 
Three observations suggest that the interface add-on in 
TrpEx acts as an explicit negative design element to 
differentiate TrpEx from PabB and thus ensure the specific 
formation of AS (TrpEx2:TrpG2) and ADCS (PabB:PabA) 
complexes: First, its location in the interface between TrpEx 
and TrpG. Second, the high conservation of charged and polar 
residues in its interface helix H2, a characteristic of insertions 
that modulate the association of protein complexes 
(Hashimoto and Panchenko, 2010). Third, the fact that some 
organisms like E. coli contain homologous ADCS complexes 
whose glutaminase subunit PabA is highly similar to the TrpG 
glutaminase subunit of AS. Consequently, the interface add-
on in TrpEx may prevent the putative cross-interactions TrpEx-
PabA and PabB-TrpG and thus the formation of non-
physiological complexes. 
 
Phylogenetic distribution of AS and ADCS complexes 
In contrast to the genomes of γ-Proteobacteria like E. coli and 
S. typhimurium that contain the four genes coding for the 
individual AS and ADCS complexes, the genome of Bacillus 
subtilis, for example, contains the genes for TrpE and PabB, 
but only a single glutaminase gene annotated as pabA. This 
specific situation in B. subtilis has been investigated 
extensively (Gollnick et al., 2005; Slock et al., 1990) and it has 
been shown that the single PabA glutaminase serves both 
TrpE and PabB. To get an overview of such gene co-
occurrences, we determined phylogenetic distributions of 
trpEx, trpE, trpG, pabB, and pabA across more than 15 000 
bacterial and archaeal species. To this end, we developed a 
computational genetic profiling routine that utilizes BLAST 
and Hidden-Markov-Models (HMMs, Figure S3) to find, 
annotate, and distinguish the homologous TrpEx/TrpE/PabB 
synthases and TrpG/PabA glutaminases in these species with 
high sensitivity and selectivity (Figure S4). HMM-approaches 
have proven successful to distinguish highly similar 
sequences or to find distantly related homologs (Söding, 
2005; Yoon, 2009). 
 
 
Figure 2: Reactions catalyzed by AS and ADCS in tryptophan and 
folate biosynthesis. 
Both the glutaminase subunits (ellipses) and the synthase subunits 
(rectangles) are homologs. 
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Figure 3: Sequence-structure relationships in the TrpE(x)/PabB family. 
A) The TrpEx2:TrpG2 AS complex from S. typhimurium (PDB ID 1i1q) is composed of two TrpEx:TrpG hetero-dimers. The interface add-on is colored 
in a rainbow gradient. Active sites of TrpEx and TrpG are indicated by superimposed space-filling ligand models (from 1i7q). The structure of the 
TrpEx:TrpG heterodimer on the right hand side shows that loop L2 and α-helix H2 of the interface add-on protrude into the dimer interface. B)
Sequence logo of the TrpEx interface add-on. Amino acids are colored according to their chemical properties. Residue numbers are according to 
1i1q. The 2D elements of the interface add-on are shown in a rainbow-color cartoon representation. C) The largest cluster of the SSN generated 
for this family (IPR019999) at an E-value cut-off of 1E-77. It contains all TrpE(x) and most PabB sequences. Nodes are colored according to the 
annotation of InterPro. Grey nodes represent sequences with ambiguous annotation. The full network is provided in the Supplemental Information
(Figure S2). D) Crystal structures of TrpEx from S. typhimurium (1i1q), TrpE from M. tuberculosis (4pen), and PabB from E. coli (1k0e, a helix that 
is not resolved is sketched in cartoon representation). The structures are linked to the corresponding nodes in the SSN. The TrpEx interface add-
on is colored in a rainbow gradient. 
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Figure 4: Co-occurrences of synthase and glutaminase subunits of AS and ADCS and their phylogenetic distribution. 
A) Fractions of TrpEx- and TrpE-species that possess a certain pattern of co-occurring synthases and glutaminases. For details see Table S4. B)
Phylogenetic tree showing the co-occurrences in 120 representative archaeal and bacterial species. The split between TrpEx- and TrpE-species 
is indicated by a dashed line. For ease of representation some edges were shorted. Protein function is represented by different shapes and colors. 
The HMM assignment scores from our computational routine are indicated for each function in four color shades that represent the four quartiles 
of scores from less reliable (lighter shades) to highly reliable (darker shades). For TrpEx scores ranged from 85 to 171, for TrpE and PabB from 2 
to 99, for TrpG from 10 to 74, and for PabA from 2 to 73.  
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Figure 5: Structural and functional characterization of interactions between TrpEx/TrpE/PabB and TrpG/PabA. 
A) Oligomeric states of glutaminase and synthase subunits as well as of cognate and hybrid complexes as determined by SEC-SLS. Blank spaces 
indicate no complex formation. Combinations that were additionally characterized by native mass spectrometry are marked by asterisks. Lists of 
oligomeric states together with determined molecular weights are provided in Table S5 for SEC-SLS and in Table S6 for native mass spectrometry. 
Spectra are provided in Figure S6. B) Catalytic efficiencies for the glutamine-dependent conversion of chorismate (CH) to anthranilate 
(combinations involving TrpEx and TrpE) and aminodeoxychorismate (combinations involving PabB). Each combination was assayed in 
triplicates. Exact values with standard deviations are provided in Table S7. bsPabB did not display ADCS-activity with any of the available 
glutaminases under the applied experimental conditions. C) Apparent turnover rates of glutamine hydrolysis by TrpG (kapp) and stimulation of 
PabA glutamine hydrolysis by the presence of TrpEx, TrpE, and PabB (fstim). Each combination was assayed in triplicates in the presence of 4 mM 
glutamine. Exact values with standard deviations are provided in Table S8. 
In brief, we created five HMMs to represent each type of 
synthase and each type of glutaminase. We applied BLAST to 
scan bacterial and archaeal genomes for homologs of the 
synthases (glutaminases) and compared the respective three 
(two) HMM scores of the hits to assign them as TrpEx, TrpE, 
or PabB (TrpG or PabA). The dataset was made non-
redundant and sequences with low HMM scores (ambiguous 
assignments) were rejected. Eventually, we determined the 
co-occurrences of synthases and glutaminases for 1463 
species that constitute the TrpEx sub-cluster (TrpEx-species) 
and for 4386 species that constitute the TrpE sub-cluster 
(TrpE-species) of the SSN shown in Figure 3C. The 
phylogenetic distribution of the co-occurrences was derived 
by mapping them onto a tree-of-life comprising a 
representative set of archaeal and bacterial species (Letunic 
and Bork, 2007). representative set of archaeal and bacterial 
species (Letunic and Bork, 2007). 
As expected, the majority of TrpEx-species (84%) possess 
both the synthase-glutaminase pairs TrpEx-TrpG and PabB-
PabA (Figure 4A). In not more than 16% of the genomes, 
corresponding genes were present in multiple copies or 
missing (Table S4). Most of the TrpEx-species are γ-
Proteobacteria and belong preferentially to the orders 
Vibrionales and Enterobacteriales (Figure 4B). The 
evolutionary oldest TrpEx-species are Shewanella, an 
offspring of Pseudomonadales and Xanthomonadales. Most 
plausibly, TrpEx and TrpG have emerged in Shewanella and 
have been conserved in the γ-proteobacterial lineage since 
then. Apart from γ-Proteobacteria, TrpEx and/or TrpG are only 
present in Helicobacter pylori, Pseudomonas aeruginosa, and 
the Corynebacteria C. diphteriae, C. efficiens, and 
C. glutamicum, which is a result from horizontal gene transfer 
(Farrow and Pesci, 2007; Xie et al., 2003).  
All other species, including archaea and all major bacterial 
phyla are TrpE-species. 59% of them possess, like B. subtilis, 
TrpE and PabB, but only PabA and no TrpG glutaminases 
(Figure 4A). Some TrpE-species (23%) lack PabB and possess 
only TrpE and PabA. Among them are Euryarchaeota and 
Crenarchaeota, which lack the classical folate-biosynthesis 
genes and use alternative biosynthetic pathways or rely on 
methanopterin-related methyl donors instead of 
tetrahydrofolate (White, 1988; Worrell and Nagle, 1988). In not 
more than 18% of TrpE-species genomes, corresponding 
genes were present in multiple copies or missing (Table S4). 
Taken together, TrpEx-species generally contain a full set of 
synthases (TrpEx, PabB) and glutaminases (TrpG, PabA). In 
contrast, TrpE-species generally contain one or both 
synthases (TrpE and/or PabB) and only one type of 
glutaminase (PabA). Consequently, in TrpE species, PabA has 
to interact with both synthases, whereas a more specific 
interaction pattern seems plausible for TrpEx-species. 
 
Protein-protein interaction specificity in AS and ADCS 
complexes 
We experimentally analyzed the influence of the TrpEx 
interface add-on on the specificity of glutaminase-synthase 
interactions in AS and ADCS complexes. For this purpose, we 
expressed and purified three TrpEx, two TrpE, and four PabB 
representatives: TrpEx from S. typhimurium (stTrpEx), E. coli 
(ecTrpEx), and S. marcescens (smTrpEx); TrpE from 
Pseudomonas putida (ppTrpE) and Sulfolobus solfataricus 
(ssTrpE); PabB from P. putida (ppPabB), S. typhimurium 
(stPabB), E. coli (ecPabB), and B. subtilis (bsPabB). The 
identity of the synthases was validated by an HPLC assay 
showing that all bona fide TrpEx, TrpE, and PabB enzymes 
formed the expected anthranilate and aminodeoxy-
chorismate, respectively (Figure S5).  
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Figure 6: Design of stTrpEx_Δ and mass-spectrometric characterization of stTrpEx_Δ:ppPabA complexes. 
A) Overlay of the structure of the stTrpEx:stTrpG dimer from S. typhimurium (PDB ID 1i1q) with a model of stTrpEx_Δ. The TrpEx subunits are 
colored dark grey, the TrpG subunit light grey. The interface add-on of stTrpEx is colored green, the corresponding region of stTrpEx_Δ red. The 
model of stTrpEx_Δ was generated with the homology modelling module of YASARA 16.4.6 using 1i1q, chain A as template with default settings 
(Krieger et al., 2009). The cutout shows a detailed view of the modified interface add-on part. The insert shows an alignment of the interface add-
on regions detailed in the cutout. The residue sequence LLDENA in stTrpEx (green) was replaced with SG in stTrpEx_Δ (red) to mimic a type-I β-
turn (dashed line). B) Representative mass spectrum of an equimolar mixture of stTrpEx_Δ and ppPabA (20 µM each). Pictograms denote 
monomers and complexes. Charges of the most populated charge species are included. 
Furthermore, we expressed and purified two TrpG and four 
PabA homologs: TrpG from S. typhimurium (stTrpG) and 
E. coli (ecTrpGD); PabA from P. putida (ppPabA), 
S. marcescens (smPabA), E. coli (ecPabA), and B. subtilis 
(bsPabA). ecTrpG could only be solubly expressed as a fusion 
construct with TrpD.  
We analyzed the ability of the synthases to form 
complexes with the glutaminases by analytical size exclusion 
chromatography in combination with static light scattering 
(SEC-SLS) and by native mass spectrometry. We made three 
striking observations, which are schematically illustrated in 
Figure 5A. 
First, all three TrpEx synthases exclusively interacted with 
the two TrpG glutaminases. These combinations resulted in 
tetrameric complexes, in accordance with the oligomeric 
states deduced from AS crystal structures (Morollo and Eck, 
2001; Spraggon et al., 2001). In other words, none of the TrpEx 
synthases formed complexes with any of the PabA 
glutaminases. The absence of any interaction between TrpEx 
and PabA was confirmed by native mass spectrometry for the 
stTrpEx/ppPabA combination at a concentration similar to 
those that produced native TrpEx:TrpG complexes 
(Figure S6). 
Second, all TrpE and PabB synthases interacted with all 
PabA but none of the TrpG glutaminases. The TrpE:PabA 
complexes were dimers or tetramers, whereas the PabB:PabA 
complexes were exclusively dimeric. The complexes 
ppTrpE:ppPabA, ppPabB:ppPabA, and ecPabB:ecPabA were 
validated by native mass spectrometry, as was the absence of 
a complex for the ppTrpE-stTrpG combination (Figure S6). 
Based on these results, we regard the denomination PabA 
(Huang and Gibson, 1970) as anecdotal, because the 
respective glutaminases are not only part of ADCS but also of 
AS complexes in most microbial species. 
Third, interactions between TrpEx and TrpG on the one 
hand and between TrpE/PabB and PabA on the other hand are 
conserved across species and kingdom borders. All 15 tested 
enzymes were able to interact with a partner from a different 
organism, independent of their positions in the tree of life. For 
instance, TrpE from the Crenarchaeon S. solfataricus formed 
complexes with PabA from phylogenetically distant 
Firmicutes (bsPabA) and γ-Proteobacteria (ppPabA, smPabA, 
and ecPabA). 
 
Functional characterization of cognate and hybrid AS and 
ADCS complexes 
We followed the glutamine-dependent conversion of 
chorismate (CH) to anthranilate (AA) and aminodeoxy-
chorismate (ADC) for all 54 possible combinations of 
synthases and glutaminases by continuous fluorimetric 
assays. The results are summarized in Figure 5B. Notably, all 
stable complexes detected by SEC-SLS, except those 
containing bsPabB, were catalytically active. AS complexes 
displayed catalytic efficiencies kcat/KMCH between 8.7 · 103 
and 1.3 · 106 M-1s-1 with practically no differences in the 
highest efficiencies of TrpEx:TrpG and TrpE:PabA complexes. 
ADCS complexes (PabB:PabA) converted CH to ADC with 
catalytic efficiencies kcat/KMCH between 9.9 · 102 and 
2.8 · 104 M-1s-1. These data show that functional AS and ADCS 
complexes can be formed by synthases and glutaminases 
from different species. This indicates a strong conservation 
of the synthase-glutaminase interface, because functional 
complexes require efficient channeling of nascent ammonia 
between the subunits. We could not detect measurable AS or 
ADCS activity for all “non-interacting” pairs. The only 
exception was ssTrpE which did not only display AS activity 
with all four PabA glutaminases but also to a certain degree 
with ecTrpGD, indicating the formation of a transient complex 
during catalysis. 
It is known that glutaminase activity in GATase complexes 
is allosterically stimulated by the synthase (Bera et al., 1999; 
Goto et al., 1976; Miles et al., 1998). In order to quantify this 
effect for the 54 combinations of glutaminases and 
synthases, we incubated TrpG and PabA with glutamine and 
monitored its hydrolysis before and after the addition of 
TrpEx, TrpE, or PabB (Figure S7). The results are illustrated in 
Figure 5C. We found that both TrpG representatives do not 
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Figure 7: Generation of ppPabA* by interface design. 
A) Predicted interface region in an artificial smTrpEx:ppPabA complex. A 3D model of ppPabA was generated with iTASSER (Zhang, 2008) using 
default parameters and superimposed onto smTrpG in the crystal structure of the smTrpEx:smTrpG complex (PDB ID 1i7q). Positions of ppPabA 
selected for mutation are highlighted in blue, the smTrpEx interface add-on in green. B) Interface region of the smTrpEx:smTrpG dimer (1i7q). 
Residues highlighted in pink correspond to those chosen for mutations in ppPabA. C) Sequence logos of the highlighted residues and their 
surroundings. 
display measurable activity in the absence of TrpEx, in 
accordance with previous findings on stTrpG (List et al., 2012) 
and other related glutaminases (Beismann-Driemeyer and 
Sterner, 2001; Miles et al., 1998; Strohmeier et al., 2006). The 
presence of each of the TrpEx synthases, however, leads to 
apparent turnover rates for glutamine hydrolysis of up to 
0.07 s-1. In most cases the presence of TrpE/PabB, as 
expected, did not lead to glutamine hydrolysis activity. Only 
the presence of ppTrpE and ssTrpE activated the TrpGs to a 
certain degree.  
In contrast to a previous report (Roux and Walsh, 1992), all 
PabA glutaminases proved to be slightly active already in the 
absence of any synthase; the apparent turnover rates were 
between 0.003 and 0.015 s-1. When supplemented with TrpE 
or PabB, the rates increased up to 70-fold. Thus, PabA 
glutaminases are stimulated by allosteric signals from both 
TrpE and PabB. As expected, the presence of the three TrpEx 
synthases did not stimulate their glutaminase activity. 
 
The interface add-on determines interaction specificity in 
AS and ADCS complexes 
The hitherto presented data strongly indicate that the 
interface add-on in TrpEx synthases is a negative design 
element that prevents the binding of PabA glutaminases and 
only allows the formation of correct TrpEx-TrpG pairs. As an 
ultimate test, we deleted six residues in α-helix H2 and the 
adjacent loop L2 of the interface add-on from stTrpEx while 
leaving the remaining interface to stTrpG untouched 
(Figure 6A). The resulting stTrpEx_Δ variant could be 
expressed in soluble form and purified. It was enzymatically 
active for the formation of anthranilate with ammonium 
chloride as the nitrogen source; the catalytic efficiency 
(kcat/KMCH = 1.6 ± 0.1 · 103 M-1s-1) was identical to that of 
stTrpEx (kcat/KMCH = 1.5 ± 0.01 · 103 M-1s-1).  
Strikingly, stTrpEx_Δ was able to bind to ppPabA, with 
mass spectrometry demonstrating a tetrameric 
stTrpEx_Δ2:ppPabA2 complex (Figure 6B, Table 1). Moreover, 
the binding of stTrpEx_Δ to ppPabA leads to a 2-fold 
stimulation of ppPabA glutaminase activity (Table 1), 
compared to the 4.5-fold stimulation of ppPabA by its native 
interaction partners ppTrpE and ppPabB. This demonstrates 
that the interaction between stTrpEx_Δ and ppPabA is 
productive as the catalytic activity of the glutaminase is 
enhanced by the binding of the synthase. At the same time, 
the propensity of stTrpEx_Δ to form a tetrameric complex with 
stTrpG was significantly reduced (Figure S8). Neither the 
stTrpEx_Δ2:ppPabA2, nor the stTrpEx_Δ2:stTrpG2 complex 
was catalytically active in the context of glutamine-dependent 
anthranilate formation. Most plausibly, the channel required 
for transferring ammonia from the glutaminases to stTrpEx_Δ 
is not functional. In any case, our data clearly show that the 
TrpEx interface add-on determines interaction specificity in 
AS and ADCS complexes. A deletion of only six residues was 
sufficient to convert stTrpEx into a TrpE-like synthase, 
allowing for binding ppPabA. 
 
Generation of functional TrpEx-PabA interactions by 
interface design 
So far we have demonstrated that the interactions in 
TrpEx2:TrpG2 and PabB/TrpE:PabA complexes are specific 
and that synthase-glutaminase cross-interactions are 
prevented by the interface add-on in TrpEx. Thus possible 
cross-interactions are physiologically highly unlikely. This 
raises the question how the transition from TrpE to TrpEx took 
place and how the orthogonal TrpEx2:TrpG2 – PabB:PabA 
system has evolved in γ-Proteobacteria. One possible 
scenario is that TrpG evolved in response to the emergence of 
the TrpEx interface add-on. However, this scenario implies a 
cell that temporarily tolerates the existence of a non-
interacting and thus non-functional TrpEx-PabA pair, which 
seems improbable given the essential metabolic function of 
AS in tryptophan biosynthesis. 
 
 
Table 1: Structural and enzymatic characteristics of complexes 
comprising stTrpEx or stTrpEx_Δ and stTrpG or ppPabA 
 complex formationa glutaminase activityb 
 native MS fstim kapp /s-1 
stTrpEx_Δ + ppPabA Ex_Δ2:A2 tetramer 2.0 ± 0.1 n.a. 
stTrpEx_Δ + stTrpG Ex_Δ2:G2 tetramer n.a. 0.160 ± 0.004 
a Representative spectra are provided in Figure S8. A corresponding 
list of deduced oligomeric states together with determined 
molecular weights is provided in Table S9. 
b Stimulation factors fStim are based on the apparent glutamine 
hydrolysis rate of ppPabA: kapp 0.015 s-1. For comparison, fStim for the 
combinations of ppPabA with ppPabB and ppTrpE are 5.0 and 4.7, 
respectively. n.a.: not applicable. 
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Table 2: Structural and enzymatic characteristics of complexes comprising ppPabA* and TrpEx, TrpE, or PabB synthases. 
 
 complex formationa kinetic parameters of AS formationb glutaminase activityc 
 native MS kcat /s-1 KMCH /µM kcat/KMCH /M-1s-1 fstim 
ppPabA* + stTrpExd Ex2:A2 tetramer 0.31 ± 0.05 6.2 ± 3.5 5.6 · 104 41.8 ± 3.0 
ppPabA* + ecTrpEx Ex2:A2 tetramer 0.63 ± 0.05 9.6 ± 2.0 6.7 · 104 45.2 ± 3.3 
ppPabA* + smTrpEx Ex2:A2 tetramer 0.04 ± 0.004 5.2 ± 2.8 8.8 · 103 49.0 ± 2.7 
ppPabA* + ppTrpEe E2:A2 tetramer 0.9 ± 0.06 8.4 ± 1.8 1.1 · 105 11.5 ± 3.0 
ppPabA* + ppPabBf B:A dimer 0.2 ± 0.03 25.0 ± 2.6 6.7 · 103 19.1 ± 0.6 
a Representative spectra are provided in Figure S9. A corresponding list of deduced oligomeric states together with determined molecular 
weights is provided in Table S10. 
b Values are the mean and standard deviation from at least three independent measurements. 
c Stimulation factors fStim are based on the apparent glutamine hydrolysis rate of ppPabA*: kapp 0.005 s-1 (wild-type ppPabA: kapp 0.015 s-1). 
d For comparison: stTrpEx2:stTrpG2 complex: kcat 3.7 ± 0.3 s-1, KMCH 11.3 ± 2.9 µM, and kcat/KMCH 3.5 · 105 M-1s-1. 
e For comparison: ppTrpE2:ppPabA2 complex: kcat 3.4 ± 0.3 s-1, KMCH 6.3 ± 1.5 µM, and kcat/KMCH 5.4 · 105 M-1s-1. 
f For comparison: ppPabB:ppPabA complex: kcat 0.2 ± 0.08 s-1, KMCH 33.3 ± 2.3 µM, and kcat/KMCH 6.7 · 103 M-1s-1. 
 
A more plausible evolutionary route is in line with recent 
findings by Laub and co-workers (Aakre et al., 2015). They 
showed that novel toxin-antitoxin complexes, which are 
important for cell defense and viability, can evolve without 
non-functional inter-stages by passing through promiscuous 
intermediates with relaxed interaction specificity. A similar 
evolutionary path might have led from PabA to TrpG via 
intermediates that display relaxed interaction specificity 
towards synthases. This would imply that few mutations in 
PabA are sufficient to allow for TrpEx binding without 
compromising its function and the interaction with its cognate 
partner PabB. 
To test the plausibility of this evolutionary scenario we 
first generated a homology model of ppPabA and 
superimposed it with smTrpG in the smTrpEx2:smTrpG2 
crystal structure to yield an artificial smTrpEx:ppPabA 
complex (Figure 7A). Using this model, we identified five 
interface residues of ppPabA that are located in structural 
elements that lie close to the interface add-on. We replaced 
these five residues with the corresponding ones of smTrpG 
(Figure 7B), which resulted in the variant ppPabA*. Four of the 
substitutions (Q19D, Y20Q, G22R, I31Y) lead to residues that 
are mainly conserved within TrpG glutaminases whereas the 
D34Q substitution leads to a residue that is only present in a 
minor fraction of TrpG homologs (Figure 7C) but removes the 
highly conserved aspartate found in PabA glutaminases. 
The ppPabA* variant could be expressed in soluble form 
and purified. It formed tetrameric complexes with all three 
TrpEx homologs as shown by native mass spectrometry 
(Table 2). Moreover, all three complexes were functional and 
converted CH to AA in a glutamine-dependent assay with 
catalytic efficiencies kcat/KMCH between 8.8 · 103 and 6.7 · 104 
M-1s-1. These values are only one order of magnitude lower 
than those of native TrpEx2:TrpG2 complexes. Moreover, the 
glutaminase activity of ppPabA* is stimulated about 45-fold 
by the presence of stTrpEx, smTrpEx, or ecTrpEx. Therefore, 
ppPabA* possesses the three hallmark features of wild-type 
glutaminases: (i) Formation of stable glutaminase-synthase 
complexes, (ii) channeling of nascent ammonia from 
glutaminase to synthase, and (iii) allosteric stimulation of 
glutaminase activity. 
Notably, ppPabA* displays a relaxed interaction specificity 
towards synthases, as it retained its ability to form stable and 
functional complexes with both ppTrpE and ppPabB, which do 
not contain the interface add-on (Table 2). The composition 
and catalytic efficiencies of these complexes were 
comparable to those of genuine ppTrpE:ppPabA and 
ppPabB:ppPabA complexes. Thus, the five substitutions only 
marginally impair the native ppPabA function but permit an 
additional functional interaction with TrpEx. PpPabA* is 
therefore promiscuous with regard to interacting with 
synthases that contain an interface add-on and with such that 
do not contain an interface add-on. It may thus represent a 
promiscuous evolutionary intermediate that fills the gap 
between the TrpE/PabB-specific PabA glutaminases and the 
TrpEx-specific TrpG glutaminases. 
 
Experimental evidence for harmful metabolic cross-talk in 
TrpE species 
Our genetic profiling of over 15 000 bacterial and archaeal 
species has shown that Vibrionales and Enterobacteria have 
evolved a conserved orthogonal system of glutamine 
amidotransferase complexes for the two important 
biosynthetic pathways leading to tryptophan and folate. The 
observation that TrpEx and TrpG have been retained in all 
descendants after the split between Pseudomonas and 
Shewanella species approximately 950 million years ago 
(Battistuzzi and Hedges, 2009) suggests that two orthogonal 
AS and ADCS complexes entail some kind of selective 
advantage like the prevention of metabolic cross-talk. 
In principle, such cross-talk is conceivable in bacteria that 
do not possess TrpEx but TrpE. As shown above, these 
species only contain PabA glutaminases that form functional 
AS and ADCS complexes with both TrpE and PabB. This raises 
the question how ammonia flow is directed towards either 
tryptophan or folate biosynthesis in these organisms. The 
existence of sophisticated regulatory mechanisms in 
Firmicutes illustrates the enormous effort that has been 
invested by Nature to solve this problem (Figure S10). 
The central player in regulating tryptophan and folate 
biosynthesis in B. subtilis is the tryptophan-sensing protein 
TRAP (Babitzke, 1997), which binds excessive tryptophan and 
exercises transcriptional attenuation and translational control  
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Figure 8: B. subtilis growth experiments. 
The bars charts show the average sizes of B. subtilis colonies grown for 48 hours on minimal medium lacking (dark grey bars) or containing (light 
grey bars) 2 mM IPTG. The values for the cells transformed with the indicated plasmids are normalized to the average colony size of cells with 
the empty plasmid (pDG) and grown in the absence of IPTG. Error bars indicate the standard deviation from at least four independent replicates 
using different transformants. A) The overexpression of bstrpE leads to a significant reduction of colony size (p-value < 0.0001 at a confidence 
interval of 99%). The insets show the respective colonies grown in the absence and presence of IPTG. The black line is a reference scale of 1 cm. 
For representative images of all transformants see Figure S11. B) The presence of p-aminobenzoic acid (PABA) or folate offsets the effect of 
bstrpE overexpression. The insets show the respective colonies grown in the presence of IPTG and either PABA or folate.  
 
 
both on the tryptophan and the folate operon. A problematic 
situation develops if biosynthesis of folate is required while 
cellular levels of tryptophan are high. Under such conditions 
the production of the single available glutaminase PabA 
required for folate biosynthesis is blocked by TRAP. However, 
a dual promoter system allows for the translation-mediated 
displacement of TRAP resulting in the full ADCS complex 
required for folate biosynthesis (Yakhnin et al., 2007).  
As long as a cell contains TrpE and PabB concurrently, the 
TRAP-based mechanism cannot guarantee specific direction 
of ammonia flow to one pathway or the other. Moreover, this 
sophisticated regulatory network could easily be disturbed 
resulting in potentially harmful metabolic cross-talk. We 
simulated such a situation by overexpressing trpE in B. subtilis 
and hypothesized that the resulting high amounts of TrpE 
synthase will take up all PabA glutaminase and thus deduct it 
from folate biosynthesis. Vice versa, we also assumed that 
the overexpression of pabB will lead to a shortage of PabA 
glutaminases in tryptophan biosynthesis. 
We transformed the prototrophic B. subtilis strain SB491 
(Zeigler et al., 2008) with expression plasmids that contained 
either bspabB or bstrpE, or bspabA, sttrpEx, or smtrpEx as 
controls. To test the phenotypic effects of IPTG-induced 
overexpression, we let the transformants grow on defined 
minimal medium and determined average colony sizes 
(Figure 8A). Overexpression of bspabB had no effect on the 
average colony size. However, overexpression of bstrpE 
resulted in significantly smaller colonies, which grew to only 
about 20% of the size observed in the absence of IPTG. 
We did not observe similar growth deficiencies for the 
empty plasmid, nor for the overexpression of bspabA, sttrpEx, 
and smtrpEx. Thus, the growth deficiency under 
overexpression of bstrpE is not caused by toxic effects from 
IPTG or high protein concentrations. To test if it this effect is 
caused by a compromised folate biosynthesis, we performed 
the same growth experiments in the presence of folate or its 
precursor p-aminobenzoic acid (Figure 8B). Indeed, the 
supple-mentation of these metabolites resulted in normally 
sized colonies, thus offsetting the effect of bstrpE 
overexpression. 
 
DISCUSSION 
Interface add-ons are an evolutionary tool for the 
diversification of protein-protein interfaces and protein-
protein interactions 
It is intriguing how protein complexes form with the specificity 
and selectivity required for their proper function in almost all 
biological processes. A profound understanding of this 
specificity and selectivity is not possible without detailed 
knowledge about how protein-protein interfaces and 
interactions between proteins change and evolve. Given the 
limited number of different protein architectures (Chothia, 
1992; Hashimoto and Panchenko, 2010), quaternary structure 
topologies (Ahnert et al., 2015), and interface geometries 
(Gao and Skolnick, 2010; Garma et al., 2012), the 
diversification of most protein-protein interactions is the 
result of adaptational mutations (Capra et al., 2012) of 
interface residues that did not change interface geometry. 
Although interfaces possess such mutational variability 
(DePristo et al., 2005; Harms and Thornton, 2013), mutational 
adaptation is inherently restrained if the interface does not 
only serve as a binding surface but also performs an 
additional function like the propagation of an allosteric signal, 
the completion of an active site, or the channeling of reaction 
intermediates between the interacting proteins. In such cases, 
mutations of interface residues, while increasing interaction 
specificity, may concurrently compromise function. This 
greater selective constraint imposed on interfaces compared 
to other regions of proteins is reflected in the lower mutational  
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Figure 9: Conservation of the interface region in TrpEx and PabB. 
A) On the left TrpEx and PabB are depicted as circle segments with 
their half of the ammonia channel marked by a yellow box and the 
TrpEx interface add-on is indicated by a green square. On the right 
hand side, a top view of the interface region of TrpEx is shown in 
surface representation (PDB ID 1i7q) with the interface add-on 
marked by a green outline and the entry to the ammonia channel 
marked by a yellow mesh. The normalized CONSURF conservation 
score ranges from below -1 (cyan, most variable) to above 1 
(magenta, most conserved) and were calculated from 5849 TrpEx and 
PabB sequences with a pairwise identity <90%. 
 
 
rate of interface residues relative to non-interface residues 
(Ames et al., 2016; Mintseris and Weng, 2005). 
Our systematic survey of protein-protein interfaces in 
heteromeric complexes highlights one solution to such 
dilemmas: the addition of add-ons to existing interfaces. 
These interface add-ons have a typical length of 10-20 amino 
acids and also mostly a well-defined secondary structure. All 
of them contain at least one residue that falls into the 
category of a binding hot spot, which is that a mutation of this 
residue to alanine decreases the binding free energy of at 
least 2 kcal/mol (Thorn and Bogan, 2001). In fact, many of the 
interface add-ons contain three or more and some even up to 
nine hot spot residues. Interface add-ons seem to be quite 
frequent, consistent with the assumption that negative design 
elements are important evolutionary traits (Schreiber and 
Keating, 2011). Under very stringent filter conditions we found 
them in about 10% of the structures in our representative 
dataset. Interface add-ons are also not limited to certain phyla 
as they are present in complexes from Actinobacteria, the 
Deinococcus-Thermus group, Firmicutes, Thermotogae, as 
well as several classes of Proteobacteria.  
Large interface insertions with similar effects on protein-
protein interaction specificity have, to the best of our 
knowledge, not been identified so far. Though significant 
insertions have been described in other enzymes, they merely 
modulate self-association of homo-oligomers (Hashimoto 
and Panchenko, 2010) or allosteric regulation (Sintchak et al., 
2002), but have no impact on interaction specificity. 
Moreover, interface add-ons are to be discriminated from 
small, independently folding interaction-mediating domains 
like ankyrin-repeats (Li et al., 2006), POZ-domains (Bardwell 
and Treisman, 1994), or bromodomains (Filippakopoulos and 
Knapp, 2012). These elements are stand-alone mediators of 
protein-protein interactions and do not change the specificity 
of an already existing interaction. 
The case of the AS and its TrpEx subunit is particularly 
interesting for several reasons: First, with a length of 51 amino 
acids, the TrpEx interface add-on is particularly extensive. 
Such large insertions are rare because of their high risk of 
impairing protein stability. Consequently, insertions or 
deletions commonly comprise only one residue and most are 
shorter than eight residues (Hashimoto and Panchenko, 2010; 
Pascarella and Argos, 1992). Second, the synthase-
glutaminase interface in AS does not only mediate complex 
formation but is also crucial for ammonia channeling and 
allosteric communication between the two subunits. 
Obviously, the TrpEx interface add-ons extends the interface 
in a way that does not compromise these functional 
properties. Third, and most importantly, many bacteria, in 
addition to AS, also contain the homologous ADCS complex, 
which catalyzes a similar reaction in folate biosynthesis. In 
these organisms, the TrpEx interface add-on determines the 
specific formation of AS and ADCS complexes, despite the 
highly similar core interfaces of PabB and TrpEx (Figure 9). 
This is exemplified by the properties of the stTrpEx_Δ variant 
where the deletion of six residues allowed for the binding of a 
PabA glutaminase.  
 
The interface add-on in TrpEx has far-reaching physiological 
consequences 
The in vivo growth experiments with B. subtilis clearly show 
that the overexpression of bstrpE and the resulting high 
cellular concentration of TrpE synthases sequesters the 
available PabA glutaminases, whereby impairing folate 
biosynthesis and significantly affecting cellular fitness 
(Figure 8). From a broader perspective, we have 
demonstrated that cross-talk between metabolic pathways 
can be harmful for an organism. A metabolic conflict 
comparable to that in Firmicutes does not exist in species that 
possess TrpEx and its specific, associated glutaminase TrpG. 
In these species, trpG is an integral part of the trp-operon and 
is translationally coupled to trpEx by overlapping start and 
stop codons, which facilitates an equimolar synthesis of the 
both AS components (Oppenheim and Yanofsky, 1980). 
Consequently, the synthesis of the two AS components can 
be controlled independent of cellular folate levels and a 
simple repression and attenuation mechanism is sufficient to 
regulate the trp-operon (Kelley and Yanofsky, 1985; Roesser 
and Yanofsky, 1991; Yanofsky et al., 1984). 
 
Glutaminase intermediates with relaxed interaction 
specificity enabled the evolution of TrpEx-species 
Phylogenetic distribution and sequence similarities of the 
glutaminases suggest that TrpG has evolved from a PabA 
ancestor. It is however highly unlikely that the appearance of 
TrpG was a compensatory response to the emergence of 
TrpEx. Our experimental characterization of TrpEx shows that 
it cannot interact with PabA. Thus, an organism containing 
TrpEx, PabB, and only PabA would be non-viable due to non-
functional tryptophan biosynthesis.  
Plausible scenarios that lead from a TrpE to a TrpEx 
species avoid such evolutionary dead-ends by assuming 
promiscuous PabA* glutaminase intermediates with relaxed 
interaction specificity. Promiscuity in this context refers to 
their ability to interact with synthases that contain an interface  
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add-on, i.e. TrpEx, and likewise with synthases that do not 
contain an interface add-on, i.e. TrpE and PabB. Our designed 
ppPabA* variant displays such a relaxed interaction 
specificity: It contains five amino acid substitutions that are 
sufficient to establish stable and functional interactions with 
TrpEx. Moreover, it forms stable and functional complexes 
also with ppTrpE and ppPabB, which both lack the TrpEx 
interface add-on. 
A parsimonious approach building on comparable inter-
mediates leads to two different plausible evolutionary 
trajectories (Figure 10). In the neo-functionalization trajectory 
(Figure 10, left path), the gene of an ancestral PabA was 
duplicated, thus allowing the acquisition of mutations that 
lead to a relaxed interaction specificity. Mutational drift and 
co-evolution (Pazos and Valencia, 2008) finally led to a 
specialization of PabA* to the contemporary TrpG 
glutaminase found in γ-Proteobacteria. In the alternative sub-
functionalization trajectory (Figure 10, right path), the 
presence of a promiscuous PabA* intermediate made it 
possible to tolerate the integration of the interface add-on into 
TrpE. After gene duplication the copies co-evolved with TrpEx 
and PabB, respectively, and sub-functionalization led to 
specific, contemporary AS and ADCS complexes. With the 
data at hand, it is not possible to decide which evolutionary 
trajectory might more accurately describe the evolutionary 
history of TrpG. For example, it is known that most duplicated 
genes do not stay in the gene pool of a population long 
enough to accumulate function- or specificity-changing 
mutations and are lost instead (Hughes, 1994; Lynch and 
Conery, 2000), arguing against the neo-functionalization path. 
On the other hand, the promiscuity-inducing mutations in a 
PabA* variant must not be at the expense of catalytic 
efficiency or protein stability; an important point to consider 
with the sub-functionalization path. However, irrespective of 
which trajectory reflects the actual evolutionary path, a 
promiscuous PabA* intermediate is required to interact with 
both TrpEx and PabB, ensuring that ammonia is made 
available for tryptophan and folate biosynthesis. This principle 
of evolutionary utilization of interaction-promiscuity and the 
concurrent prevention of non-functional protein complexes 
has recently also been highlighted on the example of bacterial 
toxin-antitoxin complexes (Aakre et al., 2015). There, 
promiscuous interaction partners allowed the expansion and 
diversification of toxin-antitoxin systems without impairing 
cell viability. Moreover, the exploit of interaction promiscuity 
and the gain of interaction specificity by just few changes in 
sequence have been highlighted by studies of complexes 
between colicin endonucleases and immunity proteins (Levin 
et al., 2009). 
 
Final perspective 
To conclude, our work adds to the understanding how highly 
conserved protein interfaces are tinkered towards novel 
interaction specificities in the course of evolution. Our 
systematic characterization of homologous synthases and 
glutaminases in a GATase family shows that diversification 
can be achieved by the integration of interface add-ons. We 
also provide in vivo evidence that the incorporation of the 
interface add-on in TrpEx entails selective advantages by  
 
 
Figure 10: Possible evolutionary trajectories leading to the 
orthogonal complexes of γ-Proteobacteria. 
Two evolutionary scenarios leading to separate AS and ADCS 
complexes in TrpEx-species. The left path consists of the following 
steps: duplication of PabA, neutral drift of PabA to PabA*, integration 
of the interface add-on into TrpE, and specialization of PabA* to TrpG. 
Within the right path, neutral drift initially leads from PabA to PabA*. 
After duplication of PabA*, specialization and co-evolution gives rise 
to contemporary PabA and TrpG enzymes. On the right hand side 
experimentally characterized interactions from this work are shown 
that represent the respective evolutionary phases. 
 
 
assuring independent regulation of ammonia influx into 
tryptophan and folate biosynthesis. Importantly, our in silico 
survey of bacterial heteromeric protein complexes suggest 
that TrpEx is not a single case but that interface add-ons are 
common mediators of interaction specificity in various 
physiological contexts. From a biomedical perspective, the 
TrpEx interface add-on could provide an anchor point for the 
grafting of peptides that may inhibit the formation of the AS 
complex and thus impair tryptophan biosynthesis, specifically 
targeted at pathogenic TrpEx-species. In the context of 
protein design, interface add-ons might prove as valuable 
tools for the generation of orthogonal pairs of interacting 
proteins that all utilize the same core interface. 
 
EXPERIMENTAL PROCEDURES 
Survey of interface add-ons in heteromeric protein complexes 
The initial dataset contained 1739 heteromeric bacterial protein 
complex structures deposited in PDB that were devoid of non-protein 
macromolecules and had subunit stoichiometries of AB, A2B2, A3B3, 
A4B4, A6B6, ABC, and A2B2C2. To avoid redundancy, identical proteins 
crystallized under different experimental conditions were excluded, 
leaving a subset of 918 complex structures. The InterPro dataset 
distinguishes protein families, which represent groups of 
homologous proteins at different levels of functional and structural 
similarity, and domains, which often occur in numerous non-
homologous proteins (Hunter et al., 2012). We thus removed all 
complex structures whose subunits are only associated with 
“domain”, “repeat”, and “site” entries and selected those that were 
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assigned to highest-level InterPro families. For the remaining 305 
complex structures we extracted all bacterial sequences from the 
corresponding InterPro families. In the following, we name these 
complexes “reference complexes” and use SU to address one of the 
subunits A, B, or C; a homologous sequence from the corresponding 
family is denoted by H.  
Due to the average number of 12 000 homologs per family, it is 
difficult to create a reliable multiple sequence alignment. To identify 
insertions in SU or H, we thus computed individual pairwise sequence 
alignments PW(SU, H) by means of MAFFT (Katoh and Standley, 
2013) with the -localpair option and a gap-opening penalty of 3.0. In 
order to exclude heavily fragmented alignments, only those were 
considered further that contained a maximum of 40 isolated gaps in 
SU. Furthermore, PW(SU, H) that contained N- or C-terminal indels 
were also ignored because these may arise from erroneous sequence 
annotations. Finally, all PW(SU, H) were selected that showed in SU or 
H an additional fragment comprising at least eight residues.  
The insertions resulting from all PW(SU, H) were mapped onto the 
sequence of SU and a histogram hist was computed; hist(k) specifies 
for each residue position k of SU how often it is part of an insertion 
(for examples see Figure S1A). Due to the high number of mappings 
and the sequence variability of the chosen InterPro families, most 
residue positions k are part of insertions, which results in noisy 
histograms. After correcting for this noise, the maximal number 
max_hist of all hist(k) values was determined and all continuous 
sections with hist(k) > 0.3 max_hist were identified as significant 
insertions. Analogously, for each SU a histogram was computed that 
specifies how often an insertion in H starts at residue position k 
(Figure S1B). Again the maximal value max_hist of all hist(k) values 
was determined and all positions k with hist(k) < 0.5 max_hist were 
identified as starting points of significant insertions in H. In total, 209 
insertions were identified in 117 reference complexes and 418 
insertions were identified in InterPro homologs associated with 226 
reference complexes (Table S1). 
From these 209 insertions we selected those that are part of a 
protein-protein interface in the respective reference complex 
structure. To this end for each reference structure the biological 
quaternary assembly was generated using the PDBePISA server 
(Krissinel and Henrick, 2007) or taken from author-provided assembly 
files from the PDB. Then, we calculated for each residue of an 
insertion the shortest distance to any residue belonging to the other 
subunits based on the position of their heavy atoms. A residue was 
designated as an IFR, if this distance was less than 4.5 Å which is a 
commonly chosen cut-off (Barlow and Thornton, 1983; Gao and 
Skolnick, 2010; Ofran and Rost, 2003b; Xu et al., 1997).  
The contribution of these insertions to protein-protein 
interactions in the respective complexes was analyzed using mCSM 
(Pires et al., 2014) with the protein-protein option as follows: All i non-
alanine IFRs of an insertion were mutated in silico to alanine in the full 
quaternary assembly resulting in i predicted protein-protein affinity 
change values ∆∆????→???
???????. Analogously, these i IFRs were mutated to 
alanine in the isolated subunit structure giving i ∆∆????→??????????  values. An 
insertion was designated as a candidate interface add-on, if at least 
one mutation resulted in ∆∆????→?????????? <  −2 
????
???
. Finally, after manual 
inspection, candidate interface add-ons were removed based on the 
following conditions: i) No 3D structure available for a homolog H that 
does not contain the interface add-on, ii) highly similar duplicates, iii) 
location of an interface add-on in a homomeric interface, which is 
present for example in complexes with the stoichiometry A2B2, and iv) 
candidates were N- or C-terminal extensions, not detected by the 
previous sequence filtering. In the end, 30 interface add-ons in 26 
different reference structures remained.  
 
 
 
 
Computation of sequence similarity networks 
SSNs of the InterPro entries IPR019999 and IPR015890 were 
computed according to (Atkinson et al., 2009; Gerlt et al., 2015) and 
visualized with Cytoscape 3.3 (Shannon et al., 2003; Smoot et al., 
2011). A detailed description is available in the Supplemental 
Experimental Procedures. 
 
Computation of amino acid conservation and sequence logos 
TrpEx sequences were extracted from the SSN of IPR015890 via their 
UniProt identifiers and aligned with MAFFT (Katoh and Standley, 
2013). The MSA was made non-redundant at 90% identity and 
contained 210 TrpE sequences. The amino-acid conservation of the 
TrpEx interface add-on was derived from the MSA and visualized as a 
sequence logo by means of WebLogo (Crooks et al., 2004). The amino 
acids in the sequence logo are colored according to their chemical 
properties: purple, amido functionality; red, acidic; blue, basic; black, 
hydrophobic; green, hydroxyl functionality and glycine. Sequence 
logos of PabA and TrpG glutaminases were generated accordingly 
from MSAs of corresponding sequences in TrpExrepr and TrpErepr (see 
below). 
 
Genetic profiling of Archaea and Bacteria to determine the 
phylogenetic distribution of AS and ADCS complexes 
To investigate whether the presence of TrpEx or TrpE affects the 
distribution of PabB and the type and number of associated 
glutaminases, we determined the occurrence of TrpEx, TrpE, PabB, 
TrpG, and PabA for all species associated with the TrpEx and TrpE 
sub-clusters in the SSN of IPR015890. The Hidden-Markov-Model 
based grouping routine that we developed for this application is 
described in detail in the Supplemental Experimental Procedures and 
sketched in Figure S3. In brief, all species that contribute sequences 
to the TrpEx and TrpE sub-clusters were individually scanned for the 
presence of TrpEx, TrpE, and PabB as well as for the presence of TrpG 
and PabA using BLAST (Altschul et al., 1990). Hits were assigned as 
either of these five enzymes by sensitive comparison with enzyme-
specific Hidden Markov Models (Figure S12). Finally, the two 
representative datasets TrpExrepr and TrpErepr containing the co-
occurring proteins for TrpEx- and TrpE-species, respectively, were 
generated. 
 
Computation of interface conservation 
The similarity of the interface regions between TrpEx and PabB was 
computed from structure-based MSAs comprising sequences from 
TrpExrepr and TrpErepr. A detailed description is available in the 
Supplemental Experimental Procedures. 
 
Cloning and mutagenesis 
The genes of TrpEx, TrpE, PabB, TrpG, and PabA proteins were 
amplified from genomic DNA or whole cell lysate in standard PCR 
reactions and cloned into pET21a, pET28a, or pMAL-c5X vectors. 
SttrpEx_Δ was generated by deletion of codons 111 to 116 inclusive 
and inserting the codons AGC and GGC coding for serine and glycine, 
respectively, in pET21a_sttrpEx. using the NEB Q5® site-directed 
mutagenesis kit. The gene of ppPabA* was optimized for expression 
in E. coli and synthesized (Life Technologies). A detailed description 
of all cloning procedures is available in the Supplemental 
Experimental Procedures. 
 
Expression and purification of proteins 
If not stated otherwise, all proteins were produced by gene expression 
in E. coli BL21-Gold (DE3) cells. ssTrpE was produced by gene 
expression in E. coli BL21-CodonPlus (DE3)-RIPL cells. Cells were 
grown in Luria broth medium at 20° C or 37° C over night. Proteins 
were purified from the soluble fraction of the cell extracts by Ni2+-
affinity and size exclusion chromatography. A detailed description is 
available in the Supplemental Experimental Procedures. 
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HPLC analysis of anthranilate and aminodeoxychorismate formation 
TrpEx, TrpE, and PabB were assayed in 20 mM bicine buffer pH 8.5, 
5 mM MgCl2, 1 mM DTT, 200 mM NH4Cl, and 500 µM CH. PabB-
assays additionally contained 10 µM aminodeoxychorismate-lyase 
from E. coli (ecPabC) for conversion of the PabB product 
aminodeoxychorismate (ADC) to p-aminobenzoate (PABA). A 
detailed description of the HPLC setup is provided in the 
Supplemental Experimental Procedures. 
 
Analysis of complex formation between different synthases and 
glutaminases 
The ability of the different synthases and glutaminases to form 
heteromeric complexes was examined by a combination of size 
exclusion chromatography and static light scattering (SEC-SLS). The 
experimental setup of SEC comprised Superdex 75 10/300 GL or S200 
10/300 GL columns (GE Healthcare) operated on an ÄKTAmicro 
system (GE Healthcare) connected to an ALIAS autosampler (Spark 
Holland). For SLS a Viscotek TDA 305 detector array (Malvern), 
including right-angle light scattering and refractive index detectors 
was used. The system was operated at 25 °C with a flow-rate of 
0.5 mL/min of degassed buffer (50 mM Tris-HCl, pH 7.5, 150 mM KCl, 
5 mM MgCl2) and was calibrated with Ribonuclease A and rabbit 
muscle aldolase from the GE Healthcare SEC Low-Molecular-Weight 
calibration kit for experiments with S75 and S200 columns, 
respectively. Individual synthases and glutaminases were assayed at 
a concentration of 50 µM (applied volume 100 µL). For analysis of 
complex formation, synthases and glutaminases were equimolarilly 
mixed to a final concentration of 50 µM. Data were analyzed with the 
OmniSec software (version 4.7, Malvern). 
Several synthases and glutaminases as well as combinations of 
them were additionally analyzed by native mass spectrometry. 
Proteins were exchanged into 100 mM ammonium acetate using 
Micro Bio-Spin columns (Bio-Rad). Single proteins and mixtures of 
synthases and glutaminases were analyzed on a Synapt G2 
quadrupole ion mobility time-of-flight mass spectrometer (Waters), 
equipped with a nano-electrospray ionization (nESI) source. 
Nanospray borosilicate capillaries were prepared in-house and filled 
with 5 µL of a mixture of 20 µM synthase and 20 µM glutaminase 
(30 µM ppPabA*). Analytes were sprayed by applying a capillary 
voltage of 1-1.2 kV. The following instrument settings were used: 30 V 
sample cone voltage, 10 V trap collision voltage, and 5 mbar backing 
pressure. The source was kept at room temperature. Data were 
analyzed with MassLynx 4.1 (Waters) and spectra were assigned 
based on m/z values with separation of overlapping charge or 
oligomeric states by ion mobility. 
 
Steady-state enzyme kinetics 
The TrpEx/TrpE reaction was measured at 25 °C in a fluorimetric 
assay monitoring AA fluorescence (excitation 313 nm, emission 
390 nm). A standard glutamine-dependent assay contained 100 mM 
potassium phosphate buffer, pH 7.0, 5 mM MgCl2, 1 mM DTT, 20 mM 
glutamine, and 90, 100, or 110 µM CH, respectively. After 
preincubation, 0.1 µM TrpEx or TrpE and 0.3 µM glutaminase were 
added. Entire progress curves were recorded for the three different 
substrate concentrations. For ammonia-dependent assays glutamine 
was substituted with 200 mM ammonium chloride and 100 mM 
bicine buffer, pH 8.5 was used. The PabB reaction was measured in 
an analogous fluorimetric assay at 25 °C monitoring PABA 
fluorescence (excitation 320 nm, emission 350 nm). The PabB 
product ADC was converted in situ to PABA by PabC. A standard 
assay contained 100 mM potassium phosphate buffer, pH 7.0, 5 mM 
MgCl2, 1 mM DTT, 20 mM glutamine, 5 µM PabC, and 90, 100, or 
110 µM CH, respectively. After preincubation, 0.5 µM PabB and 
1.5 µM glutaminase were added. Entire progress curves were 
recorded for the three different substrate concentrations. The kcat and 
KMCH values were determined by fitting the progress curves with the 
Michaelis-Menten equation included in COSY (Eberhard, 1990). 
The glutaminase activity was measured spectrophotometrically 
in a coupled enzymatic assay. Glutamate formed by the glutaminases 
was converted to α-ketoglutarate by glutamate-dehydrogenase (GDH) 
with simultaneous reduction of NAD+ to NADH (Figure S7A). A 
standard assay contained 50 mM tricine-KOH buffer, pH 8.0, 5 mM 
MgCl2, 1 mM DTT, 10 mM NAD+, 1 mg/mL GDH, and 4 mM glutamine. 
Following preincubation, 1 µM glutaminase was added and the 
reaction was monitored at 340 nm and 25 °C for at least 15 minutes. 
After making sure that the progress curve proceeded with a constant 
slope, 3 µM synthase were added and the reaction was again 
monitored for at least 15 minutes. The slopes of the linear parts of the 
progress curves before and after the addition of the synthase were 
used to calculate a stimulation factor that describes the increase of 
the apparent turnover rate upon the addition of the synthase 
(Figure S7B). As TrpG glutaminases were not active without any 
synthase, no stimulation factor could be calculated. Therefore, only 
the apparent turnover rates after the addition of the synthases were 
used for further evaluation. 
 
Bacillus subtilis growth experiments 
The bspabA, bspabB, bstrpE, sttrpEx, and smtrpEx genes were cloned 
into the pDG148 vector following the ligation-independent cloning 
protocol from (Joseph et al., 2001) using standard PCR reaction 
conditions and the oligonucleotides listed in the Supplemental 
Experimental Procedures. Electro-competent B. subtilis SB 491 cells 
were generated and transformed with plasmid DNA as described in 
the Supplemental Experimental Procedures. In vivo competition 
assays with pDG148_bspabA, pDG148_bspabB, pDG148_bstrpE, 
pDG148_sttrpEx, and pDG148_smtrpEx were performed on Spizizen’s 
minimal medium agar plates. For a detailed description please see 
the Supplemental Experimental Procedures. 
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Supplemental Experimental Procedures 
Materials 
Glutamate dehydrogenase was purchased from Roche. Chorismate was purchased from Sigma Aldrich as 
the barium salt and barium ions were precipitated by the addition of a slight excess of sodium sulfate. All 
other chemical reagents were purchased from Sigma Aldrich in analytical or HPLC grade and used without 
further purification. 
Computation of sequence similarity networks 
The SSN of the InterPro entry IPR019999 was computed according to (Atkinson et al., 2009; Gerlt et al., 
2015). To exclude sequence fragments and multi-domain proteins, only sequences between 320 and 620 
amino-acids in length were chosen for the initial all-by-all BLAST. An E-value cut-off of 1E-77 was 
applied and the complexity of the resulting network was reduced by computing a representative network in 
which sequences with >75% identity were grouped into single nodes. Networks were visualized with the 
organic y-files layout in Cytoscape 3.3 (Shannon et al., 2003; Smoot et al., 2011). Similarly, 
we computed a SSN for the InterPro entry IPR015890, which is a “domain” entry that contains the 
sequences from IPR019999 as well as additional sequences belonging to the “chorismate binding domain” 
fold. For this SSN we chose an E-value cut-off of 1E-80. Both SSNs showed the same aggregation of TrpE 
sequences in one large cluster with a noticeable separation of the TrpEx sequences to a distinct subcluster. 
At more stringent E-values, the TrpEx subcluster becomes separated from the TrpE cluster in both SSNs. 
 
Genetic profiling of Archaea and Bacteria to determine the phylogenetic distribution of AS 
and ADCS complexes 
BLAST-scans of TrpEx and TrpE species 
In the following, we name the content of the TrpEx cluster SSNTrpEx  and that of the TrpE cluster SSNTrpE . 
The species that comprise SSNTrpEx  and SSNTrpE  were extracted from the SSN of IPR015890 by their 
NCBI taxonomy identifiers (TaxIDs). After eliminating duplicate identifiers, 4297 and 11561 unique 
TaxIDs remained. The two datasets of TaxIDs are hereafter referred to as TaxIDSSNTrpEx  and 
TaxID
SSNTrpE . To 
scan each species in TaxIDSSNTrpEx  and 
TaxID
SSNTrpE  individually for the presence of TrpEx, TrpE, PabB, TrpG, 
and PabA, it was necessary to limit the BLAST-search space to the proteome of the individual species. To 
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circumvent limitations of the command line version of blastp 2.2.30+ each search was restricted to a 
species-specific (i. e. TaxID-specific) subset of proteins from the nr database. For the BLAST-searches 
with default parameters the sequences of PabB and PabA from E. coli were used as queries for the 
synthases and glutaminases, respectively (see table below). Hits with E-values lower than 1E-20 were 
further processed and their full sequences were added to the two sets of candidate sequences TaxIDcandidatesTrpEx  
and TaxIDcandidatesTrpE . 
 
Query sequences used for BLAST searches. 
ecPabA MILLIDNYDSFTWNLYQYFCELGADVLVKRNDALTLADIDALKPQKIVISPGPCTPDEAG 
ISLDVIRHYAGRLPILGVCLGHQAMAQAFGGKVVRAAKVMHGKTSPITHNGEGVFRGLAN 
PLTVTRYHSLVVEPDSLPACFDVTAWSETREIMGIRHRQWDLEGVQFHPESILSEQGHQL 
LANFLHR 
ecPabB MKTLSPAVITLLWRQDAAEFYFSRLSHLPWAMLLHSGYADHPYSRFDIVVAEPICTLTTF 
GKETVVSESEKRTTTTDDPLQVLQQVLDRADIRPTHNEDLPFQGGALGLFGYDLGRRFES 
LPEIAEQDIVLPDMAVGIYDWALIVDHQRHTVSLLSHNDVNARRAWLESQQFSPQEDFTL 
TSDWQSNMTREQYGEKFRQVQEYLHSGDCYQVNLAQRFHATYSGDEWQAFLQLNQANRAP 
FSAFLRLEQGAILSLSPERFILCDNSEIQTRPIKGTLPRLPDPQEDSKQAVKLANSAKDR 
AENLMIVDLMRNDIGRVAVAGSVKVPELFVVEPFPAVHHLVSTITAQLPEQLHASDLLRA 
AFPGGSITGAPKVRAMEIIDELEPQRRNAWCGSIGYLSFCGNMDTSITIRTLTAINGQIF 
CSAGGGIVADSQEEAEYQETFDKVNRILKQLEK 
 
Generation of representative HMMs 
To annotate the sequences in TaxIDcandidatesTrpEx  and 
TaxID
candidatesTrpE  as either one of the three eligible synthases, or 
as one of the two eligible glutaminases, each entry was compared to Hidden-Markov-Models representing 
the five enzymes. To parametrize the HMMs, sequence sets for TrpEx, TrpE, PabB, TrpG, and PabA were 
compiled and MSAs were generated with MAFFT in L-INS-i mode (Katoh and Standley, 2013). MSATrpEx 
contained sequences taken from SNNTrpEx . Sequences for MSATrpE and MSAPabB were taken from a previous 
study (Plach et al., 2015). Sequences for MSATrpG and MSAPabA were retrieved from nr by means of PSI-
BLAST searches with TrpG from Serratia marcescens and PabA from E. coli as queries, respectively. For 
HMM generation by means of hhmake (Söding, 2005) the MSAs were made non-redundant at 90% 
sequence identity and columns with more than 50% gaps were ignored. All other parameters of hhmake 
were kept default. TrpExHMM , TrpEHMM , PabBHMM , TrpGHMM , and PabAHMM  were based on 101, 107, 
103, 28, and 133 sequences, respectively. All five HMMenz  were subjected to four-fold cross-validation to 
confirm their specificity (Figure S12). To this end, 25% of the sequences in an MSA were randomly 
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selected and served as a test set. The remaining 75% served as a training set to generate *HMMenz . Each test 
set was compared to the corresponding *HMMenz  and the other four unaltered HMMenz . For example, 25% 
of PabA-sequences from MSAPabA were chosen as a test set and the remaining 75% used to parametrize 
*
PabAHMM . The PabA test-set was then compared to PabAHMM , TrpGHMM , PabBHMM , TrpEHMM , and 
TrpExHMM . This process was repeated four times. Each 
*HMMenz  identified the corresponding test-set with 
E-values between 40 and 60 orders of magnitude lower than sequences belonging to the other four groups. 
These findings make clear that the five HMMs are well-suited to classify TrpEx, TrpE, PabB, TrpG, and 
PabA sequences. 
Sequence-to-HMM comparisons 
Using hhsearch (Söding, 2005) and the five HMMenz , sequences from TaxIDcandidatesTrpEx  and TaxIDcandidatesTrpE  
were assigned to the group giving the lowest E-value. Glutaminases were compared with TrpGHMM  and 
PabAHMM . Accordingly, synthases were compared with TrpExHMM , TrpEHMM , and PabBHMM . The 
assignments were stored in the sets predictionsTrpEx  and predictionsTrpE . The selectivity of the assignments was 
examined by calculating log-odds ratios Skl, which relate the E-values of HMMk  and HMMl : 
10
E-val(HMM )log
E-val(HMM )
k
kl
l
S
 
=   
 
For the classification of PabA homologs, HMMk  = PabAHMM  and HMMl  = TrpGHMM  were used. For the 
classification of PabB homologs, HMMk  = PabBHMM  was used in all cases; for the set predictionsTrpEx  
HMMl  = TrpExHMM  and for the set predictionsTrpE  HMMl  = TrpEHMM  was used. The refinement of the 
HMMs based on an iterative sequence selection process similar to the PSI-BLAST approach did not 
improve their specificity. 
Creating representative datasets TrpExrepr and TrpErepr 
Elements in TaxIDcandidatesTrpEx  and 
TaxID
candidatesTrpE  were further processed to assess the phylogenetic distribution of 
the corresponding enzymes. At first, all entries were removed that were mapped to sequences with score 
Skl < 10 in order to exclude species possessing sequences that could not be assigned unambiguously. 
Subsequently, for species which are over-represented in nr due to many strain-level entries, only one entry 
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was chosen. All species with incomplete TaxIDs were removed and for all entries with an identical 
common name determined via Key2Ann (Pürzer et al., 2011) only one entry was chosen. The final datasets 
reprTrpEx  and reprTrpE  contained 1463 and 4386 entries, respectively. 
Determining the phylogenetic distribution of synthase-glutaminase co-occurrences 
To determine the phylogenetic distribution of the co-occurrences a tree-of-life (TOL) based on 31 
concatenated orthologs (Ciccarelli et al., 2006) was used in combination with iTOL 3.0 (Letunic and 
Bork, 2007). For cases where 
reprTrpEx  and reprTrpE  contain several elements for a species of the TOL 
(e.g. several E. coli strains) a consensus approach was used. The final TOL comprised 120 species from all 
major bacterial and archaeal phyla with mapped co-occurrences of TrpEx, TrpE, PabB, TrpG, and PabA. 
Computation of interface conservation 
The similarity of the interface regions between TrpEx and PabB was determined as follows: We first 
computed a structure-based sequence alignment of smTrpEx (PDB ID 1i7q) and ecPabB (1k0e) using 
STRAP (Gille and Frommel, 2001) with the TM-align algorithm (Zhang and Skolnick, 2005). This 
alignment was then supplemented with TrpEx and PabB sequences from 
reprTrpEx  and reprTrpE  by means 
of MAFFT (Katoh and Standley, 2013) with the “keeplength” option. The MSA was made non-
redundant at 90% identity and was finally mapped onto the crystal structure of smTrpEx using CONSURF 
(Ashkenazy et al., 2010). 
Cloning and mutagenesis 
The genes of TrpEx, TrpE, PabB, TrpG, and PabA proteins were amplified from genomic DNA or whole 
cell lysate in standard PCR reactions using the combinations of oligonucleotides specified in the table 
below. If not stated otherwise, all genes were cloned into the pET21a vector (Stratagene, providing a C-
terminal hexahistidine-tag) via the introduced restriction sites for NdeI and XhoI. SttrpG and sttrpE were 
already available cloned into the pET21a vector (Plach et al., 2015). EcpabC was cloned into the pET28a 
vector (Stratagene, providing an N-terminal hexahistidine-tag). EctrpE was initially amplified and cloned 
into the pET21a vector using NheI and XhoI restriction sites, because it contains an intragenic NdeI 
restriction site. This site was then deleted via a modified QuickChange mutagenesis protocol (Wang and 
Malcolm, 1999) introducing a silent mutation of a histidine codon (CAT → CAC). The resulting ectrpE* 
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was then amplified with an NdeI forward primer and cloned into the pET21a vector via NdeI and XhoI 
restriction sites. bspabB was cloned into a modified version of the pMAL-c5X vector (New England 
Biolabs). This vector is designed such that the gene of interest can be inserted downstream of the malE 
gene (which encodes for the maltose-binding-protein, MBP) via restriction sites for NdeI and XhoI. The 
vector additionally features the coding sequence for a hexahistidine-tag upstream of malE and a linker 
region between malE and the gene of interest that contains a thrombin cleavage site. Gene expression from 
this vector results in the fusion of the protein of interest to the C-terminus of N-terminally hexahistidine-
tagged MPB. The protein of interest can subsequently be cleaved off with thrombin. 
The gene coding for stTrpEx_Δ was generated by deleting codons 111 to 116 inclusive in 
pET21a_sttrpEx and inserting the codons AGC and GGC coding for serine and glycine, respectively, using 
the NEB Q5® site-directed mutagenesis kit and the 5’-phosphorylated oligonucleotides listed in the table 
below. The gene coding for ppPabA* (see table below) was optimized for expression in E. coli, synthesized 
(LifeTechnologies), and cloned into the pET21a vector using the terminal restriction sites for NdeI and 
XhoI. 
 
Template DNA and oligonucleotides used for cloning and site-directed mutagenesis. 
Restriction sites are underlined; mismatches for site-directed mutagenesis are in bold; 5’-phosphorylated 
oligonucleotides are marked with Ⓟ; “n.a.”: not applicable. 
Gene Organism Template DNA Primer (5ʹ?3ʹ) 
bspabA 
Bacillus  
subtilis (bs) 
Whole cell lysate 
Bacillus subtilis 
strain 168 
Fo_NdeI  CAGGGCATATGATTTTAATGATTGATAACTACG 
Re_XhoI  CCCTGCTCGAGCGCAATAACTTCCTTGCG 
bspabB Fo_NdeI  CAGGGCATATGGCACAACGCAGACC Re_XhoI  CCCTGCTCGAGTCTAATTTTTGTCTCTTCTTCGC 
bstrpE Fo_NdeI  CAGGGCATATGAATTTCCAATCAAACATTTC Re_EcoRI CCCTGGAATTCCTAGTGATGGTGATGATGATGACGCACAATTGTAGAAATC 
ecpabA 
Escherichia 
coli (ec) 
Whole cell lysate 
Escherichia coli 
K12 
Fo_NdeI  CAGGGCATATGATCCTGCTTATAGATAACTACG 
Re_XhoI  CCCTGCTCGAGGCGATGCAGGAAATTAGCCAGC 
ecpabB Fo_NdeI  CAGGGCATATGAAGACGTTATCTCCCGCTGTG Re_XhoI  CCCTGCTCGAGCTTCTCCAGTTGCTTCAGG 
ecpabC Fo_NdeI  CAGGGCATATGTCTTAATTAACGGTC Re_XhoI  CCCTGCTCGAGATTCGGGCGCTCACAAAG 
ectrpGD Fo_NdeI  CAGGGCATATGGCTGACATTCTGCTG Re_XhoI  CCCTGCTCGAGCCCTCGTGCCGCC 
ectrpEx 
Fo_NheI  CAGGGGCTAGCATGCAAACACAAAAACCGACTCTCG 
Fo_NdeI  CAGGGCATATGCAAACACAAAAACCGACTCTCG 
Re_XhoI  CCCTGCTCGAGCGCAATAACTTCCTTGCG 
QCM_fo   GTTTCCGTGCCGCACATGCGTTGTGAATGTAATC 
QCM_re   GATTACATTCACAACGCATGTGCGGCACGGAAAC 
pppabA 
Pseudomonas 
putida (pp) 
Genomic DNA 
Pseudomonas 
putida F1 
(DSMZ 6899) 
Fo_NdeI  CAGGGCATATGTTACTGATGATCGACAATTACGACTC 
Re_XhoI  CCCTGCTCGAGACGGCGGCCGCC 
pppabB Fo_NdeI  CAGGGCATATGCCGACCTGCACGCTAC Re_XhoI  CCCTGCTCGAGCAAGCCCTGCAGGGTCTG 
pptrpE Fo_NdeI  CAGGGCATATGAACCGCGAAGAATTCC Re_XhoI  CCCTGCTCGAGTCTGGCGGAAGTCTGC 
submitted for publication  
smpabA 
Serratia 
marcescens 
(sm) 
Genomic DNA  
Serratia 
marcescens 
subsp. 
marcescens 
(DSMZ 30121) 
Fo_NdeI  CAGGGCATATGCTGCTGCTGATCGATAAC 
Re_XhoI  CCCTGCTCGAGACGGTTGAGGAAGTTATCC 
smpabB Fo_NdeI  CAGGGCATATGAGCGTAACCGCCC Re_XhoI  CCCTGCTCGAGCGACAGGGCATACTCCC 
smtrpEx Fo_NdeI  CAGGGCATATGATGAACACCAAACCAC Re_XhoI  CCCTGCTCGAGGAACACCTCCTTGGC 
sstrpE 
Sulfolobus 
solfataricus 
(ss) 
Genomic DNA  
Sulfolobus 
solfataricus P2  
(DSMZ 1617) 
Fo_NdeI  CAGGGCATATGGAAGTTCATCCAATAAGTG 
Re_XhoI  CCCTGCTCGAGCCTCACCCCTATTGCTG 
stpabB 
Salmonella 
typhimurium 
(st) 
Genomic DNA  
Salmonella 
enterica subsp. 
enterica serovar 
typhimurium LT2  
(DSMZ 17058) 
Fo_NdeI  CAGGGCATATGATGAAGACGTTATCTCCC 
Re_XhoI  CCCTGCTCGAGGTTCTCCAGTGGGTGC 
sttrpG Fo_NdeI  GGAATTCCATATGGCTGATATTCTGCT Re_XhoI  AATCTCGAGCTTTTGCTGCGCCCAG 
sttrpEx Fo_NdeI  GGAATTCCATATGCAAACACCAAAACCC Re_XhoI  AAACTCGAGGAAGGTCTCCTGT 
sttrpEx_Δ n.a. pET21a_sttrpEx 
Fo       ⓅGGCCGTTTATGCTCTCTGTCGGTATTTGATGC 
Re       ⓅGCTTGGGCTGACGGGCGGGAAGC 
 
Nucleotide and amino acid sequence of ppPabA*. 
The nucleotide sequence was optimized for expression in E. coli. Restriction sites for NdeI (5ʹ) and XhoI 
(3ʹ) are underlined. The C-terminal hexahistidine-tag and two linker amino acids are in bold. 
Nucleotide sequence 
5ʹCATATGCTGCTGATGATCGACAACTATGATAGCTTTACCTATAACGTTGTTGATCAGCTGCGTGAACTGGG
TGCAGAAGTTAAAGTTTATCGTAATCAAGAACTGACGATCGCACAGATTGAAGCACTGAATCCGGAACGTAT
TGTTGTTAGTCCGGGTCCGTGTACCCCGAGCGAAGCCGGTGTTAGCATTGAAGCAATTCTGCATTTTGCAGG
TAAACTGCCGATTCTGGGTGTTTGTCTGGGTCATCAGAGCATTGGTCAGGCATTTGGTGGTGATGTTGTTCG
TGCACGTCAGGTTATGCATGGTAAAACCAGTCCGGTTTATCATCGTGATCTGGGTGTGTTTGCAAGCCTGAA
TAATCCGCTGACCGTTACCCGTTATCATTCACTGGTTGTTAAACGTGAAACCCTGCCGGATTGTCTGGAAGT
TACCGCATGGACCAGCCATGCAGATGGTAGCGTTGATGAAATTATGGGTCTGCGTCATAAAACCCTGAATAT
TGAAGGTGTTCAGTTTCATCCGGAAAGCATTCTGACCGAACAGGGTCACGAACTGTTTGCAAATTTTCTGAA
ACAGACCGGTGGTCGTCGCCTCGAG3ʹ 
 
Amino acid sequence 
MLLMIDNYDSFTYNVVDQLRELGAEVKVYRNQELTIAQIEALNPERIVVSPGPCTPSEAGVSIEAILHFAGK
LPILGVCLGHQSIGQAFGGDVVRARQVMHGKTSPVYHRDLGVFASLNNPLTVTRYHSLVVKRETLPDCLEVT
AWTSHADGSVDEIMGLRHKTLNIEGVQFHPESILTEQGHELFANFLKQTGGRRLEHHHHHH 
 
Expression and purification of proteins 
If not stated otherwise, all proteins were produced by expression in E. coli BL21-Gold (DE3) cells (Agilent 
Technologies). SsTrpE was produced by expression of the sstrpE gene in E. coli BL21-CodonPlus (DE3)-
RIPL cells (Agilent Technologies). For protein production, overnight cultures of individual clones were 
used to inoculate 4 L of Luria broth medium supplemented with 150 µg/mL ampicillin. Cells were grown 
at 37 °C to an OD600 of 0.6 and then cooled to 20 °C (except for ssTrpE). Expression was induced by 
adding 0.5 mM isopropyl β-D-1-thiogalactopyranoside and growth was continued overnight at 20 °C 
(37 °C for ssTrpE). Cells were harvested by centrifugation (2700 g, 4 °C), resuspended in 50 mM Tris-HCl, 
pH 7.5, 300 mM potassium chloride, 10 mM imidazole, and lysed by sonification. The insoluble fraction 
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was removed by centrifugation (23000 g, 4 °C) and the soluble extracts were filtered through a 0.8 µm 
membrane. 
Supernatants containing C-terminal or N-terminal hexahistidine-tagged proteins were loaded onto a 
HisTrapFF crude column (5 mL, GE Healthcare), which had been equilibrated with resuspension buffer, 
and eluted from the column by applying a linear gradient of 10 – 750 mM imidazole. Enzyme-containing 
fractions, as judged by SDS-PAGE, were pooled and further purified by preparative gel filtration (Superdex 
75 HiLoad 26/60, 320 mL, GE Healthcare, 50 mM Tris-HCl, pH 7.5, 50 mM KCl, 5 mM MgCl2, 2 mM 
DTT, 4 °C). Elution fractions were analyzed by SDS-PAGE and the fractions containing pure protein were 
pooled. The enzymes were finally concentrated to 100-200 µM and flash frozen in liquid nitrogen. Protein 
concentrations were determined by measuring the absorbance at 280 nm, using the molar extinction 
coefficient calculated via ExPASy ProtParam (http://web.expasy.org/protparam/). 
The MBP-bspabB fusion protein was purified from the soluble cell extract by Ni2+-affinity 
chromatography on a HisTrapFF crude column as described above. The pooled elution fractions were then 
dialyzed against 50 mM Tris-HCl pH 7.5, 300 mM KCl, 2.5 mM CaCl2 for six hours at 4 °C. The MBP was 
cleaved off by digestion with thrombin (1 U/mL, 15 °C, overnight). BsPabB was separated from undigested 
fusion protein and MBP by Ni2+-affinity chromatography. The flowthrough fractions (containing the 
untagged bsPabB) were analyzed by SDS-PAGE and appropriate fractions were pooled. BsPabB was 
further purified by preparative gel filtration, concentrated, and stored as described above. The final enzyme 
preparations contained 0.5 – 2 mg of >95% pure protein.  
HPLC analysis of anthranilate and aminodeoxychorismate formation 
The TrpEx, TrpE, and PabB synthases were assayed in 20 mM bicine buffer pH 8.5, 5 mM MgCl2, 1 mM 
DTT, and 200 mM NH4Cl. The enzyme and chorismate concentrations were 10 µM and 500 µM, 
respectively. PabB-assays additionally contained 10 µM aminodeoxychorismate-lyase from E. coli 
(ecPabC) for conversion of the PabB product aminodeoxychorismate (ADC) to p-aminobenzoate (PABA). 
The bsPabB assay additionally contained bsPabA, because without it, no formation of PABA could be 
observed. Enzymes were incubated with chorismate at 25 °C for three hours. Samples were ultrafiltrated 
(Amicon Ultra 0.5 mL centrifugal unit, 10 kDa molecular weight cut-off, 4 °C) and protein-free filtrates 
were analyzed on an Agilent 1200 HPLC system equipped with a 5 µm Agilent Zorbax Eclipse XDB C18 
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column (150 mm × 4.6 mm). Mobile phase A was 0.1% formic acid in H2O, mobile phase B 0.1% formic 
acid in acetonitrile. Separation was performed at 10 °C with a flow rate of 1 mL/min in the following 
manner: isocratic elution at 5% B from 0-5 minutes, linear gradient from 5-100% B from 6-20 minutes. 
Elution was monitored by absorbance at 280 nm and 320 nm and fluorescence emission at 400 nm 
following excitation at 310 nm. AA and PABA peaks were assigned based on a comparison of retention 
times with those of authentic chemical standards. 
Bacillus subtilis growth experiments 
The bspabA, bspabB, bstrpE, sttrpEx, and smtrpEx genes were cloned into the pDG148 vector following 
the ligation-independent cloning protocol from (Joseph et al., 2001), using standard PCR reaction 
conditions and the plasmids and oligonucleotides listed in the table below. Electrocompetent cells of the 
prototrophic B. subtilis strain SB491 (DSM-No. 6397) were prepared as follows: a 50 mL over-night 
culture of B. subtilis SB491 in Luria broth (LB) medium was used to inoculate 1 L LB medium 
supplemented with 0.5 M sorbitol. Cells were grown at 37 °C to an OD600 of 1.0, harvested by 
centrifugation (4000 g, 4 °C) and washed four times with 250 mL poration medium (10% v/v glycerol, 
9.1% w/v mannitol, 0.5 M sorbitol). The cells were finally resuspended in 5 mL poration medium and 
stored at -80 °C. Before electroporation, 100 µL frozen cells were thawed on ice and incubated with 100 ng 
of plasmid DNA for five minutes. Cell were electroporated at a voltage of 2500 V, immediately 
resuspended in 900 µL regeneration medium (LB medium with 7% w/v mannitol and 0.5 M sorbitol), 
cured at 37 °C for three hours and plated on LB agar plates containing 50 µg/mL kanamycin. Individual 
colonies were picked and the presence of the pDG148 plasmids containing the respective genes was 
checked in standard colony PCR reactions using the oligonucleotides listed in the table below. Positive 
colonies were used to inoculate 20 mL LB medium containing 50 µg/mL kanamycin. After growth over 
night cells were harvested and plasmid DNA was isolated and sequenced using the colony PCR primers to 
verify the presence of the correct plasmids and to exclude inadvertent mutations in the inserted genes. 
Correct clones were stored as glycerin stocks at -80 °C. 
Growth experiments with pDG148, pDG148_bspabA, pDG148_bspabB, pDG148_bstrpE, 
pDG148_sttrpEx, and pDG148_smtrpEx were performed on Spizizen’s minimal medium (SMM) agar 
plates that were prepared as follows: 2 g (NH4)SO4, 14 g K2HPO4, 6 g KH2PO4, 1 g Na3-citrate dihydrate, 
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and 0.2 g MgSO4 heptahydrate were dissolved in 700 mL water and autoclaved. After sterilization the 
solution was mixed with 300 mL of sterile 1.5% agar solution (USP grade, MP Biomedicals). 
Subsequently, L-arginine, L-proline, L-glutamic acid, and L-glutamine were added to a final concentration 
of 1 mg/mL each, glucose to a final concentration of 0.5% (w/v), and kanamycin to a final concentration of 
50 µg/mL. All stock solutions were prepared separately and sterilized by ultrafiltration. If necessary, 
isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to a final concentration of 2 mM and para-
aminobenzoate and folic acid to a final concentration of 10 µg/mL (Wegkamp et al., 2010). 
For the growth experiments an identical procedure was followed in all cases: Glycerin stocks of 
B. subtilis SB491 transformed with the different pDG148 plasmids were streaked out on LB agar plates and 
incubated over night at 37 °C. Single colonies were then used to inoculate 50 mL of LB medium containing 
50 µg/mL kanamycin, which was incubated at 37 °C over night. This overnight culture was then used to 
inoculate 50 mL of LB medium containing 50 µg/mL kanamycin (to an optical density of 0.1 at 600 nm), 
which was incubated at 37 °C until an optical density of 1 at 600 nm was reached. Subsequently, 1 mL cell 
suspension was collected by centrifugation (4000 g, 4 °C) and washed three times with 1% sterile sodium 
chloride solution and finally dissolved in 1 mL of the sodium chloride solution to adjust the optical density 
to 1 mL-1. Finally, 1:104 and 1:105 dilutions of the cell suspension in 1% sodium chloride were plated on 
SMM-agar plates and incubated at 37 °C. After 48 hours the average colony size of a plate was determined 
from high-quality tiff images using ImageJ (Schneider et al., 2012). 
 
Plasmid templates and oligonucleotides used for ligation-independent cloning of genes into the 
pDG148 vector. 
Adapter sequences for integration into the StuI-digested pDG148 vector are in lowercase. Regions 
complementary to the genes specified in the first column are in uppercase. 
Gene Template plasmid Primer (5ʹ?3ʹ) 
bspabA pET21a_bspabA LIC_fo aaggaggaagcaggtATGATTTTAATGATTGATAACTACGATTC LIC_re gacacgcacgaggtTCACGCAATAACTTCCTTGCG 
bspabB pET21a_bspabB LIC_fo aaggaggaagcaggtATGGCACAACGCAGACC LIC_re gacacgcacgaggtTCATCTAATTTTTGTCTCTTCTTCGC 
bstrpE pET21a_bstrpE LIC_fo aaggaggaagcaggtATGAATTTCCAATCAAACATTTCCG LIC_re gacacgcacgaggtTCAACGCACAATTGTAGAAATCTGTTC 
sttrpEx pET21a_sttrpEx LIC_fo aaggaggaagcaggtATGCAAACACCAAAACCCAC LIC_re gacacgcacgaggtTCAGAAGGTCTCCTGTGCATGATG 
smtrpEx pET21a_smtrpEx LIC_fo aaggaggaagcaggtATGATGAACACCAAACCACAAC LIC_re gacacgcacgaggtTCAGAACACCTCCTTGGCATG 
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Supplementary Tables 
 
Table S1. Related to Figure 1: Statistics of the survey for interface add-ons in bacterial, heteromeric 
protein complexes. 
 Stoichiometries  
 AB A2B2 A3B3 A4B4 A6B6 ABC A2B2C2 Σ 
Heteromeric complex structures 705 424 112 68 89 197 144 1739 
Representative complexes 426 209 47 36 30 102 68 918 
Reference complexes 118 93 15 12 7 28 32 305 
         
Survey of insertions in subunits of the reference complexes (SU) 
SU with insertions 42 43 5 2 5 8 12 117 
 insertions 69 70 7 6 5 14 38 209 
SU with ≥ 1 IFR in insertion 30 37 2 2 4 8 12 95 
 insertions 45 56 3 4 4 14 36 162 
SU with IFRs with ∆∆????→???
???????
 < -2 kcal/mol 14 24 1 1 2 4 7 53 
 insertions 16 28 1 1 2 7 11 66 
SU with interface-addons 5 13 0 1 1 2 3 26 
 interface add-ons 7 15 0 1 1 2 4 30 
         
Survey of insertions in InterPro homologs (H) of SU 
H with insertions 75 68 12 10 7 22 18 212 
 insertions 134 132 19 18 15 38 36 392 
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Table S2. Related to Figure 1: List of reference structures with interface add-ons. The 30 interface 
add-ons are grouped by subunit stoichiometry of the corresponding complex structure. For each interface 
add-on, the chain in which it is located and the start and end positions (according to the corresponding 
FASTA sequence) are given as well as the greatest mCSM-predicted protein-protein affinity change. 
Stoichiometry PDB-ID Chain Location of interface add-on lowest ∆∆????
??????? / ????
???
 
AB 1H32 B 97-114 -2.671 
AB 3NY7 A 515-525 -3.545 
AB 3OCD B 29-70 -2.616 
AB 3OCD B 108-123 -2.718 
AB 4HSR B 353-371 -3.048 
AB 4HSR B 427-436 -2.828 
AB 4YLF A 246-267 -2.734 
A2B2 1I1Q A 71-121 -2.369 
A2B2 1JJC A 154-169 -2.063 
A2B2 1WDK C 186-207 -2.069 
A2B2 3CDK A 216-228 -2.936 
A2B2 3NUH B 566-730 -2.489 
A2B2 3PVT A 243-278 -2.044 
A2B2 3RPF A 122-133 -2.065 
A2B2 3WWN A 48-59 -2.138 
A2B2 3WWN A 67-79 -2.325 
A2B2 4CHG A 9-20 -3.575 
A2B2 4CHG A 43-49 -2.315 
A2B2 4LW4 A 252-265 -2.136 
A2B2 4ML0 A 51-81 -3.434 
A2B2 4N6E B 29-57 -3.132 
A2B2 4P69 C 171-194 -2.473 
A4B4 3TND A 19-32 -2.727 
A6B6 3J3R A 405-463 -4.587 
ABC 1GX7 E 50-71 -2.966 
ABC 3IP4 A 299-374 -3.033 
A2B2C2 1E7P A 114-133 -2.403 
A2B2C2 1E7P C 103-124 -2.186 
A2B2C2 1EEX B 177-202 -2.136 
A2B2C2 1MHY B 55-90 -4.342 
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Table S3. Related to Figure 1: Examples of reference structures that contain interface add-ons (IAs). 
The subunits possessing or lacking interface add-ons are shown in cartoon representation; these subunits 
are homologs and belong to the same InterPro family. Interface add-ons are colored in shades of green, the 
position of a missing interface add-on is indicated by a reddish sphere. The interaction partners are shown 
in surface representation. All structures and protein names are from the Protein Data Bank. 
Reference structures 1h32, 3ocd 
 
1h32 3ocd 
Rhodovulum sulfidophilum 
SoxAX c-type cytochrome 
Starkeya novella 
SoxAX c-type cytochrome 
Heterodimeric c-type cytochrome complexes involved in the oxidation of thiosulfate (Friedrich et al., 2001). 
IA present in 18% of IPR030999 sequences 
 (mainly Rhodobacterales) 
IA present in 20% of IPR030999 sequences 
 (mainly α- and β-Proteobacteria) 
 
 
 
IA present in 20% of IPR030999 sequences 
 (mainly Proteobacteria) 
 
The IA (green) consitutes a major structural difference of 
SoxX to other members of the cytochrome c superfamily 
(Bamford et al., 2002). The IA is missing in SoxX from 
Chlorobium tepidum, Aquifex aeolicus, and Rhodo-
pseudomonas palustris. These organisms do not contain 
permanent SoxAX complexes (Bamford et al., 2002). 
R. sulfidophilum SoxX lacks the IA found in the homolog from 
Starkeya novella (panel B), the corresponding position is 
indicated by a magenta sphere. 
 
Misses the IA observed in 1h32 (position indicated by a dark 
red sphere) but contains an alternative IA at a different location 
(light green) that contributes to the interaction between SoxA 
and SoxX (Kilmartin et al., 2011). Also contains a IA at the N-
terminus that wraps around the SoxA subunit. 
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Reference structure 4hsr 
 
4hsr 1ghd 
Pseudomonas N176 
Glutaryl-7-aminocephalosporanic acid acylase 
Pseudomonas sp. 130 
Glutaryl-7-aminocephalosporanic acid acylase 
Catalyzes the deacylation of glutaryl-7-aminocephalosporanic acid to 7-aminocephalosporanic acid (Kim et al., 1999). 
IA present in 0.4% of the IPR002692 sequences 
 (mainly β- and γ-Proteobacteria) 
 
IA present in 1.7% of the IPR002692 sequences 
 (mainly α- and γ-Proteobacteria) 
 
 
The class-III glutaryl-7-aminocephalosporanic acid acyclase 
(GCA) from Pseudomonas N176 contains two IAs (green and 
light green) in its β-subunit that have been desribed as unique to 
class-III GCA enzymes (Golden et al., 2013). 
The class-I GCA from Pseudomonas sp. 130 lacks the two 
IAs found in its class-III homolog (red and magenta spheres) 
and the interface between the α-and β-chains is less extended. 
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Reference Structure 1i1q 
 
1i1q 4pen 1qdl 
Salmonella typhimurium 
Anthranilate synthase 
Mycobacterium tuberculosis 
Anthranilate synthase 
Sulfolobus solfataricus 
Anthranilate synthase 
Catalyze the conversion of chorismate to anthranilate in the committed step of tryptophan biosynthesis (Zalkin, 1973). 
IA present in 6% of the IPR019999 
sequences (mainly γ-Proteobacteria) 
  
 
  
This large IA folds into α-helices, β-strands, 
and loops that are, for example, not present 
in anthranilate synthases from 
M. tuberculosis and S. solfataricus. It 
significantly extends the contact area 
between the TrpE and TrpG protomers. 
Lacks the IA found in the 
anthranilate synthase from 
S. typhimurium (panel A). 
Lacks the IA found in the anthranilate 
synthase from S. typhimurium (panel A). 
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Reference Structure 1jjc 
 
1jjc 2rhq 
Thermus thermophilus 
Phenylalanyl-tRNA-synthetases 
Staphylococcus haemolyticus 
Phenylalanyl-tRNA-synthetases 
Class II tRNA-synthetases that catalyze the aminoacylation of tRNAPhe (Meinnel et al., 1995). 
IA present in 1% of the IPR004529 sequences 
 (mainly the Deinococcus-Thermus group) 
 
 
 
The IA is located at the interface between the PheS and PheT 
protomers. 
The IA from T. thermophilus is missing in this homolog and 
also in related PheS enzymes from Gram-positive bacteria like 
Staphylococcus haemolyticus, Streptococcus mutans, Mora-
xella catarrhalis, and Haemophilus influenza (Evdokimov et 
al., 2008). 
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Reference Structure 1wdk 
 
1wdk 
Pseudomonas fragi 
1ulq 
Thermus thermophilus 
Fatty acid β-oxidation complex including 3-ketoacyl-CoA 
thiolase subunits (FadA) 
3-ketoadipyl-CoA thiolase 
Catalyze the degradation of 3-ketoacyl-CoA to acetyl-CoA and a shorter acyl-CoA as well as the reverse condensation reaction 
(Haapalainen et al., 2006). 
IA present in 17% of the IPR002155 sequences 
 (mainly γ-Proteobacteria) 
IA present in 1% of the IPR002155 sequence 
 (mainly α-, β-, and γ-Proteobacteria) 
 
 
The IA is located at the interface between the 3-ketoacyl-CoA-
thiolase subunit (FadA) and the FadB subunit which contains the 
2-enoyl-CoA-hydratase/isomerase and L-3-hydroxyacyl-CoA-
dehydrogenase activities. The IA is important for anchoring the 
FadB subunit to the FadA subunit (Ishikawa et al., 2004). The IA 
is for example missing in the FadA homolog “nonspecific lipid-
transfer protein” from Halorubrum distributum. FadA does not 
contain the IA found in tetrameric thiolases (indicated by 
magenta spheres, cf. panel B).  
Contains an IA (pale green), which is needed for 
tetramerization (Harijan et al., 2013). Also contains the IA 
(green) found in the thiolase from P. fragi (panel A). 
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Reference Structure 3wwn 
 
3wwn 2j5v 
Thermus thermophilus 
Acetyl-glutamate/acetyl-aminoadipate kinase 
Escherichia coli 
Glutamate-5-kinase 
Phosphorylate acetyl-glutamate and acetyl-aminoadipate in arginine and lysine biosynthesis and glutamate in proline 
biosynthesis, respectively (Miyazaki et al., 2001). 
IA present in 1% of the IPR001057 sequences 
 (mainly the Deinococcus-Thermus group) 
 
 
 
The LysZ IA is part of its interface with LysW, which acts as a carrier 
protein for the phosphorylated LysZ products (Yoshida et al., 2015). The 
IA distinguishes LysZ from other kinase homologs; a LysZ-LysW 
system is mainly found in thermophilic bacteria and archaea (Yoshida et 
al., 2015). 
The glutamate-5-kinase (ProB) comprises two or four 
identical protomers that lack the LysZ IA. Here the 
homodimer is shown. ProB is part of proline 
biosynthesis and phosphorylates only L-glutamate, 
whereas LysZ phosphorylates L-acetyl-glutamate and 
L-acetyl-aminoadipate. The LysZ IA (panel A) is 
located in the ProB interface (red sphere) required for 
the formation of homotetramers (Marco-Marin et al., 
2007). 
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Reference Structure 4lw4 
 
4lw4 3lvk 
Escherichia coli 
Cysteine desulfurase 
Escherichia coli 
Cysteine desulfurase 
Catalyze the transfer of sulphur from cysteine to an acceptor substrate (Mihara and Esaki, 2002). 
IA present in 1% of the IPR016454 sequences 
 (mainly in Firmicutes) 
  
 
 
E. coli CsdA contains an IA comprising two β-strands, which is not 
found in its homolog IscS from E. coli (panel B). The IA is located 
at the interface to the sulfur-acceptor subunit CsdE. This interface is 
different to the one utilized for interaction between IscS and TusA in 
the homologous complex (Kim and Park, 2013). CsdA accepts both 
L-cysteine and L-selenocystein as substrates and is part of the Csd 
(cysteine sulfinite desulfinase) system, whose implications are not 
completely clear yet (Loiseau et al., 2005).  
E. coli IscS lacks the IA found in its CsdA homolog 
(panel A). IscS binds its interaction partner TusA in a 
different mode compared to the CsdA-CsdE interaction. 
The IscS-TusA complex is part of the Isc system, which 
is important for Fe-S-cluster biogenesis in E. coli 
(Mihara and Esaki, 2002). 
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Reference Structure 4p69 
 
Reference structure 4p69 1hqs 1cm7 
Escherichia coli 
Isocitrate dehydrogenase 
Bacillus subtilis 
Isocitrate dehydrogenase 
Escherichia coli 
Isopropylmalate 
dehydrogenase 
Isocitrate dehydrogenase catalyzes the converion of isocitrate to α-ketoglutarate in the Krebs cycle (Dean and Koshland, 1993). 
Isopropylmalate dehydrogenase catalyzes a similar reaction (decarboxylation of isopropylmalate to oxomethylvalerate) in leucine 
biosynthesis (Parsons and Burns, 1969). 
IA present in 15% of the IPR001804 sequences  
 (mainly in Proteobacteria, Firmicutes, and  
 Bacteroidetes) 
 
IA present in 5% of IPR001804 seq. 
 (mainly in Firmicutes) 
 
 
 
The isocitrate dehydrogenase from E. coli (IcdA) 
contains an IA that folds into a short α-helix (green). 
This helix and its surroundings have been desribed as a 
clasp domain that mediates interactions between the two 
IcdA monomers (Vinekar et al., 2012). It also contributes 
to the interface to the isocitrate dehydrogenase 
kinase/phosphatase AceK, which phoshporylates and 
dephosphorylates IcdA to regulate isocitrate flux 
between the Krebs cycle (LaPorte and Koshland, 1982) 
and the glyoxylate bypass (LaPorte, 1993). This helix is 
also present in the homologous enzyme CitC from 
B. subtilis (cf. panel B). Our analysis indicated the 
absence of the large insertion in IcdA that is found in 
CitC (magenta spheres; light green insertion in panel B). 
The absence of this insertion has been discussed as 
important for interactions with AceK (Yates et al., 2011). 
The isocitrate dehydrogenase CitC 
from B. subtilis cotaints the same 
clasp-domain helix as IcdA (dark 
green). Additionally it contains a 
relatively large insertion comprising 
two helices (light green) that prevents 
interaction with AceK (Singh et al., 
2002). 
The isopropylmalate dehy-
drogenase from E: coli 
lacks both insertions found 
in IcdA (red spheres) and 
CitC (magenta spheres). No 
interactions with kinase-
phosphates like AceK has 
been described for LeuB.  
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Table S4. Related to Figure 4A: Fractions of TrpEx- and TrpE-species that possess a certain pattern of co-
occurring synthases (TrpEx, TrpE, PabB) and glutaminases (TrpG and PabA). 
TrpEx-species 
Fraction co-occurrences Comment 
84% TrpEx + TrpG 
PabB + PabA 
Typical TrpEx-species with two separate glutaminases for the two 
synthases TrpEx and PabB. 
16% various patterns These TrpEx-species mostly contain various combinations of multiple 
copies of one or more of the synthases and glutaminases. The situation is 
unclear for some species. This is presumably due to incompletely 
sequenced genomes or a symbiotic lifestyle, which lead to the loss of one 
or the other protein. 
TrpE-species 
Fraction co-occurrences Comment 
59% TrpE/PabB + PabA 
 
Typical TrpE-species with only a single PabA glutaminase for the two 
synthases TrpE and PabB. 
23% TrpE + PabA TrpE-species that lack PabB. Among these species are many Archaea that 
lack the classical pab genes for folate biosynthesis. Incompletely 
sequenced TrpE-species may also contribute to this fraction. 
18% various patterns These TrpE-species contain various combinations of TrpE- and PabA-
homologs or lack one or the other proteins; again, most likely due to 
incomplete genome sequences. Some of these species contain additional 
copies of one or the other protein that may have developed specialized 
roles in supporting metabolism. 
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Table S5. Related to Figure 5A: SEC-SLS experiments for determining complex formation. The 
apparent molecular weight (MWapp) was determined from refractive index and right-angle light scattering 
measurements. The calculated molecular weight (MWcalc) derives from the amino-acid sequence and was 
determined via Expasy ProtParam. Abbreviations: n.i.: peak(s) not identifiable, e. g. when proteins could 
not be separated with S75 or S200 SEC-columns. Table continues over two pages. 
Synthase Glutaminase MWapp / kDa MWcalc / kDa Percentage Error 
Deduced oligomeric 
state 
stTrpEx --- 58.2 59.8 3% monomer 
ecTrpEx --- 58.9 58.6 1% monomer 
smTrpEx --- 60.9 58.2 5% monomer 
ppTrpE --- 117.1 110.5 6% dimer 
ssTrpE --- 48.9 48.7 <1% monomer 
ppPabB --- 55.9 50.2 11% monomer 
stPabB --- 56.1 52.0 8% monomer 
ecPabB --- 50.1 52.3 4% monomer 
bsPabB --- 59.8 54.3 10% monomer 
--- stTrpG 21.2 21.9 3% monomer 
--- ecTrpGD 58.5 57.9 1% monomer 
--- ppPabA 23.1 22.7 2% monomer 
--- smPabA 23.1 22.2 4% monomer 
--- ecPabA 23.5 21.8 8% monomer 
--- bsPabA 23.7 22.8 4% monomer 
stTrpEx stTrpG 156.9 160.1 2% Ex2:G2 Tetramer 
stTrpEx ecTrpGD 427.5 464.3 8% Ex4:GD4 Octamer 
stTrpEx ppPabA 
--- 
59.4 
22.1 
--- 
58.2 
22.7 
--- 
2% 
3% 
no complex 
stTrpEx monomer 
ppPabA monomer 
stTrpEx smPabA 
--- 
57.4 
22.1 
--- 
58.2 
22.3 
--- 
1% 
1% 
no complex 
stTpEx monomer 
smPabA monomer 
stTrpEx ecPabA 
--- 
57.5 
19.5 
--- 
58.2 
21.8 
--- 
1% 
11% 
no complex 
stTrpEx monomer 
ecPabA monomer 
stTrpEx bsPabA 
--- 
56.6 
20.8 
--- 
58.2 
22.8 
--- 
3% 
8% 
no complex 
stTrpEx monomer 
bsPabA monomer 
ecTrpEx stTrpG 158.6 160.9 1% Ex2:G2 Tetramer 
ecTrpEx ecTrpGD 424.8 466.0 9% Ex4:GD4 Ocatmer 
ecTrpEx ppPabA 
--- 
55.8 
20.7 
--- 
58.6 
22.7 
--- 
5% 
9% 
no complex 
ecTrpEx monomer 
ppPabA monomer 
ecTrpEx smPabA 
--- 
58.8 
22.2 
--- 
58.6 
22.3 
--- 
<1% 
1% 
no complex 
ecTpEx monomer 
smPabA monomer 
ecTrpEx ecPabA 
--- 
61.9 
25.1 
--- 
58.6 
21.8 
--- 
6% 
15% 
no complex 
ecTrpEx monomer 
ecPabA monomer 
ecTrpEx bsPabA 
--- 
60.9 
23.3 
--- 
58.6 
22.8 
--- 
3% 
2% 
no complex 
ecTrpEx monomer 
bsPabA monomer 
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Synthase Glutaminase MWapp / kDa MWcalc / kDa Percentage Error 
Deduced oligomeric 
state 
smTrpEx stTrpG 155.1 160.2 3% Ex2:G2 Tetramer 
smTrpEx ecTrpGD 238.6 232.3 3% Ex2:GD2 Tetramer 
smTrpEx ppPabA 
--- 
61.8 
23.2 
--- 
58.2 
22.7 
--- 
6% 
2% 
no complex 
smTrpEx monomer 
ppPabA monomer 
smTrpEx smPabA 
--- 
64.2 
23.4 
--- 
58.2 
22.3 
--- 
10% 
5% 
no complex 
smTpEx monomer 
smPabA monomer 
smTrpEx ecPabA 
--- 
63.3 
21.3 
--- 
58.2 
21.8 
--- 
9% 
3% 
no complex 
smTrpEx monomer 
ecPabA monomer 
smTrpEx bsPabA 
--- 
64.2 
26.2 
--- 
58.2 
22.8 
--- 
10% 
15% 
no complex 
smTrpEx monomer 
bsPabA monomer 
ppTrpE stTrpG 
--- 
121.8 
24.7 
--- 
110.8 
21.9 
--- 
10% 
13% 
no complex 
ppTrpE dimer 
stTrpG monomer 
ppTrpE ecTrpGD --- 
n.i. 
--- 
--- 
--- 
--- 
no complex 
--- 
ppTrpE ppPabA 156.7 156.3 <1% E2:A2 tetramer 
ppTrpE smPabA 157.6 155.4 1% E2:A2 tetramer 
ppTrpE ecPabA 149.0 154.4 4% E2:A2 tetramer 
ppTrpE bsPabA 143.6 156.3 8% E2:A2 tetramer 
ssTrpE stTrpG 
--- 
54.9 
42.8 
--- 
48.7 
21.9 
--- 
13% 
13% 
no complex 
ssTrpE monomer 
stTrpG monomer 
ssTrpE ecTrpGD 
--- 
50.9 
66.1 
--- 
48.7 
57.9 
--- 
4% 
14% 
no complex 
ssTrpE monomer 
ecTrpGD monomer 
ssTrpE ppPabA 72.8 71.5 2% E:A dimer 
ssTrpE smPabA 72.6 71.0 2% E:A dimer 
ssTrpE ecPabA 71.1 70.5 1% E:A dimer 
ssTrpE bsPabA 70.5 71.5 1% E:A dimer 
ppPabB stTrpG 
--- 
50.1 
21.0 
--- 
50.2 
21.9 
--- 
<1% 
4% 
no complex 
ppPabB monomer 
stTrpG monomer 
ppPabB ecTrpGD 
--- 
51.2 
59.4 
--- 
50.2 
57.9 
--- 
2% 
2% 
no complex 
ppPabB monomer 
ecTrpGD monomer 
ppPabB ppPabA 67.0 72.9 8% B:A dimer 
ppPabB smPabA 71.9 72.5 1% B:A dimer 
ppPabB ecPabA 74.1 72.0 3% B:A dimer 
ppPabB bsPabA 60.5 73.0 17% B:A dimer 
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Synthase Glutaminase MWapp / kDa MWcalc / kDa Percentage Error 
Deduced oligomeric 
state 
stPabB stTrpG 
--- 
62.4 
21.2 
--- 
52.0 
21.9 
--- 
20% 
3% 
no complex 
stPabB monomer 
stTrpG monomer 
stPabB ecTrpGD 
--- 
n.i. 
--- 
--- 
--- 
--- 
no complex 
--- 
stPabB ppPabA 66.1 74.8 12% B:A dimer 
stPabB smPabA 69.6 74.3 6% B:A dimer 
stPabB ecPabA 67.6 73.8 8% B:A dimer 
stPabB bsPabA 62.1 74.8 17% B:A dimer 
ecPabB stTrpG 
--- 
51.7 
21.0 
--- 
52.0 
21.9 
--- 
1% 
4% 
no complex 
ecPabB monomer 
stTrpG monomer 
ecPabB ecTrpGD 
--- 
52.5 
n.i. 
--- 
52.0 
--- 
--- 
1% 
--- 
no complex 
ecPabB monomer 
--- 
ecPabB ppPabA 59.4 74.8 21% B:A dimer  
ecPabB smPabA 70.6 74.3 5% B:A dimer 
ecPabB ecPabA 66.4 73.9 10% B:A dimer 
ecPabB bsPabA 63.6 74.8 15% B:A dimer 
bsPabB stTrpG 
--- 
54.1 
21.0 
--- 
54.3 
21.9 
--- 
<1% 
4% 
no complex 
bsPabB monomer 
stTrpG monomer 
bsPabB ecTrpGD 
--- 
n.i. 
--- 
--- 
--- 
--- 
no complex 
--- 
bsPabB ppPabA 79.5 77.1 4% B:A dimer 
bsPabB smPabA 72.3 76.6 6% B:A dimer 
bsPabB ecPabA 69.0 76.2 9% B:A dimer 
bsPabB bsPabA 74.8 77.1 3% B:A dimer 
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Table S6. Related to Figure 5A: Native mass spectrometry experiments for determining complex 
formation between various synthases and glutaminases. The apparent molecular weight (MWapp) was 
determined from m/z values and is given with standard deviations. The calculated molecular weight 
(MWcalc) derives from the amino-acid sequence and was determined via Expasy ProtParam. Obtained 
molecular weights are consistent with the expected molecular weights. 
Synthase Glutaminase MWapp / Da MWcalc / kDa Percentage Error 
Deduced oligomeric 
state 
stTrpEx --- 58235 ± 78 116768 ± 102 
58153 
116306 
1% 
<1% 
monomer 
dimer 
ecTrpEx --- 58956  ± 116 118655 ± 323 
58559 
117118 
<1% 
1% 
monomer 
dimer 
smTrpEx --- 58331 ± 61 116758 ± 59 
58229 
116458 
<1% 
<1% 
monomer 
dimer 
ppTrpE --- 112126 ± 36 110482 1% dimer 
ppPabB --- 50339 ± 15 50205 <1% monomer 
ecPabB --- 52470 ± 41 52035 <1% monomer 
--- stTrpG 21787 ± 0 43599 ± 21 
21915 
43830 
<1% 
<1% 
monomer 
dimer 
--- ecTrpGD 58041 ± 34 57935 <1% monomer 
--- ppPabA 22727 ± 0 22734 <1% monomer 
--- ecPabA 21866 ± 22 43904 ± 78 
21837 
43674 
<1% 
<1% 
monomer 
dimer 
stTrpEx stTrpG 122026 ± 330 160727 ± 29 
116306 
160136 
5% 
<1% 
Ex2 dimer 
Ex2:G2 tetramer 
stTrpEx ecTrpGD 
117527 ± 157 
176069 ± 376 
234252 ± 286 
116306 
174241 
232176 
1% 
1% 
1% 
Ex2 dimer 
Ex2:GD trimer 
Ex2:GD2 tetramer 
stTrpEx ppPabA --- --- --- no complex 
ecTrpEx ecTrpGD 
118202 ± 75 
184066 ± 232 
235458 ± 36 
117118 
175053 
232988 
1% 
5% 
1% 
Ex2 dimer 
Ex2:GD trimer 
Ex2:GD2 tetramer 
smTrpEx ecTrpGD 
116888 ± 124 
175649 ± 107 
234467 ± 45 
116458 
174393 
232916 
<1% 
<1% 
<1% 
Ex2 dimer 
Ex2:GD trimer 
Ex2:GD2 tetramer 
ppTrpE stTrpG 111771 ± 72 133650 ± 36 
110482 
132397 
1% 
<1% 
E2 dimer 
E2:G trimer 
ppTrpE ppPabA 157468 ± 176 155950 <1% E2:A2 tetramer  
ppPabB ppPabA 73482 ± 44 72939 <1% B:A dimer 
ecPabB ecPabA 74615 ± 150 73872 1% B:A dimer 
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Table S7. Related to Figure 5B: Kinetic parameters of synthases in complex with different 
glutaminases for the glutamine-dependent formation of anthranilate (for TrpEx and TrpE) and 
aminodeoxychorismate (for PabB). Values were determined at 25 °C and in the presence of 20 mM 
glutamine. Each combination was assayed at three different chorismate concentrations (90, 100, and 
110 µM) and average values with standard deviations are listed. Combinations were assigned not active 
(n.a.), if the initial rates of anthranilate or aminodeoxychorismate formation were at least 240-fold lower 
(for TrpEx/TrpE) or 20-fold lower (for PabB) as the average initial rates of corresponding functional 
complexes. In these cases, no catalytic efficiency kcat/KMCH could be determined (n.d.). Table continues to 
the next page. 
Synthase Glutaminase kcat /s-1 KMCH /µM kcat/KMCH /M-1s-1 
stTrpEx stTrpG 3.7 ± 0.3 11.3 ± 2.9 3.5 ·  105 
stTrpEx ecTrpGD 3.6 ± 0.5 10.5 ± 2.3 3.6 ·  105 
stTrpEx ppPabA n.a. n.a. n.d. 
stTrpEx smPabA n.a. n.a. n.d. 
stTrpEx ecPabA n.a. n.a. n.d. 
stTrpEx bsPabA n.a. n.a. n.d. 
ecTrpEx stTrpG 3.8 ± 0.8 12.0 ± 2.6 3.3 ·  105 
ecTrpEx ecTrpGD 3.7 ± 0.1 10.0 ± 2.8 3.9 ·  105 
ecTrpEx ppPabA n.a. n.a. n.d. 
ecTrpEx smPabA n.a. n.a. n.d. 
ecTrpEx ecPabA n.a. n.a. n.d. 
ecTrpEx bsPabA n.a. n.a. n.d. 
smTrpEx stTrpG 5.1 ± 0.2 28.0 ± 3.6 1.9 ·  105 
smTrpEx ecTrpGD 4.3 ± 0.2 20.0 ± 5.0 2.2 ·  105 
smTrpEx ppPabA n.a. n.a. n.d. 
smTrpEx smPabA n.a. n.a. n.d. 
smTrpEx ecPabA n.a. n.a. n.d. 
smTrpEx bsPabA n.a. n.a. n.d. 
ppTrpE stTrpG n.a. n.a. n.d. 
ppTrpE ecTrpGD n.a. n.a. n.d. 
ppTrpE ppPabA 3.4 ± 0.3 6.3 ± 1.5 5.4 ·  105 
ppTrpE smPabA 3.4 ± 0.8 7.3 ± 1.2 4.6 ·  105 
ppTrpE ecPabA 2.7 ± 0.03 2.1 ± 0.2 1.3 ·  106 
ppTrpE bsPabA 0.8 ± 0.1 5.7 ± 1.0 1.4 ·  105 
ssTrpE stTrpG n.a. n.a. n.d. 
ssTrpE ecTrpGD 0.1 ± 0.01 16.0 ± 2.1 4.4 ·  103 
ssTrpE ppPabA 0.1 ± 0.01 11.6 ± 5.5 8.7 ·  103 
ssTrpE smPabA 0.2 ± 0.01 10.9 ± 0.5 1.6 ·  104 
ssTrpE ecPabA 0.2 ± 0.01 9.8 ± 2.3 1.7 ·  104 
ssTrpE bsPabA 0.3 ± 0.01 8.6 ± 2.7 3.6 ·  104 
ppPabB stTrpG n.a. n.a. n.d. 
ppPabB ecTrpGD n.a. n.a. n.d. 
ppPabB ppPabA 0.2 ± 0.02 33.3 ± 2.3 6.7 ·  103 
ppPabB smPabA 0.2 ± 0.04 35.3 ± 11.9 5.7 ·  103 
ppPabB ecPabA 0.1 ± 0.02 21.9 ± 3.9 5.8 ·  103 
ppPabB bsPabA 0.1 ± 0.01 76.7 ± 21.0 9.9 ·  102 
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Synthase Glutaminase kcat /s-1 KMCH /µM kcat/KMCH /M-1s-1 
stPabB stTrpG n.a. n.a. n.d. 
stPabB ecTrpGD n.a. n.a. n.d. 
stPabB ppPabA 0.6 ± 0.03 35.9 ± 1.5 1.6 ·  104 
stPabB smPabA 0.8 ± 0.1 44.5 ± 5.9 1.9 ·  104 
stPabB ecPabA 0.7 ± 0.1 34.3 ± 3.0 2.0 ·  104 
stPabB bsPabA 0.1 ± 0.01 43.4 ± 2.1 3.0 ·  103 
ecPabB stTrpG n.a. n.a. n.d. 
ecPabB ecTrpGD n.a. n.a. n.d. 
ecPabB ppPabA 0.7 ± 0.1 24.8 ± 3.4 2.8 ·  104 
ecPabB smPabA 0.7 ± 0.1 24.3 ± 2.8 2.8 ·  104 
ecPabB ecPabA 0.6 ± 0.1 20.9 ± 5.1 2.7 ·  104 
ecPabB bsPabA 0.1 ± 0.01 15.6 ± 3.4 5.2 ·  103 
bsPabB stTrpG n.a. n.a. n.d. 
bsPabB ecTrpGD n.a. n.a. n.d. 
bsPabB ppPabA n.a. n.a. n.d. 
bsPabB smPabA n.a. n.a. n.d. 
bsPabB ecPabA n.a. n.a. n.d. 
bsPabB bsPabA n.a. n.a. n.d. 
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Table S8. Related to Figure 5C: Apparent turnover rates (kapp) of various glutaminases for the 
hydrolysis of glutamine at 25 °C and in the presence of 4 mM glutamine. Each glutaminase was 
assayed alone and in the presence of the listed synthases. The apparent turnover rates are average values of 
at least three independent measurements and are listed with standard deviations. The stimulation factors 
(fstim) were calculated from kapp of a glutaminase in the presence of a given synthase and kapp in the absence 
of any synthase. Note that the latter was determined separately for each of the listed combinations. 
Abbreviations: n.a.: not active (kapp smaller than 0.001 s-1); n.d.: not determined. Table continues to the next 
page. 
Glutaminase Synthase kapp /s-1 fstim 
stTrpG --- n.a. --- 
stTrpG stTrpEx 0.065 ± 0.004 n.d. 
stTrpG ecTrpEx 0.073 ± 0.003 n.d. 
stTrpG smTrpEx 0.058 ± 0.005 n.d. 
stTrpG ppTrpE 0.024 ± 0.007 n.d. 
stTrpG ssTrpE 0.019 ± 0.001 n.d. 
stTrpG ppPabB n.a. n.d. 
stTrpG stPabB 0.002 ± 0.0001 n.d. 
stTrpG ecPabB 0.001 ± 0.0001 n.d. 
stTrpG bsPabB n.a. n.d. 
ecTrpGD --- n.a. --- 
ecTrpGD stTrpEx 0.065 ± 0.007 n.d. 
ecTrpGD ecTrpEx 0.061 ± 0.005 n.d. 
ecTrpGD smTrpEx 0.010 ± 0.002 n.d. 
ecTrpGD ppTrpE 0.005 ± 0.001 n.d. 
ecTrpGD ssTrpE 0.019 ± 0.001 n.d. 
ecTrpGD ppPabB n.a. n.d. 
ecTrpGD stPabB n.a. n.d. 
ecTrpGD ecPabB n.a. n.d. 
ecTrpGD bsPabB n.a. n.d. 
ppPabA --- 0.015 ± 0.004 --- 
ppPabA stTrpEx 0.012 ± 0.001 0.9 ± 0.1 
ppPabA ecTrpEx 0.008 ± 0.001 0.9 ± 0.1 
ppPabA smTrpEx 0.014 ± 0.001 1.0 ± 0.1 
ppPabA ppTrpE 0.048 ± 0.001 4.7 ± 0.8 
ppPabA ssTrpE 0.337 ± 0.012 20.8 ± 0.6 
ppPabA ppPabB 0.061 ± 0.005 5.0 ± 0.7 
ppPabA stPabB 0.077 ± 0.006 3.7 ± 0.6 
ppPabA ecPabB 0.124 ± 0.010 10.3 ± 0.2 
ppPabA bsPabB 0.129 ± 0.005 12.6 ± 1.4 
smPabA --- 0.007 ± 0.002 --- 
smPabA stTrpEx 0.007 ± 0.001 0.9 ± 0.1 
smPabA ecTrpEx 0.008 ± 0.001 0.8 ± 0.1 
smPabA smTrpEx 0.008 ± 0.001 0.9 ± 0.1 
smPabA ppTrpE 0.059 ± 0.003 10.0 ± 1.7 
smPabA ssTrpE 0.159 ± 0.015 16.6 ± 0.4 
smPabA ppPabB 0.054 ± 0.005 11.0 ± 2.1 
smPabA stPabB 0.117 ± 0.003 20.0 ± 4.9 
smPabA ecPabB 0.126 ± 0.006 24.4 ± 8.4 
smPabA bsPabB 0.199 ± 0.012 30.5 ± 4.1 
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Glutaminase Synthase kapp /s-1 fStim 
ecPabA --- 0.004 ± 0.001 --- 
ecPabA stTrpEx 0.010 ± 0.001 3.6 ± 0.2 
ecPabA ecTrpEx 0.005 ± 0.001 1.8 ± 0.2 
ecPabA smTrpEx 0.007 ± 0.001 2.2 ± 0.1 
ecPabA ppTrpE 0.043 ± 0.007 17.5 ± 4.6 
ecPabA ssTrpE 0.176 ± 0.008 47.1 ± 5.6 
ecPabA ppPabB 0.042 ± 0.001 13.8 ± 2.4 
ecPabA stPabB 0.069 ± 0.013 14.2 ± 1.7 
ecPabA ecPabB 0.093 ± 0.003 41.1 ± 8.5 
ecPabA bsPabB 0.219 ± 0.022 55.9 ± 12.1 
bsPabA --- 0.003 ± 0.001 --- 
bsPabA stTrpEx 0.003 ± 0.001 1.3 ± 0.1 
bsPabA ecTrpEx 0.002 ± 0.001 1.1 ± 0.1 
bsPabA smTrpEx 0.003 ± 0.001 1.1 ± 0.1 
bsPabA ppTrpE 0.033 ± 0.002 10.1 ± 0.6 
bsPabA ssTrpE 0.217 ± 0.017 67.5 ± 2.5 
bsPabA ppPabB 0.016 ± 0.001 8.6 ± 0.5 
bsPabA stPabB 0.011 ± 0.002 3.8 ± 1.4 
bsPabA ecPabB 0.013 ± 0.003 3.8 ± 1.3 
bsPabA bsPabB 0.073 ± 0.005 20.9 ± 2.0 
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Table S9. Related to Table 1: Mass spectrometric characterization of interactions between 
stTrpEx/stTrpEx_Δ synthases and stTrpG/ppPabA glutaminases. The apparent molecular weight 
(MWapp) was determined from m/z values and is given with standard deviations. The calculated molecular 
weight (MWcalc) derives from the amino-acid sequence and was determined via Expasy ProtParam. 
Obtained molecular weights are consistent with the expected molecular weights. 
Synthase Glutaminase MWapp /kDa MWcalc /kDa Percentage 
Error 
Deduced Oligomeric 
State 
stTrpEx stTrpG 
160727 ± 29 
122026 ± 330 
58235 ± 78 
160136 
116306 
58153 
<1% 
5% 
<1% 
Ex2:G2 tetramer 
Ex2 dimer 
Ex monomer 
stTrpEx ppPabA 
116768 ± 102 
58235 ± 78 
22727 ± 0 
116306 
58153 
22734 
<1% 
<1% 
<1% 
Ex2 dimer 
Ex monomer 
A monomer 
stTrpEx_Δ stTrpG 
160866 ± 77 
58409 ± 130 
43791 ± 32 
21784 ± 2 
159112 
57641 
43830 
21915 
<1% 
1.3% 
<1% 
<1% 
Ex_Δ2:G2 tetramer 
Ex_Δ monomer 
G2 dimer 
G monomer 
stTrpEx_Δ ppPabA 
162033 ± 32 
81043 ± 22 
58210 ± 82 
22753 ± 12 
160750 
80375 
57641 
22734 
<1% 
<1% 
<1% 
<1% 
Ex_Δ2:A2 tetramer 
Ex_Δ: A dimer 
Ex_Δ monomer 
A monomer 
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Table S10. Related to Table 2: Mass spectrometric characterization of interactions between ppPabA* 
and TrpEx, TrpE, and PabB, respectively. The apparent molecular weight (MWapp) was determined from 
m/z values and is given with standard deviations. The calculated molecular weight (MWcalc) derives from 
the amino-acid sequence and was determined via Expasy ProtParam. Obtained molecular weights are 
consistent with the expected molecular weights. 
Synthase Glutaminase MWapp /kDa MWcalc /kDa Percentage 
Error 
Deduced Oligomeric 
State 
stTrpEx ppPabA* 
162612 ± 30 
81143 ± 51 
45708 ± 35 
22843 ± 0 
161794 
80897 
45488 
22744 
<1% 
<1% 
<1% 
<1% 
Ex2:A2 tetramer 
Ex:A dimer 
A2 dimer 
A monomer 
ecTrpEx ppPabA* 
163392 ± 51881
530 ± 47454568
8 ± 1 
22843 ± 0 
162606 
81303 
45488 
22744 
<1% 
<1% 
<1% 
<1% 
Ex2:A2 tetramer 
Ex:A dimer 
A2 dimer 
A monomer 
smTrpEx ppPabA* 
162751 ± 37881
394 ± 31 
45688± 1 
22843 ± 1 
161946 
80973 
45488 
22744 
<1% 
<1% 
<1% 
<1% 
Ex2:A2 tetramer 
Ex:A dimer 
A2 dimer 
A monomer 
ppTrpE ppPabA* 
158485 ± 177 
135377 ± 94 
112410 ± 62 
45825 ± 80 
22843 ± 0 
155950 
133226 
110482 
45488 
22744 
1.6% 
1.5% 
1.7% 
<1% 
<1% 
E2:A2 tetramer 
E2:A trimer 
E2 dimer 
A2 dimer 
A monomer 
ppPabB ppPabA* 
73365 ± 62 
50399 ± 67 
45750 ± 81 
22843 ± 0 
72949 
50205 
45488 
22744 
<1% 
<1% 
<1% 
<1% 
A:B dimer 
B monomer 
A2 dimer 
A monomer 
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Supplementary Figures 
 
 
 
Figure S1. Related to Figure 1. 
Example histograms resulting from the mapping of insertions in PW(SU, H). 
A) Exemplary histograms used to identify insertions in subunits SU of the reference complexes with PDB IDs 1i1q 
(chain A), 1h32 (chain B), and 2grx (chain A). Above the first histogram, a schematic representation of five 
alignments PW(SU, H1-5) with insertions (boxes) in SU is shown. The number of total alignments computed (Tot.) as 
well as the number and proportion of alignments selected for generating the histograms (Sel.) is given on the right of 
each panel. hist(k) specifies for each residue position k of SU how often it is part of an insertion with a length of at 
least eight residues. Black lines represent raw counts; green lines represent data corrected for potential noise. Note 
that corrected data can sometimes contain artifacts (compare panel 1i1q:A) that were not considered for further 
evaluation. The dashed horizontal line represents the detection cut-off of 0.2 ·  max_hist. B) Exemplary histograms 
used to identify insertion in InterPro homologs H of the subunits SU of the reference complexes with PDB IDs 3clr 
(chain D), 1wdk (chain C), and 3aeq (chain B). Above the first histogram, a schematic representation of five 
alignments PW(SU, H1-5) with insertions (boxes) in H1-H5 is shown. The histograms were generated analogously to 
those described in panel A with the exception that hist(k) specifies for each residue position k of SU how often it is the 
start of an insertion with a length of at least eight residues in H. The mean length of the insertions is given by the 
cyan-magenta color gradient. The dashed horizontal line represents the detection cut-off of 0.5 · max_hist. 
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Figure S2. Related to Figure 3. 
Sequence similarity network of the “anthranilate synthase component I-like” InterPro family (IPR019999) 
generated with an E-value cut-off of 1E-77. 
Nodes are colored according to the functional annotation of InterPro. Grey nodes represent sequences with ambiguous 
annotation. Nodes represent a single sequence or groups of sequences with greater than 75% median sequence 
identity. Edges correspond to bi-directional BLAST hits with E-values lower than 1E-77 (median sequence identities 
greater than 37%). In addition to TrpE and PabB, this InterPro family includes few sequences that represent 
isochorismate synthases and salicylate synthases; both homologs of TrpE that use water instead of ammonia as a 
nucleophile and that are part of secondary metabolic biosynthesis pathways of iron-chelating siderophores and 
menaquinone (He et al., 2004; Plach et al., 2015)  
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Figure S3. Related to Figure 4 and Experimental Procedures. 
Schematic description of the computational routine used to determine phylogenetic distributions of the genes 
coding for TrpEx, TrpE, TrpG, PabB, and PabA. 
The species that constitute SSNTrpEx and SSNTrpE  were extracted from the SSN and stored in TaxIDSSNTrpEx  and 
T axID
S SNT rpE  in the form of taxonomy identifiers (TaxIDs). For each species, an individual BLAST-search space was 
generated by linking one TaxID with all NCBI-listed, corresponding protein-related GI numbers, which were retrieved 
from the NCBI-provided gi_taxid_prot_dmp database. This information was stored in the local database taxid2GI_db. 
BLAST searches were conducted with blastp, using PabB and PabA from E. coli as query sequences for synthases 
and glutaminases, respectively. Default search parameters were used, except the argument –gilist, which was used 
to limit the search space to the species-wise TaxID-to-GI mappings stored in taxid2GI_db. TaxID-specific BLAST-
hits with E-values lower than 1E-20 were stored in TaxID
candidatesTrpEx  and T a xIDca n d id a tesT rp E . The sequences were annotated 
as either TrpEx, TrpE, PabB, TrpG, or PabA by comparison with Hidden-Markov-Models (HMMs) using hhsearch 
with default parameters. The five HMMs were parametrized with MSAs composed of verified TrpEx, TrpE, PabB, 
TrpG, and PabA sequences. The selectivity of the assignments was described by log-odds ratio scores ??? . 
Assignments with scores 10klS < were rejected, leading to predictionsTrpEx  and predictionsTrpE . The computational 
routine includes the option for iterative refinement of group-specific HMMs. Filtering out sequencing-bias and 
duplicate entries gave the final datasets 
reprTrpEx  and reprTrpE . 
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Figure S4. Related to Figure 4. 
Distribution of E-values in sequence-to-HMM comparisons for species in TrpExSSN (A) and TrpESSN (B). 
Sequences retrieved from BLAST-searches with the glutaminase PabA from E. coli as a query were compared to 
HMMs representing PabA and TrpG (left panels). Sequences retrieved from BLAST-searches with the synthase PabB 
from E. coli as a query were compared to HMMs representing TrpEx and PabB or TrpE and PabB, respectively (right 
panels). The dashed diagonals indicate the area of assignments with scores ??? ? 10. These assignments were 
rejected. 
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Figure S5. Related to Results. 
HPLC chromatograms of the reaction mixtures of PabB (A) and TrpEx/TrpE (B) with chorismate (CH) and 
ammonium chloride. 
Reaction schemes are given on the right. The aminodeoxychorismate-lyase PabC from E. coli was added to the 
reaction mixtures of the PabB enzymes to convert the PabB product aminodeoxychorismate (ADC) to p-
aminobenzoate (PABA), which could be identified by comparison with a chemical standard. Notably, bsPabB was 
only active when supplemented with its associated glutaminase bsPabA. Aminodeoxyisochorismate (ADIC) is an 
intermediate specific for the bsPabB-catalyzed conversion of chorismate to ADC and was identified based on 
previously reported HPLC analyses of chorismate derivatives (He et al., 2004; He and Toney, 2006). Anthranilate 
(AA) was identified by comparison with a chemical standard. 
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Figure S6. Related to Figure 5A. 
Mass spectrometric characterization of interactions between selected TrpEx, TrpE, and PabB homologs and 
selected TrpG and PabA glutaminases. 
For each combination, a representative mass spectrum and pictograms of complexes and sub-complexes are shown. 
Charges of the most populated charge species are included. The assembly of the TrpEx2:TrpG2 and ppTrpE2:ppPabA2 
tetramers most likely proceeds via dimeric and trimeric intermediates. As it was shown that biophysically 
characterized assembly pathways strongly reflect evolutionary histories of protein complexes (Levy et al., 2008; 
Marsh et al., 2013), we assume that these intermediates are also physiologically relevant. 
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Figure S7. Related to Figure 5C. 
Glutaminase stimulation assay. 
A) Schematic representation of the steady-state glutaminase activity assay. Glutamine is hydrolyzed to glutamate and 
ammonia by the glutaminases. Glutamate, in turn, is deaminated to α-ketoglutarate by glutamate dehydrogenase 
(GDH) with concomitant reduction of NAD+ to NADH. B) Schematic representation of progress curves for the assay 
with TrpG glutaminases (left) and PabA glutaminases (right). After preincubation, glutaminases are added to the assay 
mixture and the progress curve is recorded for at least 15 minutes. Then, synthases are added and the progress curve is 
again monitored for at least 15 minutes. The stimulation factor for a pair of synthase and glutaminase is calculated by 
dividing the apparent turnover rates of the glutaminase-synthase complex (kglut+synt) with that of the glutaminase alone 
(kglut). TrpG glutaminases display no basal glutaminase activity (only kglut+synt available). Therefore, no stimulation 
factor can be calculated. 
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Figure S8. Related to Figure 6 and Table 1. 
Mass spectrometric characterization of interactions between stTrpEx/stTrpEx_Δ synthases and 
stTrpG/ppPabA glutaminases. 
For each combination, a representative spectrum and pictograms of complexes and sub-complexes are shown. Charges 
of the most populated charge species are included. Synthases and glutaminases were mixed equimolarily prior to 
analysis (20 µM each). Apparent molecular weights are provided in Table S9. 
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Figure S9. Related to Table 2. 
Mass spectrometric characterization of interactions between ppPabA* and stTrpEx, ecTrpEx, smTrpEx, 
ppTrpE, and ppPabB. 
For each combination, a representative spectrum and pictograms of complexes and sub-complexes are shown. Charges 
of the most populated charge species are included. 30 µM ppPabA* were mixed with 20 µM of the other proteins 
prior to analysis. Apparent molecular weights are provided in Table  S10. 
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Figure S10. Related to Results and Figure 8. 
Differential regulation of tryptophan and folate biosynthesis in B. subtilis. 
A) Organization of the tryptophan and folate biosynthetic genes within the trp- and folate-operons. The genes coding 
for the components of the tryptophan biosynthetic machinery are grouped in the trp-operon, which itself is part of the 
larger aro-supraoperon (Henner et al., 1985). Notably, the trp-operon does not contain a gene for a glutaminase; 
instead the single PabA glutaminase of B. subtilis is encoded together with PabB in the folate operon that has an 
unusual two-promoter structure (Slock et al., 1990; Yakhnin et al., 2007). B) Mechanisms for the differential 
regulation of tryptophan and folate in B. subtilis and their response to tryptophan starvation or abundance. The central 
player in regulating tryptophan and folate biosynthesis in B. subtilis is the tryptophan-sensing protein TRAP 
(Babitzke, 1997), which binds excessive tryptophan and exercises transcriptional attenuation and translational control 
both on the tryptophan and the folate operon. TRAP is represented as a wheel of 11 identical subunits. In a situation 
where the cell is in need for tryptophan (left-hand side), neither the transcription of the trp-operon, nor the translation 
of trp- and folate-operon transcripts is inhibited by TRAP. In a situation of excess tryptophan (right-hand side), 
activated TRAP binds to a region downstream of the trp-operon promotor which results in the formation of a 
terminator structure and blocks transcription. In addition, the binding of TRAP to the Shine-Dalgarno region of trp-
operon transcripts sequesters this region, thereby blocking translation (Merino et al., 1995). Activated TRAP also 
reduces the levels of PabA, the glutaminase required for tryptophan biosynthesis, by directly blocking ribosome 
binding to the Shine-Dalgarno sequence of pabA transcripts (Babitzke et al., 1994; Du et al., 1997). If biosynthesis of 
folate is required while cellular levels of tryptophan are high, production of the single available glutaminase PabA 
required for folate biosynthesis is unfavorably blocked by TRAP. This situation is resolved by two mechanisms: First, 
evolutionary fine-tuning of binding affinities has led to the circumstance that the binding of TRAP to the pabA-
transcript only reduces translation about 12-fold, whereas translation of trp-operon transcripts is down-regulated by 
about 900-fold (Yakhnin et al., 2007). Second, the additional promoter of the folate-operon, which is located upstream 
of pabB leads to transcripts that contain the coding regions for PabB and PabA (right-hand side, lower part). 
Translation-mediated displacement of TRAP by the ribosome now enables the synthesis of PabB and the glutaminase 
PabA, resulting in the full ADCS complex required for folate biosynthesis (Yakhnin et al., 2007). 
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Figure S11. Related to Figure 8. 
Minimal medium agar plates with colonies grown from different B. subtilis transformants in the absence and 
presence of IPTG. 
B. subtilis cells were transformed with pDG148 plasmids containing the indicated genes and grown at 37 °C for 48 
hours. A) Representative plates with colonies grown in the absence (left column) and presence (right column) of 
2 mM IPTG. B) Representative plates showing the offsetting effect of 10 µg/mL p-aminobenzoic acid (PABA) and 
10 µg/mL folate on bstrpE overexpression. In the presence of PABA or folate colonies grow to the same size as in the 
absence of IPTG. 
  
submitted for publication  
 
 
Figure S12. Related to Experimental Procedures. 
Cross-validation of HMMenz . 
Comparison of randomly selected PabA-sequences from PabAHMM  results in the lowest E-values for PabAHMM  
(top left panel). The distance to the next “best” HMM, in this case TrpGHMM , is around 60 orders of magnitude. The 
same is true for the other four cross-validations, although the E-value distances between the genuine and the improper 
sequence-to-HMM comparisons are somewhat lower for the cases of PabB, TrpEx, and TrpE. This is the result of 
higher sequence identities between these enzymes compared to the sequences identities between PabA and TrpG. 
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